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ABSTRACT 
 
The transmission of the malaria parasite Plasmodium is governed by a complex 
developmental cycle. This PhD thesis describes the transcriptional profiling of the 
rodent malaria parasite Plasmodium berghei developmental migration through its A. 
gambiae vector. The study was conducted in vivo, using a near complete P. berghei 
genome microarray platform. Emphasis was placed on the oocyst stage, as little is 
known about the genes implicated in the ookinete to oocyst transition, and oocyst 
maturation. The data presented here provide novel transcriptional information about 
Plasmodium transmission. The analysis revealed a large shift in gene utilisation as the 
parasite makes its transition from the motile ookinete to the sessile oocyst. 
Furthermore, this work has shown that different sets of co-regulated genes are 
important for early and late oocyst development.  
 
In addition, this PhD thesis outlines the characterisation of a novel Plasmodium 
formin-like protein essential for rodent malaria transmission named the male inherited 
sporulation factor important for transmission (misfit). MISFIT is expressed in the 
early mosquito stages, where the protein localises to the parasite nucleus. Misfit 
exhibits an absolute requirement for paternal inheritance, which is in accordance with 
an observed male-biased expression pattern. pbmisfitΔ ookinetes display significant 
ultrastructural and gene expression defects and fail to complete zygotic meiosis. 
However, pbmisfitΔ ookinetes retain functionality and can successfully cross the 
midgut epithelial barrier. In contrast, mosquito infections with pbmisfitΔ resulted in an 
arrest immediately upon ookinete-oocyst transformation, where defective oocysts fail 
to sporulate. An essential role in chromosome segregation during mitosis / meiosis is 
postulated for MISFIT. In conclusion, the work presented in this thesis has established 
the ookinete-oocyst transition as a major cell cycle check point during malaria 
transmission and identified misfit as the first male inherited Plasmodium gene known 
to affect development post-fertilisation. 
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CHAPTER 1: GENERAL INTRODUCTION  
 
“The screws of my microscope were rusted with sweat from my forehead and hands, 
and its last remaining eye-piece was cracked!” Ronald Ross 
 
1.1  Malaria: An ancient disease and a contemporary global health problem 
1.1.1 Historical aspects and milestone discoveries 
Malaria is an ancient disease, which febrile symptoms were first described in the 
Chinese Canon of Medicine, the Nei Ching, 2700 BC (Oaks S. C. Jr., 1991). The 
causative agents of malaria are protozoan parasites belonging to the phylum 
Apicomplexa in the class of Sporozoa, order Coccidiida, suborder Haemosporidiidae, 
family Plasmodiidae and genus Plasmodium (Bruce-Chwatt, 1987a). Its discovery 
was made in 1880 by Charles Louis Alphonse Laveran, a French army surgeon 
stationed at a military hospital in Algeria. Laveran discovered the parasite by 
microscopic observation of its pigmented granules in the blood and organ lesions of 
patients who suffered or died from malarial symptoms (Bruce-Chwatt, 1987b). 
Laveran also observed the flagellated sexual stage of the parasite in infected blood. 
Based on his observations, Laveran correctly hypothesised that the causative agent 
was a protozoan parasite (http://www.cdc.gov/malaria/history/laveran.htm).  
 
Human malaria is primarily caused by four different Plasmodia spp.; Plasmodium 
falciparum (originally named Oscillaria malariae by Laveran 1880 but renamed by 
William H. Welch in 1897), Plasmodium vivax, and Plasmodium malariae (both 
described in 1890 by Giovanni Batista Grassi and Raimondo Filetti), and finally, 
Plasmodium ovale (reported in 1922 by John W. Watson Stephens), (Bruce-Chwatt, 
1987a), (http://www.cdc.gov/malaria/history/index.htm#ancienthistory). The simian 
malaria parasite Plasmodium knowlesi can also be transmitted to human, and is 
responsible for a considerable proportion of malaria cases, foremost in southeast Asia 
(Cox-Singh and Singh, 2008).  
 
The first link in literature between malarial fevers and their frequent occurrence in 
close proximity to stagnant water and marshes was made by Hippocrates in ancient 
Greece. This connection was also made by the ancient Romans, and the word malaria 
originates from the Italian expression for bad air, mala aria (Oaks S. C. Jr., 1991). 
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Guided by this notion, many scientists made considerable but futile efforts to isolate 
the causative agent from water and soil samples collected from malarial areas. It 
would take until 1897, when a British military doctor working in India, Ronald Ross, 
was able to demonstrate that the parasite is transmitted between its vertebrate hosts by 
mosquitoes. Ross was strongly influenced by the British parasitologist Patrick 
Manson, and made his ground-breaking discovery by the use of an avian malaria 
model system (http://www.cdc.gov/malaria/history/ross.htm). He was closely 
followed by the Italians, Giovanni Battista Grassi, Amico Bignami, and Guiseppe 
Bastianelli, who in 1898, were the first to document the complete transmission 
(sporogonic) cycle of P. falciparum, P. vivax and P. malariae in Anopheles 
mosquitoes (http://www.cdc.gov/malaria/history/index.htm#ancienthistory).  
 
1.1.2 Disease burden, diagnosis and symptoms 
The latest figure from the World Health Organisation (WHO) estimates an annual 
malaria caseload of 247 million cases world wide, with 86% of cases occurring in 
Africa. The disease caused nearly one million deaths in 2006, out of which 85% were 
in African children under the age of 5 years (Maru Aregawi and Dye, 2008). Pregnant 
women are also of special consideration as placental infections causes anaemia in the 
mother and enhanced risk of premature delivery, low birth-weight and increased 
infant mortality (Miller et al., 2002). The current estimate is of 3.3 billion people to 
currently to be at risk of infection. (Maru Aregawi and Dye, 2008). The majority of 
cases are those of uncomplicated malaria. Nevertheless, malaria associated morbidity 
poses an enormous barrier to socioeconomic development. Malaria related absence 
from school and work significantly hampers economic growth, with a 10% decrease 
in malarial disease directly correlating to an estimated annual economic growth of 
0.3% (Gallup and Sachs, 2001). 
 
Microscopic examination of thick (unfixed drop of blood) and thin (methanol-fixed 
monolayer) blood smears remain the gold standard in malaria diagnosis (Pasvol, 
2005). However, microscopic facilities are scarce in many malaria endemic areas and 
symptom-based diagnosis still dominates in rural regions (Bell et al., 2006). Correct 
symptom-based diagnosis of uncomplicated malaria is difficult due to its non-specific 
symptoms of fever, headache, sweats, chills, rigors (shaking or shivering) and joint 
pain (Bell and Winstanley, 2004). As a result, late and inaccurate diagnosis (false 
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positive and false negative) significantly enhances both malaria and non-malaria 
related mortality (Bell et al., 2006). More cost-effective antibody-based Rapid 
Diagnostic Tests (RDT) are now available, but are yet to find widespread application 
in endemic countries (Bell et al., 2006). 
 
The factors that determine why a proportion of patients develop severe, and 
sometimes fatal, malaria are complex and poorly understood. The clinical outcome of 
any malaria infection is governed by a combination of parasite, host and socio 
geographical factors. Patient age, genetic background, pregnancy, previous exposure 
(as influenced by endemic transmission rates) as well as parasite drug-susceptibility 
and poor clinical management of uncomplicated malaria are important known 
contributing factors (Miller et al., 2002), (Greenwood et al., 1991). Symptoms of 
severe malaria vary with patient age and regional malaria endemicity. Patients with 
severe malaria typically present symptoms ranging from cerebral malaria (manifested 
as an unrousable coma, with children often displaying vomiting and convulsions), 
severe anaemia, metabolic acidosis, respiratory difficulties, renal failure and 
coagulation failure (World Health Organization, 2000, Pasvol, 2005).  
 
1.1.3 Overview of the malaria lifecycle and pathogenesis 
In short, the malaria life cycle consists of a series of intracellular replication events 
alternated by extracellular invasion stages. Its developmental cycle spans across both 
a vertebrate host and a mosquito vector (Figure 1.1). In the vertebrate host, liver stage 
infection is completely asymptomatic (silent) and all malaria associated pathology 
stems from the asexual blood stage (ABS) cycle of invasion and replication 
(Matuschewski, 2006). P. falciparum is responsible for almost all cases of severe 
malaria, while the other three human malaria species typically cause febrile but non-
fatal disease (Pasvol, 2005). The enhanced virulence of P. falciparum is linked to 
several known parasite factors. In contrast to P. vivax, which is restricted to 
reticulocytes (immature red blood cells, RBC), P. falciparum can invade a large 
proportion of circulating RBCs. P. falciparum also displays a great redundancy in its 
invasion pathways and can thereby invade RBCs using different ligand-receptor 
combinations. This is in stark contrast to P. vivax that invades only Duffy blood group 
positive RBCs, which also largely determine its geographical distribution. Together 
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these two factors allows for invasion of a maximum number of RBCs, determining the 
maximum parasitaemia and influencing clinical severity (Miller et al., 2002).  
 
 
Figure 1.1 Overview of the malaria vertebrate lifecycle. The malaria parasite enters a 
vertebrate host by the passive transfer of infective sporozoites from an infected female 
mosquito during uptake of a blood meal. The sporozoite travels through the dermis and 
reaches the blood stream, where they eventually come in contact with the liver. The 
sporozoite actively enters the liver through Kupfer cells, subsequently migrates through 
several hepatocytes and finally arrests intracellularly where it develops into the 
exoerythrocytic schizont. One single schizont generates several thousand merozoites, which 
are released into the blood stream. These merozoites initiate a cycle of RBC invasion and 
intracellular replication. The merozoite enters a RBC by an active process and transforms in 
to the young ring stage that matures into the trophozoite. The trophozoite gives rise to the 
blood-stage schizont, which ruptures to release a new set of merozoites into the bloodstream 
and the asexual cycle continues. A subset of trophozoites escapes the cycle of invasion and 
replication, and transforms into sexual progenitor cells, the male and female gametocytes. The 
gametocytes are essential for transmission and enter the mosquito vector during uptake of an 
infected blood meal by a female mosquito. Information summarised from (Bannister and 
Mitchell, 2003), Figure adapted from (Miller et al., 2002). 
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Another important factor influencing the enhanced pathogenicity of P. falciparum is 
its ability to sequester. P. falciparum modifies the infected RBC surface to allow 
cyto-adherence of gametocytes, trophozoites and schizonts to the endothelium of the 
brain and placenta and the microvasculature of the heart, lung, subcutaneous tissues 
and liver (Figure 1.1). As a consequence, only immature ring-forms are found 
circulating in the host blood stream. This is of great importance as circulating infected 
RBCs are efficiently cleared by destruction in the spleen (Miller et al., 2002),. The 
adherence to a range of different host tissue receptors is mediated by a single parasite 
encoded protein with multiple adhesion domains, the P. falciparum erythrocyte 
membrane protein - 1 (PfEMP1), displayed on the surface of infected RBCs. PfEMP1 
is encoded by the multigene var family comprising of 60 members, which are subject 
to clonal antigenic variation that in turn enables the parasite to evade the host immune 
response and establish chronic malaria infections. PfEMP1 is hence critical for P. 
falciparum pathogenicity.  
 
Sequestration to brain and placenta is likely to contribute to cerebral and placental 
malaria (Weatherall et al., 2002). Furthermore, clumping of infected RBCs and 
rosetting (the binding of uninfected RBCs) often occur in higher frequency in severe 
compared to uncomplicated malaria. However, exactly how adhesion and 
sequestration is linked to clinical pathology is poorly understood. It has been 
proposed that damage to the host endothelium and organs may be caused by 
obstruction to the blood flow and localized or systemic production of pro-
inflammatory cytokines (Heddini, 2002).  
 
1.2 Malaria control and obstacles to eradiction 
Malaria has not always been a disease of the poor tropical regions of the world. 
However, the world-wide malaria eradication campaign that followed the end of the 
Second World War, saw the successful eradication of malaria from many temperate 
zone countries (including the U.S., former Soviet Union and the Mediterranean). A 
significant reduction in disease burden was also achieved in some tropical regions 
(notably parts of South East Asia, South America and India but also some African 
nations), (Mabaso et al., 2004). Malaria differs from many other infectious diseases in 
that the Plasmodia life-cycle is not only dependent upon the vertebrate host but also 
on its mosquito vector, which may be regarded as a second host. This dual-host 
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relationship of the disease adds a layer of complexity to its management, but also 
opens up an additional window for disease control. Malaria control measures can be 
broadly divided into four categories, out of which three are centred on vector control 
(Bruce-Chwatt, 1987c): 
1) Elimination of parasites from the human host. 
2) Mosquito-host contact reduction / bite prevention. 
3) Elimination of adult vector mosquitoes.  
4) Elimination of vector mosquito breeding sites or direct elimination of mosquito 
larvae. 
 
1.2.1 Elimination of parasite from the human host 
1.2.1.1 Anti-malarial drugs 
Anti-malarial drugs have found wide-spread use in both treatment and prevention 
strategies. The latter has mostly been in the form of prophylactic treatment for 
travellers but also for residents of endemic regions, foremost as Intermittent 
Presumptive Therapy (IPT) for pregnant women (White, 2005). Anti-malarial drugs 
can be broadly classified by their parasite subcellular and biochemical targets: food 
vacuole (haem-detoxification), cytoplasm (folate synthesis), mitochondrion (electron 
transport chain) and the chloroplast-like organelle, the apicoplast (protein synthesis), 
(Greenwood et al., 2008). 
 
Quinine is a natural compound extracted from the bark of the Cinchona tree. Quinine 
and its derivatives are effective against the mature trophozoite and inhibit the parasite 
haem-detoxification process. Cytotoxic levels of haem accumulate as a result of 
parasite metabolism of host-derived haemoglobin, which serves as the main amino 
acid source for the intra-erythrocytic parasite. Parasite survival is dependent on 
aggregation of free haem into inert crystalline haemozoin (the pigment observed by 
Laveran in 1880), in the parasite food vacuole (Egan, 2008, Hanscheid et al., 2007). 
Chloroquine (as well as mefloquine, halofantrine and lumefantrine) are synthetic, 
cheaper and more effective alternatives to the natural quinine (Cooper and Magwere, 
2008). The antifolates interfere with the parasite folate synthesis pathway, which 
ultimately inhibits parasite nucleic acid synthesis. This sub-set of drugs includes 
pyrimethamine, proguanil and the sulpha drugs such as sulphadoxine, sulphalene and 
dapsone (Hyde, 2007). The cytochrome b inhibitor atovaquone instead selectively 
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interferes with the parasite electron transport chain and collapses the mitochondrial 
membrane potential, thus blocking parasite respiration. Atovaquone is only licensed 
for use in fixed-dose combination with proguanil and is marketed under the name of 
Malarone® (Hyde, 2007). 
 
A compound that has largely revolutionised anti-malaria drug therapy is the naturally 
derived compound artemisinin, extracted from the shrub Artemesia annua. In contrast 
to quinine, artemisinin has the advantage of being active against all asexual blood 
stages. The clearing of young, circulating ring-stages leads to a more rapid reduction 
in parasitaemia and significantly, blocks parasite maturation and thus prevents 
sequestration. Today artemisinin is largely replaced by its derivatives artesunate and 
artemether, which display greater anti-malarial efficacy and bioavailability. In 
addition, artemisinins display efficacy against the sexual stage gametocytes, which 
may result in transmission-reduction in high transmission areas (White, 2008). The 
biochemical target of artemisinins remains unclear. There is growing evidence for that 
artemisinins might directly interfere with a parasite sarcoplasmic endoplasmic 
reticuclum calcium (SERCA) adenosine triphosphatase (ATP) enzyme, PfATP6, a 
putative calcium transporter. Artemisinin treatment may thereby severely impair 
protein folding and post-translational processing in the parasite endoplasmic 
reticulum (Golenser et al., 2006).  
 
However, malaria chemotherapy is plagued by two significant problems, a lack of 
discovery of new drugs and wide-spread resistance against existing drugs. Drug 
resistance is a major problem, fuelled by patient non-compliance, inappropriate 
dispensing of drugs and misdiagnosis. Chloroquine was the drug of choice after the 
Second World War, but emergence of world-wide resistance in the 1960s has today 
rendered the drug virtually powerless against P. falciparum (Egan and Kaschula, 
2007). Different forms of Artemisinin Combination Therapy (ACT) is currently 
recommended as first-line treatment for all P. falciparum malaria in endemic 
countries, which also has the advantage of reduced treatment time (from seven to 
three days), thus increasing the rate of patient compliance (White, 2008). Current 
malaria chemotherapy is largely artemisinin dependent. There is today no proven 
artemisinin resistance existing in the field. Nevertheless, the lack of alternative drugs 
increases the pressure on artemisinin. In addition, artemisinin and its derivatives are 
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costly to produce, with one course costing 1 USD (compared to 0.2 USD for quinine), 
rendering it unaffordable for many endemic countries (White, 2008). 
 
1.2.1.2 Vaccine prospects 
There is currently no effective malaria vaccine available. There are a number of leads 
emerging, with three conceivable vaccine strategies (Matuschewski, 2006): 
1) Pre-erythrocytic, liver stage vaccines 
2) Erythrocytic, blood-stage vaccines 
3) Transmission blocking, mosquito stage 
 
The targeting of sporozoite-infected hepatocytes is appealing as sporozoite epidermal 
injection (transmission) constitutes a natural bottle-neck. Nevertheless, the vaccine 
has to be 100% effective, as one sporozoite successfully transforming into an exo-
erythrocytic schizont, generates thousands of infective merozoites (Matuschewski, 
2006). Complete (sterile) long-lasting protection using irradiated, live attenuated 
sporozoites has been achieved in both a rodent model (Nussenzweig et al., 1967) and 
human volunteers (Herrington et al., 1991, Hoffman et al., 2002). Live attenuated 
sporozoites remain the gold standard for malaria vaccines.  
 
However, irradiation results in an undefined mixed population of sporozoites, with a 
random selection of mutations. The safety concerns raised by its poor genetic 
definition and instability, together with practical reservations regarding high-
throughput production, preservation and distribution makes irradiated sporozoites 
unpractical as a vaccine (Matuschewski, 2006). Recent developments regarding the 
generation of genetically engineered, live attenuated sporozoites by a defined single 
gene knock-out have re-ignited interest in this field (Mueller et al., 2005b, Mueller et 
al., 2005a, van Dijk et al., 2005). Compared to that of a whole organism vaccine, the 
production and delivery of a potential sub-unit vaccine would be much more cost-
effective. The most promising subunit-vaccine candidate so far is RTS,S. The vaccine 
is based on the S antigen of hepatitis B virus fused to fragments of the sporozoite 
major surface protein (the circumsporozoite protein (CSP)), expressed in 
Saccharomyces cerevisiae and delivered with an adjuvant, AS02A. Although clinical 
trials have showed the vaccine to be well-tolerated, highly immunogenic and 
associated with a reduction in malaria related morbidity, immunity appears to be 
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relatively short-lived and with only partial efficacy (Bojang et al., 2005, Alonso, 
2006).  
 
Sterile immunity against malaria can only be induced artificially by vaccination. 
Nonetheless, semi-immunity can be naturally acquired through continuous malaria 
exposure. Children in high-transmission areas are often resistant to severe malarial 
disease by the time they reach puberty, although infection itself is not prevented. This 
acquired semi-immunity appears to be antibody mediated (Matuschewski, 2007). For 
blood-stage vaccines, two complementary antibody targeting strategies can be 
envisaged; anti-merozoite (anti-parasitic) and anti-cytoadhesion (anti-disease) 
vaccines. Antibody mediated inhibition of merozoite RBC invasion has focused on 
targeting the members of the merozoite surface protein (MSP) family, most notably 
MSP1 but also MSP3. Despite that initially promising results has been obtained, real 
progress has been hampered by the polymorphic nature of MSP1, and more severely, 
the apparent inability of individuals to establish a long-term B-cell memory repertoire 
against MSP members (Matuschewski, 2006).  
 
Natural resistance is associated with the acquisition of protective antibodies against 
the complete PfEMP1 repertoire. Targeting cyto-adherence by anti-PfEMP1 
antibodies could hence protect against severe malaria. The genetic switching between 
different members of the var family severely hampers the development of an effective 
anti-cytoadhesion vaccine. Nonetheless, in contrast to pre-erythrocytic targeting, 
partial protection by any of the two blood-stage strategies may still act so to reduce 
malaria associated mortality and morbidity. There are however fears that partial 
efficacy may result in rapid selection of vaccine resistant strains with enhanced 
virulence (Matuschewski, 2007, Matuschewski and Mueller, 2007). The third 
potential vaccine strategy, transmission blocking vaccines, will be discussed in detail 
in context of malaria transmission biology. 
 
1.2.2 Vector control 
1.2.2.1 Host-mosquito contact reduction 
The use of bednets as a protection against malaria was suggested by Ronald Ross in 
1910, due to the nocturnal feeding pattern of most Anopheline vector species (Pates 
and Curtis, 2005). Today insecticide treated nets (ITN) impregnated with pyrethroids 
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are an important tool in malaria control, with numerous ITN efficacy trials reporting a 
significant reduction in malaria related morbidity and mortality in ITN protected 
cohorts (Takken, 2002). In comparative trials, treated nets demonstrate several 
significant advantages compared to untreated nets. Pyrethroid treatment reduces the 
risk of mosquitoes entering the net through any gaps or biting through the net. 
Exposure to lethal insecticides also significantly impairs mosquito survival, with 
fewer female mosquitoes surviving until an age at when infective sporozoites are 
formed, thus providing protection to the wider community (Curtis, 1998, Curtis et al., 
2006).  
 
The largest problems currently facing ITN-based malaria control is the low coverage 
of people at risk and the issue of re-treatment (Guyatt and Snow, 2002). Both issues 
are linked to the low socioeconomic status of endemic regions, and are most 
efficiently tackled by programmes which both distribute and re-treat bed-nets free of 
charge (Curtis et al., 2006). Another issue, which has surfaced in relation to ITN is the 
emergence of genetic based pyrethroid resistance and behavioural resistance, such as 
a shift in mosquito nocturnal biting patterns. In addition, the loss of natural malaria 
immunity, acquired as a result of living in high transmission areas, may be 
compromised by ITN campaigns (Curtis et al., 2006, Pates and Curtis, 2005).  
 
1.2.2.2 Destruction of adult vector mosquitoes  
The implementation of large scale indoor residual spraying (IRS) using 
dichlorodiphenyltrichloroethane (DDT) formed the corner-stone of the WHO Global 
Malaria Eradication campaign launched in 1955. It was initiated on the back of the 
hugely successful post-World War II DDT spraying campaigns, which in conjunction 
with chloroquine saw the disappearance of malaria from many temperate and tropical 
low-transmission zones (Sadasivaiah et al., 2007). IRS works on the basis of an 
endophilic (indoor) feeding pattern of many Anopheline females. Following uptake of 
a blood meal, the female mosquito will seek out a resting place within the dwelling. 
Coating the walls of human and animal dwellings with a low concentration of DDT 
causes the female mosquito to be exposed to a lethal dose of insecticide during her 
resting period. As a consequence, IRS leads to a significant reduction in the number 
of females that survive until the time of sporozoite-development and a reduction of 
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total mosquito population numbers (Bruce-Chwatt, 1987c). However, eradication was 
not achieved in the high-transmission tropical zones.  
 
The chief problem hampering the DDT-based IRS campaign was the emergence of 
DDT resistance by the early 1960s, quashing the vision of easily achievable 
eradication and reducing public willingness to fund IRS. The campaign also failed 
largely due to operational, administrative and economic problems in the developing 
nations (Mabaso et al., 2004). The use of DDT has also suffered greatly from negative 
publicity regarding environmental concerns and poorly substantiated (for the low 
concentration of DDT applied during IRS) human health hazard links (Rogan and 
Chen, 2005). Emerging behavioural resistance, with vector females changing feeding 
and / or resting behaviour in response to IRS implementation, may also reduce its 
effectiveness (Pates and Curtis, 2005) 
 
1.2.2.3 Destruction of mosquito breeding sites and larvicidal methods 
Prior to the introduction of DDT, environmental engineering (resulting in draining 
breeding grounds of water) and larvicidal methods such as spreading oil or Paris 
green (copper acetoarsenate) onto the surface of breeding pools were the main 
methods for controlling mosquito vector populations. In addition, biological larvicidal 
methods such as introduction of larvivorous fish (primarily Gambusiaf finis) have 
been successfully implemented. Trials with pathogenic fungi, bacteria and nematodes 
have also been conducted with varying success. The emergence of insecticide 
resistance by adult mosquitoes has lead to a renewed interest in larvicidal based 
control methods (Bruce-Chwatt, 1987c). However, successful application is highly 
dependent on in-depth understanding of regional differences in ecology, population 
dynamics and mosquito behaviour. Any interference with mosquito breeding success 
is also highly amenable to behavioural resistance leading to a change in breeding 
behaviour, rendering the previously successful method useless (Pates and Curtis, 
2005). 
 
1.2.3 Obstacles to eradication  
As outlined above, all current malaria control methods are associated with their 
inherent benefits and limitations. Control methods in both host and vector are severely 
hampered by two interlinked parameters; the availability of few effective compounds 
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and the rapid emergence of resistance to the limited chemical repertoire available 
(Egan and Kaschula, 2007). Importantly, socioeconomic factors and lack of the 
appropriate infrastructure in endemic countries has also greatly prevented eradication 
efforts. In addition, no method should be considered in its isolation. The best outcome 
in terms of malaria control is likely to be achieved by a combination strategy, tailored 
to suit specific regional circumstances (Bruce-Chwatt, 1987c).  
 
In summary, malaria is in essence a both preventable and curable disease. However, 
due to numerous complicating factors, its eradication has not yet been possible. The 
continued loss of over one million human lives annually clearly warrants continued 
funding of malaria research. The rapid emergence of drug and insecticide resistance 
indicate that any long-term strategy for malaria management will require the 
development of novel control methods aimed at interrupting transmission (Miller and 
Greenwood, 2002). 
 
1.3 The study of malarial transmission stages 
1.3.1 Transmission blocking vaccines 
1.3.1.1 The concept of transmission blocking vaccines 
A potential strategy aimed at breaking the cycle of malaria transmission is that of 
Transmission Blocking Vaccines (TBV). The principle of TBV is the vaccination of 
individuals with mosquito-stage parasite proteins, using the human adaptive immune 
response to generate antibodies that are subsequently transferred to the mosquito 
midgut during uptake of a blood meal (Dinglasan and Jacobs-Lorena, 2008). The 
antibodies are targeted so to bind the parasite within the mosquito midgut and thus 
facilitate antibody (and in some cases complement) mediated killing or alternatively, 
interfere with parasite protein function, thereby blocking development and 
consequently abolishing transmission (Saul, 2007). All vaccines aim to diminish the 
prevalence of the targeted pathogen in the host pool, reduce its transmission and 
thereby protect the community from contracting the disease (herd immunity). 
However, in contrast to classical vaccines, the TBV approach does not directly protect 
the immunised individual from contracting the disease. Instead it is an “altruistic 
vaccine”, indirectly protecting individuals in the vaccinated community by reducing 
the number of infection carrying vectors (Dinglasan and Jacobs-Lorena, 2008). 
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1.3.1.2 Transmission blocking targets 
Four Plasmodium protein candidates have been the focus for most of the TBV 
developing efforts (their biological roles, expression and localisation are discussed in 
detail in Chapter 1.3 together with an overview of the Plasmodium transmission cycle 
outlined in Figure 1.3). These fall into two different groups in terms of their 
expression pattern: pre- or post transmission. (Saxena et al., 2007).  
 
Antibodies against two P. falciparum gametocyte expressed proteins Pfs48/45 and 
Pfs230 (present already within the vertebrate host) successfully blocks transmission 
by killing the parasite upon entry into the midgut lumen, when the proteins become 
exposed on the gamete surface as a result of gametocyte activation. However, any real 
progress in development of a Pfs48/45 or Pfs230 based TBV has been hampered by 
difficulties in expressing the proteins in vitro whist retaining a conformation which 
confers the correct immunogenicity (Saul, 2007, Williamson, 2003). 
 
In contrast, Pfs25 and Pfs28 are only expressed and displayed on the parasite surface 
following activation upon entry into the mosquito midgut (not present within the 
vertebrate host apart from low level expression of Pfs25 in mature gametocytes). This 
confers an advantage over blood-stage expressed vaccine candidates. Since they are 
only expressed in the absence of selective pressure from the vertebrate host adaptive 
immune response, Pfs25 and Pfs28 display minimal polymorphisms and immunity is 
thereby not strain-specific (Saxena et al., 2007). A major practical drawback of Pfs25 
and Pfs28 is the high concentration of antibody required to block transmission (Saul, 
2007). Increased immunogenicity may be tackled by improving delivery strategies, 
such as implementation of a heterologous prime boost strategy, where the same 
antigen epitope is delivered by different vaccine vectors at a few weeks apart 
(Dunachie and Hill, 2003). 
 
1.3.1.3 Transmission blocking vaccine strategies 
Another issue associated with TBV is that by the nature of the approach, which 
paradoxically also is one of its strengths, the antigens are never naturally expressed in 
the human host. This has the implication that there is no natural boosting and thereby 
antibody responses may be short-lived. An additional concern is that the efficacy of 
the vaccine will be limited by the proportion of the gametocyte carriers who are 
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immunised in a local transmission area. As a result, a high proportion of carriers must 
be vaccinated and develop a robust immune response in order to achieve adequate 
transmission blocking levels (Saul, 2007, Carter, 2001).  
 
Nevertheless, continued efforts to develop an effective vaccine are well warranted as 
TBV offer many advantages over pre-erythrocytic or blood-stage vaccines. Since 
TBV mediated parasite killing is well defined (antibody or antibody and complement 
mediated killing), simple mosquito membrane feeding assays where gametocytes are 
fed in presence of immunised sera, provides a powerful way of assessing efficacy ex 
vivo without putting immunised individuals at risk of infection. Furthermore, malaria 
transmission is a localized event, with mosquito dispersal ranges within a few 
hundred to a thousand meters. This has the advantage that a relatively small, localised 
vaccination cohort would give rise to a significant reduction in local transmission 
rates. In addition, TBV implementation may prevent the spread of drug and vaccine 
resistance by inhibiting transmission of resistant parasite populations, thereby 
prolonging the life-span of other important malaria control tools (Carter, 2001).  
 
In low transmission zones, a TBV program alone may be enough to completely 
interrupt transmission. In high transmission areas, strategic deployment of TBV as a 
part of a multi-pronged malaria control program could form an important role in 
reducing transmission to a level where eradication may become possible. One 
concrete example is that of a putative TBV component in a future multi-target and 
multi-stage vaccine. Combining a TBV component with a pre-erythrocytic and / or 
blood stage vaccine would not only enhance its transmission blocking potential by 
providing a more robust protection, but would also increase its appeal in endemic 
communities by offering individual protection for the vaccinated cohort (Saul, 2007). 
 
Currently, many more gametocyte or ookinete proteins are under investigation for 
their transmission blocking potential (Pradel, 2007). In addition, it possible to 
envisage the use of mosquito protein targets to raise transmission blocking antibodies. 
These mosquito-derived targets may be those directly binding to the parasite surface, 
thus mediating parasite killing. Or alternatively, may be essential parasite-interaction 
partners so that when access is blocked to these proteins, parasite development is 
inhibited (Dinglasan and Jacobs-Lorena, 2008). In any case, the historical success of 
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vector control highlights the importance of studying transmission and vector-host 
interactions in order to assist the development of successful malaria control methods.  
 
1.3.2 Plasmodium berghei: A rodent malaria transmission model  
The establishment of continuous, in vitro culturing of P. falciparum (Trager and 
Jensen, 1976) has been pivotal for our understanding of malaria. It is fundamental to 
the ongoing dissection of the molecular mechanisms, which underpin basic parasite 
biology, as well as studies of direct clinical relevance. However, work with the human 
pathogen P. falciparum is restricted by its risk to human health. In addition, there is 
no non-primate animal model compatible with P. falciparum (Herrera et al., 2002). 
The strict legal and practical constraints associated with primate research, together 
with the ethical and safety related restrictions regarding human (clinical) trials, have 
lead to the employment of a number of Plasmodium model organisms. These models 
have been hugely important for vaccine, pathogenesis, drug and transmission studies. 
They have also facilitated significant progress in understanding basic parasite biology 
especially that of the less tractable liver and vector stages of the parasite lifecycle.  
 
Different Plasmodia species infect a range of mammals, birds and reptiles. Due to the 
ease of breeding and handling, rodent model systems dominate non-human malaria 
research today. Several natural occurring species of rodent malaria have been 
reported. The best characterized out of these are four lab-adapted West African 
species of murine malaria native to the Thicket rat; Plasmodium berghei, Plasmodium 
chabaudi, Plasmodium yoelii and Plasmodium vinckei (Carlton et al., 2001). The life 
cycles of the mammalian malaria parasites are well conserved and thus validate the 
use of rodent malaria models. The similarity in life-cycle progression is reflected by a 
conservation of genome arrangement, as well as individual gene composition and 
structure. Importantly, this translates to a conservation of house keeping genes, 
biochemistry and parasite stage-specific protein repertoires, including that of surface 
proteins that represent potential vaccine targets (Waters, 2002, Janse and Waters, 
1995). The different murine rodent models are suitable for different aspects of malaria 
research. In contrast to P. berghei, which rapidly causes fatal murine malaria, P. 
chabaudi is able to establish persistent non-lethal murine malaria. P. chabaudi 
thereby offers an opportunity to study drug resistance and antigenic variation (Carlton 
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et al., 2001, Phillips et al., 1997), while P. yoelii is extensively used for exploratory 
vaccine studies (Doolan et al., 1998).  
 
In our laboratory we use P. berghei for the study of the malaria transmission cycle, 
with a specific interest in parasite-vector interactions. P. berghei is an excellent 
malaria transmission model system, which provides efficient and reliable murine and 
mosquito malaria infections. P. berghei allows scientists to handle and manipulate 
malaria infected mosquitoes in the absence of risk of human infection (Sinden, 1996). 
In contrast to P. falciparum, it is also possible to readily in vitro cultivate and purify 
several of the P. berghei vector stages such as the zygote and ookinete (Janse and 
Waters, 1995). In the field, the only known natural vector of P. berghei is Anopheles 
dureni (Boete, 2005). Most Anopheles species for which established laboratory 
colonies exist are part- or completely refractory to P. berghei infection. The species 
which provides the most efficient experimental P. bergehi transmission is Anopheles 
stephensi (Sinden, 1996). Some species of the Anopheles gambiae complex are also 
susceptible to P. berghei infection, although to a much lesser degree. However, A. 
gambiae (sensu stricto) is the principal vector of malaria in Africa (Christophides et 
al., 2004), lending the study of A. gambiae malaria transmission added value.  
 
1.3.3 Genome sequencing and reverse genetics: A gateway to new discoveries 
As whole organism genome sequencing became possible, malaria research entered a 
new era. Today the full genome sequences are available for two human malaria 
parasites P. falciparum (Gardner et al., 2002) and P. vivax (Carlton et al., 2008), the 
vector A. gambiae (Holt et al., 2002) as well as the human host (McPherson et al., 
2001, Venter et al., 2001). In addition, several of the malaria model organisms have 
also been sequenced, with full genome sequences existing for the rodent malaria 
parasites P. berghei (Hall et al., 2005), P. yoelii (Carlton et al., 2002) and P. chabaudi 
(Unpublished work by The Wellcome Trust Sanger Institute and available through 
PlasmoDB), as well as the simian and human malaria parasite P. knowlesi (Pain et al., 
2008). 
 
The availability of Plasmodium genome sequences has not only provided the genomic 
blue-print for each organism, but has also allowed for comparative genomic studies 
and paved the way for functional genomics at the level of the transcriptome and 
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proteome (discussed in more detail in Chapter 3). The P. berghei genome is 
distributed across 14 chromosomes (universal for Plasmodium) and encodes just over 
5,800 putative open reading frames (ORF), with a core of 4,500 genes conserved 
between P. falciparum, P. yoelii and P.berghei (Hall et al., 2005). In common with P. 
falciparum, which exhibits an 81% AT bias, the P. berghei genome is characterised 
by an extreme AT-richness (Carlton et al., 2005). 
 
The establishment of Plasmodium stable transfection technology has enabled 
functional, reverse genetic studies in P. berghei (van Dijk et al., 1995) and P. 
falciparum (Wu et al., 1996). In contrast to P. falciparum, P. berghei transfections 
can be performed with linear DNA constructs. Vector linerisation facilitates the 
permanent integration of the vector into the target loci via double homologous 
recombination at a much shorter time span (2 weeks versus >3 months), than 
experienced during transfection of P. falciparum with circular gene targeting vectors 
that preferentially integrate via single homologous cross over. The increased selection 
time for P. falciparum is due to the preference for episomal replication over 
integration exhibited by circular constructs (Carvalho and Menard, 2004). 
 
Similarly, the development of microarray-based transcription profiling (Dimopoulos 
et al., 2002) and the adaptation of RNA interference (RNAi) to A. gambiae has 
facilitated the functional dissection of the mosquito immune response and its 
interactions with the malaria parasite (Blandin et al., 2002). Together these technical 
advances have facilitated our ever increasing understanding of parasite and vector 
molecular biology, and continue to guide an empirical approach to the identification 
of novel malaria control methods. 
 
1.4 Malaria transmission biology 
1.4.1 Plasmodium sexual development: Gametocytogenesis 
1.4.1.1 A complex set of factors triggers the onset of gametocytogenesis  
Sexual development is essential to malaria transmission. In the infected vertebrate 
host, a sub-set of blood-stage parasites escape the continuous cycle of invasion and 
replication. Within the host these cells mature into the sexually competent gamete-
progenitor cells, the male and female gametocytes.  
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The factors that govern gametocytogenesis are poorly defined (Alano, 2007). The rate 
of gametocytogenesisis is variable and influenced by genetic factors as well as 
environmental stimuli. High parasitaemia, depletion of fresh RBC and the presence of 
chloroquine increases the rate of gametocyte differentiation in P. falciparum in vitro 
cultures (Bruce et al., 1990, Buckling et al., 1999). Worryingly, enhanced 
gametocytaemia and mosquito infectivity in response to chloroquine treatment is 
especially pronounced in chloroquine resistant parasite strains (Hogh et al., 1998). 
The female to male sex ratio is also highly variable, but generally, across Plasmodia a 
female bias is observed. In contrast to the total rate of gametocytogeneis, drug 
treatment does not appear to influence gametocyte sex ratios (Talman et al., 2004b). 
Anaemia, host-derived hormones and the presence of multiple parasite strains in 
mixed infections, all enhance gametocytogenesis and influence sex ratio towards a 
less female biased gametocyte population (Talman et al., 2004a), (Dixon et al., 2008). 
The sex-ratio alteration in response to environmental factors is thought to be 
evolutionarily driven so as to optimise transmission in the short term (Talman et al., 
2004a).  
 
1.4.1.2 Commitment to sexual differentiation  
The asexual blood stages of Plasmodium are haploid and hermaphrodite, with all cells 
having the potential to develop into a female or male gametocyte. The commitment to 
sexual differentiation in P. falciparum occurs one asexual developmental cycle ahead 
of initiation of sexual development. Once the differentiation pathway has been 
initiated, the P. falciparum sexual schizont commits all its merozoite progeny to 
sexual differentiation in the following developmental cycle (Bruce et al., 1990). 
Furthermore, all merozoites deriving from a single sexually committed schizont are 
pre-determined to all develop into male or all female gametocytes (Silvestrini et al., 
2000).  
 
P. berghei and P. falciparum gametocyte development differ in two key aspects; 
gametocyte shape and the time required for maturation. In contrast to the other 
mammalian malaria parasites that reach maturity within a couple of days of 
differentiation, the gametocytes of P. falciparum and its chimpanzee relative 
Plasmodium reichenowi requires 9-12 days until development is complete. For most 
mammalian malaria parasites, young gametocytes closely resemble the trophozoite 
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they originated from. Furthermore, male and female gametocytes remain 
indistinguishable for a large proportion of the time required for gametocyte 
development (Sinden, 1998). For P. berghei, distinct morphological differences 
between male and female gametocytes can be observed by electron microscopy at 24 
hours following initiation of sexual differentiation, which reaches its completion after 
35 hours (Mons, 1986). In contrast, P. falciparum gametocytogenesis can be divided 
into five morphologically distinct stages (stage I-V). While stage I P. falciparum 
gametocytes are also indistinguishable from the trophozoite, from stage II onwards 
they become gradually more elongated in shape. Stage V P. falciparum gametocytes 
display a distinct crescent shape, with its name derived from falciform, the Latin word 
for sickle-shaped (Hawking et al., 1971). 
 
1.4.1.3 Gametocytogenesis and cytoadherence 
Prolonged in vitro cultivation of P. falciparum commonly leads to an inability to 
undergo gametocytogenesis. This is frequently linked to the loss of cytoadherence, 
which in turn is associated with a lack of PfEMP-1 expression (Day et al., 1993, 
Kemp et al., 1992, Alano et al., 1995). The simultaneous loss of both traits has been 
genetically linked to a 0. 3Mb subtelomeric deletion of the right arm of chromosome 
9 (Day et al., 1993, Barnes et al., 1994). The region contains members of the stevor, 
rifin and var (coding for PfEMP-1) gene families that mediate cytoadherence and are 
subject to antigenic variation. This group of genes are believed to facilitate 
gametocyte sequestration (immature P. falciparum gametocytes sequester in the bone 
marrow and spleen and only mature stage V P. falciparum parasites are found in 
circulation) and immunoevasion, and hence provide protection against the host 
immune response during the lengthy gametocyte maturation period of P. falciparum 
(Gardner et al., 2002, Trenholme et al., 2000, Petter et al., 2008, Alano, 2007, 
Smalley et al., 1981). This region also contains another 19 P. falciparum genes, 
including that of an additional protein essential for cytoadherence, the cytoadherence-
linked asexual gene (clag9), (Trenholme et al., 2000) and the P. falciparum gene 
implicated in gametocytogenesis (gig), which targeted deletion results in a significant 
decrease in the number of gametocytes produced (Gardiner et al., 2005). 
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1.4.1.4 Molecular markers of gametocytogenesis 
The identification of genes that governs the onset of gametocytogenesis has been 
hampered by the fact that early stage gametocytes are morphologically 
indistinguishable (by light and electron microscopy) from the asexual stage 
trophozoite they developed from (Sinden, 1982). However, the early gametocyte 
expresses a number of known sexual stage-specific proteins. One of the earliest 
known markers of P. falciparum gametocytogenesis is Pfs16. Its expression is 
initiated shortly after RBC invasion by a sexually committed ring-stage parasite (24 
hours post-invasion) and continues throughout gametocytogenesis and is also found 
on the surface of the female (macro) gamete (Dechering et al., 1997). Pfs16 
expression is regulated at the level of transcriptional initiation (Dechering et al., 
1997), localises to the Parasitophorous Vacuole (PV) of the developing gametocyte 
(Bruce et al., 1994) and its targeted disruption results in a significant decrease in the 
rate of gametocytogenesis (Kongkasuriyachai et al., 2004). Furthermore, the early 
expression pattern of Pfs16 has facilitated the recent development of a Pfs16-GFP 
assay for Fluorescence Activated Cell Sorting Assay (FACS)-based identification of 
early stage, sexually committed parasites (Dixon et al., 2009). Another early marker 
of P. falciparum gametocytogenesis is pfg27, expression of which can be detected 30 
hours following RBC invasion by a sexually committed ring form (Carter et al., 1989, 
Alano et al., 1991). Pfg27 is an extremely abundant protein in stage I and II 
gametocytes, representing as much as 5-10% of the total cellular protein content 
(Lobo et al., 1994), it is distributed across the gametocyte cytoplasm (Lobo et al., 
1994) and is essential to P. falciparum gametocytogenesis (Lobo et al., 1999).  
 
Further progress in the identification of sexual differentiation markers has been made 
by the microarray-based comparison between the gametocyte producing P. falciparum 
clone 3D7 and a gametocyte-deficient clone F12 (obtained by long-term asexual 
passage from 3D7). 117 genes were identified as up-regulated in 3D7 compared to 
F12, all displaying gametocyte-specific expression profiles (Silvestrini et al., 2005). 
Two of these genes, peg-3 and peg-4 (proteins of early gametocyte), were further 
characterised. Peg3 localises to the parasite surface or PV and its expression peaks in 
stage I gametocytes (Silvestrini et al., 2005). Peg3 has also been described as the male 
development gene 1 (mdv-1). In gene disruption experiments, the majority of 
Δpfmdv1/Δpfpeg3 gametocytes arrest at stage I of gametocytogenesis. The lack of 
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MDV-1 / PEG3 affects both female and male gametocytes; however, male 
development appear to be more severely impaired (Furuya et al., 2005). Peg4 
expression is limited to stage II gametocytes and localises to a currently undetermined 
sub-cellular compartment (Silvestrini et al., 2005).  
 
An additional microarray study, comparing the 3D7 gametocyte-producing strain to a 
non-gametocyte producing derivative, identified six additional genes expressed during 
the early stages of gametocyte differentiation, all belonging to a novel subtelomeric 
gene family with a total number of 36 members (Eksi et al., 2005). One of the 
members (Pfg14.748) is expressed already in the sexual schizont prior to release of its 
sexually committed merozoites, while a second member (Pfg14.744,) is expressed 
shortly after RBC invasion in the young sexual ring-stage parasite. Both gene 
products localises to the parasite PV, while only Pfg14.744 is exported to the host 
RBC. The expression of both genes declines in stage II gametocytes, and thus 
constitute two novel markers specific to the elusive, early gametocyte (Eksi et al., 
2005). Overall, the bias for PV localisation of the known early gametocyte proteins, 
presumably reflects the need for the maturing gametocyte to continuously modify its 
host RBC to facilitate its growth, immunoprotection and nutritional requirements 
(Alano, 2007). In P. berghei, a member of the antioxidant enzyme family of 
peroxiredoxins named Tpx-1 (a 2-Cys peroxiredoxin), has been identified as 
important for gametocytogenesis. (Yano et al., 2006)  
 
Sexual development is also associated with a switch in ribosomal RNA (rRNA) gene 
utilisation. The Plasmodium genomes encode four rRNA genes in total, two of A-type 
and two of S-type. Although exact switching mechanisms and timing differ between 
different Plasmodia, generally sexual commitment is linked to a gradual shift from 
the A- to S-type (Waters et al., 1997b). 
 
1.4.1.5 Regulation of sexual stage and sex-specific gene expression  
Its well established that the Plasmodium transcriptional and translational repertoires 
radically change when the parasite enters the sexual differentiation pathway (Florens 
et al., 2002, Hall et al., 2005, Lasonder et al., 2002, Young et al., 2005, Hayward et 
al., 2000). However, the mechanisms of regulation of sexual stage and sex-specific 
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gene expression are poorly understood although in recent years some progress has 
been made.  
 
The identification of SET, a Plasmodia nuclear chromatin remodelling protein, 
revealed a novel mechanism by which a single copy gene can form distinct functions 
during different developmental stages by the control of two different, stage-specific 
promoters (Pace et al., 2006, Pace et al., 1998). In P. falciparum and P. berghei SET 
is transcribed in all asexual and sexual blood stages from a single constitutive 
upstream promoter. During sexual differentiation SET transcriptional regulation is 
modulated by a second promoter (silent in the preceding asexual stages but turned on 
in the sexually committed schizont), which results in the accumulation of SET in the 
nucleus of the male gametocyte (Pace et al., 2006). Pace et al. suggested that this type 
of dual-promoter control may not be specific to SET, but instead a universally 
important mechanism for the male-specific accumulation of single copy gene products 
involved male gametocytogenesis.  
 
Although Plasmodium sexual stage specific gene regulation appear to be governed 
primarily at the transcriptional level (Kumar et al., 2004), post-transcriptional 
modulation is also an important mechanism (Hall et al., 2005, Le Roch et al., 2004). 
The best characterized example is that of the P. berghei surface proteins P28/25. 
Their respective transcripts are abundant in the female gametocyte but remain 
translationally silent until macro-gametogenesis is triggered in the mosquito vector 
(Thompson and Sinden, 1994, Sinden et al., 1987, del Carmen Rodriguez et al., 
2000). The P25/28 protein family is conserved across murine, human and bird 
Plasmodia. The mechanism that underpins post-translational repression in the female 
gametocyte has now been elucidated.  
 
A DDX6-class RNA helicase; development of zygote inhibited (DOZI) localises to 
cytoplasmic bodies in the female P. berghei gametocyte, and strongly co-localises 
with translationally repressed p25 and p28 transcripts (Mair et al., 2006, Khan et al., 
2005). Targeted disruption of dozi completely inhibited development of fertilised 
macrogametes into ookinetes and was associated with a near complete loss of P25 and 
P28 transcripts, as well as a significant reduction (>2 fold) in transcript abundance of 
another 368 genes. Together these data indicate an essential role for DOZI in the 
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storage, repression and stabilisation of a discrete sub-set of transcripts in the 
unfertilised female gametocyte (Mair et al., 2006). More recently, a common U-rich 
region in the 3’ and 5’ Un-Translated Regions (UTR) of a sub-set of translationally 
repressed transcripts in the female was identified and shown to play an essential role 
in mediating translational repression (Braks et al., 2008).  
 
Intriguingly, a study in P. yoelli has identified a potential transcriptional regulator for 
gametocyte translationally repressed genes. The family of high mobility group 
proteins (HMGP) bind DNA, facilitate the recruitment of RNA polymerase and 
influence chromatin remodelling so to promote transcription. The deletion of hmgp2 
in P. yoelli inhibited the transcription of 30 genes, with the majority of affected genes 
transcribed in the gametocyte, but known to be translationally repressed in P. berghei 
until post-fertilisation (Gissot et al., 2008). The wider importance of post-translational 
regulation during Plasmodium sexual development is demonstrated by the expression 
of two P. falciparum PUF-domain containing proteins, Puf1and Puf2, during 
gametocytogenesis (Cui et al., 2002), (Fan et al., 2004). The PUF domain is well-
conserved among eukaryotes and is found in 3’UTR-binding proteins that are known 
to mediate translational repression. 
 
1.4.2 The transition from host to vector: Gametogenesis 
1.4.2.1 Gametocyte biology 
The mature male and female gametocytes are arrested in G0 in the blood stream 
(Sinden, 1998) and measurements of their DNA content demonstrate that they have a 
genome value that is between that of the haploid and diploid (Janse et al., 1986). 
Despite the frequent appearance of a nuclear spindle in maturing gametocytes (Sinden 
and Smalley, 1979), there is no direct evidence of genome replication during 
gametocytogenesis, and the excess of haploid value has been suggested to be a result 
of selective gene amplification (Janse et al., 1986, Janse et al., 1989). During 
maturation, the gametocyte remains within the PV of its host erythrocyte. The most 
significant morphological feature of gametocyte development is the formation of the 
subpellicular membrane vacuole, and the array of transient (stage II-IV of P. 
falciparum gametocytes) subpellicilar microtubules radiating from directly 
underneath it (Pradel, 2007) With maturation, male and female gametocytes become 
distinguishable.  
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The proteomic analysis of purified P. berghei male and female gametocytes revealed 
two highly divergent proteomes, with only 69 proteins shared between the two sexes 
(Khan et al., 2005). The contents of each proteome closely mirrored the fate of the 
male or female gametocytes, which maturation process and roles in fertilisation are 
distinctly different. A total of 36% (236 of 650 proteins) of the male proteome was 
male-specific and was enriched in genes facilitating the male gamete maturation 
process, which requires rapid genome replication and flagellar-based motility. In 
contrast, only 19% of the female genome was female-specific and largely reflected 
the role of the female gamete in the cell growth, protein translation and post-
fertilisation meiosis (Khan et al., 2005). 
 
1.4.2.1.1 The female gametocyte 
The mature female gametocyte is enriched in membrane bound vesicles known as 
osmophilic bodies. The female nucleus remains small in size (Figure 1.2), whilst 
mRNA (a substantial sub-set of which is subject to translational repression), 
mictochndria, apicoplasts and ribosomes accumulate in the cytoplasm. The increased 
ribosome production is accompanied by the development of an extensive endoplasmic 
reticulum (ER) in the female gametocyte (Sinden, 1998). The maturation process of 
the female gametocyte thus is a preparative stage for the large scale protein synthesis 
associated with female gametocyte activation.  
 
1.4.2.1.2 The male gametocyte 
In contrast (despite the absence of genome replication), the male gametocyte nucleus 
enlarges with its genome taking upon a highly organised and aggregated state (Figure 
1.2). The kinetochores of each chromosome are attached, through a nuclear pore, to 
the Microtubule Organising Centre (MTOC) situated on the cytoplasmic face of the 
nuclear envelope. The mature male gametocyte is largely devoid of ER and contains 
few mitochondria, osmophilic bodies and apicoplasts (Sinden, 1998).  
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Figure 1.2 Electron micrographs of female and male gametocytes. Transmission electron 
micrographs of mature (36 hour) male (A) and female (B) P. berghei gametocytes, clearly 
illustrating the difference in nuclear size (N) and number of osmophilic bodies (small arrow) 
between the male and female. The large arrows indicate the existence of a third membrane 
surrounding the male gametocyte. Scanning electron micrograph of an exflagellating P. yoelii 
male gametocyte upon activation (C). Images were adapted from the P. berghei resource 
material on the Leiden Malaria Research Group (LMRG) website (A-B) and from R.E. 
Sinden (C). 
 
1.4.2.2 Gametocyte activation: Gametogenesis 
The sensitivity of gametocytogenesis to environmental factors indicates the existence 
of a parasite signal transduction cascade, ultimately facilitating the transcriptional 
repertoire change coupled with the switch from asexual to sexual development 
(Alano, 2007). The female and male specific proteome analysis of P. berghei 
gametocytes identified 60 protein kinases and 16 protein phosphatases. Out of these, 
ten of each were gametocyte specific, and four of each had one-to-one orthologues in 
P. falciparum (Khan et al., 2005). However, to date the components of such a 
gametocytogenesis-promoting signalling cascade remains unknown. Instead, a 
number of the potential signalling components identified as present in the gametocyte 
have proven to play essential roles during gametogenesis and post-fertilisation 
development (Alano, 2007). As outlined below, this is the case for not only putative 
signalling components, but also for many other proteins expressed in the gametocyte.  
 
Transmission of gametocytes from the blood stream of the vertebrate host to the 
mosquito is facilitated by the uptake of an infected blood meal. Within the bolus of 
the vector the gametocytes encounter a drop in temperature (Sinden and Croll, 1975, 
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Billker et al., 1997), which accompanied by the presence of xanthurenic acid (Billker 
et al., 1998), stimulates activation of gametocytes into gametes (Figure 1.3).  
 
 
Figure 1.3. Plasmodium mosquito transmission cycle. The parasite must complete a 
complex programme of developmental migration through its Anopheline vector. During its 
migration the parasite is subjected to antagonistic as well as agonistic interactions with its 
vector. Adapted from (Vlachou et al., 2006)♣. 
 
Within minutes of activation, the osmophilic bodies disappear from the cytoplasm as 
they are trafficked to the parasite surface and their content is released into the PV. The 
gametocytes round up and emerge from the RBC as the cargo of the osmophilic 
bodies causes the PV and then RBC membrane to break-down and thus releases the 
activated gametocyte into the mosquito midgut (Sinden, 1998, de Koning-Ward et al., 
                                                 
♣ The developmental migration of Plasmodium in mosquitoes (2005) Vlachou, D. Schlegelmilch, T. 
Runn, E., Mendes, A.Kafatos, F. C. Current Opinion Genetic Development 16 (4) 384-91. 
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2008, Sinden, 1982). From this point, male and female gametogenesis is achieved by 
two dramatically different processes. 
 
1.4.2.2.1 Female gametogenesis  
The activated, free female (macro)gamete enlarge in size (<3 fold size increase) in a 
process which occurs in absence of DNA replication (Sinden, 1998). Female 
gametocyte-emergence is a more efficient process compared to that of the male. This 
is linked to the female enrichment of osmophilic bodies (Sinden, 1998). In P. 
falciparum the generation of osmophilic bodies is dependent on the gametocyte 
specific expression of Pfg377 (Alano et al., 1995, de Koning-Ward et al., 2008). 
Disruption of pfg377 significantly inhibits female gamete emergence and as a result 
causes a near complete block in mosquito infectivity, thus demonstrating the essential 
role of osmophilic bodies in macrogamete maturation (de Koning-Ward et al., 2008). 
In P. berghei the orthologue of pfg377 was specifically detected in the female 
gametocyte (Khan et al., 2005), indicating a putative similar role in the rodent model.  
 
Another gene family of gametocyte expressed proteins, which function requires a 
female-specific inheritance, is the P. berghei limulus clotting factor C, Coch-5b2 and 
LglI (LCCL) / lectin adhesive-like protein (lap) family; (lap 1-6 (Claudianos et al., 
2002, Trueman et al., 2004, Raine et al., 2007).  LAP 1 expression has been detected 
in asexual blood stages, gametocytes and in all the mosquito stages. In contrast, 
LAP2, 4 and 6 has only been detected in gametocytes, ookinetes and the oocysts, with 
a an additional hit for LAP6 in the sporozoite (as summarized in (Raine et al., 2007). 
However, a recent study revealed that all six pblap genes are predominantly 
transcribed in the gametocyte, with only residual activity in the oocyst (Lavazec et al., 
2009). Furthermore, three of the members (LAP 1-3) was only detected in female and 
not male gametocytes (Khan et al., 2005). 
 
PbLAP 1-6 has clear orthologues in P. falciparum where the family has been 
described as PfCCP (Delrieu et al., 2002, Pradel et al., 2004). Unfortunately the 
numbering nomenclature of the orthologues is inconsistent between the two species. 
In P. falciparum all six PfCCP proteins are expressed on the surface of male and 
female gametocytes, with expression first detected in stage II gametocytes (Scholz et 
al., 2008). PfCCP expression rapidly declines post-fertilisation (Pradel, 2007). 
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PfCCP1 (PbLAP2), PfCCP2 (PbLAP4) and PfCCP3 (PbLAP1) co-localises to the 
gametocyte PV. Upon gametocyte emergence, the three proteins are partially released 
and gain an extracellular localisation, where they surround the exflagellation centres 
formed during fertilisation (discussed below), (Pradel et al., 2004, Pradel et al., 2006). 
All PfCCP members can be detected on the surface of macro-gametes but not micro-
gametes (Scholz et al., 2008). The expression of the PfCCP members is co-dependent, 
with the loss of one member resulting in the loss of all other family members. Such a 
co-dependency can be explained by the detection of large multi-protein complexes 
with all PfCCP members present (Simon et al., 2009). Intriguingly and as discussed in 
more detail below, the targeted disruption of selected pfccp / pblap members does not 
prevent fertilisation, ookinete formation or oocyst development (Raine et al., 2007, 
Trueman et al., 2004, Claudianos et al., 2002, Pradel et al., 2004, Pradel et al., 2006). 
 
P. falciparum and P. berghei female gametocytes express P47, a protein which upon 
emergence acquires a macrogamete surface location. The role of P47 is unknown. 
Contrastingly, Pfs47 is not essential for malaria transmission, while the female-
specific expression of its P. berghei orthologue is required for successful oocyst 
development (the most common readout for the ability of the parasite to establish 
infection in the vector), (van Schaijk et al., 2006, van Dijk et al., 2001), (A. Waters, 
personal communication). Pfs47 belongs to a conserved family of multi-copy (>2) six 
cysteine (6-Cys) repeat proteins. The family has a total of ten members from which 
eight are closest-pair paralogs, arranged as tandem repeats in the genome. Four of 
these members; Pfs47, Pfs230, Pfs48/45 and PFB0400w are specific to the sexual 
stages (Williamson, 2003, van Schaijk et al., 2006).  
 
Macrogamete maturation is also associated with the translation of a subset of 
translationally repressed mRNA species. In P. berghei P25/28 macrogamete surface 
expression can be detected 2 hours post-activation, an event which is independent of 
fertilisation, although P25/28 later becomes the predominant ookinete surface protein 
and is also expressed in the zygote and ookinete. However, the translation of other 
transcripts, also subject to translational repression in the female gametocyte, appears 
to be delayed until post-fertilisation (Mair et al., 2006). 
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1.4.2.2.2 Male gametogenesis  
In contrast to female gametogenesis, the activated male rapidly replicates it genome to 
that of an octoploid value as it undergoes three subsequent rounds of mitosis, which 
climaxes in the release of eight haploid flagellated microgametes (Sinden, 1998, Janse 
et al., 1986). The nuclear and cell division associated with microgametogensis is 
facilitated by the formation of the axoneme (the cytoskeletal core of the flagellum) 
that upon flagellum activation, pulls the haploid genome into the developing 
microgamete (Sinden, 1998). This dramatic process, termed exflagellation (Figure 
1.2), is regulated by a Ca2+ dependent signalling cascade for which, two P. berghei 
key players have been identified. The calcium dependent protein kinase CDPK4, 
controls the initiation of genome replication upon activation (Billker et al., 2004), 
while a downstream mitogen-activated protein kinase, MAP-2, is known to regulate 
the onset of cytokinesis and release of microgametes (Tewari et al., 2005, Khan et al., 
2005). Cyclic GMP (cGMP) signalling, acting upstream or in parallel with calcium 
signalling also play a crucial role during gametogenesis and male gamete 
exflagellation. Two P. falciparum cGMP signalling components that are essential for 
this process have been characterised to date, a phosphodiesterase (PDE-δ) and a 
cGMP dependent protein kinase (PKG), (McRobert et al., 2008, Taylor et al., 2008).  
 
The low number of osmophilic bodies compared to the female gametocyte has lead to 
the suggestion that microgametes rely on flagella driven motility to exit their 
erythrocyte host (Alano and Billker, 2005). However, the gametocyte expressed 
PF11.1 protein localises to the membrane of the RBC ghost following gamete 
emergence, and has been implicated in gamete release (Scherf et al., 1992). In P. 
berghei, MDV-1 / PEG-3 has very recently been shown to be important for both male 
and female gamete emergence and has been implicated as playing a role in 
destabilising the PV membrane (Ponzi et al., 2009). In contrast to the male 
gametocytogenesis defective phenotype reported in P. falciparum (Furuya et al., 
2005), P. berghei male and female gametocytes develop normally in the absence of 
MDV-1 / PEG-3 (Ponzi et al., 2009, Lal et al., 2008).  
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Exflagellation and subsequent fertilisation involves the generation of exflagellation 
centres, where the emerging male (micro) gametes bind uninfected RBC, infected 
RBC and macrogametes, causing them to cluster around the exflagellating male 
gametocytes. The exflagellation centres is important for the establishment of infection 
in the vector, (Eksi et al., 2006). However, their exact function is not well understood. 
It has been suggested they may play a role in microgamete release or motility through 
the densely packed blood meal (Eksi et al., 2006). The formation of exflagellation 
centres is known to be dependent on sialic acid and glycophorins on the surface of the 
RBCs, and on the P. falciparum microgamete surface protein Pfs230 (Eksi et al., 
2006, Templeton et al., 1998, Eksi et al., 2002). Pfs230 contains seven copies of the 
6-Cys repeat motif and is expressed in the male and female gametocyte, where it 
localises to the gametocyte plasma membrane (Williamson, 2003). During activation 
the full-length form of Pfs230 (360kD) is protolytically processed resulting in two 
cleavage products, which both are retained on the male and female gamete surface 
(Brooks and Williamson, 2000).  
 
1.4.2.3 Fertilisation 
In P. berghei and P. falciparum fertilisation between the male and female gamete is 
dependent on the expression of a second microgamete surface protein of the 6-Cys 
repeat motif family; P48/45, which corresponding gene is the closest-pair paralog of 
P47. Intriguingly, similarly to Pfs230, the function of P48/45 is male-specific despite 
an abundant surface expression in the male and female gametocyte, as well as in 
macro and microgametes. Based on the ΔP48/45 phenotype observed, a role in micro 
to macrogamete adhesion during the initial stages of fertilisation has been proposed 
(van Dijk et al., 2001). Pfs230 and Pfs48/45 exist as a complex on the gametocyte 
surface, this complex is maintained after gamete emergence and appears essential to 
the function of the two proteins (Kumar, 1987, Eksi et al., 2006). More recent data 
shows that at least PfCCp4, but possibly all PfCCp4 proteins, are also present in the 
Pfs230 / Pfs48/45 complex (Scholz et al., 2008, Simon et al., 2009). In contrast to 
Pfs230 and Pfs48/45, PFB0400w, is only expressed in male stage V gametocytes, not 
microgametes, and its role remains unknown (Eksi and Williamson, 2002).  
 
Fertilisation results in the fusion of the plasma membrane of the two cells, with the 
male nucleus and its axoneme entering the macrogamete cytoplasm (Sinden et al., 
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1985). The ability of P. berghei microgametes to fuse with the macrogamete is 
governed by a male-specific microgamete surface protein encoded by the conserved 
male sterility gene hap2 (Liu et al., 2008), also described as the generative cell 
specific 1 (gcs-1) gene (Hirai et al., 2008).  
 
1.4.3 Ookinete biology 
1.4.3.1 Post-fertilisation gene expression and ookinete maturation 
The male and female derived nuclei fuse shortly after fertilisation (Aikawa et al., 
1984). The resulting diploid zygote undergoes meiosis, which occurs in absence of 
nuclear division or cytokinesis (Sinden et al., 1985), and is associated with an increase 
of genome value to that of tetraploid (Janse et al., 1986). DNA replication during this 
meiotic event is regulated by the female-specific expression of two NIMA (never in 
mitosis/Aspergillus) related kinases, Nek2 and Nek4 (Reininger et al., 2005, Khan et 
al., 2005, Reininger et al., 2009). The initially spherical zygote gradually elongates 
and transforms in to the ookinete via the retort stage, characterised by a growing 
apical protrusion.  
 
Within 12-24 hours the zygote has developed into the crescent-shaped mature 
ookinete. This process is associated with the generation of an extensive network of 
subpellicular microtubules lining the inside of the ookinete, and the formation of their 
associated MTOC, the apical polar ring. In parallel, anterior secretory organelles 
known as micronemes are synthesised (Canning and Sinden, 1973). Ookinete 
maturation is accompanied by de novo protein synthesis, some of which transcripts 
are translationally repressed in the female gametocyte and others which transcription 
is ookinete specific (Hall et al., 2005, Mair et al., 2006). Together these events 
facilitate the motility and invasive ability required for the ookinete to escape the bolus 
and traverse the midgut epithelium.  
 
1.4.3.2 Ookinete midgut invasion 
The first barrier encountered by the invading ookinete is the chitin-rich peritrophic 
matrix (Figure 1.3), coating the apical side of the midgut epithelium. Crossing of this 
gel-like matrix is assisted by the expression of a chitinase (CHIT1), (Dessens et al., 
2001).  
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Next, the ookinete must attach to the apical side of the midgut epithelium and gain 
entry to the lumen of the epithelial cells by disrupting the cell membrane (Figure 1.3). 
This process is facilitated by expression of members of a conserved Plasmodium 
perforin like protein (PPLP) family, unified by a signature membrane-attack complex 
and perforin (MACPF)-related domain. The pplp gene family consists of five 
members, out of which the P. berghei ookinete expresses three; pplp3, pplp4 and 
pplp5 (Kaiser et al., 2004, Kadota et al., 2004, Raibaud et al., 2006, Ecker et al., 
2007). Two members, PPLP1 and PPLP3, have been located to the micronemes of 
sporozoites and ookinetes respectively, supporting the secretion of PPLPs during 
parasite cell invasion (Kadota et al., 2004, Kaiser et al., 2004). PPLP5 and PPLP3 
(also described as membrane attack ookinete protein, MAOP) both play essential roles 
in ookinete midgut invasion. A specific role in membrane disruption, potentially by 
pore forming activity, is indicated by the observation that Δpplp3 and Δpplp5 
ookinetes are able to attach to the midgut epithelium but are unable to enter the 
cytoplasm (Ecker et al., 2007, Kadota et al., 2004). 
 
A number of other Plasmodium surface or secreted proteins are also known to 
mediate the invasion process. Among these proteins are the major ookinete surface 
proteins P25 and P28 (previously denoted Pbs21 in P. berghei). The P25/P28 proteins 
are conserved across Plasmodia and encode three or four epidermal growth factor 
(EGF) domains. In eukaryotes, the EGF domain is widespread and EGF containing 
proteins play roles in numerous receptor-ligand interactions (as summarised by 
(Tomas et al., 2001)). In P. berghei single-gene KO of either pb25 or pb28 only 
slightly reduces oocyst numbers. However, ookinetes lacking both P25 and P28 
displayed increased sensitivity to proteases in the mosquito midgut, a significant 
reduction in the ability to traverse the midgut epithelium and reduced ability to 
transform into oocysts. This indicates an important role for P25/P28 in ookinete 
development and midgut invasion, but also demonstrates the functional redundancy of 
P25 and P28 (Tomas et al., 2001).  
 
Another gene subject to DOZI-mediated translational repression in the female 
gametocyte is the von Willebrand factor A domain-related protein (WARP), (Mair et 
al., 2006). In contrast to P25/28, WARP protein expression can only be detected 8 
hours post-fertilisation, with a micronemal localisation in the mature ookinete (Yuda 
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et al., 2001). However, despite its abundance in the ookinete and transmission 
blocking activity using anti-WARP antibodies, WARP is not essential for P. berghei 
transmission (Ecker et al., 2008, Yuda et al., 2001, Li et al., 2004). An additional 
ookinete micronemal protein implicated in ookinete midgut invasion is the secreted 
ookinete adhesive protein (SOAP), (Dessens et al., 2003).  
 
The identification and functional characterisation of ookinete surface or secreted 
proteins has been further expanded by a recent study. Candidates were identified by 
applying expression and localisation based selection filters to a previously published 
P.berghei life-cycle proteomics survey and a dozen gene-specific P. berghei knock-
out (KO) lines were generated (Hall et al., 2005, Ecker et al., 2008). The novel genes 
identified in this study were named putative secreted ookinete proteins (PSOPs). 
PSOP 2, 7 and 9 all play roles in the traversal of the midgut barrier. However, while 
PSOP 7 and 9 are essential for transmission, PSOP2 is not required for infectivity to 
mice. In addition, a marginal reduction in oocyst numbers was detected for Δpbpsop1 
and Δpbpsop12. In contrast, Δpbpsop13, Δpbpsop20, Δetramp11.1 (a member of the 
early transcribed membrane protein family, first described in the PV membrane of 
asexual blood stages), Δasp (aspartyl protease) and Δpiesp15 (parasite infected 
erythrocyte surface protein) all played a non-essential role in ookinete midgut 
invasion or ookinete-oocyst formation (Ecker et al., 2008). 
 
1.4.3.3 Ookinete motility, invasion and micronemal secretion 
In Apicomplexa the molecular machinery required for invasion and motility is tightly 
linked and is conserved across the three invasive zoite stages; the merozoite, the 
sporozoite and the ookinete (Baum et al., 2006b), (Figure 1.4). Universally, the 
Plasmodium motility and invasion machinery is dependent on apical discharge of 
secretory vesicles. 
 
The apical complex of merozoites and sporozoites contain four types of secretory 
vesicles; micronemes, rhoptries, dense granules and exonemes (Baum et al., 2008a). 
In contrast, ookinete motility and invasion appear to be solely dependent on 
micronemal secretion (Li et al., 2004). Microneme vesicles are synthesised in the 
Golgi apparatus (Schrevel et al., 2008). A recent proteomic analysis of P. berghei 
micronemes identified an abundance of proteins carrying the hall-marks of a 
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eukaryotic, regulated secretory pathway (Lal et al., 2009). This finding supports that, 
in accordance with classical eukaryotic vesicle trafficking, the micronemal cargo is 
loaded already in the Golgi apparatus. Furthermore, in P. falciparum merozoites it has 
been shown that AMA-1 pre-loaded vesicles are trafficked along the sub-pelliclular 
microtubules to the apical complex at the merozoite apical pole (Bannister et al., 
2003). Mature, loaded micronemes accumulate in the apical complex of the ookinete 
(Lal et al., 2009) and are released onto the cell surface (membrane-bound cargo) or 
into the environment (luminal cargo), (Li et al., 2004). Secretion may potentially be 
triggered in response to calcium mediated signalling and subsequently facilitate host-
cell entry (Carruthers and Sibley, 1999, Carruthers et al., 1999). 
 
 
 
Figure 1.4. Plasmodium invasive zoite stages. Apical Polar Ring (APR), Inner Membrane 
Complex (IMC). Adapted and simplified from (Baum et al., 2008a). 
 
TRAP (thrombospondin related anonymous protein) is the founding member of the 
TRAP protein family, to which the circumsporozoite and TRAP related protein 
(CTRP) belong to. Targeted disruption of ctrp renders the ookinete non-motile and as 
a consequence completely abolishes P. berghei midgut invasion (Dessens et al., 1999, 
Yuda et al., 1999a). CTRP localises to the micronemes in the ookinete and is thus 
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secreted during invasion to gain a cell surface localisation (Dessens et al., 1999). 
CTRP is synthesised de novo following fertilisation and its transcript can readily be 
detected four hours after parasite uptake into the mosquito midgut (Vlachou et al., 
2004). TRAP is expressed on the surface of sporozoites, and in similarity to Δpbctrp 
ookinetes, Δpbtrap loss of function mutant sporozoites are non-motile and cannot 
enter the salivary glands (Sultan et al., 1997, Kappe et al., 1999). The identification of 
an additional TRAP family member in Plasmodium, the merozoite TRAP homologue 
(MTRAP), highlights the conserved nature of the molecular machinery underpinning 
motility and invasion by the different Plasmodium invasive stages (Baum et al., 
2006b).  
 
Two of the cell signalling molecules involved in ookinete motility have recently been 
identified. The first is another calcium dependent protein kinase, CDPK3, which 
targeted disruption significantly impairs, but does not abolish rodent malaria 
transmission (Ishino et al., 2006, Siden-Kiamos et al., 2006). The second identified 
signalling component is the cGMP signalling molecule guanylate cyclase β (GCβ), 
which is essential for P. berghei transmission (Hirai et al., 2006). The intracellular 
signalling that drives ookinete motility thus appears to be similar to that which 
underpins gametogenesis. With a combination of calcium and cGMP signalling, 
working in parallel or alternatively, concerted processes. The absence of CDPK3 or 
GCβ significantly reduces ookinete motility and thereby its ability to access the 
midgut epithelium, resulting in an arrest on the apical surface of the epithelial barrier.  
 
The force for Plasmodium motility and invasion is generated by an actomyosin motor 
located between the plasma membrane and the Inner Membrane Complex (IMC) at 
the apical end of the parasite (Kappe et al., 2004), (Figure 1.5). The cytoplasmic tail 
of TRAP binds aldolase, a molecule with actin binding properties (Buscaglia et al., 
2003). In parallel, the tail of the myosin component (MyoA) of the actomyosin motor, 
binds the MyoA tail domain-interacting protein (MTIP), which localises to the inner 
membrane complex (Green et al., 2006), (Bergman et al., 2003).  
 
In a simplified model of the gliding motility exhibited by the zoites, transient actin 
scaffolds (Schuler et al., 2005, Schmitz et al., 2005) are captured through aldolase 
binding by the transmembrane-bound members the TRAP family. The extracellular 
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domains of the TRAP proteins also interact with host ligands, providing a link 
between the parasite motility machinery and its substrate in the host. Intracellularly, 
the TRAP-Aldolase-Actin complex binds to MyoA, which in turn interacts with the 
inner membrane complex through MTIP and the gliding associated proteins (GAP) 45 
and 50 (Baum et al., 2006b, Baum et al., 2008a). By passing the transient filamentous 
actin scaffolds back onto another MyoA molecule, the parasite glides forward with a 
“push and grab” mechanism (Schuler and Matuschewski, 2006a). Release from the 
substrate to allow forward movement and subsequent reattachment is orchestrated by 
rhomboid mediated TRAP cleavage (Baum et al., 2008a). 
 
 
 
Figure 1.5. Apicomplexa gliding motility machinery. Details in the main  text Adapted from 
(Baum et al., 2006a). Regulation of actin dynamics and actin polymerisation is discussed in 
Chapter 5.1. 
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As the P. berghei ookinete traverses the mosquito midgut epithelium, it invades 
multiple epithelial cells before it reaches the sub-epithelial space and transforms into 
the oocyst (Figure 1.3). The route though the epithelial barrier is primarily 
intracellular, during which the ookinete glides on the cell membranes in foldings of 
the basolateral domain. During this journey, the ookinete uses three discrete types of 
motility: stationary rotation, translocational spiralling (rotational motility in 
conjunction with directional changes and translocation) and straight-segment motility 
(Vlachou et al., 2004). Navigation across the cytoplasm of the invaded midgut 
epithelial cells is mediated by a protein termed cell-traversal protein for ookinetes and 
sporozoites (CelTos). In P. berghei, Δceltos ookinetes are motile, successfully disrupt 
the midgut epithelial barrier and enter the cell lumen, where they are subsequently 
arrested. Interestingly, the same phenotype is observed for Δceltos sporozoite 
hepatocyte, but not salivary gland, cell traversal (Kariu et al., 2006). 
 
1.4.4 Ookinete interactions with the mosquito midgut epithelium 
1.4.4.1 The mosquito immune response –Antagonistic interactions 
The invading P. berghei ookinete causes substantial damage to the midgut epithelia 
and invaded cells become apoptotic. The process of programmed cell death is 
associated with a loss of microvillus, extensive DNA fragmentation and protrusion of 
the invaded cells towards the midgut lumen. The invaded dying cells are subsequently 
expelled from the epithelium and wound healing mechanisms such as extensive 
lamellipodia crawling by neighbouring cells facilitates the restoration of the epithelial 
barrier (Vlachou et al., 2004, Han et al., 2000), (Figure 1.3).  
 
Parasite numbers are significantly reduced as the ookinete penetrates the midgut 
barrier (Alavi et al., 2003), (Figure 1.6). This bottleneck in parasite development has 
been shown to be at least partly attributed to the mosquito innate immune response. 
Pre-genome sequencing, a limited number of Anopheles genes were known to be 
subject to transcriptional activation during P. berghei midgut invasion. Among the 
first genes to be identified were those encoding the antibacterial peptide defensin, a 
putative Gram-negative bacteria-binding protein (GNBP) and IGALE20, a galactose-
specific lectin (Richman et al., 1997, Dimopoulos et al., 1997). However, RNAi 
knock-down (KD) experiments targeting defensin, revealed that defensin is not a 
major determinant of parasite development in A. gambiae (Blandin et al., 2002). This 
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is in stark contrast to the key parasite antagonists identified following the publication 
of the full A. gambiae genome sequence (Holt et al., 2002, Christophides et al., 2002, 
Dimopoulos et al., 2002).  
 
 
 
Figure 1.6. P. berghei transmission dynamics through its Anopheline vector. Figure gifted 
by G. Christophides. 
 
A member of the leucine rich–repeat immune gene family, LRIM1, and the thioester 
containing complement-like protein TEP1, are major determinants of A. gambiae 
vectorial capacity for P. berghei transmission (Osta et al., 2004, Blandin et al., 2004). 
The KD of LRIM1 or TEP1 results in a significant increase in oocyst numbers. 
Similarly, it restores susceptibility in the genetically-selected refractory strain of A. 
gambiae, L3-5 (Collins et al., 1986) by abolishing its melanotic refractory 
mechanism, which melanise or lyse ookinetes as they complete midgut invasion (Osta 
et al., 2004, Blandin et al., 2004), (G. Christophides personal communication).  
 
Furthermore, TEP1, LRIM1 and a second LRIM family member, LRIM2 (also 
described as APL1), are essential to the immune-mediated refractoriness of the non-
malaria vector species Anopheles quadriannulatus; a conserved mechanism governing 
P. berghei and P. falciparum transmission (Habtewold et al., 2008). TEP1 is 
homologous to the mammalian complement protein 3 (C3) and directly binds the 
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surface of P. berghei ookinetes, thus mediating their killing by lysis via a postulated 
A. gambiae complement-like pathway (Blandin et al., 2004, Blandin et al., 2008). 
Recent data demonstrate that LRIM 1 and 2 exist as a multimeric protein complex in 
the mosquito hemolymph, directly interact with TEP1 and is responsible for TEP1 
activation (Fraiture et al., 2009, Povelones et al., 2009). 
 
It is now known that seven percent of the A. gambiae transcriptome is differentially 
regulated in response to P. berghei midgut invasion. This transcriptional response 
encompasses genes with putative involvement in actin / microtubule cytoskeleton 
dynamics, cell adhesion and extracellular-matrix remodelling, apoptosis and 
immunity. The KD of two genes implicated in the positive regulation of actin 
polymerisation, CIBULOUT and Wilskott-Aldrich syndrome protein (WASP), 
revealed significant anti-parasitic activity during P. berghei midgut invasion (Vlachou 
et al., 2005). Furthermore, the KD effect of WASP is conserved in P. falciparum 
under semi-natural conditions in the field, indicating the existence of a conserved 
actin-based mechanism regulating parasite transmission during midgut invasion 
(Mendes et al., 2008).  
 
Interestingly, the P. berghei ookinete secretes a subtilisin-like serine protease, Sub2, 
during midgut invasion. Sub2 has been postulated to play a role in modifying the host 
cell cytoskeleton as the parasite moves through the midgut epithelia (Han et al., 
2000). It is intriguing to hypothesize that as the ookinete moves through the midgut 
barrier, it is dependent on its ability to modify the host cell cytoskeleton, while 
simultaneously the mosquito utilises the very same cytoskeletal components in its 
immune-mediated protection against the parasite and the subsequent wound-healing 
process.  
 
1.4.4.2  Evading the mosquito immune response –The time bomb theory 
As outlined above, not only refractory and but also susceptible mosquitoes mount an 
anti-parasitic immune response. It is thus an interesting observation that the immune 
response of susceptible mosquitoes is strong enough to severely decimate the parasite 
population at the midgut bottleneck, but does not lead to sterile immunity 
(transmission blockage). Three hypotheses, not necessarily mutually exclusive, have 
been put forward to explain this only partially effective immune response (Han and 
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Barillas-Mury, 2002). Firstly, it is possible that the immune response is actively 
contained by the mosquito so to protect the reproductive fitness of the mosquito, and 
thus the immune attack is curbed at (for the parasite population as a whole) a sub-
lethal level. Secondly, it possible the parasite has developed protective mechanisms 
allowing them to withstand the immune response mounted. Such a notion gains 
support from the enhanced protease sensitivity observed for the pb25/28 double KO 
(Siden-Kiamos et al., 2000). Finally, it has been proposed that the timing of invasion 
and exit may be crucial to parasite survival, as suggested by the Time Bomb model 
(Han et al., 2000).  
 
P. berghei ookinete midgut invasion triggers the transcriptional activation of nitric 
oxide synthase (NOS) in both A. stephensi and A. gambiae. NOS has strong anti-
parasitic activity and parasite survival is linked to the level of active NOS available in 
the midgut (Dimopoulos et al., 1998, Han et al., 2000, Luckhart et al., 1998). The 
Time-Bomb model suggests that since invasion triggers the transcription of NOS, 
extensive cytoskeletal remodelling and the significant morphological changes 
associated with the impending cell death, the ookinete must rapidly traverse and exit 
the increasingly hostile environment of the cell in order to survive. Survival may 
therefore be a matter of timing, with early ookinetes successfully completing the 
migration before “the detonation of the time-bomb” (Han et al., 2000). 
 
1.4.4.3 The ookinete and the mosquito vector: Agonistic interactions 
Nevertheless, the parasite is also dependent on a number of direct or indirect 
molecular interactions with mosquito components (not all belonging to the immune 
system) in order to complete its journey through the vector. This is highlighted by the 
identification of genes that exert a protective effect upon parasite development.  
 
Melanotic encapsulation (melanisation) is a wide spread mechanism of pathogen 
killing and / or disposal in all arthropods, including its insect subphylum. The serine 
protease signalling cascade that drives melanisation is tightly controlled and involves 
the activation of pro-phenoloxdiase (PPO) into its active form, phenoloxidase (PO) by 
PPO activating factors (PPAFs) as well as negative regulators such a serine protease 
inhibitors (serpins), (Cerenius et al., 2008). The KD of an A. gambiae serpin, SRPN2, 
significantly reduces P. berghei oocyst numbers as a result of extensive ookinete 
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melanisation and lysis in the absence of SRPN2 (Michel et al., 2005). In addition, the 
KD of two members of the C-type lectin family, CTL4 or CTLMA2, also results in 
widespread parasite melanisation, which in the case of CTL4 leads to near complete 
refractoriness (Osta et al., 2004). Similarly, the KD of the mosquito apolipophorin 
precursor gene, APOI/II (RFABG) leads to a reduction in P. berghei oocyst formation 
(Vlachou et al., 2005) with the KD effect of APOI/II conserved during P. falciparum 
semi-natural infections (Mendes et al., 2008). In contrast, the KD of a third 
component of the apoplipophorin complex, APOIII, does not affect P. berghei or P. 
falciparum development in susceptible mosquitoes. However, the loss of APOIII 
significantly increases the number of melanised ookinetes in L3-5 mosquitoes, 
indicating an inhibitory regulatory role in melanisation for APOIII (Mendes et al., 
2008).  
 
The observation of that a phage display-derived peptide, salivary gland and midgut 
peptide-1 (SM-1) binds to the apical side of the mosquito midgut epithelium and 
inhibits the invasive ability of P. berghei ookinetes, suggest that the recognition of the 
midgut epithelium is mediated by a specific receptor-ligand interaction (Ghosh et al., 
2001, Ito et al., 2002). However, midgut recognition and binding appears to be a 
complex process, not only mediated by protein-protein, but also putative protein-
carbohydrate and protein-lipid, interactions.  
 
The microvilli on the apical side of the mosquito midgut epithelium is coated by 
oligosaccharides and the addition of glycans or lectins reduces the P. gallinaceum 
ookinetes ability to bind the midgut (Zieler et al., 1999, Zieler et al., 2000). 
Furthermore, monoclonal antibodies to midgut glycans (Dinglasan et al., 2003) and 
lectins (Dinglasan et al., 2007b) blocks or inhibits P. falciparum and P. berghei 
invasion. In line with these observations, P. falciparum ookinetes bind chondroitin 
glycosaminoglycans. This interaction appears to be important for malaria 
transmission, as KD of a peptide-O-xylosyltransferase homolog blocks A. gambiae 
glycosaminoglycan chain synthesis, which reduces midgut chondroitin sulfate levels 
and as a result significantly inhibits P. falciparum ookinete midgut invasion 
(Dinglasan et al., 2007a). Conversely, the introduction of bee venom phospholipase 
A2 (PLA2) by administration in the blood meal or by genetic engineering of 
transgenic A. stephensi PLA2 expressing mosquitoes significantly impairs parasite 
 65
development. This effect has been attributed to the modification of the lipid content of 
midgut epithelial cell membranes by PLA2, thus inhibiting ookinete midgut invasion 
(Moreira et al., 2002, Zieler et al., 2001). 
 
1.4.5 Oocyst development 
1.4.5.1 Ookinete to oocyst transformation 
As the ookinete exits the midgut epithelial cell through its basolateral membrane, it 
encounters the hemolymph (residing in the sub-epithelial space) and the basal lamina. 
The basal lamina supports the midgut epithelial cell layer at its basal side. The known 
components of insect basal lamina are laminin, collagen (IV), entactin and perlecan, 
with evidence for a role of midgut epithelial cells in synthesis of the basal lamina 
components (Nacer et al., 2008b). Intriguingly, it has been suggested that it is the 
actual contact with the basal lamina that acts as the trigger of the ookinete to oocyst 
transformation. Ookinetes injected into the mosquito haemocoel can transform into 
oocysts not only on the basal lamina of the midgut but also on that of the malpighian 
tubules and the fat body (Weathersby, 1954). The same is also true for ookinetes 
injected into the haemocoel of Drosophila melanogaster (Schneider and Shahabuddin, 
2000).  
 
This hypothesis is strengthened by that the KD of mosquito laminin-γ1 (LANB2) 
results in a reduction in oocyst numbers (Arrighi et al., 2005). Furthermore, CTRP 
(Mahairaki et al., 2005), P25 and P28 (Vlachou et al., 2001, Arrighi and Hurd, 2002) 
and SOAP (Dessens et al., 2003) bind mosquito laminin and other components of the 
basal lamina. These proteins, in addition to mediating invasion, have thereby been 
postulated to play a role in the developmental transition between ookinete and oocyst. 
However, the true role of the interaction between the basal-lamina and the 
transforming ookinete remains unsure. Ookinete-oocyst transformation has been 
reported in vitro, in the absence of any basal lamina components. In this system, 
ookinete-oocyst transformation occurs in a two-step process, where the addition of 
bicarbonate to the growth media acts as the trigger, while a defined range of nutrients 
must be present for completion of the transformation (Carter et al., 2007).  
 
No further DNA replication, chromosome segregation or nuclear division occurs until 
the motile ookinete is arrested upon contact with the basal lamina, where it rounds up 
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and transforms into the sessile oocyst (Figure 1.3). The morphological changes 
associated with oocysts transformation results from a loss of the subpellicular 
microtubules, apical complex and pellicle, which characterise the ookinete (Canning 
and Sinden, 1973). An intermediate developmental form, the transforming ookinete 
(took), has recently been reported and studied in vitro. The took develops as a hump is 
formed at the convex outer side of the crescent-shaped ookinete. As transformation 
proceeds, the tetraploid nucleus moves into the newly formed area of the took, and the 
protrusions (former apical and posterior tips) are gradually absorbed. In parallel, the 
ookinete double-membrane pellicle is replaced by the single-membrane plasmalemma 
of the oocyst (Carter et al., 2007).  
 
1.4.5.2 Sporogony: Oocyst development at the ultrastructural level 
With time, the developing oocyst becomes encased in a protinaceous capsule, which 
surrounds its plasmalemma (Sinden and Strong, 1978, Vanderberg and Rhodin, 1967). 
As development progresses, the oocyst nucleus starts to enlarge and becomes 
digitated as it undergoes multiple rounds of endomitosis (Sinden and Strong, 1978). It 
is from this large polyploid nucleus that the haploid sporozoite nuclei originate. In 
parallel to genome replication, the plasmalemma invaginates so to form vacuolated 
structures known as sporoblasts. At the onset of sporozoite formation, nuclear 
divisions occur simultaneous to sporozoites budding off from the sporoblasts, 
ultimately resulting in the mature oocyst which contains thousands of haploid 
sporozoites (Sinden and Strong, 1978, Vanderberg and Rhodin, 1967), (Figure 1.7).  
 
1.4.5.3 Sporogony: Molecular mechanisms of oocyst development 
Despite the comprehensive understanding of Plasmodium sporogonic development at 
an ultrastructural level, the molecular machinery that underpins this process is largely 
unknown. The best characterised gene known to be essential for sporozoite formation 
is csp, which is conserved across Plasmodia. In the maturing oocyst CSP is 
distributed to the plasmalemma, which lines the inner capsule surface. As sporogony 
proceeds, CSP is mobilised into the developing sporoblasts and subsequently localises 
to the outer surface of the sporoblast plasma membrane. CSP remains associated with 
the surface of the budding sporozoites and becomes the main surface protein of 
haemocoel and salivary gland sporozoites, distributed uniformly over the sporozoite 
surface (Nagasawa et al., 1988, Nagasawa et al., 1987).  
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Figure 1.7. Scanning electron micrographs of P. falciparum oocysts. A. gambaie midguts 
infected with six day old oocysts (A). Excystment of sporozoites from day 8 oocysts, arrows 
indicate pores in the cyst wall through which sporozoites egress (B). Immature sporozoites 
attached to sporoblasts (C). Pictures adapted from (Sinden and Strong, 1978). 
 
Targeted disruption of the csp gene in P. berghei blocks the cytokinesis event that 
completes the budding process by which sporozoites are formed. As a result, oocysts 
developing in the absence of CSP are void of sporozoites (Menard et al., 1997). 
Furthermore, CSP function is dependent on its glycosylphosphatidylinositol (GPI) 
anchor. A lack of CSP-GPI sequence, even in presence of additional TM sequence 
conferring membrane localisation, abolishes sporozoite formation (Wang et al., 
2005b). CSP appear to play a direct structural role in sporogony as attenuation of CSP 
expression results in a phenotype which is intermediate to that of the WT and KO 
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(Thathy et al., 2002). A membrane skeleton component, the inner membrane complex 
protein (IMC1α), is also involved in P. berghei sporozoite development. Its targeted 
disruption generates sporozoites of abnormal shape, which display reduced motility 
and infectivity (Khater et al., 2004). 
 
Oocyst development requires the parasite to persist for a minimum of 10-14 day in the 
hostile, immune-rich environment of the haemocoel. The developing oocyst is 
protected by its capsule, or cyst wall. The protein constitution of the cyst wall is 
largely unknown. To date, only one Plasmodium capsule–specific protein has been 
identified. CAP380 is essential to P. berghei transmission, as in its absence, normal 
number of oocysts are formed but are gradually decimated with time (Srinivasan et 
al., 2008). In addition, mosquito-derived laminin is also found on the outer surface 
and within the capsule structure (Nacer et al., 2008b). It has been proposed that the 
ookinete becomes coated in laminin during its passage through the midgut epithelium 
and as it transforms into the oocyst, it continuously incorporates laminin into its 
capsule, which may mask the oocyst from the mosquito immune response (Arrighi et 
al., 2005, Nacer et al., 2008b). This hypothesis is further supported by detection of 
transglutaminase activity in oocysts, which may function in cross-linking mosquito 
and parasite proteins (Adini et al., 2001). 
 
The functional screen of P. berghei predicted surface and secreted proteins also 
identified two genes essential for formation of infective sporozoites. Despite normal 
numbers of oocysts; Δasp and Δpsop13 oocysts largely failed to sporulate and 
displayed a degenerate, abnormal morphology. As a result, transmission to mice was 
abolished. Intriguingly, the KO phenotype of Δasp and Δpsop13 occurs over ten days 
after its expression can be detected in the ookinete, indicating that the phenotype 
observed is a “knock-on effect” of the lack of ASP or PSOP13 at an earlier, pre-
oocyst developmental stage (Ecker et al., 2008).  
 
This disjunction between protein expression and first observable phenotype is 
mirrored by the gametocyte-expressed LAP protein family. The targeted disruption of 
lap1,2,4,5 or 6 also results in parasites able to produce ookinetes and oocysts but 
significantly reduced in their ability to sporulate (Claudianos et al., 2002, Trueman et 
al., 2004, Raine et al., 2007, Ecker et al., 2008). The lack of a pre-oocyst phenotype in 
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the absence of any single LAP family members is not down to functional redundancy, 
since the generation of Δpblap1/2 and Δpblap2/6 double mutants display consistent 
phenotypes to that of the single mutants (Lavazec et al., 2009). Intriguingly, in P. 
falciparum, a loss of PfCCP2 (PbLAP4) or PfCCP3 (PbLAP1) results in normal 
levels of sporozoites but which are unable to enter the salivary glands (Pradel et al., 
2004). In contrast, PfCCP4 (PbLAP6) is not essential for P. falciparum transmission 
(Scholz et al., 2008). The function of the LAP family members, psop13 and asp are to 
date unknown. The temporal distance between protein expression and phenotype 
detection in KO experiments makes functional delineation difficult. However, 
extended genetic-crossing experiments with male and female specific mutant lines in 
P.berghei has revealed an absolute requirement for maternal inheritance of the lap1-
2,4,6, psop13 and asp genes. This suggests that the gene products of these genes may 
provide crucial functions before both the male and female genome becomes available 
for transcription post-fertilisation in the developing zygote (Raine et al., 2007, Ecker 
et al., 2008). 
 
1.4.5.4 Completion of Sporogony: Sporozoite egress 
In the mature oocyst, sporozoites are fully formed but confined within the cyst-wall. 
Sporozoite excystment is an active process (Sinden, 1974), (Figure 1.7). In P. berghei 
the oocyst stage-specific egress cysteine protease (ECP) plays a crucial role in 
sporozoite release (Aly and Matuschewski, 2005). In addition, a region of CSP, 
containing a series of positively charged amino acids, is also necessary for successful 
P. berghei sporozoite egress. When this conserved region, denoted II plus, is 
disrupted, sporozoites are formed but cannot exit the oocyst (Wang et al., 2005a). The 
sporozoites exiting the rupturing oocyst are released into the mosquito haemocoel, 
from where they must make their way to the salivary glands. Salivary gland invasion 
poses another natural bottleneck in parasite development. Only 19% of the 
sporozoites released into the haemocoel invade the salivary glands. Sporozoites that 
fail to invade are rapidly (>8 hours) degraded by the mosquito immune response 
(Hillyer et al., 2007).  
 
It is poorly understood how sporozoite migration to the salivary glands is achieved. 
On the behalf of the parasite, it may be a passive process, mediated solely by  
sporozoites being transported by the circulating haemocoel (Hillyer et al., 2007, 
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Rodriguez and Hernandez-Hernandez Fde, 2004). However, an in vitro study has 
suggested that chemotaxis may play a role in salivary gland location, indicating a 
more active role on behalf of the sporozoite (Akaki and Dvorak, 2005). Thus, whether 
sporozoite motility is necessary for locating the salivary glands is not known. It is 
however an absolute requirement for salivary gland invasion. 
 
1.4.6 The sporozoite’s journey: From mosquito vector to vertebrate host  
1.4.6.1 Motility: An absolute requirement for salivary gland invasion  
At the salivary gland epithelial barrier (Figure 1.3), the sporozoite faces similar 
challenges as the ookinete does at the midgut epithelium. Sporozoite motility, 
epithelial recognition and invasive ability are essential to salivary gland entry.  
 
Together with TRAP, the region II domain of CSP is essential for sporozoite motility 
and salivary gland invasion (Tewari et al., 2002). A recent study reported the 
identification of a third sporozoite surface protein playing an important role in 
motility and invasion; the transmembrane protein S6. Intriguingly, in contrast to CSP 
and TRAP, for which transcription and translation are closely linked, S6 is subject to 
post-transcriptional regulation. Its associated transcript is highly expressed in 
ookinetes and young oocysts, while the S6 protein is not expressed until the mature 
oocyst stage and then gradually accumulates, peaking in salivary gland sporozoites 
(Steinbuechel and Matuschewski, 2009). 
 
1.4.6.2 Salivary gland invasion- Interactions with salivary gland epithelia  
One important difference between salivary gland and midgut invasion is that the 
polarity of the salivary gland epithelial cell is reversed. The sporozoite first 
encounters the basal side of the epithelium, and then traverses from basal to apical 
side of the epithelial cell layer. Also, significantly, the main body of the salivary 
gland epithelial cell is occupied by the secretory cavity, which opens up to the 
salivary ducts of the glands; the ultimate target for the sporozoite (Pinto et al., 2008).  
 
Little is known about vector responses to salivary gland invasion. A proteomic study 
identified five saliva proteins and 122 salivary gland proteins in A. gambiae, 
(including 89 novel proteins). A comparison between uninfected and P. berghei 
infected salivary glands detected only five secreted proteins, which were differentially 
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expressed in response to invasion (Choumet et al., 2007). Similarly, a transcriptomic 
analysis of A. gambiae salivary glands identified 57 differentially regulated genes 
following P. berghei sporozoite invasion (Rosinski-Chupin et al., 2007). A 
significantly smaller sub-set of genes compared to the 7% of total transcriptome found 
to be differentially regulated in response to ookinete midgut invasion (Vlachou et al., 
2005). This is reflected in that, in contrast to ookinete midgut invasion, sporozoite 
invasion does not appear to be harmful since the salivary gland epithelial cells do no 
become apoptotic following invasion (Pimenta et al., 1994).  
 
Few mosquito salivary gland immune factors have been functionally characterised. A 
member of the serpin family, SRPN6, was first identified an an antagonistic marker of 
P. falciparum and P. berghei ookinete midgut invasion (Abraham et al., 2005). 
However, SRPN6 is also upregulated in A. gambiae salivary glands in response to 
sporozoite invasion, where it mediates an anti-parasitic response (Pinto et al., 2008). 
An expansion of the functional characterisation of salivary gland immune responses 
can be expected to further highlight the conserved and divergent immune mechanisms 
of midgut and salivary gland epithelia. 
 
The SM-1 peptide, which inhibits the invasive ability of the ookinete, also blocks 
salivary gland invasion (Ghosh et al., 2001). This implies that the recognition and 
initial binding of the salivary gland and midgut epithelium may be mediated by a 
common receptor-ligand interaction. The salivary gland receptor for SM-1 has been 
identified as the A. gambiae salivary protein, saglin (Okulate et al., 2007, Ghosh et al., 
2009). In addition, the binding of TRAP to saglin was reported, with directed point 
mutations in binding domain A of TRAP completely blocking this interaction. 
Furthermore, KD of A. gambiae saglin resulted in a significant reduction of salivary 
gland invasion. The results thus suggest that TRAP-saglin interaction is crucial for 
sporozoite salivary gland invasion (Ghosh et al., 2009). CSP has also been implicated 
in the binding of salivary gland epithelium (Sidjanski et al., 1997).  
 
A mosquito protein family, which also has been implicated as salivary gland receptors 
for sporozoite invasion, is the salivary gland specific (SGS) proteins. The SGS 
proteins encode putative heparin-binding domains and are highly suphated at their 
tyrosine residues. A total of four members have been detected in A. gambiae. In Aedes 
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aegypti, antibodies against AaSGS1 inhibited Plasmodium gallinaceum (avian 
malaria) sporozoite salivary gland invasion. Putative interactions with CSP and TRAP 
(based on their heparin and sulphoconjugate binding properties) have been postulated 
(Korochkina et al., 2006). Another sporozoite surface protein that is essential for 
salivary gland attachment and / or recognition is a paralogue of the merozoite 
erythrocyte binding ligand, MAEBL. In contrast to TRAP, the targeted disruption of 
MAEBL in P. berghei does not affect motility (Kariu et al., 2002). MAEBL is 
expressed in midgut and salivary gland sporozoites and alternate splicing gives rise to 
two alternative open reading frames (ORFs); one transmembrane-bound form (ORF1) 
and one secreted form (ORF2). Translation of ORF1 dominates in oocyst sporozoites 
and it has been shown that the transmembrane form of MAEBL is essential for 
salivary gland entry (Saenz et al., 2008). Out of four Plasmodium proteins known to 
be essential to salivary gland invasion, three (CSP, MAEBL and TRAP) localise to 
the micronemes of the sporozoite. 
 
1.4.7 Sporozoite maturation: From salivary gland to vertebrate host 
A Suppression Subtractive Hybridisation (SSH) based comparison of P. berghei 
midgut and salivary gland sporozoites identified 30 genes that are upregulated in 
salivary gland (termed UIS genes) compared to oocyst, sporozoites (Matuchewski et 
al. 2002). A more recent microarray study in P. yoelii identified 124 UIS genes and 47 
genes that are upregulated in oocyst sporozoites (UOS) compared to their salivary 
gland progeny (Mikolajczak et al., 2008b). These studies clearly indicate that 
although there are many similarities between invasion of insect and vertebrate cells, 
salivary gland sporozoites must undergo significant developmental changes in order 
to prepare for the final transition between its vector and host. A number of UIS genes 
with crucial roles in hepatocyte infection have now been characterised and are under 
special interest due to their promising potential as targets for the construction of a 
genetically attenuated live sporozoite vaccine (Mueller et al., 2005a, Mueller et al., 
2005b).  
 
The passive transfer of sporozoites to a new vertebrate host through the bite of an 
infected female mosquito completes the transmission cycle. 
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1.5 Project aims 
The aim of this PhD project was to identify genes that are differentially expressed in 
the oocyst and to investigate their role in oocyst development. Of particular interest 
were genes that may be of importance for the transition between the ookinete and 
oocyst. The immature oocyst may be sensitive to mosquito innate immune-responses, 
as the oocyst capsule is not fully formed at this stage. Of special concern was thereby 
identification of Plasmodium genes that may mediate protection against the immune 
system.  
 
The working hypothesis is that genes specifically up or down-regulated during 
Plasmodium oocyst development are likely to be important for oocyst differentiation 
and interaction with its vector. Candidate genes identified through transcriptional 
profiling and proteome mining were taken forward to functional characterisation 
through targeted gene disruption and antibody mediated analysis. The overall goal 
with this project is to increase our understanding of the molecular processes by which 
Plasmodium completes its life cycle in the mosquito vector, but might also identify 
novel targets towards malaria transmission blocking. 
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CHAPTER 2: MATERIAL AND METHODS 
 
“I have failed in finding parasites in mosquitoes fed on malaria patients, but perhaps 
I am not using the proper kind of mosquito.” Ronald Ross 
 
2.1 Bioinformatics 
2.1.1 Plasmodium spp. sequence retrieval and domain prediction 
Plasmodium protein and DNA sequences were primarily retrieved from PlasmoDB 
(http://plasmodb.org/plasmo/), (Bahl et al., 2003). Prior to addition of the P. berghei 
and P. yoelii genomes to PlasmoDB, P. berghei sequences were retrieved from the 
Sanger Institute web interface (http://www.sanger.ac.uk/DataSearch/blast.shmtl) and 
P. yoelii sequences were obtained from Tigr (http://www.tigr.org/tdb/e2k1/pya1/). 
Nucleotide and protein BLAST searches were conducted using the BLASTN and 
BLASTP tools available through PlasmoDB and NCBI 
(http://www.ncbi.nlm.nih.gov/blast/). Confirmation of signal peptide and 
transmembrane predictions were performed using SignalP Server v 3.0 (Bendtsen et 
al., 2004) and ConPred II (Arai et al., 2004). Functional domain predictions were 
confirmed and updated by InterproScan (Quevillon et al., 2005) and SMART 
sequence analysis (Schultz et al., 1998). Nuclear localisation predictions were 
performed utilising the Predict NLS Online tool from the Rost lab (Cokol et al., 
2000).  
 
2.1.2 Sequence alignments 
Multiple sequence alignments were conducted using ClustalW (Thompson et al., 
2002) run through, and visualised by, Bioedit Sequence Alignment Editor v.7.0.5.3 
(Hall, 1999). 
 
2.1.3 MISFIT FH2 phylogenetic analysis 
MISFIT, Formin1 and Formin2 proteins were aligned separately using Probcons, and 
their respective FH2 domains were isolated by removal of any sequence up- and 
down-stream of the predicted FH2 domains. The Formin1 FH2 alignment was then 
aligned with the Formin2 FH2 alignment using the profile alignment feature 
implemented in ClustalW. By the same method, the MISFIT FH2 alignment was 
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added to the Formin1-2 FH2 alignment, and the remaining sequences were 
individually added to the combined alignment. The phylogenetic tree was built from 
this final alignment using ClustalW’s neighbor-joining algorithm, ignoring all gapped 
columns and performing 1000 bootstrap samples (branch lengths indicate 
evolutionary distance).  
 
2.2 Parasite maintenance, cultivation, purification and mosquito infections  
2.2.1 Parasite maintenance 
P. berghei was maintained in Theiler’s Original mice (Harlan, UK) as previously 
described (Sinden et al., 2002). Parasitaemia was monitored by the counting of blood-
stage parasites in air dried, methanol fixed and Giemsa (Fluka) stained thin tail-blood 
smears. Giemsa solution was prepared by a 1:5 dilution in Giemsa buffer (0.7% (w/v) 
anhydrous KH2PO4, 1% (w/v) anhydrous Na2HPO4) and staining was performed for 
15 min at room temperature. Mice were infected by intraperitoneal (IP) injection of 
100-200 μL P. berghei infected blood. For infections where a high parasitaemia / 
gametocytaemia was desirable, reticulocyte proliferation was stimulated by IP 
injection of phenylhydrazinium chloride (PH); (6 mg/mL stock (Sigma) solution in 
Phosphate Buffer Saline (PBS); 10X stock solution of 0.2 M phosphate, 1.5 M NaCl, 
pH 7.4) 2-3 days prior to P. berghei infection. Infected blood for passage or 
experimental use was collected by cardiac puncture (syringe heparinised with 15 U 
heparin per mL of blood, Sigma) on day 3-4 of infection from terminally anesthetised 
mice (intramuscular injection (IM) of 0.05mL / 10g body weight of Rompun (2% 
stock solution, Bayer), Ketastet (100 mg / mL ketamine, Fort Dodge Animal Health 
Ltd.) and Phosphate Buffer Saline (PBS, Sigma) prepared to a ratio of 1:2:3). All 
animal procedures were performed according to UK Home Office project licence 
agreements. Parasite stocks were maintained at -80ºC in 90% v/v Alsever’s solution 
(Sigma) and 10% v/v glycerol, prepared with infected blood at 1:2 ratio of blood to 
freezing solution. For long term storage the samples were transferred to liquid 
nitrogen. Upon thawing the stocks were immediately injected into mice. 
 
2.2.2 Parasite strains 
The parasite strain used for transcriptional profiling by Quantitative Real-Time 
Polymerase Chain Reaction (qRT-PCR) and microarrays was the P. berghei ANKA 
clone 259c12 (referred to as PbGFPcon). The 259c12 clone is a transgenic parasite line 
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in which the expression of enhanced Green Fluorescent Protein (eGFP) is under 
control of native elongation factor-α loci (ef-1α) promoter, resulting in constitutive 
expression of eGFP throughout the parasite lifecycle (Franke-Fayard et al., 2004). For 
the generation of transgenic parasites by targeted gene disruption, a second GFP 
reference line was used, the P. berghei ANKA clone 507 (referred to as Pbc507), 
(Janse et al., 2006a). In similarity with the 259c12 line, eGFP expression is under 
control of the eef-1a promoter and the expression cassette was introduced into the 
genome by homologous crossover into the type D small subunit (dssu) ribosomal 
RNA locus of P. berghei. However, the 259c12 line was generated by using the 
Toxoplasma gondii dihydrofolate reductase-thymidylate synthase (tgdhfr-ts) 
pyrimethamine based selection system (Waters et al., 1997a, Dessens et al., 1999). In 
contrast, the 507 clone was selected for in the absence of a drug resistance marker by 
the use of flow-cytometry (Janse et al., 2006a). This crucial advancement in selection 
technology allows for subsequent gene KO by the use of the established tgdhfr-ts-
pyrimethamine selection system. Consequently it allows for the generation of 
transgenic parasite in a GFP background, assisting phenotypic analysis. For 
generation of targeting constructs by sub-cloning, genomic DNA from the P. berghei 
ANKA 2.34 (Wild-type, WT) clone was used. 
 
2.2.3 Parasite cultivation and purification methodology 
2.2.3.1 Purification of mixed blood-stage parasites 
White blood cells were removed from infected blood by passage over CF11 cellulose-
columns (Whatman) pre-equilibrated with PBS, from which the purified blood was 
collected through elution with PBS. Parasites were harvested by centrifugation at 
1500 g for 10 min prior to 30 min incubation in ice-cold 0.17M NH4Cl (Sigma) to 
facilitate red blood cell lysis. Parasites were subsequently pelleted by 10 min 
centrifugation at 1500 g, supernatant removed and pellet washed in PBS. 
 
2.2.3.2 Ookinete and zygote  in vitro cultivation  
1 mL of infected mouse blood was collected from terminally anesthetised mice with a 
parasitaemia of >10 %. The blood was immediately transferred to a tissue culture 
flask containing 30 mL 80% (v/v) ookinete culture medium (RPMI1640 (Sigma), 
25mM Hepes (Gibco), 2mM L-glutamine (Sigma), 0.2% (w/v) sodium bicarbonate 
(Sigma), 50 U / mL penicillin, 0.05 mg / mL streptomycin (PenStrep; Gibco), 50 mg / 
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mL hypoxanthine (Sigma), 100 μM xanthurenic acid (pH 7.4, Aldridge) and 20% 
(v/v) foetal bovine serum (FBS, Gibco). Cultures were incubated at 19ºC for 8 hours 
for zygote harvest and 24 hours for mature ookinete production.  
 
2.2.3.3 Ookinete and zygote purification 
Ookinete and zygote purifications were facilitated by utilizing sheep anti-mouse IgG 
Dynal Dynabeads (Invitrogen) coated in an anti-P28 mouse monoclonal antibody 
(13.1) as previously described (Siden-Kiamos et al., 2000). All washing and 
separation steps were conducted using a magnetic separation rack (Magna Rack™, 
Invitrogen). Briefly, 13.1 coated Dynabeads were prepared by washing the beads four 
times in PBS prior to incubation with the 13.1 antibody (1/50 in PBS, antibody a kind 
gift by O. Billker) for 30 min at room temperature on a rotating rack. Unbound 
antibody was washed off as above and the 13.1 coated Dynabeads were resuspended 
in PBS (equivalent to the volume of storage buffer the aliquot of beads were 
originally kept in) and stored at 4ºC until use.  
 
Ookinete or zygote cultures were harvested by centrifugation at 500g for 10 min at 
room temperature. The resulting pellets were resuspended in their own supernatant 
prior to addition of 10 μL coated beads followed by 5 min incubation on a rotating 
rack at room temperature. Following 1 min incubation on the Magna Rack™, the 
supernatant was collected. The ookinetes / zygotes bound to the beads were washed 
with 2 mL ookinete medium twice, the wash medium was transferred to the 
supernatant and another 10 μL of 13.1 coated Dynabeads was added. The procedure 
above was subsequently repeated, however, this time discarding the resulting 
supernatant and wash medium. Purifed ookinetes / zygotes were pooled and pelleted 
at 500g for 5 min. A small sub-fraction of the pellets was mixed with 1 μL Foetal Calf 
Serum (FCS, Gibco) smeared onto glass slides, methanol fixed and Giemsa stained 
prior to microscopic observation to check the quality of the preparation. Pellets were 
stored at -20ºC for Western Blot analysis, -80ºC for RT-PCR or directly prepared for 
immunofluorescence assays. 
 
2.2.3.4 Gametocyte purification 
For preparation of pure viable gametocytes, sulphadiazine treatment was used in 
conjunction with Nycodenz (Axis-Shield PoC) density gradient purification as 
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previously described (Billker et al., 2004). In short, P. berghei infected mice 
(parasitaemia ideally <10%) were treated with sulphadiazine (20 mg / L, administered 
in drinking water, Sigma) on day 3 post-passage. Infected blood was collected on day 
5 post-passage and diluted in 5 mL Coelenterazine Loading Buffer (CLB), (20 mM 
Hepes, 20 mM Glucose, 4 mM Sodium bicarbonate, 1 mM EDTA (all chemicals from 
Sigma) and 0.1% bovine albumin serum (BSA, Sigma) prepared in PBS, pH 7.25. 
Following passage over CF11 columns pre-equilibrated with CLB (elution in 5 mL 
CLB) the blood was harvested at 500g for 5 min at room temperature. The resulting 
pellets were resuspended in 3 mL of their own supernatant and loaded onto a 5 mL 
48% Nycodenz gradient cushion (52% CLB v/v and 48% v/v Nycodenz stock solution 
(27.6% w/v Nycodenz (Life Technologies) made up in Nycodenz buffer (5.0 mM 
Tris, 3.0 mM KCl, 0.3 mM EDTA Na2Ca, pH 7.2), (all chemicals from Sigma). 
Following low acceleration and de-acceleration centrifugation at 1000g for 10 min at 
room temperature, purified gametocytes were collected from the gradient interface 
and washed in CLB twice. Gametocytes were then either harvested immediately (non-
activated) or activated by incubation in ookinete culture medium at 19ºC. Gametocyte 
viability was tested before and after purification by microscopic observations of 
exflagellation in ookinete medium. Quality control by Giemsa-staining and sample 
storage were performed as for purified ookinete preparations. 
 
2.2.3.5 Microgamete purification 
Microgamete preparations of high purity were obtained by modifying (A. Talman, 
personal communication) a previously described protocol (Carter and Chen, 1976). P. 
berghei infected mice were treated with Sulphadiazine as described above, infected 
blood was collected day 4-5 post-passage and immediately added to 5 mL ookinete 
medium to stimulate exflagellation. Following 30 min of incubation at 19ºC, the 
infected blood was pelleted by 5 min centrifugation at 500g at room temperature. This 
low centrifugal speed is enough to pellet non-infected RBC and infected RBC but not 
released microgametes, which remain in the supernatant. The pellets were then 
vigorously resuspended in their own supernatants to assist further release of 
microgametes and then centrifuged as previously. The resulting supernatants was 
aliquoted into 1.5 mL Eppendorf tubes and centrifuged at 13 000g for 10 min at 4 ºC. 
At this stage the pellet contains microgametes as well as some macrogamete 
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contamination and is of suitable quality for immunofluorescence assays but not 
Western Blot or Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) based 
assays. For enhanced purity, the pellets were incubated in their own supernatant for 
12 min at r/t to allow microgametes to move out of the pellet into the supernatant. The 
final supernatant was then removed and centrifuged at 20 000g for 10 min at 4 ºC, 
resulting in a small pellet of high-purity microgametes. Quality control by Giemsa-
staining and sample storage were performed as above. 
 
2.2.4 Mosquito infections  
2.2.4.1 Mosquito maintenance and P. berghei mosquito infections 
A. gambiae Yaounde and Anopheles stephensi sda500 were cultivated according to 
standard methods (Sinden, 1997) and were reared and supplied by T. Habtewold and 
K. Baker. Adult (3-6 days post-emergence) A. gambiae or A. stephensi females were 
infected with P. berghei by direct feeding on anaesthetised mice with a parasitaemia 
of 5-10%, with the mice directly placed on net-covered mosquito pots. Alternatively, 
mosquitoes were infected by ookinete membrane feeds. Ookinete culture volumes 
corresponding to 4x105 ookinetes (equivalent to 1600 ookinetes per mosquito as 
mosquitoes feed approximately 2 μL infected blood) were centrifuged for 5 min at 
500 g at room temperature. Pelleted ookinetes were resuspended in 0.5 mL naïve 
blood and the ookinete suspensions were loaded onto membrane feeders heated to 
37ºC and covered in thinly stretched Parafilm (Pechiney Plastic Packaging Company, 
VWR) to allow mosquitoes to probe and access the ookinetes. Mosquitoes were 
allowed to feed for 15-30 minutes in the dark at 19ºC and unfed females were 
removed 48 hours after the blood meal so to not interfere with the quality of infection.  
 
2.2.4.2 Ookinete hemocoel microinjection  
Ookinetes from culture volumes equivalent of 11.6x105 ookinetes (800 ookinetes in 
69nL ookinete medium injected per mosquito) were pelleted by centrifugation at 500 
g for 5 min at room temperature. The resulting pellets were resuspended in 100 μL 
(adjusted depending on hematocrit volume) ookinete medium. 69 nL of the ookinete 
suspensions were injected directly into the haemocoel through the thorax of 1 day old 
A. stephensi mosquitoes using glass capillary needles and the Nanoject II 
microinjection system (Drummond Scientific Company).  
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2.2.4.3 Microinjection of dsRNA for RNAi-mediated mosquito gene silencing 
Double stranded RNA (dsRNA) for RNAi mediated knock-down (KD) of A. gambiae 
CTL4 and LRIM1 were prepared from PCR or plasmid template (Osta et al., 2004) 
using the T7 Megascript kit (Ambion Inc.) according to manufacturer’s instructions. 
69nL of 3 mg / mL of purifed (Qiagen RNAeasy spin column kit) dsRNA was 
injected into the thorax of 1 day old A. gambiae mosqitoes. The injected mosqitoes 
were allowed to recover and were subsequently infected with P. berghei by direct 
feeds at day 5 (Blandin et al., 2002). 
 
2.2.5 Tissue harvesting and sample processing 
2.2.5.1 Mosquito midgut dissections 
P. berghei infected A. stephensi or A. gambiae midguts were dissected in PBS under a 
dissection microscope to remove the carcass, foregut, ovaries and malpighian tubules. 
Midguts were subsequently processed for counting of oocysts / melanised ookinetes, 
imaging or RNA / protein extraction accordingly. 
 
2.2.5.2 Harvest of P. berghei infected midguts for transcriptional analysis 
30 midguts were isolated from P. berghei (PbGFPcon) infected A. gambiae at discrete 
time points, each corresponding to a distinct stage of parasite sexual development. 
The time points investigated were; 1-3 hours (mixed asexual and sexual blood stages), 
22-26 hours (invading ookinetes), 48 hours (ookinete-oocyst transformation), 5 days 
(young oocyst), 10 days (mid-mature oocyst) and 13-15 days (mature oocyst - 
sporozoite release) post-infection. The dissections were performed on ice and the 
tissue was snap-frozen in liquid nitrogen prior to storage at -80ºC.  
 
2.2.5.3 Total RNA extractions 
Immediately upon thawing, tissues or cells were immersed in Trizol® reagent 
(Invitrogen), mechanically homogenised and total RNA was isolated according to 
manufacturer’s instructions under RNAse free conditions. RNA quality was assessed 
by standard gel electrophoresis using a Tris / Borate / EDTA (TBE) buffer (J. 
Sambrook, 2001) and denaturing Loading Buffer II (Ambion). Total RNA amount 
was quantified in 1μL sample volume using the nucleic acid application of 
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NanoDrop® ND-1000 Spectrophotometer (Thermo Scientific). RNA samples were 
stored at -80ºC. 
 
2.2.5.4 Protein sample preparation for Western Blot analysis 
Tissues or cells were immersed in reducing protein loading buffer (J. Sambrook, 
2001), mechanically homogenised, boiled for 5 min, briefly spun down and stored at -
20ºC. 
 
2.2.5.5 Genomic DNA isolation 
P. berghei genomic DNA was prepared from purified mixed blood stage parasites 
using the Promega Wizard Genomic DNA extraction kit according to manufacturer’s 
instructions. 
 
2.3 Transcriptional profiling 
2.3.1 Microarray based transcriptional profiling 
2.3.1.1 Microarray platform 
The P. berghei microarray platform used in this study was manufactured by Agilent in 
collaboration with Dr G. Dimopoulos at John Hopkins Bloomberg School of Public 
Health, Baltimore. The array is a spotted oligonucleotide platform with 21, 444 
features, which contain the representative oligos of 5,361 P. berghei open reading 
frames (ORFs). Each ORF is represented by two unique oligos (sense directionality) 
and with each oligo spotted twice on the array. This corresponds to an approximate 
coverage of 91%, based on the prediction of 5,864 protein encoding genes (Hall et al., 
2005). The platform also carries a number of technical control probes (918 positive 
and 162 negative controls) and 51 Anopheles genes.  
 
2.3.1.2 Experimental design 
2.3.1.2.1 P.berghei developmental arrays 
Cy3-labelled RNA derived from PbGFPcon infected A. gambiae midguts collected at 
six discrete time points (as outlined above) was competitively hybridised against a 
Cy-5 labelled standard-reference in six separate, two-dye hybridisation reactions 
(Figure 2.1).  
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Figure 2.1. Experimental design: Developmental microarrays and qRT-PCR. P. berghei 
infected A. gambiae midguts were collected by dissection at 1 hours, 24 hours, 2 days, 5 days, 
10 days and 13 days post-infection (P.I). All samples were processed for RNA extractions and 
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used for transcriptional profiling using either QRT-PCR or oligonucleotide microararys. For 
microarray based profiling, individual samples were labelled with CTP-Cy3 and were all 
competitively hybridised against a CTP-Cy5 labelled standard reference. 
 
The standard reference was composed of a pool of samples from all six time-points, 
where the individual contribution of each sample was calculated based on the parasite 
numbers present in each time-point sample pool. Parasite numbers were estimated by 
eGFP copy numbers as measured by qRT-PCR and driven by the constitutive  eef1-α 
promoter in the PbGFPcon parasite line (Franke-Fayard et al., 2004).  
 
2.3.1.2.2 P. berghei WT vs. Δpbmisft ookinete arrays 
P. berghei (Pbc507) WT and Δpbmisft ookinetes were cultivated in vitro. Cy-3 
labelled Δpbmisft ookinete RNA was competitively hybridised against Cy-5 labelled 
WT ookinete RNA in a two-dye hybridisation reaction. 
 
2.3.1.3 cRNA labelling 
For each sample pool of 30 midguts, or individual ookinete sample, 2 μg of total RNA 
was utilised for generation of complementary double-stranded cDNA through reverse 
transcription. During cDNA production, poly dT primer and T7 polymerase promoter 
sequences were simultaneously incorporated into the C-terminal end of the cDNA by 
annealing to the poly A+ tail of the mRNA component of the sample. The ds cDNA 
was then used as a template for in vitro transcription of cRNA using T7 RNA 
polymerase, during which process Cy3 or Cy5 labelled CTP (PerkinElmer) was 
incorporated. The full procedure was completed using the Agilent Low RNA Input 
Fluoresence Amplification Kit Protocol according to manufacturer’s instructions. 
Following purification of labelled cRNA via Qiagen RNAeasy purification columns, 
the cRNA concentration and level of dye -incorporation was measured using the 
Microarray application of NanoDrop® ND-1000 Spectrophotometer. Labelled probes 
For the P. berghei developmental arrays, the standard reference was processed in 
parallel to the sample cRNA.  Labelled probes were stored at -80°C in the dark. 
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2.3.1.4 Hybridisations 
1X Control Target solution, 2 μg of Cy3-labelled and 2 μg Cy5-labelled cRNA (10-20 
pg Cy-dye/ μg cRNA) was mixed and subjected to fragmentation by incubation with 
fragmentation buffer at 60ºC for 30 min in the dark. The fragmented probes were 
mixed with 1X Hybridisation solution to a final volume of 80 μL and applied 
underneath a cover slip onto the array. The array was immediately placed in a 
GeneMachine HybChamber™ and incubated at 60ºC for 17 hours in the dark. 
Following hybridisation, slides were washed at room temperature for 1 min in 6X 
SSC and 0.005% Triton X-102, followed by 1 min in 0.1X SSC and 0.005% Triton X-
102. Slides were then immediately dried using compressed air and stored under 
vacuum in the dark. All reagents used for hybridisations and washes were supplied by 
Agilent in the In situ Hybridisation Kit Plus. 
 
2.3.1.5 Image analysis 
Washed and dried arrays were scanned using a Gene-Pix 4000B scanner in 
conjunction with Gene-Pix Pro 4.0 software (Axon instruments). Gene-Pix Pro 4.0 
was also utilised for grid-alignment, recording of spot signal intensity, estimation of 
local backgrounds and the manual inspection of spot quality. The spots were visually 
evaluated based on size, shape and uniformity of signal. 
 
2.3.1.6 Analysis of microarray data 
For all microarray experiments, each hybridisation was performed in triplicate, with 
each replica stemming from three individual biological experiments (i.e. mosquito 
infection time-course or ookinete culture). Arrays were processed as previously 
described (Vlachou et al., 2005). Briefly, subsequent to manual spot inspection, the 
spots were statistically evaluated. For each spot, the average spot diameter was 
calculated and spots which diameter differed by more than three times the standard 
deviation (StDev) were removed. Furthermore, the ratio between spot intensity and 
local and global background intensity (as defined by negative control spots on the 
array) was calculated (Figure 2.2). Only spots which intensity (foreground) exceeded 
the local and global background values (spot intensity > average intensity of negative 
control spots plus one times the StDev) were taken forward for further analysis and 
subjected to normalization in GeneSpring 6.1 (Axon Instruments) by locally weighted 
linear regression method (Lowess) method.  
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Figure 2.2. Procedure for microarray analysis. Following hybridisation and scanning of 
each array, all of the 21, 444 spots on the array undergo visual and statistical validation. Only 
spots which fulfil the appropriate criteria in terms of spot quality and consistency between 
spot duplicates and biological experiments are considered valid for the final global 
transcriptional analysis 
 
Since each P. berghei ORF is represented by two unique oligos (Oligo A and B; 
Figure 2.2), with each oligo spotted twice (Spot 1 and 2; Figure 2.2); the average, P-
value and standard deviation (StDev) were calculated from a pool of 12 spots 
(deriving from three independent biological experiments) for each predicted ORF 
represented on the array. Only ORF exhibiting consistent expression values within the 
pool of representative spots were considered for the final transcriptome analysis. The 
expression value criteria used was that of expression values present in at least 60% of 
all spot replicates, with mean expression values higher than twice the standard 
deviation. Cluster analysis gene expression data was performed by using a 
hierarchical clustering algorithm and was visualised using TreeView (Eisen et al., 
1998). 
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2.3.2 Preparation of qRT-PCR and RT-PCR templates 
2.3.2.1 DNAse treatment 
Total RNA was treated with TurboTMDNase (Ambion Inc.) for 30 min at 37ºC to 
remove residual genomic DNA contamination. Treatment and DNAse inactivation 
was performed according to manufacturer’s instructions. 
 
2.3.2.2 cDNA production 
Reverse transcription of mRNA (1μg total DNAse-treated, RNA) into cDNA was 
performed using a combination of random hexamers and T7 primers (TaqMan reverse 
Transcription Reagents Kit; Applied Biosystems). For each RT-PCR cDNA sample, a 
non-RT reaction control was always produced in parallel. The resulting cDNA was 
stored at -20ºC. 
 
2.3.3 qRT-PCR 
2.3.3.1 Primer sequences for qRT-PCR  
qRT-PCR primers were designed using the web-interface of Primer3 (Rozen, 2000) 
according to the following specifications; optimum primer length 20bp, GC-content 
20-80%, Tm 58-60ºC and an amplicon length of 50-150 bp. Primer concentrations 
were optimised (Table 2.1) and products run on a 2.5% agarose gel to ensure 
specificity 
 
2.3.3.2 qRT-PCR procedure 
Transcriptional profiles of selected genes were generated from the freshly produced 
cDNA by qRT-PCR using gene specific primers (Table 2.1) and the SYBR-Green 
detection and amplification reagent (Applied Biosystems) in conjunction with ABI 
PRISM 7000 sequence detector (Applied Biosystems) as previously described 
(Vlachou et al., 2005). 
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Table 2.1. Primer sequences and optimised concentrations for qRT-PCR. Forward (F), Reverse (R). 
 
Primer  
Name 
Primer 
Description 
 
Primer sequence 5’-3’ 
Primer 
concentration 
GFP-F gfp F  CCT GTC CTT TTA CCA GAC AAC CA 900nM 
GFP-R gfp R GGT CTC TCT TTT CGT TGG GAT CT 200nM 
Pbs21-F pbs21 F AAT GCA CAG GTA CAG GAG AAA CTA AAT 900nM 
Pbs21-R pbs21 R CAC ACT CAT AAT GTT TTC CAG TCA ATT 900nM 
CTRP-F ctrp F TGC AAT GAT GTT TGT GGT GAT TT 900nM 
CFRP-R ctrp R TGG TGA TAC ATT TCT GGT TCT TAT TCT T 50nM 
CSP-F csp F GAATTCGTTAAACAGATCAGGGATAGTA 900nM 
CSP-R csp R TTATACCAGAACCACATGTTACGTTACA 200nM 
ER1F PB300510.00.0 (pdog-1) F 'TGCCGAAGAATTAACGGTTT 200nM 
ER1R PB300510.00.0 (pdog-1) R CGTGCATTAATGTCGATACCA 200nM 
ER2F PB300603.00.0 (pdog-1) F GTATGCCTTTTGGGCACTGT 200nM 
ER2R PB300603.00.0 (pdog-1) R TTCATTTTGGTGGAGTGCAA 900nM 
ER3F PB103906.00.0 F TCCCTCGAAACAAGAAGCAT 200nM 
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Primer  
Name 
Primer 
Description 
 
Primer sequence 5’-3’ 
Primer 
concentration 
ER3R PB103906.00.0 R TACAAAGCCAAACGCAACTG 900nM 
ER4F PB000035.01.0 F GAAAGCGATGTAAACCAGCA 200nM 
ER4R PB000035.01.0 R ATTTGCTTTGGCGATCTCAT 900nM 
ER5F PB000064.01.0 (pdog-2) F CAAATGATTCGGAAATGTTGC 200nM 
ER5R PB000064.01.0 (pdog-2) R CAATTTGCTATCATCGCCCT 900nM 
ER6F PB000043.01.0 (pdog-3) F CAACCTCAACTTGGGAAATGA 900nM 
ER6R PB000043.01.0 (pdog-3) R TGGGTACCAGGGTTTTCACT 200nM 
ER7F PB000072.03.0 F AGGGGAAGAAAACGGAAAGA 900nM 
ER7R PB000072.03.0 R TTTCCGACTCCCATGAACTC 200nM 
ER8F PB001118.00.0 F TGCGGTCAAAATGATGAAAG 900nM 
ER8R PB001118.00.0 R GCGCTTAATTTGTTCTTGCC 200nM 
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2.3.3.3 Analysis of qRT-PCR results 
All reactions were run in triplicates and the final transcriptional profile generated 
from the average of three biological experiments. For the analysis, all gene specific 
transcript levels were normalised against eef1-α driven eGFP expression. Final 
transcriptional profiles were presented with values for all time points calibrated 
against the time point with lowest expression level for the individual genes being 
assayed. 
 
2.3.4 Semi-quantitative RT-PCR 
2.3.4.1 Primer sequences for semi-quantitative RT-PCR 
Gene specific RT-PCR primers were manually designed with a Tm of 50-52ºC and an 
amplicon length of 0.6-1.0 Kb (Table 2.2). 
 
2.3.4.2 Semi-quantitative RT-PCR procedure 
Semi-quantitative RT-PCR was performed using gene specific primers and GoTaq 
Green DNA polymerase master mix (Promega). PCR products were amplified by as 
denaturation step of 5 min at 94ºC followed by 25, 30 or 35 cycles comprising of 45 
seconds at 94ºC (denaturation), 45 seconds at 52ºC (primer annealing) and 1 min at 
62ºC (elongation) and concluded by a final elongation step of 5 min at 62ºC. 
 
2.3.4.3 Analysis of semi-quantitative RT-PCR results 
Semi-quantitative RT-PCR products were analysed using standard gel electrophoresis 
run with TBE buffer (J. Sambrook, 2001). 
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Table 2.2. Primer sequences for RT-PCR 
 
Primer 
Description 
 
Primer sequence 5’-3’ 
ama1 RT-PCR F TATGGGTCCAAGATATTGTAGTAATAA 
ama1 RT-PCR R GAATTAGCTTTACCATAAATATCTGC 
chit RT-PCR F GCCCGCCCAGATGTAATTATA 
chit RT-PCR R TGCCAAATTCCTACACCATCG 
ctrp RT-PCR F AGAGAAGAAGATTGCCCAACAG 
ctrp RT-PCR R ATCGGATCATTTGCATCGATAAC 
soap RT-PCR F TCGAAGGAGCAAGGAAAAATTCC 
soap RT-PCR R ATGAACAGCTACATTCTTCGGTC 
warp RT-PCR F ATGAAGAGTGTTAAAGGAATAACATATAT 
warp RT-PCR R CAGACGTCAGTGAAGAAGGATT 
maebl RT-PCR F GAATTGAAGAAGCTAAGAAAGCAG 
maebl RT-PCR R TTCTTCGTACCATCTTCCTCC 
misfit RT-PCR F GATGAAGAAAAGGACAAAGAAATTTC 
misfit RT-PCR R AAGGGATACATATTCACAATCAAG 
p28 RT-PCR F AATGCACAGGTACAGGAGAAACTAAAT 
p28 RT-PCR R CACACTCATAATGTTTTCCAGTCAATT 
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2.4 Generation of transgenic parasites  
2.4.1 Candidate selection 
2.4.1.1 Transcriptome Derived Oocyst Genes (tDOG) 
Repeated supervised hierarchical clustering and manual filtering of microarray data 
was performed to identify genes that were upregulated in the oocyst stage (2-13 days 
post-infection) compared to the pre- midgut invasion stages (2-24h post-infection). 
Candidates for functional analysis by targeted disruption was selected based on their 
transcriptional profile and any putative functional domains that together implicated 
them as playing potential roles in either protection against the mosquito immune 
response or in the extensive membrane biogenesis and remodelling that occurs during 
sporogony. Three genes were selected for targeted disruption and were named 
Transcriptome Derived Oocyst genes (tDOG) 1-3.  
 
Based on the available P. berghei genome sequence and annotation, a complete 
disruption vector was constructed for the deletion of tDOG-1 (Pb000024.01.0 / 
Pb001219.02.0) and tDOG-3 (Pb000811.00.0) while a partial disruption vector was 
made for tDOG-2 (Pb300124.00.0). The resulting gene targeting vectors were as 
follows; ptDOG1-TgDHFR-TS, ptDOG2-TgDHFR-TS and ptDOG3-TgDHFR-TS. 
 
2.4.1.2 Proteome Derived Oocyst Genes (pDOG) 
Proteome data has previously been published for P. berghei sexual development in its 
Anopheline mosquito vector (Hall et al 2005). This data set includes proteome data 
for day 9-12 post-infection P. berghei oocysts (corresponding to late oocyst 
development). Based on this proteome we selected, for further characterisation, 8 P. 
berghei genes which associated peptides had hits during late oocyst development. Our 
selection screen was founded on a number of different criteria. Firstly, the genes 
selected had no recorded peptide hits in asexual blood stages, gametocytes or 
ookinetes, and hence may be genes which are specifically required for oocyst 
development. Secondly, genes were selected on the basis of the presence of predicted 
signal peptide or transmembrane domain structures, as surface-located proteins have a 
potential for interaction with the mosquito vector and were for this reason deemed of 
special interest. Thirdly, genes with functional domains predicting house keeping 
roles were selected against. Furthermore, genes were prioritised if they had 
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orthologues in P. falciparum and were also prioritised based on abundance as 
indicated by the number of spectral hits of its associated peptides.  
 
Eight genes were finally selected for a detailed transcriptional, qRT-PCR based 
analysis (Figure 2.1). From these eight genes, three were chosen for functional 
analysis by targeted gene disruption and were denoted Proteome Derived Oocyst 
Genes (pDOG) 1-3. Based on the P. berghei genome sequence and annotation 
available at the time, one partial disruption (pDOG-1A; targeting Pb300603.00.0 / 
Pb300510.00.0) and one complete KO (pDOG-1B; targeting Pb300603.00.0 / 
Pb300510.00.0 / Pb000071.00.0) vector was made for pDOG 1. Partial disruption 
pDOG-2 (Pb000064.01.0) and complete KO pDOG-3 (Pb000043.01.0) vectors were 
constructed, respectively. The resulting vectors for targeted disruption were as 
follows; ppDOG1A-TgDHFR-TS (partial disruption), ppDOG1B-TgDHFR-TS 
(complete KO), ppDOG2-TgDHFR-TS and ppDOG3-TgDHFR-TS. 
 
2.4.2 Molecular cloning: Construction of vectors for parasite transgenesis 
All molecular cloning procedures were performed according to manufacturer’s 
instructions and standard protocols (J. Sambrook, 2001).  
 
2.4.2.1 PCR-based amplification of homology regions for transgenesis vectors 
Homology regions for the introduction of disruption or tagging vectors through 
homologous recombination were amplified from P. berghei ANKA clone 2.34 
genomic DNA by PCR (Amplitaq, BD) using gene specific primers with restriction 
enzyme site overhangs (Table 2.3). The PCR program was as follows: A single 
denaturation step of 5 min at 94ºC followed by 30 cycles comprising of 45 seconds at 
94ºC (denaturation), 45 seconds at 52ºC (primer annealing) and 2 min and 15 seconds 
at 62ºC (elongation), concluded by a final elongation step of 5 min at 62ºC.  
 
2.4.2.2 Homology regions and vectors for targeted gene disruption  
Upstream (A) and downstream (B) homology regions were amplified by PCR and 
cloned into the pBS-DHFR vector, in which polylinker sites flank a tgdhfr-ts 
pyrimethamine resistance cassette (Dessens et al., 1999). The homology regions 
corresponded to 600-1000 bp of the 5' UTR and 3'UTR or the most upstream and 
downstream coding sequences available of respective ORF. Following transfection, 
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introduction of gene disruption vectors into respective target loci was facilitated by 
double homologous recombination. 
 
2.4.2.3 Homology regions and vectors for c-terminal tagging of misfit / pdog-2 
MISFIT was fused to a c-terminal MYC or GFP tag by replacing 1 kb of the most 3′ 
terminal portion of the endogenous misfit locus with a tagged counterpart. 2.0 kb 
corresponding to the most 3′ terminal portion of misfit was amplified by PCR and 
cloned in-frame with a c-terminal myc-or gfp tag held in the pDR0007 tagging vector 
(kind gift from D. J. Raine), which also carries a tgdhfr/ts selection cassette. 
Following transfection, introduction of tagging vectors into the misfit locus was 
facilitated by single crossover homologous recombination. 
 
2.4.2.4 PCR purification and restriction digests. 
PCR products were analysed by standard gel electrophoresis and the Qiagen 
QiaQuick PCR purification kit was used for vector and PCR purification throughout. 
PCR amplified targeting sequences and vectors were digested using the appropriate 
restriction enzymes (Table 2.3), (New England Biolabs).  
 
2.4.2.5 Ligations and transformations. 
Linearised vectors were de-phosphorylated for 30 min at 37ºC (Shrimp alkaline 
phosphatase; Promega) prior to ligation. Ligation reactions were incubated for 10 min 
at room temperature (T4 rapid ligation kit, New England Biolabs) prior to 
transformation into chemically competent DH5α Escherichia coli (Invitrogen) by heat 
shock methodology. Transformants were plated onto 50 μg /mL ampicillin (Sigma) 
Luria Broth (LB) agar (Merck) plates. Clones containing the correct inserts were 
identified through standard diagnostic digests of plasmid DNA purified from over-
night cultures grown in 50 μg /mL ampicillin LB medium (Merck) using the Qiagen 
Miniprep Spin Column kit.  
 
 
.        
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Table 2.3. Primer sequences for generation of transgenic parasite lines. Where appropriate, target restriction sites are shown as underlined italics. The 
appropriate restriction enzymes are indicated. Single (Homology region A), (*) and double (Homology region B), (**) asterisks denotes the enzymes utilised 
for the release of the disruption cassette by double restriction digests of gene disruption vectors prior to transfection. Forward (F), Reverse (R), Integration 
(INT), Wild type (WT), Knock-out (KO). 
 
 
Primer 
Name 
 
Description 
 
Primer sequence 5’-3’ 
 
Restriction 
enzyme 
ER12F Homology region A pDOG-1 KO 
PB300510.00.0/PB300603.00.0 
TTGGGCCCGCAAAAGGTATTATATGTAAGGTG ApaI* 
ER12R Homology region A pDOG-1 KO 
PB300510.00.0/PB300603.00.0 
CCAAGCTTACAAATATAATATGAAAATTCTTTTAAGTTG HindIII 
ER12INT Diagnostic – pDOG-1 KO Locus 348 bp upstream of ER12F GTTACAACGGTGTGATTATTTTAATAT  
ER13F-1 Homology region B pDOG-1A KO 
PB300510.00.0/PB300603.00.0 
TGAATTCTCCTCAGATATATGTTTAGTTCTTTTG EcoRI 
ER13R-1 Homology region B pDOG-1A KO 
PB300510.00.0 / PB300603.00.0 
GG GGATCC AGTTTGTAATACGATTTCAGGATAAG BamHI** 
ER13F-2 
Homology region B pDOG-1B KO 
PB300510.00.0 / PB300603.00.0/ 
PB000071.00.0 
TGAATTCTATCCAATTATATTGACATTATTTAGTGG EcoRI 
ER13R-2 
Homology region B pDOG-1B KO 
PB300510.00.0 / PB300603.00.0/ 
PB000071.00.0 
GGGGATCCCATAACCATATATACAGTATTTAATTATCG BamHI** 
ER14F Homology region A pDOG-2 KO (MISFIT) PB000064.01.0 TTGGGCCCAAGATGATAGTAATTATAAAGAATTAGAAG ApaI* 
ER14R 
Homology region A pDOG-2 KO 
(MISFIT) PB000064.01.0 CCAAGCTTGAACAATAATACTGTTACTAGTGG HindIII 
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Primer 
Name 
 
Description 
 
Primer sequence 5’-3’ 
 
Restriction 
enzyme 
ER14 INT Diagnostic –  pDOG-2 KO Locus 38 bp upstream of ER14F CATAAATTTTTACGATGAGGTA  
ER14 WT R Diagnostic – pDOG-2 WT Locus 332 bp downstream of ER14R GCCTGATCAACATATGAATCATTG  
ER15F Homology region B pDOG-2 KO PB000064.01.0 TGAATTCTTGTTGCATATTTAGCAGTGAATTAG EcoRI 
ER15R 
Homology region B pDOG-2 KO 
PB000064.01.0 GGGGATCCGAATCAAATTCTGCTTCATCCATG BamHI** 
ER1415-myc F 
Tagging 3’ pDOG-2 (MISFIT) 
PB000064.01.0 GGGGTACCCAGAAGGAAGATTAAGTTGTATGG ApaI 
ER141-5myc R 
Tagging 3’ pDOG-2 (MISFIT) 
PB000064.01.0 TTGGGCCCAGCAGAAGAATCAAATTCTGC KpnI 
ER1415-myc Seq 
F(1) 
Sequencing pDOG-2 (MISFIT) 
 tagging construct CAACAGTTCCACTTTCAAAAACTG  
ER1415-myc Seq 
F(2) 
Sequencing pDOG-2 (MISFIT) tagging 
construct TGGAAACAAACCTAATTACGAAGTT  
ER16F Homology region A pDOG-3 KO PB000043.01.0 GGGGTACCCTAGATGGAGGGCAACTAAAG KpnI* 
ER16R 
Homology region A pDOG-3 KO 
PB000043.01.0 TTGGGCCCAGAGAAACTTCGATGCAATATCAG ApaI 
ER16 INT Diagnostic – pDOG-3 KO Locus 301 bp upstream of ER16F ACAAGTATCTAAACAAACACCTGG  
ER17F Homology region B pDOG-3 KO PB000043.01.0 TGAATTCGCATAGTCAAACGGGTTACATG EcoRI 
ER17R Homology region B pDOG-3 KO PB000043.01.0 GGGGATCCTTGGTAAGGATTCCTCAATTGTG BamHI** 
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Primer 
Name 
 
Description 
 
Primer sequence 5’-3’ 
 
Restriction 
enzyme 
TgDHFR 3'UTR F 500 bp into the 3'UTR of tgdhfr-ts TCGTGGGCTACGTCCCGCAC  
TgDHFR 5'UTR R 200 bp into the 5'UTR of tgdhfr-ts GATGTGTTATGTGATTAATTCATACAC  
VR01 KO A F Homology region A tDOG-1 KO PB001219.02.0/PB000024.01.0 GGGGTACCCGACTAATGTAAGAATGCATAAATAAG KpnI* 
VR01 KO A R Homology region A tDOG-1 KO PB001219.02.0/PB000024.01.0 CCAAGCTTCCACTTTTATATCTAATAAGCAATTCG HindIII 
VR01 KO B F Homology region B tDOG-1 KO PB001219.02.0/PB000024.01.0 AAGATATCCTCATTTCTGTCTAAATAAACTCTCG EcoRV 
VR01 KO B R Homology region B tDOG-1 KO PB001219.02.0/PB000024.01.0 GGGGATCCAAGAACGTCTGCGCTTGTAAATAAG BamHI** 
VR01A INT F Diagnostic – tDOG-1 KO Locus Upstream of VR01A F CACTGCAAATATAGTTAGCAAAATATG  
VR01A WT R Diagnostic – tDOG-1 WT Locus Downstream of VR01A R TTCATCACGCTCTAATATTAATGTG  
VR02 KO A F Homology region A tDOG-2 KO PB300124.00.0 GGGGTACCGAATTATAGCATTCAATAAATTTAAAGAAAG KpnI* 
VR02 KO A R Homology region A tDOG-2 KO PB300124.00.0 CCAAGCTTCATGATAATTTTTTAATATGACAGGTTG HindIII 
VR02 KO B F Homology region B tDOG-2 KO PB300124.00.0 TGAATTCCACGAATATAATGAAAATAAAGAACAAG EcoRI 
VR02 KO B R Homology region B tDOG-2 KO PB300124.00.0 GGGGATCCTTCATGTTTCATACATTCACTTTCG BamH**I 
VR02B INT R Diagnostic – tDOG-2 KO Locus Upstream of VR02A F TATGTTTCCATGCGTATTGTTCTG  
VR02B WT R Diagnostic – tDOG-2 WT Locus Downstream of VR02A R AGAGCCACTATTTAATATATCAGTTG  
 97 
Primer 
Name 
 
Description 
 
Primer sequence 5’-3’ 
 
Restriction 
enzyme 
VR03 KO A F Homology region A tDOG-3 KO PB000811.00.0 GGGGTACCTATCATGATGTGATAACATATAAAATTGTG KpnI* 
VR03 KO A R Homology region A tDOG-3 KO PB000811.00.0 CCAAGCTTACACTCTTTAATTTTTCCCTCCG HindIII 
VR03 KO B F Homology region B tDOG-3 KO PB000811.00.0 TGAATTCTACTTTGTATTCATATATATGTTTCGATG EcoRI 
VR03 KO B R Homology region B tDOG-3 KO PB000811.00.0 GGGGATCCAATTAGATAACAACGACGATATCAATG BamHI** 
VR03A INT F 
Diagnostic – tDOG-3 KO Locus 
Upstream of VR03A F CAGAAATATTCATTATATGTATCATTTGAG  
VR03A WT R Diagnostic – tDOG-3 WT Locus Downstream of VR03A R CTCGTCTGTAATCAAAATATTTGTTTG  
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2.4.2.6  Construct verification. 
The resulting vectors for targeted gene disruption were further analysed by PCR to 
confirm the correct orientation and positioning of the inserts. The primers used for the 
upstream target sequence were the gene specific forward primers for Homology target 
region A in combination with the TgDHFR-TS 5'UTR reverse primer. For the 
downstream target sequence, the TgDHFR-TS 3'UTR forward primer was used in 
combination with the gene specific reverse primers for the Homology target region B 
(Table 2.3).  
 
The misfit/pdog-2 tagging constructs were sequenced (Table 2.3) prior to transfection 
to ensure that the tagging constructs were mutation free and that the tags were 
maintained in-frame with the misfit/ pdog-2 coding sequence held on the vector. 
 
2.4.3 Preparation of DNA for transfections 
Vectors were prepared for transfection using the Qiagen HiSpeed Plasmid Midi Kit 
(100 mL cultures grown over-night in 50 μg /mL ampicillin LB medium). All 
constructs were linearised prior to transfection. The disruption vectors were linearised 
by double restriction enzyme digests at sites flanking the up and downstream gene 
targeting regions, so to release the disruption cassette (Homology region A - 
tgDHFR-TS - Homology region B). The restriction enzymes used for each construct 
corresponds to the restriction sites added to respective Homology Region A Forward 
primers and Homology Region B Reverse primers (Table 2.3). The mifsit / pdog-2 
tagging constructs were linearised by single restriction enzyme digests using Cla1, 
cutting in the centre of the 2 Kb homology region  
 
Linear constructs were purified by ethanol precipitation (J. Sambrook, 2001) and 3-5 
μg of DNA in a volume of 5-10 μL was used for each transfection. 
 
2.4.4 Transfection procedures 
The protocol for transfection was supplied by A. Waters (personal communication). 
 
2.4.4.1 Schizont cultivation 
Briefly, blood was collected on day 1-2 of infection (parasitaemia less than 5%) from 
three anaesthetised mice infected with P. berghei ANKA clone 2.34 (mechanical 
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passage number <2) to serve as a source of blood-stage parasites for the transfections. 
The blood was transferred to 120 mL of 75% (v/v) schizont culture medium 
RPMI1640 pH 7.2 (RPMI1640, 24mM L-glutamine, 25mM HEPES, 0.2% (w/v) 
NaHCO3 (Gibco), 50 U / mL penicillin, 50 μg / mL streptomycin) and 25% (v/v) FBS. 
The culture was gassed with 5%CO2, 5% O2 and 90% N2 and incubated overnight 
shaking gently at 37°C. Prior to starting transfections, the parasite quality and 
quantity was examined on a Giemsa stained smear of the culture (0.5 mL aliquot 
pelleted and thinly smeared in FCS).  
 
2.4.4.2 Purification of viable schizonts 
Schizonts were purified on a 15.2% (v/v) Nycodenz / PBS density gradient (30 min at 
300 g) and those localizing at the interface between the resulting two layers were 
collected, washed in 20 mL culture medium, centrifuged at 300 g for 8 min and 
supernatant was discarded. The pellet was re-suspended in schizont culture media, 
split into 1 mL aliquots and spun down for 1 min at 200 g.  
 
2.4.4.3 AMAXA transfection procedure 
The supernatant from previous step was discarded and the pellet re-suspended in 
100μL AMAXA supplemented nucleobuffer (AMAXA) containing the DNA which 
is to be transfected. The DNA / buffer / parasite solution was transferred to an 
electroporation cuvette (AMAXA) and electroporation was performed according to 
manufacturer’s instructions (Protocol U33; AMAXA). 150 μL of uninfected mouse 
blood (obtained from a PH treated mouse on day 2-3 after treatment; 125 mg / kg 
body weight) was added to the electroporated parasites. The parasites were incubated 
at 37ºC for 15 min to allow invasion of merozoites into erythrocytes prior to injection 
of the suspension (IP) into a mouse.  
 
2.4.4.4 Pyrimethamine-based selection of transgenic parasites 
Two rounds of selection of pyrimethamine-resistant parasites were performed in two 
subsequent host mice by administration of 0.07 mg / pyrimethamine (Sigma) in the 
drinking water. 
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2.4.4.5 Limited dilution cloning of transgenic parasites 
Clonal transgenic parasite populations were obtained by limited dilution cloning as 
previously described (Waters et al., 1997a). Briefly, blood-stage parasites were 
enumerated in fixed and stained tail blood smears from infected mice and diluted in 
RPM1 medium to a final concentration of 20 parasites / mL, prior to IP injection (200 
μL) into TO mice. 
 
2.5 Genotypic analysis of transfected blood-stage populations 
P. berghei genomic DNA was prepared from the transfected parasite populations 
following purification from infected mouse blood as outlined above. To determine 
whether parasites surviving the second round of drug selection carried integrated 
disruption constructs, diagnostic PCRs were performed in conjunction with Pulse 
Field Gel Electrophoresis (PFGE) and Southern Blot analysis. Assessment of purity 
of the dilution cloned Δpbmisfit and non-clonal pbmisfit-myc transgenic lines were 
conducted by PCR and Southern Blot analysis. 
 
2.5.1 PCR- based analysis of transfectants 
2.5.1.1 Mixed transfectant parasite populations 
Diagnostic PCRs were performed by using gene-specific forward (Integration; INT) 
primers situated upstream of the target site for homologous recombination 
(Homology region A), in combination with the TgDHFR-TS 5'UTR reverse primer 
(Table 2.3). This primer positioning ensure that a product can only be obtained if 
integration taken place. The GoTaq Green DNA polymerase master mix was used and 
cycling was performed as previously described for sub-cloning. 
 
2.5.1.2 Clonal Δpbmisfit / Δpbpdog-2 transgenic lines 
Genomic DNA obtained from the dilution cloned parasite populations were assessed 
for presence of the disrupted Δpbmisfit locus and absence of the pbmisfit WT locus. 
The Δpbmisfit locus was detected by a gene-specific forward (ER14- INT F) primer in 
combination with the TgDHFR-TS 5'UTR R primer as outlined above (Table 2.3). 
Absence of the pbmisfit WT locus was verified by the ER14-INT F primer in 
combination with a primer (ER14-WT R), Table 2.3) located within the region of the 
WT locus, which should have been excised by homologous recombination. With this 
primer positioning, a product can only be obtained if the WT locus is left intact. 
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2.5.2 Pulse field gel electrophoresis (PFGE) analysis of transfectants 
2.5.2.1 Whole chromosome preparations 
Whole chromosome preparations were prepared from fresh P. berghei mixed blood 
stage parasite populations purified as outline above and immediately transferred into 
agarose plugs as previously described (Reininger et al., 2005). Briefly, purified 
parasites were resuspended in TNE buffer (10 mM Tris HCl pH 7.5, 100 mM NaCl, 5 
mM EDTA) and 2% (w/v) low melting agarose (Sigma) in TNE was added at a 1:1 
ratio. The resulting 1% agarose solution was transferred to plug moulds and allowed 
to set on ice, prior to digestion in 5 mL Sarkosyl buffer (3 mL TNE, 1 mL 0.5 M 
EDTA pH 8.0, 1 mL 10% (v/v) Sarkosyl) with  400μg/mL proteinase K, for 72 hours, 
shaking at 37°C. Plugs were stored in Tris EDTA (TE) buffer (J. Sambrook, 2001) at 
4°C. 
 
2.5.2.2 PFGE 
Whole chromosome pulse field gel electrophoresis was performed on 1% (w/v) 
agarose gels using a 0.5x TBE buffer for 70 hrs at 14ºC, utilising the LKB Bromma 
2015 Pulsaphor Plus system (switch time 60-500 sec; 98V). 
 
All blots were hybridised against a probe recognising the tgdhfr-ts cassette. The 
tgdhfr-ts probe fragment was obtained by Hind III and EcoRV double restriction 
digest of the pBS-TgDHFR-TS vector to release the cassette. 
 
2.5.3 Southern blot analysis of Δpbtdog2  
For Southern Blot analysis of the transfectant Δpbtdog2 parasite populations, genomic 
DNA was digested over-night with MfeI (New England Biolabs). The insertion of the 
disruption-cassette results in the introduction of an additional MfeI restriction site in 
the tdog-2 locus. As a result a 1.2 kb shift from 5.6 kb (tdog-2 WT) to 4.4 kb 
(Δtdog2) is expected if successful integration of the disruption vector has taken place. 
The blot was hybridized against a PCR-generated probe recognizing a 495 bp region 
of tdog-2 produced using the Homology region A tDOG-2 KO primer pair (Table 
2.3) and the ptDOG2-TgDHFR-TS vector as template. 
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2.5.4 Southern blot analysis of Δpbmisfit (Δpbpdog2) and pbmisfit-myc  
For Southern Blot analysis of the dilution cloned Δpbmisfit lines, genomic DNA was 
digested over-night with EcoRV. The insertion of the disruption-cassette results in a 
2.5 Kb size-increase of the disrupted Δmisfit locus compared to the misfit WT locus. 
The blot was hybridized against a PCR-generated probe recognizing an 816 bp region 
of misfit produced using the Homology region A pDOG-2 (MISFIT) KO primer pair 
(Table 2.3) and the ppDOG2-TgDHFR-TS vector as template. 
 
For the pbmisfit-myc transgenic lines, genomic DNA was digested over-night with 
HindIII. The insertion of the tagging-cassette results in the introduction of an 
additional HindIII site and thus the generation of a 3 kb digestion product, which is 
present in Δpbmisfit parasites and absent from WT parasites. The blot was hybridized 
against a probe recognizing a 2 kb region of misfit, generated by PCR using the 
Tagging 3’ pDOG-2 (MISFIT) primer pair (Table 2.3) and pMISFIT-MYC-
TgDHFR-TS vector as a template. 
 
Gel electrophoresis of digested DNA was performed for approximately 6-8 hours 
(80V) on large 0.8% agarose gels prepared with Tris-Acetate (TAE) buffer (J. 
Sambrook, 2001). 
 
2.5.5 Radioactive detection of target loci 
2.5.5.1 Gel imaging 
Gels were incubated with E1510 Ethidium bromide (Sigma), (50 μL of a 10 mg/mL 
stock per 1 L of 0.5x TBE or TAE) on a rocker at room temperature for 30 min. Gels 
were subsequently imaged and photographed next to a ruler for size reference.  
 
2.5.5.2 Nucleic acid transfer 
Stained gels were depurinated for 15 min in 0.25M HCl and subsequently denatured 
in in 0.5 M NaOH and 1.5 M NaCl for 25 min. The DNA was transferred to 
HybondN+ membrane (Amersham Biosciences) by standard Southern blotting over-
night (J. Sambrook, 2001). The following day the membrane was quickly rinsed in 
3X sodium chloride sodium citrate (20x SSC stock prepared with 17.53% (w/v) NaCl, 
8.82% (w/v) sodium citrate, pH 7) prior to cross-linkage in a CL-1000 Ultraviolet 
Crosslinker (UVP; 100 μJ/cm2 for 1,500 sec). 
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2.5.5.3 P32 probe labelling 
Probe fragments were labelled with dATP (P32-α), (Amersham Biosciences) at 37ºC 
for 30 min utilising the High Prime DNA Labelling Kit (Roche). Labelled probes 
were purified using the ProbeQuant G-50 Micro columns (Amersham Biosciences). 
All procedures were carried out in a designated radioactivity work area and 
performed according to manufacturer’s instructions. 
 
2.5.5.4 Hybridisations 
Membrane pre-hybridisation was conducted at 55°C for 30 min in 50 mL of 
hybridisation buffer (0.35 M Na2HPO4 pH7, 4% (w/v) sodium dodecyl sulfate (SDS), 
1% (w/v) bovine serum albumin). The probe was denatured at 100ºC for 5 min and 
cooled on ice prior to addition of the probe to the pre-warmed hybridisation buffer 
and membrane. Hybridisation was allowed to proceed over-night at 55°C in a rotating 
hybridisation oven.  
 
2.5.5.5 Post-hybridisation stringency washes 
The membrane was washed under increased stringency in 100 mL 3 XSSC with 0.1% 
(w/v) SDS followed by a second wash in 100 mL 2 X SSC 0.1% (w/v) SDS. Washes 
were conducted at 55°C in a rotating hybridisation oven for 25 min each. The 
membrane was then wrapped in Saran wrap (SaranBrands, Dow Chemical 
Corporation) and radioactivity was monitored using a Geiger Scintillation Counter. If 
high activity was detected across the membrane, a third wash in the high stringency 
buffer was conducted. 
 
2.5.5.6 Phosphorimaging 
The membrane was exposed onto phosphorimaging screens (>2 hours). Exposed 
screens were developed using a FujiFilm FLA-5000 phosphorimager analyzer. The 
positions of the bands were visualised using the Aida352 software. 
 
2.6 Phenotypic analysis of transfected blood-stage populations 
2.6.1 Exflagellation assays  
Exflagellation assays were preformed by mixing equal parts of parasite infected tail 
blood with ookinete culture medium. Following 10 min incubation at room 
temperature, exflagellation was observed at 40X magnification in a standard 
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haemocytometer (Hausser Scientific, USA). The number of exflagellation centres and 
total number of RBC were counted (proportion of exflagellating male gametocytes) 
and were directly compared to the total male gametocytaemia (total proportion of 
male gametocytes) as determined by Giemsa stained tail-blood smears, processed in 
parallel.  
 
2.6.2 Mosquito midgut sample preparations for enumeration and imaging 
Following dissection, midguts were fixed in 4% formaldehyde (v/v) (16% methanol 
free, ultra pure stock diluted in PBS, Polysciences Inc.) for 20 min at room 
temperature and washed three times for ten minutes each in PBS, prior to mounting in 
Vectashield® (VectorLabs) on glass slides under sealed cover-slips. Slides were 
stored in the dark at 4ºC until processing. 
 
2.6.3 Ookinete enumeration 
2.6.3.1 Ookinete imaging 
In vitro cultured ookinetes were mounted on a microscope slide and covered by a 
Vaseline-sealed cover slip prior to immediate imaging. 
 
2.6.3.2 Ookinete conversion assays 
Macrogamete to ookinete conversion assays were performed in a haemocytometer in 
ookinete medium, utilizing a Cy3 conjugated P28 (13.1) monoclonal antibody (kind 
gift by O. Billker) as previously described (Billker et al., 2004). Briefly, the ookinete 
culture samples (0.5 mL) were harvested at 500g for 5 min, the resulting pellets were 
resuspended in 0.5 mL Cy3 13.1 diluted to 1:500 in ookinete medium and incubated 
on ice for 10 min. The conversion ratio was calculated from the total number of Cy3 
positive ookinetes (crescent-shaped) divided by the total number of Cy3 positive 
macrogametes (spherical). 
 
2.6.3.3 Ookinete invasion assays 
Invaded ookinetes were visualised by their melanotic encapsulation in midguts of A. 
gambiae dsCTL4 KD mosquitoes, as previously described (Ecker et al., 2008) and 
with gene silencing carried out as outlined above. Enumeration was carried out at day 
7 post-infection by light microscopy. 
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2.6.4 Mosquito infections 
2.6.4.1 Oocyst imaging and enumeration 
P. berghei infected midguts were obtained from A. stephensi or A. gambiae 
mosquitoes at 3, 10 or 15 days post-infection. Oocysts were enumerated at X10 
(fluorescence microscopy; Pbc507 GFP reference lines) or X40 (light microscopy; 
Pb2.34 WT lines). Imaging was performed at X10 and X63 magnification using light 
and fluorescence microscopy. Counting was conducted with the aim of using a 
minimum of 50 infected midguts per parasite genotype. 
 
2.6.4.2 Oocyst size measurements 
Day 10 oocyst size was measured from fluorescence microscopy images captured at 
X10 magnification. Images were imported to ImageJ 1.38x (National Institute for 
Health; http://rsbweb.nih.gov/ij/), converted to 32-bit binary images and oocyst size 
was measure in arbitrary units using the Analyse Particles tool.  
 
2.6.5 Sporozoite enumeration 
Midgut and salivary gland sporozoite numbers were calculated from homogenates of 
P. berghei infected A. stephensi midguts or salivary glands, assayed in three batches 
of ten midguts / salivary glands on day 21 post-infection. Dissected salivary glands or 
midguts were immediately transferred to a 0.1mL tissue homogenizer (Jencons 
England, VWR) using a Hamilton syringe (Hamilton Company Ltd.), mechanically 
homogenized and loaded onto a haemocytometer. The final sample volume was 
carefully measured using a Hamilton syringe, allowing for calculation of the total 
number of sporozoites per 10 mosquitoes. 
 
2.6.6 Transmission to mice 
Sporozoite infectivity was assayed by bite-back experiments, where P. berghei 
infected mosquitoes (day 18 and 21 post-infection) were allowed to feed on 
anaesthetised C57BL/6 mice for 15 min. The mice were then allowed to recover and 
parasitaemia was monitored on day 5, 7, 10 and 14 following the receipt of 
potentially infective sporozoites. Infected mice were immediately culled upon 
detection of blood-stage parasites on Giemsa stained tail blood smears, or if 
remaining uninfected, at the endpoint of the experiment (day 14). Directly after the 
bite-back, the number of successfully fed mosquitoes was counted. 
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2.6.7 Genetic crosses 
Genetic crosses between different transgenic KO parasite strains were carried out by 
infecting mice with different combinations of KO parasites. A. stephensi mosquitoes 
were subsequently infected by either directly feeding on mice harboring mixed 
infections or by membrane feeding on ookinetes cultivated in vitro using parasites 
from the co-infected mice (Raine et al., 2007). The Δpbnek4, Δpbcdpk4, and 
Δpbmap2 parasite lines were kindly provided by R. Tewari and O. Billker. The 
Δpbs47 and Δp48/45 lines were a kind gift from A. Waters and C. Janse to A. Ecker. 
 
2.6.8 Aphidicolin experiments  
2.6.8.1 Aphidicolin treatment 
Aphidicolin is a tetracyclic diterpene antibiotic, which acts as a reversible inhibitor of 
DNA replication by specific inhibition of eukaryotic DNA polymerase a,d activity, 
thus arresting cells in early S-phase. In vitro ookinete cultivation was allowed to 
proceed for 1 hour prior to addition of Nigrospora sphaerica aphidicolin at a final 
concentration of 50μM (diluted in DMSO, Sigma), (Janse et al., 1986), (Personal 
communication A. Ecker). Cultivation was then continued as normal up to 24 hours, 
followed by ookinete imaging and nuclear DNA measurements, or mosquito 
membrane-feeding. 
 
2.6.8.2 DNA measurements 
Ookinetes were smeared on glass slides and air-dried prior to fixation in 4% 
formaldehyde, followed by three washes in PBS (all steps performed for 10 minutes 
at room temperature), of which the second wash contained DAPI (1/2000, Boehringer 
Mannheim GmbH). Ookinete images for DNA measurements were captured using a 
fluorescence microscope (X100 magnification) with a fixed exposure time. Image 
processing was performed using the ImageJ software v. 1.38x (National Institute for 
Health) and calculations was performed using the analyze particle function. The 
relative nuclear DAPI intensity was calculated as the function of the total number of 
pixels (corresponding to nuclear size) and the average pixel intensity. Ookinete 
nuclear DAPI intensity was normalized against the haploid value of ring stage and 
early trophozoites on the same slide, which nuclear DAPI intensity was measured 
using the same methodology and camera settings (method modified from (Reininger 
et al., 2005).  
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2.6.8.3 FACS 
Fluorescence-Activated Cell Sorting (FACS) analysis was performed on fresh, 
unfixed in vitro ookinete cultures. Nuclear DNA was stained with DRAQ5TM (1μL 
stain per 1 mL culture; Cell Signaling Technologies) for 5 min at room temperature. 
Stained cultures were diluted in ~1:500 in Flow buffer (BD Biosciences) and 
DRAQ5TM fluorescence intensity was immediately determined by flow cytometry. 
 
2.7 Immunodetection methodology 
2.7.1 Western blot analysis 
2.7.1.1 Membrane fractionation 
Purified gametocytes were pelleted at 500g for 5 min and washed twice in PBS 
containing protease inhibitors (PI), (Complete, EDTA free protease inhibitor cocktail 
tablets, Roche). The pellet was re-suspended in 100μL PBS-PI and cells were 
sonicated to release the soluble fraction. Seven cycles of sonication at 2μM for 10 sec 
followed by 10 sec on ice were performed for each sample. The sonicated cells were 
transferred to PolyAllomer Microfuge® tubes (Beckman Coulter) and subjected to 
ultracentrifugation at 100 000 g for 30 min at 4ºC (Beckman Coulter OPTMATMTL 
Ultra centrifuge equipped with a TLA-45 rotor). The supernatant (constituting the 
soluble fraction) was collected and placed on ice.  
 
The pellet was washed twice with 100μL PBS-PI and the membrane soluble fraction 
was extracted in 100μL 1% Triton X-100 (Amresco Inc.) PBS-PI on ice for 15 min 
with occasional mixing. Following extraction the sample was subjected to 
ultracentrifugation as above. The resulting supernatant (containing membrane 
proteins, hydrophobic proteins associated with the membrane and proteins that 
interact with membrane proteins) was placed on ice.  
 
The pellet (containing Triton X-100 insoluble proteins) was washed twice with 
100μL PBS-PI prior to extraction in 100 μL Sodium Dodecyl Sulfate (SDS) sample 
loading buffer (J. Sambrook, 2001) at 100ºC for 5 min under reducing conditions 
followed by centrifugation at 16 000 g for 5 min. SDS sample buffer was added to the 
soluble and Triton X-100 soluble fractions, which were processed as above prior to 
protein fractionation. 
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2.7.1.2 Sample preparation 
All purified parasite or infected midgut samples were boiled for 5 min in SDS sample 
loading buffer. 
 
2.7.1.3 Sodium Dodecyl Sulfate (SDS) PolyAcrylamide Gel Electrophoresis (PAGE) 
Protein fractionation was performed under reducing conditions on 8% SDS-PAGE 
gels, according to standard methods (J. Sambrook, 2001), using the Bio-Rad Mini-
PROTEAN II Electrophoresis Cell system, (Bio-Rad Laboratories Ltd.). 
 
The gel, Hybond-P polyvinylidene difluoride (PVDF) membrane (Amersham, GE 
Healthcare) and Whatman filter papers (Whatman) were briefly soaked in transfer 
buffer (80% 25 mM Tris base, 150 mM glycine (v/v), 20% (v/v) methanol) prior to 
semi-dry transfer at constant voltage (15 V) for 30 min (Trans-Blot SD Semi-Dry 
Transfer Cell, Bio-Rad Laboratories Ltd.). Following transfer, membranes were 
washed briefly in PBS-Tween (0.1%), (v/v), (Fluka) prior to blocking in 5% (w/v) 
Marvel dried skimmed milk powder (Premier International Foods Ltd UK) in PBS-
Tween (0.1%) for 1 hour in room temperature.  
 
2.7.1.4 Immunoblotting 
All secondary and primary antibodies were diluted in 5% Milk PBS-Tween (0.1%), 
except for the rabbit anti-MYC antibody, which was diluted in 5% BSA PBS-Tween 
(0.1%). Primary antibodies were incubated on a rocker at 4ºC over-night. Secondary 
antibodies were incubated for 1 hour on a rocker at room temperature. Membranes 
were washed with PBS-Tween (0.1%) three times for 10 minutes each, between 
primary and secondary antibody incubation, and following secondary antibody 
incubation. Blots were developed by enhanced chemiluminescence (ECL) using the 
ECL Plus Western Blotting Detection Reagents (Amersham, GE Healthcare). 
 
2.7.2 Immuno-fluorescence assays (IFA) 
2.7.2.1 Sample preparation 
Purified and pelleted ookinetes and gametocytes were re-suspended in RPMI:FCS 
(1:1), smeared onto glass slides (2 μL /slide) and rapidly air-dried prior to fixation in 
4% formaldehyde (PBS) for 10 min at room temperature. Activated gametocytes were 
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allowed to settle onto poly-L-lysine (0.01%), (v/v), (10% stock solution; Sigma) 
coated glass slides in 4% formaldehyde o/n at 4ºC.  
 
2.7.3 Antibodies 
MISFIT-MYC was detected using a rabbit anti-MYC monoclonal antibody (Mab) 
(71D10, Cell signalling Technology, New England Biolabs) according to 
manufacturer’s instructions at a dilution of 1:1000 (WB) or 1:200 (IFA). 
Alternatively, for co-staining with the rabbit anti-SET antibody (dilution 1/400) (Pace 
et al., 2006), MISFIT-MYC was detected using a rat anti-MYC antibody (JAC6, 
AbCam), (dilution 1/500). P28 was detected with the 13.1-Cy3 Mab (1:500) 
(Reininger et al., 2005, Winger et al., 1988). For anti-α-TUBULIN I (TUB) detection, 
a mouse monoclonal antibody against Trypanosoma brucei alpha-tubulin (tat1), was 
used at 1:1000 for immunofluorescence and at 1:10000 for western blot analysis 
(Woods et al., 1989). GFP was recognized by a rabbit polyclonal antibody (GFP (FL): 
sc-8334, Santa Cruz Biotechnology Inc.) used at a 1/1000 dilution for western blot 
analysis. The secondary antibodies used for IFA were ALEXA FLUOR 488 goat anti-
rabbit IgG, ALEXA FLUOR 488 goat anti-rat IgG, ALEXA FLUOR 647 goat anti-
mouse or ALEXA FLUOR 647 goat anti-rabbit (all at 1:1500, Molecular probes). For 
western blot analysis, horseradish peroxidase (HRP) conjugated goat anti-rabbit IgG 
(1:15000) or goat anti-mouse IgG (1:10000) (Promega) was used.  
 
2.8 Microscopy 
Cells or tissue were mounted in VECTASHIELD Mounting Medium with or without 
DAPI (Vector Labs). 
 
2.8.1 Light and fluorescence microscopy 
Parasites were imaged using a Leica DMT fluorescence microscope and images 
captured using a Zeiss AxioCam HRc camera coupled to Zeiss Axiovision40 version 
4.6.1.0 software. Post-processing of images was performed using ImageJ x.38. 
 
2.8.2 Confocal microscopy 
For IFA, visualization was achieved on a Leica SP5 confocal microscope. Images 
were background-corrected and noise-filtered with the Leica LAS AF software (Leica 
Microsystems). 3D projections and additional image adjustments were performed 
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with the Volocity (PerkinElmer Inc) and Adobe Photoshop CS2 (Adobe) software 
packages. 
 
2.8.3 Transmission electron microscopy (TEM)  
Ookinetes were pelleted at 3000rpm in a 1.5mL Eppendorf and fixed in 2.5% (v/v) 
glutataraldehyde (Sigma) and 2% (v/v) formaldehyde in 0.1M sodium cacodylate 
buffer pH 7.42 at room temperature for 15 min, followed by 45 min at 4ºC. After 
rinses, samples were fixed at room temperature in buffered 1% osmium tetroxide for 
1h followed by mordanting with 1% tannic acid and 1% sodium sulphate and then 
dehydrated in an ethanol and propylene oxide series, staining en bloc with 2% uranyl 
acetate at the 30% ethanol stage. Finally samples were embedded in TAAB Araldite 
812 resin, ultrathin-sectioned at 60nm on a Leica EMU6 ultramicrotome, contrasted 
with uranyl acetate and lead citrate and imaged on a 120kV FEI Spirit Biotwin with a 
Tietz TemCam-F415. 
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CHAPTER 3: ANALYSIS OF PLASMODIUM OOCYST-SPECIFIC GENE 
EXPRESSION IN ITS MOSQUITO VECTOR  
3  
3.1  Introduction 
The Plasmodium and Anopheles genome sequencing projects (Holt et al., 2002, Hall 
et al., 2005, Carlton et al., 2002, Gardner et al., 2002) have facilitated an ever 
growing field of malarial functional genomics. Genome-wide surveys have been 
conducted both at the level of the transcriptome (Table 3.1) and the proteome (Table 
3.2). These studies have shed new light on Plasmodium gene regulation during 
parasite development in host and vector and provided insight into parasite-vector and 
parasite-host interactions. However, despite the availability of an increasing number 
of transcriptomic and proteomic data-sets, little is still known about the molecular 
machinery that underpins oocyst development. To date, only the LAP family, ASP, 
PSOP13, CAP380 and CSP are known to be specifically required for P. berghei 
oocyst maturation (Ecker et al., 2008, Raine et al., 2007, Claudianos et al., 2002, 
Trueman et al., 2004, Srinivasan et al., 2008).  
 
The majority of functional genomics studies have focused on the vertebrate stages of 
malaria rather than the mosquito stages. Although it is the longest persisting, and in 
its mature form is also the largest of the Plasmodium sexual stages, the oocyst is 
intractable due to its mosquito midgut localisation. In addition, in vitro oocyst 
cultivation and purification, although possible (Al-Olayan et al., 2002a), is associated 
with inherent difficulties. When this study was initiated,  one proteomics survey (Hall 
et al., 2005), one cDNA Subtractive Hybridisation (SH) study (Srinivasan et al., 
2004) and two microarray-based transcriptomic studies (Xu et al., 2005, Vontas et al., 
2005) had encompassed P. berghei oocyst development. However, only mature (d10-
12) oocysts were covered by the proteomics survey of the complete P. berghei life-
cycle (Hall et al., 2005). For the transcriptomic studies, an increased number of time-
points during oocyst development were included, but the data-sets were generated 
either in vitro (Vontas et al., 2005), or using an array with incomplete genome 
coverage (Xu et al., 2005). 
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Table 3.1. Transcriptome based surveys of the Plasmodium life-cycle and vector responses to P. berghei infection 
 
 
 
Species 
 
Description 
 
Developmental stages Vector 
 
Methodology 
 
Reference 
A
B
S 
G
c 
G
m
 
O
ok 
O
cy * 
Spz 
P. berghei Transcriptional profiling of in vitro cultivated parasites   √ √    SSH (Zygote and ookinete cDNA library) 
(Dessens et al., 
2000) 
P. yoelii Transcriptional profiling of salivary gland sporozoites      √  EST (Sporozoite cDNA library) 
(Kappe et al., 
2001) 
P. falciparum Building and validation of first Plasmodium  microarray platform √ √      Shotgun microarrays (gDNA library) 
(Hayward et al., 
2000) 
P. falciparum Transcriptional profiling of  in vitro cultivated, asexual blood stages √       Spotted, cDNA (EST) microarray 
(Ben Mamoun et 
al., 2001) 
P. berghei Comparative transcriptomics of oocyst and salivary gland sporozoites      √  SSH (Oocyst and sporozoite cDNA library) 
(Matuschewski 
et al., 2002) 
P. falciparum Transcriptional profiling of synchronous in vitro blood stages and sporozoitesI √ √    √  High-density oligonucleotide array (95%) 
(Le Roch et al., 
2003) 
P. falciparum Comparison between P. falciparum transcriptomeI and proteomeII √ √    √  Comparative functional genomics 
(Le Roch et al., 
2004) 
P. berghei 
In vivo transcriptional profiling of 
A. stephensi and Plasmodium oocysts*     √
*  √ SH (Oocyst cDNA (EST) library) (Srinivasan et al., 2004) 
P. berghei In vivo transcriptional profiling of A. stephensi and Plasmodium ookinetes    √   √ SH (Ookinete cDNA (EST) library) 
(Abraham et al., 
2004) 
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Abbreviations: Asexual Blood Stages (ABA), Expression Sequence Tags (EST), Gametocytes (Gc), Gametes (Gm, or activated gametocytes), Genome 
survey sequences (GSS), Oocysts (Ocy), Ookinetes (Ook), Sporozoites (Spz), Subtractive Hybridisation (SH), Suppressive Subtractive Hybridisation (SSH). 
Ticks indicate the life stages covered by each survey, with a tick in the “Vector column” signifying the monitoring of vector responses to P. berghei infection. 
Studies covering the oocyst stage are highlighted by an asterix (*). Roman numerical (I and II) indicate studies covered by the P. falciparum comparative 
functional genomics study (Le Roch et al., 2004). The table is not an exhaustive list but a comprehensive summary of relevant studies. 
 
 
Species 
 
Description 
 
Developmental stages  Vector  
 
Methodology 
 
Reference 
A
SB
 
G
c 
G
m
 
O
ok 
O
cy * 
Spz 
P. berghei 
In vivo transcriptional profiling of 
A. stephensi and Plasmodium*   √ √ √
*  √ Spotted, cDNA (EST )microarray (Xu et al., 2005) 
P. berghei In vitro transcriptional profiling of synchronous blood stage cultures √ √      Spotted, DNA (GSS) microarray (68%) 
(Hall et al., 
2005) 
P. berghei 
In vitro transcriptional profiling of parasites 
grown in a mosquito cell co-culture system*   √ √ √
*   Spotted, DNA (GSS) microarray (68%) (Vontas et al., 2005) 
P. berghei In vivo transcriptional profiling of A. gambiae responses midgut invasion       √ Spotted, cDNA (EST) microarray 
(Vlachou et al., 
2005) 
P. falciparum In vitro transcriptional profiling of gametocytes √ √      Oligonucleotide DNA microarrays 
(Silvestrini et al., 
2005) 
P. falciparum Transcriptional profiling of non-gametocyte and gametocyte producing strains √ √      High density nucleotide microarray 
(Young et al., 
2005) 
P. berghei In vitro transcriptional profiling of ookinetes    √    SSH (Zygote and ookinete cDNA library) 
(Raibaud et al., 
2006) 
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Table 3.2. Proteome based surveys of the Plasmodium life-cycle 
 
Abbreviations: Asexual Blood Stages (ABS), Gametocytes (Gc), Gametes (Gm, or activated gametocytes), Multidimensional Protein Identification 
Technology (MUD-PIT, A technique for the separation and identification of protein and peptide mixtures), Oocysts (Ocy), Ookinetes (Ook), Sporozoites 
(Spz). Ticks indicate the life stages covered by each survey. Studies covering the oocyst stage are highlighted by an asterix (*). Roman numerical (I and II) 
indicate studies covered by the P. falciparum comparative functional genomics study (Le Roch et al., 2004). The table is not an exhaustive list but a 
comprehensive summary of relevant studies.  
 
Species 
 
Description 
 
Developmental stages  
 
V
ector  
 
Methodology 
 
Reference 
A
SB
 
G
c 
G
m
 
O
kn 
O
cy * 
Spz 
P. falciparum Proteomics survey of  synchronous  in vitro  blood stage culturesII √ √      
Liquid chromatography / Mass-
spectrometry 
(Lasonder et al., 
2002) 
P. falciparum Proteomics survey of merozoites, trophozoites, gametocytes and sporozoites  √ √    √  
Mud- PIT: high resolution liquid 
chromatography / Mass-spectrometry 
(Florens et al., 
2002) 
 
P. berghei In vitro / in vivo proteomics survey* √ √  √ √* √  Mud- PIT: high resolution liquid chromatography / Mass-spectrometry (Hall et al., 2005) 
P. berghei Male and female gametocyte, sex-specific proteomic analysis  √      
Mud- PIT: high resolution liquid 
chromatography / Mass-spectrometry 
(Khan et al., 
2005) 
P. falciparum Proteomic survey of oocysts, midgut and salivary gland sporozoites     √ √  
Mud- PIT: high resolution liquid 
chromatography / Mass-spectrometry 
(Lasonder et al., 
2008) 
P. berghei Ookinete microneme proteomic survey        Mud- PIT: high resolution liquid chromatography / Mass-spectrometry (Lal et al., 2009) 
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The study presented in this PhD-thesis utilised a two-pronged approach in the 
identification of genes implicated in P. berghei oocyst development. Firstly, a detailed 
transcriptional profiling of the P. berghei developmental migration through its A. 
gambiae vector was performed, from the bolus-located gametocytes to the mature 
oocyst sporozoites. The study was conducted in vivo, using a near complete P. 
berghei genome microarray platform. Emphasis was placed on the oocyst-stage with 
four different time points covering oocyst maturation. The subsequent microarray 
analysis was tailored to facilitate the identification of genes upregulated during oocyst 
development and to aid the selection of oocyst gene candidates for functional 
characterisation by their targeted disruption. Importantly, two time points were 
included for early oocyst (day two and five) as well as the late oocyst (day 10 and 13) 
development, to allow classification of genes specifically up-regulated in the 
immature versus mature oocyst. An in-depth, comprehensive down-stream analysis of 
the entire developmental transcriptome was performed separately, but is outside the 
scope of this thesis.  
 
Secondly, the in vivo proteome data-set available for mature oocysts collected from A. 
stephensi infected midguts at day 10-12 post-infection (PI), (Hall et al., 2005) was 
utilised. This data-set encompassed asexual and sexual stage development. The 
criteria employed for proteome mining selected for genes that were specifically 
detected in the oocyst that were conserved in P. falciparum and that were predicted to 
be either surface or secreted proteins. The latter criterion was important due to a 
special interest in identifying any Plasmodium genes that may exert a protective effect 
against the mosquito immune response, and a putative surface localisation is likely to 
be a prerequisite for any potential interaction with the mosquito vector. Genes with a 
putative nuclear localisation were also retained due to their potential to influence 
oocyst gene expression. A selection of candidates was subsequently subjected to 
detailed quantitative real- time PCR (qRT-PCR) analysis. The overall goal of the 
qRT-PCR screen was to identify genes which were transcriptionally active in the early 
oocyst. This second approach thus aptly complemented the early oocyst-biased 
transcriptome. 
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This chapter will outline: 
¾ The microarray-based transcriptional profiling of P. berghei developmental 
migration through A. gambiae, with emphasis on early oocyst development. 
¾ Identification and detailed in vivo qRT-PCR based transcriptional profiling of 
selected proteome-derived oocyst candidate genes. 
¾ Bioinformatic analysis and selection of candidates for functional characterisation 
by targeted gene disruption. 
 
3.2 P. berghei developmental arrays 
3.2.1 Verification of experimental design 
3.2.1.1 Normalisation of parasite numbers by eef1-α driven eGFP expression  
Parasite numbers naturally fluctuate as the parasite migrates through its mosquito 
vector, and parasite dynamics varies between infections in a density dependent 
manner (Sinden et al., 2007), (Figure 3.1, A).  
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Figure 3.1. Comparison between a schematic representation (A) of P. berghei infection 
dynamics (Sinden, 2002), and eGFP expression levels (B) during parasite developmental 
migration. eGFP is constitutively expressed throughout the P. berghei GFPcon life cycle and 
its expression levels were used to estimate parasite numbers at each time point investigated by 
microarray or qRT-PCR. eGFP transcript levels were measured by qRT-PCR and presented 
in arbitrary units of the average values derived from three separate biological experiments, in 
ٛ ٛ瑹琣 Ѝ ach time point was run in duplicates. eGFP expression levels were used to 
qRT-PCR data and as a basis for calculating the appropriate relative contribution to the 
standard reference for each time point. Standard error bars indicate standard error of the mean 
(SEM). Parasite sample composition at the starting point (1 hour) differs between Panel A and 
B. In (A) only gametocytes are represented at 1 hour, while a combined expression value for 
asexual and sexual blood-stages is given in (B) as both are present in the bolus at 1 hour PI. 
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These natural variations and continuous changes in parasite numbers necessitate 
normalisation of transcriptional data. Data must be normalised with regards to parasite 
population numbers, and the normalisation must be specific to each sample and each 
time-point investigated. In this study we used eGFP expression driven by the eef1-α 
promoter in the transgenic PbGFPcon parasite line for normalisation purposes (Franke-
Fayard et al., 2004). eef1-α is constitutively expressed throughout the P. berghei life-
cycle. Expression is enhanced in female gametocytes but this is negated by a down-
regulation in male gametocytes (Franke-Fayard et al., 2004). A qRT-PCR based 
analysis revealed a good correlation between predicted parasite transmission 
dynamics and eGFP transcript levels as the parasite developmental migration 
proceeds through its vector (Figure 3.1, B).  
 
3.2.1.2 The construction of a standard reference 
A standard reference was composed of a pool of RNA derived from infected mosquito 
midgut samples collected from all time points investigated, where the proportional 
representation of each time point had been calculated in respect of parasite numbers 
(based on level of eGFP expression) present at each stage (Figure 3.2). This 
normalisation approach was undertaken to achieve a standard reference that was 
composed of a pool of total RNA in which all life-stages are equally represented. The 
standard reference was processed in parallel to, and under the same conditions as the 
labelled sample cRNA.  
eGFP transcript
 abundance in each sample pool
Proportional representation of 
each sample pool to standard reference
1h
24h
2d
5d
10d
13d
 
Figure 3.2. eGFP transcript abundance in each sample pool and proportional 
contribution of each sample pool to the standard reference. The pie charts demonstrate the 
inverse correlation between eGFP transcript abundance (reflecting parasite density) and 
proportional contribution to the standard reference for each time point sample pool. The final 
amount of total RNA of each standard reference reaction was 2 μg prior to amplification and 
labelling.  
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3.2.1.3 Quality control of microarray and cDNA samples; 
Prior to global (P. berghei microarrays) and targeted (qRT-PCR with gene specific 
primers) transcriptional profiling, the RNA samples collected were subjected to 
quality control. Transcript levels of three P. berghei genes with known transcriptional 
profiles were assayed using qRT-PCR. The control genes used in this study were; 
ctrp, pbs21 and csp (expression profiles and biological roles described in detail in the 
introduction). For pbs21, transcripts are already present and peak 1 hour after 
infection (mixed sexual and asexual blood stages) and remain elevated during 
ookinete midgut invasion (22-26 hours). Pbs21 transcript levels disappear below the 
threshold of detection at day five post-infection (Figure 3.3 A).  
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Figure 3.3. qRT-PCR results for P. berghei control genes. The figure displays the results 
for the qRT-PCR based analysis of transcription levels of pbs21 (A), ctrp (B) and csp (C) as 
the P. berghei infection proceeds in its mosquito vector A. gambiae between 1 hour to 13 days 
post-infection Each data point is displayed as the average of two independent biological 
experiments for which each time point was assayed in duplicates. Standard error bars 
indicates standard error of the mean (SEM).Values at all time points are normalised against 
eef1-α promoter driven eGFP expression (D). 
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In contrast, ctrp transcripts are detected first at the ookinete stage (24hours), where a 
sharp peak in transcriptional activity occurs, followed by rapid transcript depletion 
(Figure 3.3 B). For csp, transcripts cannot be detected until 5 days following initial 
infection, and transcriptional activity peaks at the end point of this study at day 13-15 
day post-infection, which corresponds to the mature oocyst ready to release fully 
formed sporozoites into the mosquito haemocoel (Figure 3.3 C). All genes were 
normalised against eGFP. 
 
3.2.2 Transcriptional profiling of P. berghei development 
3.2.2.1  P.berghei global transcriptional regulation during its developmental 
migration through its mosquito vector A. gambiae. 
The transcriptional survey of P. berghei sexual and sporogonic development in A. 
gambiae was conducted using a near full (92%) genome Agilent oligonucleotide 
microarray. The study was performed on in vivo samples collected at discrete, stage-
specific time points corresponding to: mixed asexual and sexual stages (1 hours), 
ookinete midgut invasion (24 hours), early oocyst (2 days), mid-oocyst (5 days), 
mature oocyst (10 days) and sporozoite release into the haemocoel (13-15 days). The 
stringent filtering criteria utilised during the microarray analysis identified 810 genes 
that exhibited a >0.8 (Log2) fold up- or down-regulation compared to the standard 
reference at one, or more time points (Figure 3.4).  
 
As parasite development progresses with time, clusters of genes that are differentially 
expressed during the different developmental stages can be distinguished. The global 
expression profile of the 810 P. berghei genes that are differentially regulated during 
the parasite developmental migration through its A. gambiae vector is displayed in 
Figure 3.5. In this TreeView-visualised cluster analysis, all values are displayed as 
the average of three independent biological experiments and only genes which all 
expression values passed the above filtering procedure (Figure 3.4) are included.  
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Figure 3.4. Statistical summary of results from microarray analysis. The figure displays 
the results from the filtering of genes during microarray analysis, which led to the 
identification of 810 genes exhibiting a >0.8 (Log2) fold up- or down-regulation compared to 
the standard reference, and for which data is available for all six time points. Oligos were only 
included in the final analysis if following normalisation, the statistical analysis of oligo 
replicates, within and in-between biological experiments agreed.  
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Figure 3.5. Global transcriptional profile of P. berghei development in A. gambiae. The 
presence of distinctive clusters of time-specific up- or down –regulation demonstrates the 
successful detection of genes exhibiting differential regulation across the span of the entire 
study. Genes are clustered on the basis of similarity in expression profile using a hierarchical 
clustering algorithm and were visualised by TreeView. Yellow colour indicates up- and blue 
down- regulation in relation to the standard reference. All values are displayed as the average 
of 3 independent biological experiments. Only genes which have statistically valid data for all 
time points and show up- or down- regulation of at least 0.8 (Log)-fold over the standard 
reference are shown here.  
 
A more detailed, qualitative analysis of different stage-specific clusters identified a 
number of P. berghei genes with a known transcriptional profile and / or stage-
specific functionality. Examination of the microarray derived transcriptional profiles 
of these genes served two important purposes. Firstly, these genes provided an 
important way to further validate experimental design and analysis. Secondly, the 
analysis identified co-expression clusters containing known genes as well as a large 
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number of to date uncharacterised genes. The latter facilitates the selection of novel 
candidate genes for further analysis, as similar stage-specific transcription profiles 
may be an indication of functionality at the same developmental stage.  
 
3.2.2.2 Genes with putative roles in midgut invasion or ookinete-oocyst transition 
Several genes important for midgut invasion and / or ookinete-oocyst transition 
showed a sharp peak in transcript abundance at 24 hours following parasite uptake 
into the bolus (Figure 3.6, A). Clusters showing this expression pattern contained 
cdpk3 and the known micronemal proteins warp, soap, maop / pplp3, ctrp and chit1. 
Interestingly, these clusters were very small, in total containing only 16 genes, out of 
which nine were novel, uncharacterised genes.  
 
This is in contrast to the highly populated expression clusters for which the 
transcriptional peak stretches from 1 to 24 hours post-infection. These clusters contain 
a complex mixture of genes that are (a) expressed across the life-cycle but passes the 
>0.8 LOG differential expression filtering criteria, (b) actively transcribed by the 
parasite in the mosquito midgut <24 hours post-infection (e.g. P25 and Pbs21/P28) 
and (c) exclusively transcribed in the asexual and / or sexual blood stages but for 
which the transcript persists in the bolus <24h post-infection. The transcriptional 
profiles of a representative cluster of genes are illustrated in Figure 3.6, B.  
 
The inclusion of the 1 hour time point functions as an important control to identify 
genes that are up-regulated from 24 hours and onwards. However, no conclusions 
regarding the timing of gene-product utilisation in these clusters can be made as this 
study was not designed to dissect the stage-specific origin of the multitude of 
transcripts present in the mixed parasite population within the mosquito bolus.  
 
 
 
 
 
 
 123
A 
PB000947.00.0
calcium-dependent protein kinase (CDPK3)
-2
-1
0
1
2
3
 2 hr 24 hr 48 hr  5d  10d  13d 
PB000943.03.0
conserved hypothetical protein
-1
0
1
2
 2  h r 2 4  h r 4 8  h r  5 d   1 0 d   1 3 d  
PB000233.00.0
CSP and TRAP-related protein (CTRP)
-2
0
2
4
 2  h r 2 4  h r 4 8  h r  5 d   1 0 d   1 3 d  
Ex
pr
es
si
on
 (L
og
)
1 h     24 h 2 d     5 d      10 d    13 d  1 h     24 h 2 d      5 d      10 d    13 d  
PB0001343.02.0
 conserved hypothetical protein
-2
-1
0
1
2
3
 2 hr 24 hr 48 hr  5d  10d  13d 
Time PI 
 
Ex
pr
es
si
on
 
(L
og
)
1 h     24 h 2 d     5 d    10 d    13 d  1 h     24 h 2 d     5 d      10 d    13 d  
-3
.0
-2
.0
-1
.0 0.
0
+1
.0
+2
.0
+3
.0
Ex
pr
es
si
on
 (L
og
)
 
Ex
pr
es
si
on
 
(L
og
)
-3
.0
-2
.0
-1
.0 0.
0
+1
.0
+2
.0
+3
.0
-3
.0
-2
.0
-1
.0 0.
0
+1
.0
+2
.0
+3
.0
 
 
 
PB001363.02.0>conserved hypothetical protein
PB000674.02.0>DNA ligase 1, putative
PB000947.00.0>calcium-dependent protein kinase 3
PB000943.03.0>conserved hypothetical protein
PB000712.00.0>conserved hypothetical protein
PB001343.02.0>conserved hypothetical protein
B000233.00.0>CSP and TRAP-related protein 
PB000508.03.0>conserved hypothetical protein
PB001334.02.0>secreted ookinete adhesive protein 
PB000020.03.0> von willebrand factor A-related protein 
1h    24h     2d     5d    10d   13d
 
 124
B
PB000865.00.0
P28 (Pbs21) ookinete surface protein 
-1
0
1
2
3
 2 hr 24 hr 48 hr  5d  10d  13d 
T ime PI
-3
.0
-2
.0
-1
.0 0.
0
+1
.0
+2
.0
+3
.0
PB000266.01.0
Pb25 ookinete surface antigen 
-1
0
1
2
 2  h r 2 4  h r 4 8  h r  5 d   1 0 d   1 3 d  
Ex
pr
es
si
on
 (L
og
)
1 h       24 h 2 d      5 d    10 d    13 d  1 h      24 h 2 d      5 d      10 d    13 d  
PB000311.01.0
conserved hypothetical protein
-2
0
2
4
 2  h r 2 4  h r 4 8  h r  5 d   1 0 d   1 3 d  
Ex
pr
es
si
on
 
(L
og
)
1 h     24 h 2d     5 d      10 d    13 d  2 h     24 h 2d     5 d      10 d    13 d  
PB101572.00.0
conserved hypothetical protein
-1
1
3
5
 2  h r 2 4  h r 4 8  h r  5 d   1 0d   1 3 d  
-3
.0
-2
.0
-1
.0 0.
0
+1
.0
+2
.0
+3
.0
-3
.0
-2
.0
-1
.0 0.
0
+1
.0
+2
.0
+3
.0
Ex
pr
es
si
on
 (L
og
)
Ex
pr
es
si
on
 
(L
og
)
 
 
 
PB000865.00.0>ookinete surface protein Pos28
PB000240.03.0>conserved hypothetical protein
PB000867.00.0>conserved hypothetical protein
PB000761.03.0>ribosomal protein L10, putative
PB108348.00.0>hypothetical protein
PB000019.02.0>conserved hypothetical protein
PB000266.01.0>25 kDa ookinete surface antigen 
PB001602.02.0>cyclophilin-RNA interacting protein
PB000670.02.0>casein kinase II beta chain, putative
PB000593.02.0>mitochondrial inner memb. translocase
PB000829.00.0>ADP-ribosylation factor-like protein
PB105908.00.0>hypothetical protein
PB101572.00.0>conserved hypothetical protein
PB000311.01.0>conserved hypothetical protein
PB000309.01.0>conserved hypothetical protein
PB000053.00.0>endoplasmin homolog precursor
1h   24h     2d    5d    10d   13d
 
 125
Figure 3.6. Microarray-derived transcriptional profiles of genes up-regulated during 
asexual replication, sexual development and / or ookinete midgut invasion. 
Transcriptional profiles for selected clusters in which genes are up-regulated during ookinete 
midgut invasion (24 hours), (A), or asexual replication, sexual development and ookinete 
invasion (1-24 hour), (B). The transcriptional profiles in the different clusters are visualised 
by TreeView (Bottom Panel) where yellow colour indicates up- and blue down- regulation in 
relation to the standard reference. The expression profile of a selected number of genes 
(highlighted in purple) is shown as a bar graph above the respective transcriptional profile as 
visualised by Treeview (Top Panel). Data only shown for a small selection of representative 
genes. 
 
 
3.2.2.3 Clusters of genes with putative involvement in oocyst development  
Little is known of the type of gene products required by the developing oocyst. 
Interestingly, the present analysis detected a large shift in gene utilisation as the 
ookinete makes the transition into the oocyst. This is reflected in the large number of 
genes that are down-regulated in pre midgut-invasion stages and then up-regulated as 
oocyst development commences (Figure 3.5). The analysis identified densely 
populated oocyst-specific clusters at day five post-infection, for which many genes 
are annotated as hypothetical or conserved hypothetical proteins (Figure 3.7, A). 
These genes have not been characterised, to date and may be specifically required for 
oocyst development. The microarray analysis also identified clusters of genes that are 
gradually up-regulated as oocyst maturation progresses. Within this cluster are CSP 
and many other uncharacterised genes (Figure 3.7 B).  
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Figure 3.7. Microarray-derived transcriptional profiles of genes up-regulated during 
oocyst maturation. The figure shows the transcriptional profiles for selected clusters in 
which genes are up-regulated in the immature oocyst (5 days PI), (A) and mature oocyst (10-
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14 days PI), (B). The transcriptional profiles in the different clusters are visualised by 
TreeView (Bottom Panel) where yellow colour indicates up- and blue down- regulation in 
relation to the standard reference. The expression profile of a selected number of genes 
(highlighted in purple) is shown as a bar graph above the respective transcriptional profile as 
visualised by Treeview (Top Panel). Data only shown for a small selection of representative 
genes. 
 
3.2.3 Identification of oocyst expressed genes  
3.2.3.1 Cluster analysis and identification of oocyst stage expressed genes 
A more comprehensive analysis of genes whose expression were specifically 
upregulated in the oocyst was based on the hierarchical clustering (Spearman rank 
correlation) of all genes that had retained valid data for all six time points. The 
statistical filter criteria applied were the same as outlined in Figure 3.4, omitting the 
final >0.8 differential regulation criterion in order to retain a maximum number of 
genes. 1241 out of a total of 5610 genes passed the screen for “100% presence”. The 
Treeview visualisation of the clustering analysis of the 1241 genes revealed that the 
genes fall into two super clusters (Figure 3.8). The expression of the 379 genes in 
Cluster 1 are upregulated compared to the standard reference already upon uptake of 
an infected blood meal (1 h) and subsequently display varying degrees of expression 
in the ookinete and oocyst (>24h). In contrast, the 853 genes in Cluster 2 are down-
regulated compared to the standard reference at 1 h post-infection, with an 
expressional peak either in the ookinete (24h) or during different stages of oocyst 
development (>2d), (Figure 3.8).  
 
The expressional patterns within Cluster 2 were further investigated by re-clustering 
the data from Cluster 2, which identified two major sub-clusters. Cluster 2A 
comprised the majority of the genes (817 genes) and was characterised by down-
regulation at 1h post-infection, with expressional peaks in the ookinete and / or oocyst 
(d2-d13). The smaller Cluster 2B (46 genes) contained genes with low expression at 
1h post-infection, which were upregulated during early oocyst development (2-5d) 
and three genes (encoding ctrp and two hypothetical proteins) with expressional peaks 
in the ookinete.  
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Figure 3.8. Identification of genes specifically upregulated during oocysts development. 
Clustering of data for all genes with valid data for every time point revealed two super-
clusters; genes which expression peaks pre-midgut invasion (before ookinete-oocyst 
transition, <24 hours), (Super Cluster 1) and genes that are specifically upregulated during 
oocyst development, post-midgut invasion (after ookinete-oocyst transition, >2 days), (Super 
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Cluster 2), (A). Re-clustering of the data derived from Cluster 2A identified genes that are 
predominantly expressed during early-mid (Cluster 2A I) and mid-late (Cluster 2A II) oocyst 
development (B). Genes are clustered on the basis of similarity in expression profile using a 
hierarchical clustering algorithm and were visualised by TreeView. Yellow colour indicates 
up- and blue down- regulation in relation to the standard reference. All values are displayed as 
the average of 3 independent biological experiments. Only genes which have statistically 
valid data for all time points are shown here. In order to include a maximum number of genes 
(to obtain the broadest possible overview of genes expressed during oocyst development), no 
differential regulation criterion was applied to the cluster analysis. 
 
Repeat clustering of Cluster 2A allowed for the removal of another 10 genes which 
peaked during ookinete development (including seven hypothetical proteins and 
cdpk3). The remainder of cluster 2A could subsequently be broadly separated into 
genes peaking during early-to-mid (2-5d, Cluster 2A I) or mid-to-late oocyst 
development (5-13d, Cluster 2A II). 
 
The above, oocyst-specific data set was utilised to select candidates for functional 
characterisation. However, ongoing work is aiming to gain a broader perspective of 
gene expression during oocyst development. All genes within Cluster 2A were 
subjected to Interpro scans and if possible, GO term assignment. The majority (610 
out of 853) of genes lacked any functional domain predictions and remain annotated 
as hypothetical proteins. A preliminary analysis of the existing functional domain 
assignments of oocyst Cluster 2 (243 genes), where each predicted function has been 
assigned to a broad biological process, indicate that genes implicated in transcription, 
translation, protein processing (proteolysis and post-translational modifications), 
signalling, DNA replication and DNA repair appear to be over-represented in the 
maturing oocyst. In addition, several genes involved in cell cycle regulation, lipid 
metabolism, organelle transport and vesicle trafficking were identified as upregulated 
during oocyst development (Table 3.3). 
 
Graphs depicting the overall expression trends of a selection of biological processes 
are presented as the line of average of all genes assigned to the respective biological 
process within Cluster 2 (Figure 3.9). The noisy minimum and maximum lines of the 
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highly populated Transcription/Translation and DNA repair/replication groups stems 
from a divergence in expressional profiles within early, mid and late oocyst 
development of the individual genes assigned to these groups. 
 
Table 3.3. Biological processes upregulated in the maturing oocyst 
 
Biological Process Number of genes 
Hypothetical / Conserved Hypothetical Proteins 610 
Transcription / Translation 51 
Other (Hsp, GPI anchor synthesis etc) 27 
Protein Processing (Proteolysis, Post-translational modifications) 25 
Signalling: 17 
 - Phosphatase: 2  
 - Kinase: 14  
 - Other: 1  
DNA replication / DNA repair 16 
Lipid metabolism 13 
Intracellular transport 12 
Respiration, Electron transport, Energy 11 
Carbohydrate / Sugar Metabolism 8 
RNA Binding / Metabolism 7 
BIR proteins 7 
Cytoskeleton (Actin, Tubulin) 7 
Redox 6 
Cell cycle Regulation 6 
Vesicle trafficking 5 
Protein-Protein Interaction 5 
Pfam (-1,1,4,4,3) 5 
Organelle transport Dynein 5 
RBC binding proteins 4 
Nucleotide metabolism 4 
Nitrogen metabolism 2 
TOTAL 853 
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Figure 3.9 Transcriptional trends of genes assigned to a selection of biological processes  
that are upregulated in the maturing oocyst. The profiles are represented by the line of 
average deriving from the average expression value of all genes at each time-point (Green 
line), with lines of minimum and maximum expression values for each time point (Grey). 
 
3.2.3.2 Selection of transcriptome Derived Oocyst Genes for targeted disruption 
The selection of transcriptome Derived Oocyst Gene (tDOG) candidates for 
functional characterisation was based on their respective microarray-derived 
expression profiles (Figure 3.7) and functional domain predictions, indicating 
different putative roles during sporozoite formation or transmission (Figure 3.10). All 
three candidates were detected within oocyst Cluster 2A II and have identifiable one-
to-one orthologues across all sequenced Plasmodium species. 
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Figure 3.10. Predicted gene models of the transcriptome-derived oocyst gene candidates 
(tDOG) selected for functional characterisation by targeted disruption. The figure 
presents a schematic representations of the predicted gene models for tDOG-1 (Pb000024.01 / 
Pb001219.02.0), (A), tDOG-2; (Pb300124.00.0), (B) and tDOG-3 (Pb000811.00.0), (C) in P. 
berghei (Pb), P. falciparum (PF), P. vivax (Pv) and P. yoelii (PY). Predicted signal peptides 
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(Solid Light Blue Square) and transmembrane domains (Solid Dark Blue triangle) are denoted 
together with functional domain predictions.  
 
tDOG-1 (PB00024.01.0) is specifically up-regulated in the mature oocyst (Day 10-
13), (Figure 3.7). The gene is annotated as a hypothetical protein, lacking 
Plasmodium orthologues and encodes a putative GYF-domain, a proline-rich peptide-
binding motif implicated in protein-protein interactions (http://smart.embl-
heidelberg.de/smart/do_annotation.pl? DOMAIN=GYF). However, BLAST searches 
and manual gene annotation revealed that tDOG-1 is conserved among Plasmodia and 
that the P. berghei orthologue is composed of two predicted open reading frames 
(ORFs), (Pb00024.01.0 and the upstream Pb00121902.0). The erroneous annotation 
of Pb00024.01.0 and Pb00121902.0 as two separate ORFs is supported by their 
alignments to the closely related P. yoelii tDOG-1, which comprise one single, large 
ORF spanning the length of the two separate ORFs predicted in P. berghei (Figure 
3.10, A).  
 
Pb001219.02.0 encodes a predicted WD40 domain and a eukaryotic initiation factor 
2α (eIF2α) domain. WD40 domains are implicated in a wide variety of biological 
processes and act as scaffolds in the assembly of multi-protein complexes 
(http://smart.embl-heidelberg.de/smart/do_annotation.pl?ACC=SM00320). The 
predicted WD40 domain thus comprises a second protein-protein interaction motif 
encoded by tDOG-1. The predicted eukaryotic initatation factor (eIF2) facilitates 
initiation of translation by mediating tRNAMet binding to the ribosomal complex and 
is composed of three subunits denoted α, β and γ. eIF2 activity is strictly controlled by 
a combination of phoshorylation and guanine nucleotide exchange. eIF2α is a 
regulatory subunit and the target for phosphorylation (Fennell et al., 2009). All 
domain predictions were supported by orthologues alignments (Figure 3.10, A). The 
respective orthologues in P. falciparum, P. vivax and P. yoelii all encode putative 
eIF2α domains and all orthologues but that of P. vivax encode a predicted WD40 
domain. A GYF domain was predicted in all species except for P. falciparum and an 
additional protein binding motif, a BAG domain (http://smart.embl-
heidelberg.de/smart/do_annotation.pl?DOMAIN=BAG), was identified exclusively in 
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P. yoelii tDOG-1. These findings underline the importance of mediating protein 
interactions for the function of tDOG-1 but also indicate some redundance in the 
number and nature of protein-protein interaction domains of tDOG-1. 
Up-regulation of tDOG2 (PB300124.00.0) expression is initiated during ookinete 
midgut invasion and its transcriptional activity peaks in the young oocyst (day 5), 
although expression remains at an elevated level throughout oocyst development 
(Figure 3.7). tDOG-2 encodes a putative patatin domain, associated with eukaryotic 
(lyso)phospholipid lipolytic activity and membrane homeostasis (Fernandez-Murray 
and McMaster, 2007), (Figure 3.10, B).  
tDOG-2 also encompasses a predicted TM domain and a putative FabD domain. FabD 
is a structural feature connected with lysophospholipase activity 
(http://supfam.org/SUPERFAMILY/cgi-bin/scop.cgi?ipid=SSF52151) and 
filamentous actin (F-actin) binding in eukaryotes (http://smart.embl-
heidelberg.de/smart/do_annotation.pl?DOMAIN=FABD). The potential F-actin 
binding properties of the FabD domain may serve to determine the subcellular 
location of the protein or act in an inhibitory manner of tDOG-2 protein activity. The 
prediction of a TM domain indicates an association with external or internal 
membrane structures.  
The patatin, FabD and TM domains are conserved among tDOG-2 orthologues in P. 
falciparum and P. vivax. However, P. berghei tDOG-2 appears to be truncated 
compare to its human malaria orthologues with an N-terminal TM directly adjacent to 
the patatin domain. The the P. yoelii tDOG-2 orthologue also appears to exist in a 
truncated form and curiously no functional domain predictions could be delineated in 
silico for P. yoelii tDOG-2 (Figure 3.10, B). 
tDOG-3 (PB000811.00.0) transcription is upregulated upon onset of oocyst 
development (d2) and despite some fluctuations, remain elevated throughout oocyst 
development (Figure 3.7). tDOG-3 encode a putative soluble NSF (N-
ethylmaleimide-sensitive factor) attachment protein (SNAP)  receptor, t-SNARE, 
domain. SNARE proteins mediate vesicle fusions such as those occurring during the 
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fusion of secretory vesicles with the cell membrane or membranous compartments 
such as the Golgi apparatus. There are two forms of SNAREs, vesicle SNAREs (v-
SNAREs) are incorporated into the vesicle membrane during vesicle budding, while 
target SNAREs (t-SNAREs) localise to the membrane of the target compartment 
(http://pfam.sanger.ac.uk/family?id=SNARE). Consistent with an expected membrane 
localisation, tDOG-3 contains a putative TM domain. tDOG-3 also encode a syntaxin 
domain. Syntaxin SNAREs are the founding members of the SNARE family of 
proteins. The role of the syntaxin domain varies; it generally facilitates protein-protein 
interactions, including interactions with other SNARE complex proteins, vesicle coat 
proteins and GTPases (http://pfam.sanger.ac.uk/family?acc=PF00804). The domain 
composition and positioning is extremely well conserved among Plasmodium tDOG-3 
orthologues (Figure 3.10, C). 
 
3.2.4 Discussion 
3.2.4.1 Transcriptional regulation of Plasmodium sexual and sporogonic 
development 
Transcriptional regulation plays a key role in several different aspects of Plasmodium 
biology. The mutually exclusive expression of var gene alleles, which facilitates 
immune evasion in the vertebrate host, is regulated at the level of transcriptional 
activation (Kyes et al., 2007). Furthermore, regulation of the complex cell cycle that 
drives asexual replication is mediated by a tightly controlled cascade of transcriptional 
activation. Distinct sub-sets of genes are expressed at different stages as the invaded 
merozoite develops intraerythrocytically via the ring and trophozoite forms to 
eventually undergo schizogony (Ben Mamoun et al., 2001, Bozdech et al., 2003). 
Sexual differentiation is also mediated by significant changes in the parasite 
transcriptional repertoire (Young et al., 2005, Hall et al., 2005). Similarly, this study 
has showed that the ookinete-oocyst developmental transition is associated with a 
large scale shift in transcriptional activity. In accordance with what has been observed 
during asexual blood stage replication, different sub-sets of genes were differentially 
regulated during early and late oocyst development.  
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Transcriptional regulation is thus a core mechanism in driving Plasmodium 
development. However, the components of the transcriptional machinery which 
govern the remarkable plasticity of the Plasmodium transcriptome are poorly 
understood. Initial analysis of the sequenced Plasmodia genomes identified few 
conserved cis-promoter elements and revealed a paucity of specific, regulatory 
transcription factors with homology to those found in other eukaryotes (Aravind et al., 
2003). These findings were initially interpreted as that the Plasmodium mechanisms 
of transcriptional control were significantly different from those of other eukaryotes. 
Although elusive, due to the difficulty of assigning Plasmodium gene function based 
on homology searches and identification of promoter sequences in the extremely AT-
rich non-coding regions, recent studies have identified several components consistent 
with the presence of classical eukaryotic, mono-cistronic transcription machinery in 
Plasmodium  (Coleman and Duraisingh, 2008).  
 
Ontology based Pattern Identification (OPI) uses a combination of expression data 
and gene annotations in order to identify clusters of co-expressed genes. Entry into the 
sexual differentiation pathway is associated with the upregulation of an OPI cluster of 
246 genes that share a 10-nucleotide cis-element (Young et al., 2005). This cis-
element (enriched in the promoter regions of gametocyte associated genes) forms a 
part of a more extensive intergenic region that has been experimentally determined to 
be required for the expression of pfs25 (Dechering et al., 1999). An extension of the 
search for additional cis-elements utilised OPI in conjunction with a novel algorithm 
named Gene Enrichment Motif Searching (GEMS), especially devised to overcome 
difficulties posed by the AT-rich genome when predicting cis-elements in silico. This 
approach identified an additional 34 putative cis-elements that were found in the 
promoter regions of genes implicated in a range of cellular processes spread across 21 
OPI clusters, covering not only sexual development but also antigenic variation, 
sporozoite development, invasion, DNA replication and protein translation (Young et 
al., 2008).  
 
The above studies clearly indicate that cis-elements, and thereby conventional 
eukaryotic transcriptional regulation, are likely to play a role in a wide range of 
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Plasmodium developmental processes (Young et al., 2008). This hypothesis has 
gained further strength by the identification of 26 members of a family of proteins 
with the Apelata2 (AP2) DNA binding domain encoded by the P. falciparum genome. 
The AP2-domain is commonly present in plant transcription factors and represents the 
identification of the first family of bona fide regulatory transcription factors in 
Plasmodium (Balaji et al., 2005). One of the P. falciparum AP2-family members 
(PF0200c) has been shown to specifically bind a GTGCAC palindromic sequence and 
its expression is highy correlated with transcription of genes whose promoter 
sequences contain the GTGCAC motif (De Silva et al., 2008).  
 
Very recent findings demonstrate that another member of the AP2 family, AP2-O, is 
specifically transcribed in the female gametocyte and that its associated transcript is 
translationally repressed in a DOZI-dependent manner. AP2-O translation is initiated 
post-fertilisation in the developing ookinete and its binding to a TAGCTA cis-
element, or four other closely related sequences, is responsible for the transcription of 
all known P. berghei midgut invasion genes including ctrp, soap, chit1, warp, p25, 
pbs21, maop, cdpk3 and two psop genes implicated in midgut invasion (Yuda et al., 
2009). Intriguingly, the targeted disruption of AP2-O resulted in the down-regulation 
(>5-fold) of only a small sub-set of 15 genes out of all the genes transcribed in the 
ookinete; four known ookinete specific micronemal genes, six genes known to be 
transcribed in the developing ookinete and five hypothetical genes (including the two 
psop genes), (Yuda et al., 2009). These findings are well correlated with the data 
presented here. Only a small cluster of 16 genes was specifically upregulated in the 
ookinete (including warp, soap, ctrp, maop / pplp3, chit1 and cdpk3).  
 
This is in stark contrast to the large number of P. berghei genes that in this study are 
upregulated across the first 24 hours upon entry into the mosquito vector (taking into 
account that this study was not designed for, and is unable to, separate sexual stage 
transcription from asexual stage contamination) and the 368 genes which pre-
synthesised transcripts are regulated by DOZI (Mair et al., 2006). Out of scope of the 
study presented here is the ongoing comparative transcriptional profiling between 
early stage mosquito infections with the Pb2.34 gametocyte- and Pb2.33 non-
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gametocyte- producing strains, which is expected to gain further insight into ookinete 
specific gene expression patterns. 
 
Together these results support the hypothesis that ookinete differentiation is supported 
by at least two different transcriptional strategies (Yuda et al., 2009). A substantial 
subset of genes important for ookinete development are pre-synthesised and 
transcribed in the female gametocyte but remain translationally repressed until 
immediately after fertilisation (Mair et al., 2006). A much smaller sub-set of genes 
(15-22 genes identified depending on the study) are specifically transcribed post-
fertilisation (Yuda et al., 2009, Raibaud et al., 2006). The genes transcribed de novo 
post-fertilisation are mainly genes linked to midgut-invasion, some with confirmed 
micronemal localisation. Transcription of these genes appears to be initiated 8-10 
hours post-fertilisation and expression remains active until that of midgut invasion at 
24 hours upon entry into the mosquito midgut lumen (Yuda et al., 2001, Yuda et al., 
1999b). 
 
In grossly simplified terms, zygote and ookinete differentiation appears to be mainly 
facilitated by the release of pre-synthesised, maternal transcripts from translational 
repression immediately upon fertilisation. Only once a certain stage of zygote 
development has been reached, and the ookinete starts to develop into its mature form, 
does ookinete motility and invasion specific gene transcription take place. This 
compartmentalised transcription strategy is mirrored by the transcriptional restriction 
of merozoite motility and invasion genes to late erythrocytic schizogony (Bozdech et 
al., 2003). 
 
In essence, despite occurring extracellularly in the mosquito vector, at a much larger 
scale and over a much longer period of time, sporogony is in many ways akin to blood 
and liver stage schizogony. The parasite enlarge in size and upon entry of S-phase, 
DNA replication occurs in the absence of nuclear envelope breakdown or cytokinesis, 
with nuclear and cell division events (uncoupled from DNA synthesis) eventually 
producing multiple, invasive progeny which are released into the immediate 
environment. Transcriptional profiling of erythrocytic schizogony revealed an 
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upregulation of genes associated with general cellular processes such as transcription, 
translation and DNA synthesis during early schizogony (ring and trophozoite stages). 
Analysis of genes upregulated during oocyst development indicated that this 
expressional pattern may be mirrored during oocyst development.  
 
Genes associated with transcription, translation, protein processing, signalling, cell 
cycle regulation, lipid metabolism, organelle transport and vesicle trafficking, DNA 
replication and DNA repair were all upregulated in the maturing oocyst. However, in 
this basic and preliminary analysis, all genes upregulated during oocyst development 
were analysed together; irrespectively of individual genes displaying early, mid or late 
oocyst expressional bias. A more detailed, future analysis will focus on the analysis of 
sub-clusters of genes displaying differential regulation throughout oocyst 
development and is expected to yield further insight into oocyst gene expression, and 
will allow for a clear division of genes into early, mid and late oocyst expressed genes 
and thus facilitate a more accurate comparison to erythrocytic schizogony. 
 
3.2.4.2 Putative functions of transcriptome derived oocyst gene candidates 
The selection of transcriptome Derived Oocyst Gene (tDOG) candidates for 
functional characterisation was based on their respective microarray-derived 
expression profiles and functional domain predictions. Their respective putative 
domains indicated putative roles during either membrane biogenesis or membrane 
remodelling during sporogony (tDOG-2, 3) or a potential role in the protection against 
mosquito immune response during sporozoite release into the immune-factor rich 
haemocoel (tDOG-1). 
 
tDOG-1 encodes a putative eIF2α domain and multiple protein-protein interaction 
motives. A search of eIF2α containing proteins in PlasmodDB identified two 
conserved putative P. berghei eIF2α proteins, Pb001219.02.0 (together with 
Pb000024.01.0 forming tDOG-1) and Pb001039.00.0. The eIF2 complex and its 
eIF2α subunit is essential for translational initiation and expression of the P. 
falciparum tDOG-1 orthologue has been detected in the asexual blood stages (Le 
Roch et al., 2003, Florens et al., 2002). Nevertheless, the existence of a minimum of 
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two P. berghei eIF2α subunits and the specific upregulation of tdog-1 during 
sporozoite development may indicate a degree of functional redundancy of eIF2α 
proteins during asexual blood stage replication.  
 
There are strong links between eIF2 inhibition by eIF2α phosphorylation and cellular 
stress responses. eIF2-mediated translation can only proceed when the eIF2β subunit 
is bound to GTP. Phosphorylation of eIF2α inhibits the ability of eIF2β to exchange 
GDP for GTP and thereby maintains the eIF2 complex in its inactive form (eIF2-
GDP). The overall effect of phosphorylation of the regulatory subunit eIF2α is thus 
that of global translational inhibition, conserving cellular resources and allowing the 
cell to adapt to the environmental stress exposure. However, despite the general state 
of translational inhibition as governed by eIF2α, a selected sub-set of mRNA 
transcripts are translated, which corresponding proteins are responsible for the 
subsequent cellular stress response (Holcik and Sonenberg, 2005, Fennell et al., 
2009).  
 
Upon egress from within the protective oocyst capsule, the sporozoite encounters a 
hostile environment as it encounters the haemocoel, rich in components of the 
mosquito immune response. Based on the specific upregulation of the putative eIF2α 
encoding gene tDOG-1 in the mature oocyst and the hypothesis that eIF2α based 
regulation of translation may mediate immune-protective translational responses upon 
sporozoite release into the mosquito haemocoel, tDOG-1 was selected for functional 
characterisation by targeted gene disruption. 
 
Sporogony implicates the execution of significant membrane biogenesis and 
remodelling as sporoblasts are formed by invaginations of the lipid bilayer lining the 
oocyst capsule, which eventually gives rise to individual, compartmentalised 
sporozoites. Two candidates, tDOG-2 and 3, were selected for functional analysis by 
targeted disruption based on their putative involvement in lipid metabolism or 
membrane trafficking during sporozoite formation.  
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tDOG-2 encompass a putative patatin domain, a motif generally connected to 
lysophospholipid lipolytic activity. Phosphatidylcholine is the main component of 
eukaryotic membranes. In S. cerevisae a patatin-containing protein, the 
lysophospholipase neuropathy target esterase-1 (NTE1), facilitates the deacylation of 
phosphatidylcholine to glycerophosphocholine and thus plays a crucial role in lipid 
membrane homeostasis (Fernandez-Murray and McMaster, 2007). Furthermore, the 
activity of NTE1 is regulated by components of the yeast secretory machinery which 
are involved in lipid metabolism and vesicular trafficking. NTE-1 is an integral 
membrane protein localised to the yeast endoplasmic reticulum (Fernandez-Murray 
and McMaster, 2007). Consistent with a NTE1-like function, tDOG-2 encompasses a 
predicted TM domain.  
 
tDOG-3 is a putative t-SNARE protein. SNARE proteins facilitate vesicle fusions 
such as the fusion of secretory vesicles with the cell membrane or membranous sub-
cellular compartments. The t-SNARE proteins localise to the membrane of the target 
compartment an acts as receptors for v-SNARE proteins present on the surface of 
trafficking vesicles. t-SNARE proteins are thus strongly implicated in membrane 
fusion and vesicle transport, suggesting a possible role of tDOG-3 in membrane 
biogenesis or membrane remodelling during sporogonic development. 
 
3.2.5 Summary 
¾ The use of eef1-α driven GFP transcription as a means to normalise 
transcriptional data was validated by qRT-PCR. 
¾ A microarray-based, in vivo transcriptome analysis of P. berghei developmental 
migration through its mosquito vector A. gambiae identified 810 differentially 
regulated genes. 
¾ Expressional peaks spanned the entire developmental scope of the study. 
¾ The onset of oocyst development was associated with a substantial change in 
parasite transcriptional repertoire.  
¾ Clustering analysis of microarray data identified genes specifically upregulated 
in the maturing oocyst.  
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¾ Genes implicated in transcription, translation, protein processing, cell cycle 
regulation, signalling, lipid metabolism, organelle transport and vesicle 
trafficking, DNA replication and DNA repair are all upregulated compared to 
the standard reference during oocyst development.  
¾ Based on their expressional peak during the oocyst stage and putative domain 
composition, three candidate genes termed transcriptome Derived Oocyst Genes 
(tDOG) were selected for functional characterisation by targeted gene 
disruption. 
 
3.3 Selection screen of oocyst genes derived from a proteomic survey 
3.3.1 Identification of genes with a putative role in oocyst development 
In the data-set reported for the P. berghei life-cycle proteomic survey (Hall et al., 
2005), a total of 277 genes were recorded with peptide hits in material collected from 
midguts infected with day 9-12 oocysts (Figure 3.11, A). Out of these, 122 genes had 
no hits during the asexual blood stages. From this group 48 genes were predicted to 
contain signal peptide or transmembrane sequences in P. berghei or, where 
orthologues existed, in one or more other Plasmodium species. Out of this group of 48 
putative candidates, seven genes had already been characterised by their targeted 
disruption and were not further investigated. These genes included csp (Menard et al., 
1997), imc1-α (Khater et al., 2004), trap, (Sultan et al., 1997), the p25 and p28 
ookinete surface antigens (Siden-Kiamos et al., 2000) and lap2 (Raine et al., 2007). 
As studies of the KO-lines of all the above genes have reported different forms of 
oocyst defective phenotypes, their presence served as positive controls for the 
candidate selection screen used in this study. In addition the list encompassed the 
cysteine repeat modular protein 4 (crm4), one conserved hypothetical protein and two 
serine/threonine protein kinases (Ser/Thr Pk), for which at the time of selection the 
generation of KO lines were in progress or had already been completed (personal 
communication A. Ecker and R. Tewari). An additional 11 genes which belonged to 
the Plasmodium interspersed repeat (pir) super gene family (Janssen et al., 2004) and 
six genes which were annotated as having putative house keeping functions were also 
excluded from further analysis. Out of the remaining 21genes, 15 candidates had clear 
orthologues in the human malaria species P. falciparum and / or P. vivax.  
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15 genes: Manual annotation
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36
13
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Figure 3.11 Summary of candidate selection from the proteome. The top panel outlines 
the selection screen applied to the P. berghei life-cycle proteome data-set, demonstrating the 
selection filters applied and the number of genes passing each criterion. The gene annotations 
for genes, which have already been characterised by their targeted disruption and the last 
fifteen, manually annotated genes, are also indicated (A). The bottom panel summaries the P. 
A 
B 
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berghei accession numbers, gene annotations and gene-specific peptide hits (green square) in 
the proteome for the eight candidates selected fro qRT-PCR. The numbers in the oocyst 
peptide-hit column corresponds to the number of spectral hits in the oocyst stage which may 
be taken as an indication of relative peptide abundance in the oocyst (B). Asexual blood 
stages (ASB), Gametocytes (Gc), Ookinetes (Okn), Oocysts (Ocy) and Sporozoites (Spz). 
 
The final fifteen genes were manually annotated. 12 genes were confirmed to be 
coding for conserved hypothetical proteins, lacking any known predicted functional 
domains, and hence no clue to their functionality was provided at the time of 
selection. The three remaining genes were annotated as putative orthologues of the 
235kD rhoptry protein from P. yoelii (Holder et al., 1991). The eight candidates 
selected for further characterisation are displayed in (Figure 3.11, B). These were 
chosen over the remaining 15 genes on the basis of peptide abundance (spectral hits) 
in the proteome data set. 
 
3.3.2 qRT-PCR based transcriptional profiling of oocyst candidate genes 
In order to acquire additional information about the stage of oocyst development 
during which these genes may act, the transcription profiles of the final eight 
candidates were analysed in more detailed by qRT-PCR. Two of the candidates, 
annotated as conserved hypothetical proteins, displayed very similar transcriptional 
profiles (Figure 3.12, A-B). Subsequent manual annotation revealed that these two 
ORFs are not separate genes, but in fact are two different parts of the same ORF (see 
below for further discussion). For these gene (s), little transcript appear to be present 
one hour following infection, with transcript levels rising during ookinete midgut 
invasion (22-26 hours post infection) to reach a peak during the transition between 
ookinete and oocyst (2 days post infection), after which transcripts decline to reach a 
low but steady level up to 10 days following infection. Another two candidates (both 
conserved hypothetical proteins) also exhibited a peak in transcript levels during early 
oocyst development, however detectable levels of were found already one hour 
(mixed sexual and asexual blood stages) after the uptake of infected blood meal and 
remained at a detectable level throughout the time course investigated (Figure 3.12, 
D-E).  
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Figure 3.12. qRT PCR based transcriptional profiling of genes selected from proteome 
The figure displays transcript levels throughout P. berghei sexual development in its A. 
gambiae vector. Each data point is displayed as the average of two independent biological 
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experiments for which each time point was assayed in duplicates. Standard error bar indicates 
standard SEM. Values at all time points are normalised against GFP. Genes selected for 
functional analysis are marked with red and genes excluded from further analysis are labelled 
gray. 
 
In contrast, a fifth candidate (also annotated as a conserved hypothetical protein) 
displayed a prolonged peak of transcript between one hour and 24 hours after 
infection, after which transcript levels were steadily declining until day 10 post 
infection, at which point no detectable transcript was present (Figure 3.12, C). The 
remaining three candidates were annotated as putative orthologues of P. yoelii yoelii 
rohptry proteins or rhoptry-like proteins. Transcripts of all three genes were revealed 
to be present at high levels directly after infection (Figure 3.12, F-H). For two of the 
candidates, transcript levels remained detectable until 5 days post infection (Figure 
3.12, F and H), and for one of them levels appeared to be on the increase again at the 
endpoint of the study (day 13 post infection; Figure 3.12, F). For the third putative 
rhoptry orthologue, transcript levels were almost completely depleted by the time of 
ookinete midgut invasion and undetectable in the young oocyst, day two post-
infection (Figure 3.12 G).  
 
3.3.3 Selection of proteome Derived Oocyst Genes for targeted disruption 
Out of the eight candidates that were subjected to qRT-PCR, three genes were 
selected for further functional analysis by their targeted disruption. These three genes 
were termed proteome-Derived Oocyst Genes (pDOG) and were the following 
candidates pDOG1 (Pb300603.00.0 / Pb300510.00.0), pDOG2 (Pb000064.01.0) and 
pDOG3 (Pb000043.01.0). Their respective transcriptional profiles are indicated by red 
colour graphs in Figure 3.12. The transcriptional profiles of pDOG 1 and 3 indicated 
a potential function during early oocyst development. pDOG2 was included as its 
protein was specifically detected in the oocyst, while its transcript peaked in the 
mixed blood-stages and ookinete, making it a potential candidate for translational 
repression. The predicted P. berghei gene models for these three genes are displayed 
in Figure 3.13, together with the schematic representation of their respective 
Plasmodium orthologues.  
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pdog-1 is predicted to encode a large (~310 kD) transmembrane protein, with a clear 
signal peptide predicted in P. berghei and its P. yoelii orthologues (Figure 3.13, A). 
During further in silico analysis and sequence alignment of all respective Plasmodium 
orthologues, it was revealed that two of the candidates (Pb300603.00.0 and 
Pb300510.0.00) were incorrectly annotated as separate ORFs. It was also concluded 
that in contrast to the initial annotation, the gene is conserved across all sequenced 
Plasmodium genomes. Furthermore, an additional upstream region, originally 
annotated as a separate ORF (Pb000071.00.0), was also identified as potentially being 
part of the same gene (Figure 3.13, A). 
 
The predicted transmembrane domain is N-terminally positioned, with the large 
majority of the protein predicted to be extracellular. In P. yoelii, P.falciparum and P. 
vivax the gene is predicted as one single ORF. BLAST searches and sequence 
alignments between pdog1 and its orthologues revealed that the likely reason for the 
misprediction of Pb000071.00.0 as a separate ORF is the existence of a contig gap in 
the P. berghei assembly between Pb300603.00.0 / Pb300510.0.00 and Pb000071.00.0. 
The reason for the prediction of Pb300603.00.0 and Pb300510.0.00 as separate ORFs 
is less apparent as they reside on the same P. berghei contig but were the subject to 
false calling of start and stop codons. 
 
 pdog2 encodes another large (~180kD) predicted transmembrane domain protein, 
which in contrast to pdog1 lacks a predicted signal peptide (Figure 3.13, B). With the 
exception of its P. vivax orthologues, two putative transmembrane domains are 
predicted with varying confidence. The predicted transmembrane domain(s) are 
located towards the C-terminus of the putative protein, with the majority of the 
protein (N-terminal tail) predicted to be extracellular. The N-terminus of pdog2 is 
slightly truncated in P. berghei and P. falciparum. However, in P. berghei the contig 
on which pdog2 resides starts only twenty base pairs upstream of its predicted start 
codon, with poor sequence quality at the beginning of the contig. It is thus possible 
that in reality pdog2 is of same length in P. berghei and P. yoelli, where the start 
codon can be confidently predicted.  
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Figure 3.13. Predicted gene models of the proteome-derived oocyst gene (pDOG) 
candidates (pDOG) selected for functional characterisation by targeted disruption. The 
figure presents schematic representations of the predicted gene models for pDOG-1 
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(Pb300603.00.0 / Pb300510.00.0 / Pb000071.00.0), (A), pDOG-2; (Pb000064.01.0), (B) and 
pDOG-3 (Pb000043.01.0), (C) in P. berghei (Pb), P. falciparum (PF), P. vivax (Pv) and P. 
yoelii (PY). Predicted signal peptides (Solid Purple Square) and transmembrane domains 
(high confidence -Solid Dark Blue Square, low confidence – Solid Pale Blue Square) are 
denoted. The predicted position of stop and start codons in P. berghei are indicated together 
with the predicted start codons in all Plasmodium orthologues. No significant deviation in 
stop codon position was found among any of the orthologues.  
 
Similarly, pdog3 is predicted to encode a transmembrane protein but with a centrally 
located double transmembrane domain (Figure 3.13, C). In P. yoelii the predicted 
gene is truncated due to lack of sequence data upstream of the second transmembrane 
domain. Since the predicted gene is located at the start of the P. yoelli contig, this is 
likely to be an assembly artefact rather than an actual difference in length of coding 
sequence between the P. yoelii gene and the rest of the orthologues. 
 
3.3.4 Discussion 
Three rhoptry orthologues were included in the qRT-PCR based transcriptional 
analysis as curiously, the associated proteins were detected in moderate abundance 
specifically in the oocyst (with one candidate also detected in the sporozoite stage). 
Thereby, from proteome data, a potential sporozoite rhoptry or oocyst non-rhoptry 
function could be envisaged. However, by qRT-PCR all three genes displayed blood-
stage transcriptional activity, with transcript levels steadily declining during sexual 
development. This contradicts a putative oocyst / sporozoite specific role and is 
instead consistent with their functional prediction as putative merozoite rhoptry 
proteins (Holder et al., 1991). The three rhoptry orthologues were thereby excluded 
from any further analysis.  
 
Importantly, a lack of corresponding peptide hits in the asexual blood stages for these 
rhoptry orthologues does not exclude actual blood stage expression since in proteomic 
surveys, a lack of peptide hits does not prove actual protein absence in a sample. 
Examination of a P. falciparum transcriptomic data did indeed provide evidence for 
blood-stage expression of the P. falciparum orthologues of PB103906.00.0 
(PFL2520w) and PB000072.03.0 (MAL13P1.39). The transcript of the 
 151
PB103906.00.0 P. falciparum orthologue is strongly upregulated in the late schizont 
and merozoite (Le Roch et al., 2003), with its corresponding protein detected in P. 
falciparum sporozoites (Florens et al., 2002). Together these data supports the notion 
of PB103906.00.0 as a bona fide merozoite and sporozoite rhoptry protein.  
 
Another candidate (PB001118.00.0) displayed a transcriptional peak during early 
oocyst development but was excluded due to the in silico identification of a putative 
ubiquitinylation domain at a later stage in this study. Ubiquitinylation forms an 
important role in maintaining the steady-state levels of protein turn-over, by tagging 
proteins for proteosome degradation. It is interesting that PB001118.00.0 is up-
regulated in the young oocyst as it could be envisaged that this gene specific up-
regulation is reflected in a general enhancement of ubiquitinylation activity in the 
young oocyst, which may support a substantial turn-over of the parasite protein 
repertoire as the motile ookinete morphs into the sessile oocyst. This would correlate 
with our microarray analysis, where we see an extensive shift in gene utilisation 
during ookinete to oocyst transformation. However, PB001118.00.0 was not pursued 
any further; as although strongly up-regulated in the young oocyst, it does not appear 
to be stage-specific and ubiquitinylation is likely to play an essential role throughout 
the life-cycle, possibly making it not amenable to targeted gene disruption.  
 
Three candidates, denoted proteome Derived Oocysts Genes (pDOG 1-3) were 
selected for functional characterisation by their targeted disruption. No functional 
domain predictions were available for any of the three candidates. They all encoded 
signal peptide motifs and / or transmembrane domains, which indicates a potential 
surface localisation. qRT-PCR analysis revealed that the transcripts corresponding to 
pDOG-1 and pDOG-3 are both upregulated during early oocyst development (day 2). 
In contrast, pDOG-2 transcripts are most abundant during the very early stages of 
development in the vector (1-24 hours). However the specific detection of the 
corresponding protein in the mature P. berghei oocyst merited its inclusion based on a 
potential translational repression mediated regulation of its expression. 
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The sequence alignments of Pb300603.00.0 and Pb300510.0.00 revealed that they 
constitutes different parts of the same gene, pdog-1 An additional upstream fragment 
(Pb000071.00.0) also forms a part of pdog-1. In accordance, Pb300603.00.0 and 
Pb300510.0.00 display near identical qRT-PCR profiles.  Pb000071.00.0 was also 
abundantly detected specifically in the mature oocyst in the proteome but initially 
excluded from further analysis as it lacked predicted orthologues in P. falciparum and 
P. vivax (Hall et al., 2005). An identical revision of the annotation was later reported 
by an independent group of investigators, together with their detection of 
Pb300603.00.0 / Pb300510.0.00 / Pb000071.00.0 in a subtractive hybridisation cDNA 
library obtained from P. berghei ookinetes (Raibaud et al., 2006). No peptide hits 
were recorded for either of the previously predicted separate ORFs in the ookinete 
(Hall et al., 2005). However, the reported detection of transcript corresponding to this 
novel gene in ookinetes corresponds well to our transcriptional profiling, where we 
first observe the associated transcript 24 hours post-infection. 
 
3.3.5 Summary 
¾ A combined approach of in silico candidate selection using an existing proteome 
data-set together with qRT-PCR-based transcriptional analysis, successfully 
identified three Plasmodium genes with potential roles in oocyst development.  
¾ The candidate genes were denoted proteome derived oocyst genes (pDOG) and 
were selected for functional characterisation by their targeted disruption in P. 
berghei. 
¾ Careful manual annotation resulted in the re-annotation of three P. berghei ORFs 
erroneously annotated as separate genes, which here is shown to encode one single 
large ORF, denoted pdog1. 
 
3.4 Concluding remarks 
A microarray-based, transcriptomic profiling of P. berghei developmental migration 
through A. gambiae successfully identified 813 P. berghei genes that are differentially 
regulated during the parasite journey through its mosquito vector. The expressional 
peaks of differentially regulated genes spanned across the entire span of the study, 
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from the bolus located mixed blood stages to the mature oocyst, poised to release its 
infective sporozoites into the surrounding hemocoel. 
 
A detailed analysis of genes upregulated in oocysts revealed an overrepresentation of 
genes associated with basic cellular processes such as transcription, translation, DNA 
replication and lipid metabolism throughout sporogony. Three candidate genes termed 
transcriptome Derived Oocyst Genes (tDOG), were selected for functional 
characterisation by their targeted disruption. The tDOG candidates were chosen based 
on their respective transcriptional profiles and functional domain predictions 
implicated them in lipid biogenesis / remodelling or potential defence against the 
mosquito immune response. 
 
A complementary proteome-mining approach was also used to identify genes with 
potential roles during oocyst development. qRT-PCR based transcriptional analysis of 
eight candidates selected from an already existing proteome resulted in the 
identification of three candidate genes, named proteome Derived Oocyst Genes 
(pDOG) that were subjected to targeted disruption. All three pDOG candidates encode 
putative transmembrane domains and / or a signal peptide motif, suggesting a putative 
surface location, which may implicate the pDOG genes in interacting with mosquito 
proteins and potentially mediating protection against the mosquito immue response. 
No functional domain predictions to give further clues to their respective roles were 
available at the time of candidate selection. 
 
To date the microarray analysis for the purpose of this study has focused on 
identifying genes upregulated during oocyst development. Nonetheless, the 
transcriptome data-set presented here is rich in additional information, which through 
further analysis can yield deeper insight into P. berghei gene regulation. One aspect of 
transcriptional regulation that may be explored is the chromosomal mapping of 
clusters of co-regulated genes and the identification of any shared regulatory cis 
motifs, which may assist the identification of novel transcription factors. Another 
future focus of the ongoing microarray analysis is the comparative analysis between 
existing proteome data-sets and the transcription data-set generated by this study.  
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Several P. berghei proteomic data-sets now exists, covering different stage oocysts 
and sporozoites (Hall et al., 2005, Lasonder et al., 2008), whole ookinetes, the 
ookinete surface (R. Stanway, Personal communication) and micronemes (Lal et al., 
2009), male and female gametocytes (Khan et al., 2005) and the microgamete (A. 
Talman, Personal Communication). Global correlation analysis of the dynamics 
between stage-specific transcript and protein repertoires has previously been 
conducted on P. falciparum and P. berghei vertebrate blood stages (Le Roch et al., 
2004, Hall et al., 2005). A good correlation was observed between transcripts and 
their respective proteins, emphasising the importance of transcriptional control during 
Plasmodium development. Any deviations observed were accounted for by delays in 
translation, where specific transcripts were subjected to post translational regulation 
(Le Roch et al., 2004, Hall et al., 2005). Nevertheless, an extension of this type of 
analysis to the P. berghei mosquito stages would further enrich our understanding of 
the gene regulation that underpins transmission and thus enhance our chances to 
devise novel control mechanisms to successfully interrupt malaria transmission. 
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CHAPTER 4: GENERATION OF TRANSGENIC PARASITE LINES AND 
IDENTIFICATION OF A NOVEL GENE ESSENTIAL FOR RODENT 
MALARIA TRANSMISSION 
4  
4.1 Introduction 
The availability of functional genomics data-sets clearly confers expression data upon 
genomic sequence data. Their existence allows us to answer questions centring on 
what gene products are coded for when, and upon what environmental cues. As 
outlined in previous chapters, these studies have significantly enhanced our 
understanding of gene regulation in Plasmodium. However, the functions of the vast 
majority of the around 6,000 predicted ORFs encoded by the P. berghei genome are 
unknown (Hall, 2005). 
 
Near complete, genome-wide KO or KD libraries have been generated for model 
organisms such as the budding yeast Saccharomyces cerevisiae (KO library with a 
96% coverage of 6, 227 ORFs), (Giaever et al., 2002), the roundworm Caenorhabditis 
elegans (RNAi library with 86% coverage of an estimated 19,000 ORFs), (Kamath 
and Ahringer, 2003) and the fruitfly Drosophila melanogaster (RNAi library with 
88% coverage of 13,601 ORFs), (Dietzl et al., 2007). In contrast, despite its 
comparably small genome size and the decade which has passed since the first 
publication of a P. berghei KO line in 1999 (Dessens et al., 1999, Yuda et al., 1999a), 
the functional characterisation of the P. berghei genome is still in its infant stage.  
 
The absence of RNAi tools (Baum et al., 2009) and practical constraints of 
implementing high-throughput methods for rodent malaria parasite gene KOs (the 
requirement for in vivo propagation in mice poses a major bottle-neck), has 
significantly hampered functional gene analysis in P. berghei. To date, only 
approximately 40 genes that are expressed during the mosquito stages of the P. 
berghei life cycle have been functionally characterised by their targeted disruption (as 
summarised and expanded by (Ecker et al., 2008)). The stakes have recently been 
raised with attempts to more large scale approaches to targeted gene disruption in both 
P. berghei (Ecker et al., 2008) and P. falciparum (Maier, 2008). Nevertheless, the real 
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challenge of the Plasmodium post-genomic era remains that to confer functionality 
upon developmental expression data.  
 
For Plasmodium sexual development, a question that must be addressed on the level 
of individual genes is how timing of functionality correlates to temporal expression 
data. It is becoming increasingly evident that, for a subset of Plasmodium genes, 
temporal and sex-specific expression patterns are poorly correlated to functionality. 
This can be in regard to discrepancy between timing of expression and first 
discernable KO phenotype as displayed by the PbLAP-family (Raine et al., 2007), or 
in terms of contradictory non sex-specific expression patters but sex-specific 
functionality as exhibited by for example Pfs230 (Eksi et al., 2006). Another key issue 
is the elucidation of the exact, molecular function of individual gene products.  
 
The understanding of Plasmodium sexual development has also been impaired by a 
lack of mechanistic data for many of the genes characterised to date. In contrast to the 
relatively well-defined roles of the PPLP (Kaiser et al., 2004, Kadota et al., 2004, 
Ishino et al., 2005, Ecker et al., 2007) and TRAP family members (Sultan et al., 1997, 
Dessens et al., 1999, Moreira et al., 2008, Baum et al., 2006b), despite extensive 
characterisation, the exact function remains unknown for proteins such as p25/28 
(Tomas et al., 2001, Vlachou et al., 2001, del Carmen Rodriguez et al., 2000) and the 
LAP family (Raine et al., 2007, Trueman et al., 2004, Delrieu et al., 2002, Simon et 
al., 2009, Scholz et al., 2008, Pradel et al., 2006, Pradel et al., 2004, Lavazec et al., 
2009).  
 
The difficulty in predicting Plasmodium gene function in silico (by assignment of 
functional domains based on homology with other eukaryotic genomes), has resulted 
in that over 60% of predicted proteins encoded by Plasmodium lack any functional 
domain predictions (Florens et al., 2002). The poor annotation of the P.berghei 
genome has in turn hampered the understanding of gene function at a molecular level, 
since often no functional domain prediction is available to guide functional studies. 
Nonetheless, obtaining data which strive to pin-point the exact temporal and 
mechanistic function of a gene requires detailed analysis. This analysis must stretch 
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beyond the standard read-out used to investigate P. berghei KO phenotypes. Careful 
enumeration of parasite numbers during the different life stages still forms an 
essential part in understanding the impact on development of the loss of a specific 
gene product. However, in order to obtain mechanistic data; protein localisation, 
identification of potential interaction partners and acquisition of detailed expression 
patterns are required. 
 
 
This chapter will outline: 
¾ Generation of loss of function mutants for transcriptome (tDOG) and 
proteome (pDOG) derived oocyst genes. 
¾ Basic phenotypic analysis of a loss of function mutant transgenic line for 
candidate pDOG-2 (misfit) in P. berghei, which resulted in the 
identification of a novel gene essential for sporogonic development and 
rodent malaria transmission. 
¾ Generation of a pbmisfit-myc transgenic line as a tool for MISFIT protein 
expression and localisation studies. 
 
 
4.2 Generation of loss of function mutants by targeted gene disruption 
4.2.1 Strategies for targeted disruption by double homologous recombination 
In P. berghei targeted gene disruption can be facilitated by the generation of gene-
specific targeting constructs, in which a TgDHFR pyrimethamine resistance cassette is 
flanked by downstream and upstream regions of homology to the targeted gene (van 
Dijk et al., 1996). Following transfection, integration of the disruption construct into 
the target locus is mediated by double homologous recombination (Figure 4.1).  
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Figure 4.1. Schematic representation of targeted gene disruption strategy in P. berghei. 
The target sites for homologous recombination between the WT locus target and the 
corresponding fragments carried on the disruption vector are indicated by grey shading. The 
TgDHFR expression cassette is shown in light blue with its constitutive 5' UTR promoter and 
3' UTR regions indicated in darker blue. The position of the primers used for sub-cloning 
(grey arrows), detection of wild-type (purple arrows) and assessment of integration (blue 
arrows), and the position of the restriction sites used for vector linearization are also indicated 
(green arrows).  
 
4.2.1.1 Transcriptome derived oocyst genes 
A complete disruption vector was constructed for the deletion of tDOG-1, facilitating 
the excision of the target ORF, Pb000024.01.0, as well as the upstream predicted 
ORF, Pb001219.02.0 (Figure 4.2 A). This strategy was employed since sequence 
alignments between Plasmodia tDOG-1 orthologues indicated that Pb001219.02.0 
and Pb000024.01.0 were incorrectly annotated as two separate ORFs (Chapter 3.2). 
Furthermore, contig spanning PCR analysis confirmed that Pb001219.02.0 are the 
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upstream, and Pb000024.01.0 the downstream, fragments of one single large ORF, 
thus validating this gene targeting strategy (data not shown). A partial disruption 
construct was created for the targeted disruption of tDOG-2 (Pb300124.00.0), (Figure 
4.2 B). The lack of upstream contig sequences in P. berghei and P. yoelii necessitated 
this approach. The 5’ region of the gene thus remains intact, while the 3’ end is 
deleted in the tDOG-2 partial disruption mutant. A complete KO vector was 
constructed for the deletion of tDOG-3 (Pb000811.00.0), (Figure 4.2 C). The 
resulting gene targeting vectors ptDOG1-TgDHFR-TS, ptDOG2-TgDHFR-TS and 
ptDOG3-TgDHFR-TS were transfected into P.berghei c507.  
 
PB300124.00.0
PB000811.00.0
B
C
PB001219.02.0 PB000024.01.0
A
Met?
STOP
STOP?
Met
STOPMet
 
Figure 4.2 Strategies for the targeted disruption of transcriptome derived oocysts gene 
candidates (tDOG). Schematic representation of gene targeting strategies for the disruption 
of tDOG-t (A), tDOG-2 (B) and tDOG-3 (C). Upstream (purple rectangle) and downstream 
(blue rectangle) homology regions are indicated together with the positioning of the primer 
pairs used to sub-clone the target regions held on the respective disruption vectors (purple and 
blue arrows). The gene segment deleted as a result of homologous recombination between the 
disruption vector and the WT locus is also denoted (grey rectangle). 
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4.2.1.2 Proteome derived oocyst genes 
For pDOG-1, one partial disruption vector (pDOG-1A; targeting Pb300603.00.0 / 
Pb300510.00.0) and one complete KO vector (pDOG-1B; targeting Pb300603.00.0 / 
Pb300510.00.0 / Pb000071.00.0) was generated (Figure 4.3 A). Two different 
constructs were made to account for the possibility of pDOG-1 being coded for two, 
or three, of the predicted ORFs in P. berghei. A described in Chapter 3.2, it has now 
been confirmed that the gene encoding pDOG-1 encompasses all three previously 
predicted ORFs. 
 
PB000064.01.0
PB000043.01.0
B
C
PB300603.00.0 PB300510.00.0 PB000071.00.0
A
Met STOP
STOP
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Figure 4.3 Strategies for the targeted disruption of proteome derived oocyst gene 
candidates (pDOG). Schematic representation of gene targeting strategies for the targeted 
disruption of pDOG-1(A), pDOG-2 (B) and pDOG-3 (C). Upstream (solid purple) and 
downstream (solid blue) homology regions are indicated together with the positioning of the 
primer pairs used to sub-clone the target regions held on the respective disruption vectors 
(purple and blue arrows). The gene segment deleted as a result of homologous recombination 
between the disruption vector and the WT locus is also denoted (shaded grey). 
 161
For pDOG-2 (Pb000064.01.0) a partial disruption construct was created due to lack of 
upstream and downstream sequence availability in P. berghei and P. yoelii (Figure 
4.3 B). For pDOG-3 (Pb000043.01.0) a complete KO vector was constructed (Figure 
4.3 C). The resulting disruption vectors ppDOG1A-TgDHFR-TS, ppDOG1B-
TgDHFR-TS, ppDOG2-TgDHFR-TS and ppDOG3-TgDHFR-TS, were used for 
transfection of P.berghei c507.  
 
4.2.2 Genotyping of transfectant blood-stage populations 
Following pyrimethamine-based selection, the transfected blood stage parasite 
populations were subjected to PCR and PFGE analysis to assess potential integration 
of the disruption vectors into the targeted gene loci. PCR-based detection of 
integration (resulting in the generation of a gene specific KO locus) is facilitated by 
the use of gene specific forward primers and a reverse primer situated inside the 
5’UTR region of the TgDHFR cassette. The primer positioning ensures that a PCR 
product can only be obtained if successful integration has taken place (Figure 4.1). 
Similarly, detection of gene specific WT loci in non-clonal and clonal parasite 
populations can also be facilitated by appropriate positioning of gene specific primers 
(Figure 4.1). For PFGE based analysis, transfectant populations were probed with a 
TgDHFR specific probe. All gene targeting constructs were transfected three times 
each, or until integration of the disruption construct into the chromosomal target locus 
could be detected. Attempts to generate a transgenic line were abandoned if 
integration had not been detected within three independent transfection batches. 
 
4.2.2.1 Genotyping of Δpbtdog tranfectant populations 
PCR-based analysis detected integration of the disruption vector ptDOG2-TgDHFR-
TS (Figure 4.4, A). Genotyping by PCR also indicated integration of ptDOG1-
TgDHFR-TS (Figure 4.4, A). The respective transfected plasmid (integrated or 
maintained as an episome) was detected in all transfectant populations (Figure 4.4, 
A). Although not an exact science, comparison of band intensity between the detected 
KO and WT loci can give an indication of the proportion of WT to transgenic 
parasites in the transfectant population. For both ptDOG2-TgDHFR-TS and ptDOG1-
TgDHFR-TS, the respective WT loci and episomal loci were more readily detected 
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than the KO loci. This indicates that the majority of the transfected parasites may have 
retained the targeted WT loci, which would be excised in parasites where integration 
of the disruption vector successfully taken place. No evidence for integration of 
ptDOG3-TgDHFR-TS was ever detected by PCR (Figure 4.4, A).  
 
PFGE and Southern Blot analysis of the tdog-2 locus confirmed that the ptDOG2-
TgDHFR-TS vector had integrated into its target locus on chromosome 13. Contrary 
to the PCR results, only the Δtdog-2 but not the WT tdog-2 locus could be detected in 
the ptDOG2-TgDHFR-TS transfectant population by southern blot analysis (Figure 
4.4, B-C). In contrast to the indication of integration supplied by PCR data, no 
integration of ptDOG1-TgDHFR-TS (targeted to chromosome 5) was detected by 
PFGE. A hybridisation signal in the region of chromosome 14 was observed for 
ptDOG-3-TgDHFR-TS (Figure 4.4, B). However, non-integrated plasmids 
(episomes) migrate to the same region of the pulse-field as P. berghei chromosome 
14. Thus PFGE is inconclusive for genes which loci are situated on chromosome 14, 
such as tDOG-3. Since the integration was unsupported by PCR, failure to integrate 
was assumed for ptDOG3-TgDHFR-TS.  
 
4.2.2.2 Genotyping of Δpbpdog tranfectant populations 
PCR and PFGE genotypic analysis revealed successful integration of the disruption 
vector ppDOG2-TgDHFR-TS, to generate the Δpbpdog-2 parasite (Figure 4.5, A-B). 
For a second construct, ppDOG3-TgDHFR-TS, the PCR indicates that no integration 
had taken place (Figure 4.5, A). However, the PFGE shows that the transfected 
population may consist of a mixture of Δpbpdog-3 parasites and WT parasites 
maintaining the construct as an episome (Figure 4.5 B). No integration was achieved 
for the ppDOG1A-TgDHFR-TS or ppDOG1B-TgDHFR-TS vectors, for which PCR 
and PFGE data unanimously failed to detect a possible pdog1 KO locus (Figure 4.5, 
A-B).  
 
Limited dilution cloning of the Δpbpdog-2 population rendered three clean KO clones 
in which the pDOG-2 KO locus, but not the WT locus could be detected by PCR and 
Southern Blot (Figure 4.5, C-D).  
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Figure 4.4 Genotyping of transfectant populations: Transcriptome derived oocyst gene 
candidates. Diagnostic PCR indicated integration of ptDOG1-TgDHFR-TS and ptDOG2-
TgDHFR-TS into their target loci. ptDOG3-TgDHFR-TS did not display any evidence of 
integration (A). For all three transfected populations the construct, potentially maintained as 
an episome is detected. PFGE analysis and the blot probed with a tgdhfr-ts fragment (B). 
Contrary to PCR data, no integration of ptDOG1-TgDHFR-TS (chromosome 5) was detected 
by PFGE (B1). Integration for ptDOG2-TgDHFR-TS is indicated by a hybridisation signal on 
chromosome 13 (B2). A signal on chromosome 14 was observed for ptDOG-3-TgDHFR-TS, 
whether of episomal or integration origin was not conclusive (integration of the construct was 
not supported by PCR), (B3). The band in the region of chromosome 7 is the result of the 
hybridisation of the TgDHFR probe to the native P. berghei DHFR locus (B1-3). Technical 
difficulties resulted in a gel of poor visual quality, for reference purpose, a positive control, 
which exhibits a strong hybridisation signal on chromosome 10 has been included (B+ve). 
Southern Blot analysis of the tdog-2 locus confirmed successful integration of ptDOG2-
TgDHFR-TS (C). A shift in molecular weight from 5.6 kb (tdog-2 WT locus) to 4.4 kb 
(Δtdog-2 locus) is detected by the tdog-2 probe in two Δtdog-2 transfectant lines (C1-2). The 
shift to a lower molecular weight is the result of the introduction of an additional MfeI site 
held on the disruption cassette. The 12 kb band results from hybridisation of the probe to an 
upstream tdog-2 fragment since MfeI cuts within the target site of the tdog-2 probe. The 3 kb 
band is background from a frequent cutter size band visible on the gel prior to transfer.
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Figure 4.5. Genotyping of transfectant populations: Proteome derived oocyst gene 
candidates. Diagnostic PCR displaying the successful integration of ppDOG2-TgDHFR-TS 
into its target locus. None of the other constructs display evidence of integration. For all four 
transfected populations, the construct, potentially maintained as an episome is detected (A). 
PFGE analysis of the transfected parasite populations where the blot is probed with a tgdhfr-ts 
fragment (B). Integration for ppDOG-2-TgDHFR-TS is indicated by a hybridisation signal on 
chromosome 10 (B2). ppDOG-3-TgDHFR-TS also appear integrated on chromosome 11 but 
smearing in the region of chromosome 14 indicate the presence of episomal contamination 
(B3). No integration for ppDOG1A-TgDHFR-TS or ppDOG1B-TgDHFR-TS is observed. 
The fainter band in the region of chromosome 7 is the result of hybridisation to the native P. 
berghei DHFR locus (B,1A-B). Diagnostic PCR analysis performed on the three clonal 
Δpbpdog-2 parasite populations. Successful integration of ppDOG2-TgDHFR-TS is 
demonstrated by the detection of the pDOG-2 KO locus in all three clones, which lack the 
pDOG-2 WT locus (C). Southern blot analysis of genomic DNA was digested with EcoRI and 
subsequently subjected to hybridisation against a PCR-derived probe corresponding to the 
pDOG-2 upstream region of homology. The Southern blot analysis reveals a 2. 5 kb shift to a 
higher molecular weight as a result of the insertion of the TgDHFR-TS resistance cassette in 
the pdog-2 locus. The WT pdog-2 locus is absent from the three clonal Δpbpdog-2 lines (D). 
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4.2.3 Discussion 
tDOG-2 (Pb300124.00.0) is a putative patatin-like phospholipase. Its P. falciparum 
orthologue (MAL13P1.285) is expressed during erythrocytic schizogony, from the 
late-ring stage and onwards, with an expressional peak in the early schizont (Le Roch 
et al., 2003). Intriguingly, this is well correlated with the peak in tdog-2 expression 
during early sporogony observed in this study (Chapter 3.2), supporting the 
hypothesis that tDOG-2 may play a role in membrane remodelling during sporogony, 
and possibly the related process of schizogony. However, successful disruption of the 
tdog-2 locus clearly demonstrates a non-essential role for tDOG-2 during schizogony. 
A future functional characterisation of the Δpbtdog-2 parasite line will focus on 
investigating a potential role of tDOG-2 during sporogony as well as possible function 
during schizogony. 
 
tDOG-1 (Pb001219.02.0 and Pb000024.01.0) encode a putative eukaryotic initiation 
factor-2α (eIF2α) and a number of protein-protein interaction motifs. Despite clear 
evidence of blood-stage expression (Le Roch et al., 2003, Florens et al., 2002) of its 
P. falciparum orthologue (Pf10_0183), PCR-based evidence indicated that it is 
possible to disrupt tDOG-1 and thereby that it is not likely to be essential for asexual 
replication. It is thus possible that tDOG-1 constitutes a stage- or condition- specific 
eIF2α protein. Such a notion is supported by the finding that disruption of a P. 
falciparum eIF2α kinase, PfeIK1, is dispensable for normal blood stage growth, 
sexual development and transmission, whilst still playing a role in parasite metabolic 
starvation responses (Fennell et al., 2009). Due to inconclusive evidence from PFGE 
(no integration detected) and PCR (integration indicated) based genotyping of the 
Δpbtdog-1 transfected parasite population, after three independent transfections, the 
generation of a Δpbtdog-1 parasite line was not pursued any further. 
 
No evidence of integration was ever detected for tDOG-3 (Pb000811.00.0), which 
encodes a putative syntaxin t-SNARE. The P. falciparum genome encodes a 
minimum of 18 SNARE proteins of the syntaxin, membrin-like, Bet1-like and 
VAMP-like subfamilies (Ayong et al., 2007), indicating some functional redundancy 
and / or stage-specificity. The tDOG-3 P. falciparum orthologue PFL2070w is 
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transcribed in asexual blood stages (Le Roch et al., 2003) as determined by 
microarray experiments and confirmed by RT-PCR (Ayong et al., 2007). It is thus 
possible that the inability to disrupt the tdog-3 results from an essential role of tDOG-
1 during the intra-erythrocytic growth cycle.  
 
Neither the generation of additional transgenic lines to facilitate the functional 
characterisation of more t-DOG candidates, nor the functional characterisation of 
Δpbtdog-2 has been further pursued to date. However, there are plans within the 
immediate future to dilution clone and functionally characterise Δpbtdog-2 and to 
attempt the targeted disruption of another three tDOG candidates.  
 
Nevertheless, the accuracy and value of the sexual-stage developmental transcriptome 
data-set in guiding candidate selection of stage-specific genes for functional 
characterisation has already been validated. An ongoing study in the host lab has 
utilised the transcriptome data presented in this thesis to successfully identify several 
novel genes with distinct functions in ookinete biology. The study focused on genes 
for which the microarrays analysis indicated that the respective transcripts were 
specifically upregulated in the ookinete (24 hours post infection), indicating a 
potential role in ookinete development or functionality. The successful targeted 
disruption of three candidates identified two genes that play key roles in ookinete 
formation (macrogamete ookinete conversion ratios <15%) and one gene that is 
involved in ookinete motility (K. Akinosoglou, personal communication). Another 
two novel and potentially ookinete specific genes (also deriving from the 
transcriptome) have also been successfully knocked-out and are currently awaiting 
dilution cloning. 
 
At the time of the study, no functional domain predictions existed for any of the 
pDOG candidates, allowing for no in silico based predictions about putative functions 
to be made. For the proteome derived oocyst gene candidates, one successful clonal 
transgenic KO line was obtained; the Δpbpdog-2 line, which has been subjected to 
extensive phenotypic analysis as outlined in the remainder of Chapter 4 and Chapter 
5. The pDOG-2 (Pb000064.01.0) protein was exclusively detected in the mature 
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oocyst in the Hall et al. 2005 proteome (Hall et al., 2005). However, the associated 
transcript of its P. falciparum orthologue PF14_0035 is upregulated in the late 
trophozoite and early schizont stage (Le Roch et al., 2003) and the corresponding 
protein has been detected in the trophozoite and gametocyte (Florens et al., 2002). 
Nevertheless, pDOG-2 does evidently not play an essential role in asexual blood stage 
replication in P. berghei as a knock-out line could readily be generated, as presented 
in this study. 
 
Transfection of the remaining three disruption constructs was repeated on three 
independent occasions. Integration of the ppDOG3-TgDHFR-TS disruption vector 
remained ambiguous, with contradictory results from PCR and PFGE analysis, and 
was not further pursued. The transcript associated with the P. falciparum orthologue 
of pDOG-3 (Pb000043.01.0 / PFe1520c) is strongly upregulated in the early  
trophozoite and the transcript remains at an elevated level throughout shizogany (Le 
Roch et al., 2003), with the corresponding protein also detected in the trophozoite 
(Florens et al., 2002). A potentially essential role during asexual blood stage 
replication can thus be envisaged and could be the reason targeted disruption of 
pDOG-3 was possibly not successfully. 
 
Successful integration of the ppDOG- 1A or 1B TgDHFR-TS targeting vectors was 
never detected. However, the functional characterisation of pDOG-1 (PB300510.00.0 
/ PB000071.00.0 / PB300603.00.0) was recently published by another group. The 
gene was described as coding for the essential oocyst capsule protein CAP380, a 
major structural component of the oocyst capsule that is thought to confer protection 
against the immune rich of the haemocoel that the oocyst resides in for up to fifteen 
days prior to sporozoite release (Srinivasan et al., 2008). This finding thus validates 
our selection strategy for the identification of genes involved in oocyst development. 
Importantly, our candidate screen (selecting for genes encoding proteins with putative 
transmembrane and / or signal peptide motifs) was thereby also verified as a valid 
mean to identify potential oocyst surface proteins, which may confer putative 
protection against the mosquito immune response. Nonetheless, this means that 
generation of an independent Δpbpdog-1 transgenic was not pursued. Asexual blood 
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stage expression of pDOG-1 has not been reported and the generation of the Δpbpdog-
1/ Δpbcap380 clearly demonstrates that the gene is not essential for blood stage 
replication and is amenable to targeted disruption.  In this study two different 
constructs were used for the attempted disruption of pdog-1, constructs spanning all 
three, or just two, of the predicted ORFs that constitute pdog-1. Neither approach was 
successful. The reason(s) for the apparent incompatibility between the pdog-1 locus 
and the disruption vectors used in this study is not known. 
 
The reason for why some genes are amenable to targeted disruption, while others are 
not, is not always clear. The most straight-forward explanation is an essential function 
during asexual blood stage development, which makes it impossible to generate a 
viable transgenic KO line. Another, less well understood reason is that certain loci are 
more open to introductions of gene targeting vectors due to structural and 
conformational arrangements of the coding region. One way of differentiating 
between these two scenarios is to introduce a vector carrying an epitope tag such as 
MYC. If the tagging, but not the disruption, construct can successfully be introduced 
into the gene, the locus is clearly amenable to the introduction of targeting vectors. 
However, the gene is likely to be essential in the blood stages, as the locus can only be 
modified whilst retaining protein function. Nevertheless, epitope tagging constructs 
are introduced by single, which is more efficient than double, homologous 
recombination. This means that the tagging construct has a greater chance to integrate 
compare to the disruption construct. An essential function in the blood stages can 
thereby only be proven by the successful targeted disruption in presence, but not 
absence, of episomal expression of the gene of interest to rescue the loss of function 
of the native gene. This approach is commonly taken in P. falciparum, but is less 
frequently performed in P. berghei, due to the lack of selective resistance markers for 
trangenesis. A complementation approach using the TgDHFR- pyrimethamine system 
together with the human DHFR gene and the drug WR92210 can be used (Janse et al., 
2006b, Sultan et al., 2001). If blood-stage lethality can be excluded, and disruption 
remains unfruitful via double homologous recombination, a single homologous 
recombination strategy for disruption can be attempted. Single homologous 
recombination is more efficient; however, the insertion is unstable as no region of the 
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gene is permanently excised and the spontaneous generation of WT revertants may 
mask KO phenotypes (Mikolajczak et al., 2008a). 
 
There appear to be no real correlation between successful integration of KO 
constructs and varying lengths of homology regions or the chromosomal region 
targeted for excision. Transcriptional activity during asexual blood stage replication 
does neither appear to confer any advantage for homologous recombination, as no 
inverse correlation between successful integration and transcriptionally silent loci was 
observed (A. Ecker, Personal Communication). Conversely, asexual blood stage 
expression is likely to be disadvantageous due to the risk of blood stage lethality. The 
presumable large proportion of the P. berghei genome encoding products that are 
essential for blood stage replication is currently intractable to loss of function 
mutational analysis. The development of effective methods for conditional gene 
silencing is thus urgently required. Contrary to previous reports, RNAi mediated gene 
silencing does not function in Plasmodium as significant enzymatic components of the 
RNAi pathway are absent (Baum et al., 2009). Systems for inducible gene knock-outs 
are hence probably the most promising future approach. A tetracycline inducible 
system has been developed for P. falciparum, however, it suffers from leakiness 
(Meissner et al., 2005). More recently, advances have been reported in form of the 
fusion of P. falciparum proteins to a FK506 Binding Protein (FKBP) destabilisation 
domain, which facilitates the inducible degradation of the target protein (Armstrong 
and Goldberg, 2007). In addition, the Flippase Recognition Target (Flp/Flrt) system 
has been adapted for inducible gene excision in P. berghei (Combe et al., 2009). 
 
4.2.4 Summary 
¾ Transfection of constructs for the targeted disruption of three transcriptome 
(tDOG) and three proteome (pDOG) derived oocyst genes was perfomed. 
¾ Integration of the ptDOG2-TgDHFR-TS construct was detected by diagnostic 
PCR, PFGE and Southern blot analysis.  
¾ ppDOG2-TgDHFR-TS was successfully integrated into its target locus as 
determined by PCR and PFGE. Limited dilution cloning rendered three Δpbpdog-
2 clones, in which the KO locus was present and WT locus absent. 
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¾ All remaining tDOG and pDOG candidates were subjected to three independent 
rounds of transfection and subsequent genotypic analysis. Conclusive evidence of 
integration could not be obtained for t-DOG-1, tDOG-3, pDOG-1 or pDOG-3 and 
these candidates were therby not pursued any further. 
 
4.3 Basic phenotypic analysis of the Δpbmisfit (Δpbpdog-2) mutant 
4.3.1 Δpbmisfit develops normally until the ookinete stage  
The pDOG-2 candidate was renamed the P. berghei male-inherited sporulation factor 
important for transmission (misfit). The name was derived from key features of the 
Δpbmisfit phenotypic analysis, which is described in the remainder of Chapter 4 and 
in more detail in Chapter 5♣♣. Asexual and sexual blood stage growth of Δpbmisfit 
was comparable to that of P. berghei Pbc507 WT (of an equivalent passage number, 
used throughout the study for comparison), (Figure 4.6).  
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Figure 4.6. Δpbmisfit asexual and sexual blood stage growth. Asexual blood stage growth 
(A) and gametocyte production (B) of the Δpbmisfit mutant (Green) is comparable to that of 
PbWT (Grey). 
                                                 
♣♣ Paternal Effect of the Nuclear Formin-like Protein MISFIT on Plasmodium Development in the 
Mosquito Vector (2009) Ellen S. C. Bushell†, Andrea Ecker†, Timm Schlegelmilch†, David Goulding, 
Gordon Dougan, Robert E. Sinden, George K. Christophides, Fotis C. Kafatos, Dina Vlachou. PLoS 
Pathogen 5(8): e1000539. doi:10.1371/journal.ppat.1000539. 
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Δpbmisfit male gametocytes formed and exflagellated at a rate comparable to WT 
(Figure 4.7, A-B) and were able to form ookinetes of normal numbers and 
morphology in vitro (Figure 4.7, C-D). The Δpbmisfit macrogamete to ookinete 
conversion ratio was consistently slightly lower than that of the WT. However, this 
difference was never statistically significant (p=0.33). 
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Figure 4.7. Δpbmisfit exflagellation and macrogamete to ookinete conversion assays. 
Δpbmisfit male gametocytes exflagellate at a rate comparable to that of WT (A) and Giemsa 
staining of purified gametocytes revealed the pink staining pattern typical for P. berghei male 
gametocytes and a normal female to male sex ratio (B). Anti-Pbs21-Cy3 staining 
demonstrated that Δpbmisfit female macrogametes form ookinetes (right panel) in vitro at a 
rate not statistically significant from that of the WT (p=0.33 by a two-tailed, unpaired Student 
T-test of equal variances (left panel), (C). Furthermore, Giemsa staining of purified ookinetes 
confirmed successful development of crescent shaped Δpbmisfit ookinetes in vitro (D). 
Exflagellation and ookinete conversion assays were conducted in duplicates for each parasite 
strain and the values shown are the average from a minimum of two biological experiments. 
Error bars indicates standard error of the mean. 
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4.3.2 MISFIT is important for oocyst development 
Mosquito infections revealed that at day 10 post-infection, Δpbmisfit oocyst numbers 
in A. stephensi infected midguts were significantly reduced (p<0.01) compared to that 
of the WT control. Intriguingly, the decrease in oocyst numbers in the absence of 
pbmisfit was even more pronounced at 15 days post-infection (Figure 4.8, A).  
 
A more detailed time-course of Δpbmisfit oocyst development revealed that Δpbmisfit 
oocyst numbers were significantly lower (p<0.01) already during early oocyst 
development (day 3 post-infection), with Δpbmisfit producing only 33.6% of the 
oocyst numbers recorded for the WT (Bottom left panel; Figure 4.8, A). As oocyst 
development progresses, Δpbmisfit oocyst numbers steadily decline and at the time of 
development of mature, sporulated WT oocyst (day 15 post-infection), Δpbmisfit 
oocysts numbers were decimated to 7.1% of that of the WT population.  
 
A similar oocyst defective Δpbmisfit phenotype was observed in A. gambiae (Top 
right panel; Figure 4.8, A), where the reduction in oocyst numbers was even more 
severe compared to that of the WT; peaking at 9.6% (day 3 post-infection) and 
declining to 4.5% at the end-point of the time course (day 15 post-infection), (Top 
right panel; Figure 4.8, A). 
 
Details of sample sizes, number of biological repeats and absolute oocyst numbers 
from all Δpbmisfit mosquito infections are summarised in Table 4.1, together with the 
results from the statistical analysis of oocyst numbers from PbWT and Δpbmisfit 
infections of A. gambiae and A. stephensi. Table 4.1 also includes results from 
mosquito infections performed with an independent Δpbmisfit clone, generated in the 
Pb2.34 ANKA strain genetic background (Appendix 1). Importantly, both 
independent Δpbmisfit clones, deriving from two separate genetic backgrounds and 
from independent transfection batches, displayed similar oocyst defective phenotypes. 
 
 
 
 A 
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Figure 4.8. Δpbmisfit oocyst development: Absence of MISFIT affects oocyst density. 
Δpbmisfit oocyst numbers in A. stephensi (left panels) and A. gambiae (right panels), 
expressed as the average of absolute numbers (top panels) at day 10 and 15 post-infection, 
and expressed as a percentage of WT oocyst numbers in a more detailed time-course (bottom 
panels), (A). Fluorescent microscopy images of GFP expressing oocysts (Pbc507 eGFP 
reference line) representative for WT (top panels) and Δpbmisfit (bottom panels) oocyst 
density in A. stephensi and A. gambiae midguts at X10 magnification (B). Error bars indicates 
standard error of the mean. 
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Table 4.1. Oocyst numbers in Δpbmisfit infections of A. stephensi and A. gambiae 
     Parasite density Analysis of variance  
Time 
point Parasite 
Number 
of 
experiments 
Number 
of midguts 
Prevalence 
(%) 
Arithmetic 
Mean 
Gmean 
(±SE) 
P 
value 
F 
value 
Fold 
difference 
P. berghei c507 / A. gambiae  infections 
Day 3 WT 1 36 83.3 41.8 10.0(±0.35) <0.001*** 16.7 5.8 
 Δpbmisfit   58.3 4.0 1.7(±0.2)    
Day 5 WT 1 28 85.7 54.5 20.2(±0.38) <0.001*** 30.67 9.8 
 Δpbmisfit   75 5.1# 2.0(±0.20)    
Day 10 WT 2 63 94 52.0 22.2(±0.21) <0.001*** 126.2 18.9 
 Δpbmisfit   47.6 3.4# 1.2(±0.14)    
Day 15 WT 2 39 84.6 23.1 10.0 (±0.25) <0.001*** 62.2 20.0 
 Δpbmisfit   30.8 1.0# 0.5(±0.11)    
P. berghei c507 / A. stephensi infections 
Day 3 WT 1 27 96.3 377.8 290.7(±0.26) <0.001*** 32.52 5.32 
 Δpbmisfit   92.6 117.3 54.6(±0.35)    
Day 5 WT 1 32 96.9 304.03 194.49(±0.3) <0.001*** 17.61 4.38 
 Δpbmisfit   93.8 77.56# 44.39(±0.29)    
Day 10 WT 2 66 100 356.77 306.31(±0.08) <0.001*** 169.34 8.42 
 Δpbmisfit   100 61.31# 36.37(±0.14)    
Day 15 WT 2 41 100 318.56 243.22(±0.15) <0.001*** 254.37 33.86 
 Δpbmisfit   100 12.92# 7.18(±0.17)    
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     Parasite density Analysis of variance  
Time 
point Parasite 
Number 
of 
experiments 
Number 
of midguts 
Prevalence 
(%) 
Arithmetic 
Mean 
Gmean 
(±SE) 
P 
value 
F 
value 
Fold 
Difference 
P. berghei 2.34 / A. gambiae  infections 
Day 10 WT 1 50 80 16.0 N/P N/P N/P N/P 
Day 10 MISFIT KO 1 41 58.5 2.1     
P. berghei 2.34 / A. stephensi  infections 
Day 10 WT 1 33 100 384.0 N/P N/P N/P N/P 
Day 10 MISFIT KO 1 31 96.8 16.7     
 
The table is divided into four datasets reporting results from infections of A. gambiae and A. stephensi with Δpbmisfit or WT parasites. Oocyst 
numbers were significantly lower (P<0.001; ***) in Δpbmisfit compared to WT infections as measured by one-way Analysis Of Variance 
(ANOVA) tests. Prevalence shows the percentage of midguts with at least one oocyst. Fold differences between parasite densities of WT and 
Δpbmisfit infected mosquitoes were calculated using the geometric means. # indicates small and not sporulating Δpbmisfit oocysts.  Table adapted 
from (Bushell et al., 2009). N/P = Not Performed. 
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4.3.3 MISFIT is essential for rodent malaria transmission 
Upon closer examination, two additional, distinct phenotypes of the Δpbmisfit oocysts 
were detected. At day 15 post-infection, WT oocysts were large in size and a 
proportion of oocysts had sporulated, with sporozoites neatly arranged in an array 
pattern inside the mature oocyst (Figure 4.9, A). In contrast, the remaining Δpbmisfit 
oocysts were nearly always completely void of sporozoites (Figure 4.9, A). As a 
result few sporozoites were detected in preparations of homogenised Δpbmisfit 
midguts (Table 4.2). In addition, day 15 Δpbmisfit oocysts lacked the DNA-staining 
pattern characteristic of mature WT oocysts, where the haploid nuclei of the fully 
formed sporozoites are distinct, highly organised and aligned. Although some DNA 
could be observed in Δpbmisfit oocysts, its arrangement was disorganised and its 
content appeared lesser than that of the WT oocyst (Figure 4.9, A). Nevertheless, the 
genome organisation was clearly different from that of the tight, small nucleus 
characteristic of the tetraploid ookinete, indicating that endomoitosis is at the very 
least initiated in the Δpbmisfit oocyst.  
 
Furthermore, Δpbmisfit oocysts were small in size compared to that of WT. Oocyst 
size is heterogeneous and the oocyst developmental rate is non-synchronous even in 
P. berghei WT infections. However, Δpbmisfit oocysts displayed a shift towards 
smaller size compared to that of the WT (Figure 4.9, A-B). Day 15 Δpbmisfit oocysts 
thus carried the hall-marks of immature, young WT oocysts.  
 
Importantly, the sporulation defective phenotype of the Δpbmisfit oocysts translated 
to a complete block in rodent malaria transmission. Midgut sporozoite numbers were 
significantly reduced (p<0.05) in the absence of MISFIT and no salivary gland 
sporozoites were ever detected in Δpbmisfit infected A. stephensi mosquitoes. As a 
result Δpbmisfit transmission was completely abolished in bite-back experiments 
using highly susceptible C57/BL6 mice (Table 4.2). 
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Figure 4.9. Δpbmisfit oocyst development: An absence of MISFIT affects oocyst size. 
Day 15 oocysts formed in the absence of Δpbmisfit were nearly always completely void of 
sporozoites. Δpbmisfit oocysts also lacked the DNA staining pattern characteristic for mature 
WT oocysts (oocysts imaged at X63 magnification). In addition, Δpbmisfit oocysts were 
small in size (Top Panel). Day 10 Δpbmisfit oocysts displayed a shift towards smaller size 
compared to that of the WT (Bottom Panel). Oocysts are GFP (green) positive as a result of 
constitutive eGFP expression in the Pbc507 reference line and DNA was visualised by DAPI 
(blue) staining. Relative oocyst size was calculated from binary images (X10 magnification) 
of midguts infected with the Pbc507 eGFP reference line. The area of >300 individual 
oocysts was calculated for each parasite line using the particle analysis application of ImageJ. 
Oocysts size is displayed in arbitrary units as calculated by ImageJ and divided into bins of 
500 units (range 0-2000). The frequency of the number of oocysts falling into each bin 
category was recorded and translated into a percentage of the total oocyst number for each 
parasite line.  
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Mean number of sporozoites calculated from suspensions of 30 homogenised midguts / 
salivary glands, assayed in three batches of ten at day 21 post infection (PI). Midgut 
sporozoite numbers were statistically significantly*lower in the absence of MISFIT as 
measure by a two-tailed, unpaired Student T-test of equal variances (p=0.011). Salivary gland 
sporozoites were completely absent in Δpbmisfit infected mosquitoes. Infectivity to mice was 
assayed by allowing infected mosquitoes to feed on C57BL/6 mice on day 18 and 21 of 
infection. Mice fed to Δpbmisfit mosquitoes received at least twice the number of bites of that 
of mice fed to WT infected mosquitoes. Parasitaemia of sporozoite-recipient mice was 
assayed by Giemsa-stained thin blood smears on day 5, 7 and 14 post-inoculation, with 
infected mice culled on the first day presence of blood-stage parasites could be confirmed or 
on day 14, the assay end-point. The mean oocyst numbers for the infections were 230.0 (WT) 
and 16.5 (Δpbmisfit ) oocysts / midgut as assayed on day 15 post-infection. Adapted from 
(Bushell et al., 2009). 
 
 
4.3.4 Generation of pbmisfit-myc transgenic lines: A tool for protein assays 
4.3.4.1 C-terminal MYC-tagging of endogenous MISFIT  
In order to facilitate MISFIT protein expression and localisation studies, transgenic 
pbmisfit-myc lines were generated in the 2.34 ANKA and c507 genetic backgrounds 
of P. berghei. MYC tagging of MISFIT was facilitated by replacement of the native 
C-terminal region (1 kb) of misfit with a MYC-tagged counterpart. The sub-cloned 
misfit targeting sequence was cloned (in absence of its TAG stop codon) in-frame 
with a triple MYC-tag epitope held on a gene targeting vector, which was introduced 
into the misfit locus by single homologous recombination (Figure 4.10, A). 
Table 4.2. Midgut and salivary gland sporozoite numbers and transmission 
data for Δpbmisfit infections of A. stephensi 
Parasite 
strain 
Midgut sporozoites Salivary gland sporozoites Infectivity to mice 
  Mean SEM Mean SEM d18 d21 
WT 59,463 2,572 6,762 3,372 + + 
 98,391 1,639 9,513 1,779 + + 
 48,165 7,151 22,978 8,986 + + 
       
Δpbmisfit 0* 0 0 0 - - 
 82* 82 0 0 - - 
 54* 48 0 0 - - 
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Successful integration of the MYC-tagging vector in 2.34 ANKA and c507 P. berghei 
was detected by PFGE (Figure 4.10, B). Attempts to generate a pbmisfit-gfp 
transgenic line (Pb2.34 background) were unsuccessful despite utilising identical 
misfit targeting sequences to that of the MYC transgenic. 
 
4.3.4.2 Assessing functionality of the pbmisfit-myc transgenic line 
For MYC-tag based protein studies to yield meaningful results, the introduction of the 
MYC-tag must not interfere with protein function. In this study we chose to tag the 
native MISFIT protein, as opposed to introducing an episomally expressed MYC-
tagged copy. The tagging of the native protein, in conjunction with the complete 
transmission blockade observed for the Δpbmisfit mutant, allowed us to asses the 
functionality of the MISFIT-MYC protein by a simple transmission assay.  
 
The pbmisfit-myc parasite population was fed to A. stephensi mosquitoes and after 21 
days the infected mosquitoes were allowed to feed on C57/BL6 mice. Parasite 
samples were collected from the input (gametocyte donor) and output (sporozoite 
recipient) mice, from which genomic DNA was prepared and subjected to Southern 
Blot analysis of the misfit locus. A. stephensi midguts infected with pbmisfit-myc were 
full of normal-sized, sporulated oocysts (Figure 4.11, B).  
 
Importantly, pbmisfit-myc parasites were readily transmitted to C57/BL6 mice. 
Southern blot analysis demonstrated a high purity of the pbmisfit-myc population 
(non-clonal) with no WT locus detectable. Importantly, his indicates that no WT 
parasites are present in the transgenic population, which may serve to rescue any 
potential MISFIT loss of function associated with the pbmisfit-myc parasite line 
(Figure 4.11, A). Together these results demonstrate the successful generation of a 
fully functional pbmisfit-myc parasite line. 
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Figure 4.10. Generation of pbmisfit-myc transgenic parasite lines. Schematic 
representation of the C-terminal MYC-tagging strategy of misfit. MYC-tagging was 
facilitated by replacing the final (3’) 1 kb portion of the native (WT) misfit locus with a 
MYC-tagged counterpart. The gene targeting construct holds the final 2 Kb of the misfit 
coding sequence (pbmisfitc) sub-cloned in-frame with the MYC-tag (solid purple) using Kpn1 
and Apa1 restriction sites present in the vector. The tagging vector was introduced into the 
native (genomic) pbmisfitg locus by single homologous recombination following linearisation 
by ClaI, which cuts 1Kb into the targeting sequence. Recombination between the 1 Kb MYC-
tagged misfit targeting sequence held on the construct (pbmisfitc;) and its genomic (pbmisfitg) 
counter-part (both grey; diagonal stripes) results in replacement of the native 3’ portion of 
misfit with a C-terminally MYC-tagged version. As a result, an incomplete (2kb) incomplete 
copy of misfit is also generated downstream of the TgDHFR-TS pyrimethamine resistance 
cassette (light blue with P. berghei 5’ and 3’ UTR marked in dark blue), consisting of the 
native 1 kb uttermost C-terminal genomic portion of misfit (pbmisfitg; grey; diagonal stripes), 
displaced by the MYC-tagged sequence, and 1 kb of the misfit sequence held on the construct 
upstream of the Cla1 linerisation site (pbmisfitc; solid grey), (A). Pulse field gel 
electrophoresis analysis (left panel) of the transfected parasite populations and the blot (right 
panel), probed with a tgdhfr-ts fragment. Integration of the misfit–myc TgDHFR-TS targeting 
vector is indicated by a hybridisation signal on chromosome 10 in both the 2.34 ANKA and 
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c507 genetic background of P. berghei. In contrast, no integration of the misfit–gfp TgDHFR-
TS targeting vector was detected. Strategies for MYC and GFP tagging utilised identical 
tragteing sequences sub-cloned into different vectors. The fainter band in the region of 
chromosome 7 is the result of the hybridisation of the TgDHFR probe to the native PbDHFR 
locus (B). 
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Figure 4.11. Assessment of functionality of the Pb2.34 misfit-myc transgenic. Southern 
blot analysis of the pbmisfit-myc locus. Genomic DNA was obtained from input (IN; 
Gametocyte donor mouse) and output (OUT; Sporozoite recipient mouse) pbmisfit-myc 
parasite blood-stage populations in A. stephensi back-bite experiments on C57/BL6 mice. The 
DNA was digested with EcoRI and probed with a 3' UTR fragment of misfit. Insertion of the 
tagging cassette resulted in a 3 kb digestion product, which is absent from WT parasites. The 
8.8 kb band represents a tandem insertion of two tagging vectors in the target misfit locus. 
Crucially, the misfit wt band detected for the native misfit locus is absent from pbmisfit-myc 
populations. (A). At day 15 post-infection A. stephensi midguts infected with pbmisfit-myc 
oocysts display high oocyst densities with pbmisfit-myc oocysts of normal size and capable of 
sporulation (B). Anti-MYC Western blot analysis detecting MISFIT-MYC in mixed blood 
stage populations deriving from the pbc507misfit-myc and pb2.34misfit-myc parasite lines. 
MISFIT-MYC migrates in between the 150kD and 250kD marker (180 kD in silico 
prediction). pbmisfit-gfp transfectant parasite samples served as a negative control for 
MISFIT-MYC specificity (C). 
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Anti-MYC western blot analysis revealed that MISFIT-MYC is successfully 
translated and can be detected already in mixed blood stage pbmisfit-myc parasites. 
This is well correlated with the early transcriptional peak of misfit observed by qRT-
PCR (Chapter 3.4). MISFIT-MYC runs at a slightly higher molecular weight 
(>150kD, <250kD) than the 180 kD in silico prediction made based on its full amino 
acid sequence. The MISFIT-MYC specificity of the western blot was verified by the 
absence of signal in pbmisfit-gfp transfectant parasite samples (Figure 4.11, C).  
 
4.3.5 Discussion 
The initial functional characterisation of MISFIT has lead to the identification of a 
novel gene essential for rodent malaria transmission. Despite its early transcriptional 
peak (Chapter 3.4), parasites developing in the absence of MISFIT appear to display 
normal sexual development, including that of formation of crescent-shaped ookinetes 
that by light microscopy display normal morphology. In contrast, oocyst development 
is severely compromised in the Δpbmisfit parasite line. The small oocyst size, low and 
disorganised DNA content and the inability to complete the cytokinetic event 
associated with sporulation carries the hall-marks of cell cycle arrest.  
 
During the cell cycle of S. cerevisiae and Saccaromyces pombe there are well-
established links between cell size, DNA replication and cytokinesis, with “cell size 
checkpoints” effectively linking cell size to the cell cycle machinery (as reviewed by 
(Grebien et al., 2005)). In S. cerevisae achieving critical cell mass triggers Start, a 
discrete phase in G1, preceding the initiation of DNA replication in S-phase (as 
reviewed by (Rupes, 2002)). Similar cell size checkpoints also exist in metazoan, 
with the genome wide D. melanogaster RNAi library facilitating the identification of 
<500 regulators of cell size, cell cycle and cell death in Drosophila (Cully and 
Leevers, 2006). Importantly, the discovery of cell size checkpoints implicates the 
existence of surveillance machinery, by which the monitoring of cell size is 
connected to DNA replication by some sort of feed-back mechanism (Rupes, 2002). 
 
In Plasmodium it is not know whether cell size checkpoints exist. However, oocyst 
development requires the co-ordination of DNA replication (to that of a 1000-fold 
polyploidy state) with organelle replication, cytoplasmic mass increase and extensive 
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membrane biogenesis. It is thus likely that some form of cell size regulatory 
machinery must be in place during sporogony. However, whether cell size, 
endomitosis and cytokinesis are regulated by separate mechanisms or by an 
interlinked surveillance mechanism is unknown. In the context of MISFIT, one can 
speculate that in Δpbmisfit oocysts, an inability to reach a critical cell-mass could 
result in a premature endomitotic arrest and absence of cytokinesis, generating small 
oocysts void of sporozoites. Or conversely, a failure to complete endomitosis could 
serve as a stimulus to halt cell growth.  
 
To confirm that the disruption of the targeted gene is directly causing the observed 
phenotype, it is de rigueur to complement the mutant line with the target protein. A 
complete reversal of the KO phenotype upon an “add-back” of the disrupted ORF 
thus confirms the specificity of the observed phenotype. As described for the 
episomal co-expression experiments utilised in order to investigate blood-stage 
lethality, it is possible to complement P. berghei mutants by episomal expression of a 
gene held on a vector containing a copy of the human dhfr gene, which can be 
selected by the drug WR92210 (Sultan et al., 2001). However, the large size of misfit 
(4.75 Kb) makes cloning and expressing the gene difficult. In this study, phenotyping 
of an independent Δpbmisfit clone was performed instead. Although perhaps less 
elegant than complementation, this approach holds its own merits. The original 
Δpbmisfit line was generated in the eGFP expressing Pbc507 reference line (Janse et 
al., 2006a), which in itself is a transgenic background. Analysis of a second Δpbmisfit 
clone in the Pb2.34 ANKA strain confirmed that the observed phenotype was not 
influenced by the exogenous expression of eGFP or the transfection procedure and 
population bottle-neck the Pbc507 parasite line has been subjected to. 
 
The native copy of misfit was successfully equipped with a C-terminal MYC tag 
without disrupting MISFIT function. The successful generation of pbmisfit-myc 
transgenic lines allowed for a detailed analysis of MISFIT spatial and temporal 
expression patterns (Chapter 5). Importantly, the early expression pattern of MISFIT 
indicated that to further delineate MISFIT function, particular attention to the possible 
role of MISFIT during the pre-oocyst developmental stages was required. 
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4.3.6 Summary 
¾ The phenotypic analysis of the Δpbmisfit mutant (candidate pDOG-2) resulted 
in the identification of a novel gene essential for P. berghei transmission, named 
misfit. 
¾ Δpbmisfit parasites display normal blood stage replication, successfully 
complete fertilisation and develop into crescent shaped ookinetes. 
¾ However, parasites developing in the absence of MISFIT display oocysts 
numbers significantly lower compared to that of WT infections.  
¾ Importantly, Δpbmisfit oocysts remain small in size, fail to organise their 
polyploid genome and are nearly completely void of sporozoites. 
¾ The failure of Δpbmisfit oocysts to sporulate results in a complete lack of 
salivary gland sporozoites in Δpbmisfit infected mosquitoes with transmission 
completely abolished in MISFIT deficient parasites. 
¾ A single homologous recombination tagging-strategy, where the native copy of 
misfit was equipped with a C-terminal MYC tag, successfully generated two 
pbmisfit-myc transgenic lines (2.34 ANKA and c507 P. berghei genetic 
backgrounds). 
¾ The functionality of the tagged MISFIT-MYC protein was confirmed by 
pbmisfit-myc transmission experiments coupled with genotyping of the misfit-
myc locus by Southern blot analysis. 
¾ The attempt to generate a pbmisfit-gfp transgenic was not successful. 
 
 
4.4  Concluding remarks  
The targeted disruption of three transcriptome (tDOG) and three proteome (pDOG) 
derived oocyst gene candidates was attempted. Successful integration of disruption 
constructs was confirmed for the patatin-like phospholipase gene tdog-2 and pdog-2, 
which encode a hypothetical membrane-associated protein.  
 
The pdog-2 gene was subsequently renamed misfit. The transfectant misfit KO 
population was limited dilution cloned to generate the Δpbmisfit transgenic line. The 
basic phenotypic analysis of the Δpbmisfit parasite revealed misfit to be essential for 
P. berghei transmission.  
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To date, functional characterization of tDOG-2 has not been conducted due to time-
constraints. Dilution cloning of Δpbtdog-2 is to be immediately initiated and any 
potential role in oocyst development to be investigated promptly. The targeted 
disruption of further tDOG candidates is also in the pipe-line, which will provide 
crucial functional information to supplement the expression data presented in this 
study. Nevertheless, for the purpose of this study that aimed to identify and 
characterise novel oocyst genes, the combined approach of transcriptomic profiling 
and proteome mining has successfully identified a new P. berghei gene, misfit, which 
is essential for oocyst development. 
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CHAPTER 5: FUNCTIONAL CHARACTERISATION OF MISFIT 
 
5.1 Introduction 
According to the eukaryotic dogma of cell cycle progression, DNA replication, 
chromosome segregation (mitosis / meiosis), nuclear division and cytokinesis 
progress in a highly regimented and sequential manner. In contrast, during the 
Apicomplexan cell cycle, DNA replication and chromosome segregation events are 
temporally separated from that of nuclear division and cytokinesis. Apicomplexan 
parasites maintain their nuclear envelope throughout mitosis / meiosis, which 
generates polyploid or multi-nucleated stages (Morrissette and Sibley, 2002). 
Following mitotic replication in Plasmodium, the polyploid cells are eventually (upon 
completion of genome and organelle replication) subjected to nuclear division and 
subsequent cytokinesis, resulting in the release of haploid infective progeny into their 
immediate environment (Striepen et al., 2007).  
 
There are four major mitotic events in the Plasmodium lifecycle: 
microgametogenesis, sporogony, liver-stage (exo-erythrocytic) and erythrocytic 
schizogony. In contrast, meiosis occurs only once during the lifecycle. Following 
fertilisation between the haploid female and male gametes, the resulting diploid 
zygote enters meiosis. Similarly to plasmodial mitosis, this meiotic event occurs in 
absence of nuclear division and cytokinesis. The concurrent morphological changes 
associated with ookinete development generate a mature, crescent-shaped ookinete 
with a tetraploid genome value that traverses the midgut epithelial barrier and 
subsequently transforms into the replicative oocyst (Janse et al., 1986, Sinden and 
Hartley, 1985). Spectacularly, nuclear and cell division events are delayed for over a 
week, until completion of the endomitotic events that characterises sporogony and 
which results in the release of infective sporozoites.  
 
Furthermore, Apicomplexan genome replication processes are uncoupled from the 
motility and invasion machinery by the existence of multiple microtubule organising 
centres (MTOCs). The subpellicular microtubules that confer cell-shape and are 
involved in motility and invasion are organised by the apical polar ring, while the 
spindle microtubules involved in DNA replication and chromosome segregation 
during mitosis and meiosis are organised by the spindle pole plaque. A third MTOC 
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termed the basal body, organises the axoneme microtubules that governs 
microgametogenesis (Morrissette and Sibley, 2002).  
 
Reshaping of the cytoskeleton forms an integral part in a wide variety of cellular 
processes such as mitosis, meiosis, cytokinesis, embryonic development, 
establishment and maintenance of cell polarity, motility and vesicle trafficking. 
Formins are key players in cytoskeletal remodeling processes as conferred by their 
role in mediating actin polymerisation (Wallar and Alberts, 2003). The formin 
homology 2 (FH2) domain is the defining domain of the formin protein family. 
Conventional formins, such as the BNi1p formin of S. cerevisae, also contain a 
proline-rich formin homology 1 (FH1) domain that binds profilin. The function of the 
actin-binding protein profilin is to deliver actin monomers to the fast-growing 
(barbed) end of the actin filament (Evangelista et al., 2003), (See Figure 1.5 for a 
schematic representation of profilin-mediated actin nucleation). However, profilin 
itself is not capable of mediating actin nucleation, but simply modulates its growth 
dynamics (Wallar and Alberts, 2003). Although most formins contain a FH1 and a 
FH2 domain, formins such as the Dictyostelium discoideum ForC and Nir2 in Mus 
musculus lack the FH1 domain (Wallar and Alberts, 2003). Furthermore, the ScBNi1p 
FH2 domain alone is sufficient to facilitate actin polymerisation in vitro (Evangelista 
et al., 2003). The FH1 domain and profilin is thus not essential for the actin 
polymerisation activity of the formins.  
 
Different actin structures facilitate different cellular processes and actin nucleation is 
mediated by several pathways. Two main mechanisms are utilised to form new actin 
structures, which generate either unbranched (as utilised during cytokinesis) or 
branched (as employed during amoeboid cell movement) actin filaments (Pollard, 
2007). Importantly, formin-mediated, unbranched actin assembly is independent of 
the actin related protein complex (Arp2/3) complex (Pollard and Borisy, 2003), which 
is regulated by WASP and participates in nucleation of branched actin in many cell 
types (Pollard, 2007).  
 
WASP and Arp2/3 homologs are curiously absent from Plasmodia (Schuler and 
Matuschewski, 2006b). However, Apicomplexan actin also exhibits some very 
unusual properties. Filamentous actin (F-actin) is curiously absent from the parasite 
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cytoplasm under physiological conditions. Apicomplexan F-actin can only be 
distinguished by treatment with the F-actin stabilizer jasplakinolide (Shaw and 
Tilney, 1999) or the combined treatment of the actin-depolymerisation inhibitors 
phalloidin and gelsolin (Schuler et al., 2005). These findings have been attributed to 
the formation of only exceptionally short and transient actin filaments with a high 
turn-over rate in Apicomplexa (Schuler and Matuschewski, 2006a). 
 
Recently two formins were identified in P. falciparum, denoted PfFormin1 and 2 
(Baum et al., 2008b). Formin1 and 2 are sequentially expressed following merozoite 
RBC invasion. Formin1, which FH2 domain has been shown to have actin 
polymerization activity, localizes to the parasite-erythrocyte moving junction during 
invasion (Baum et al., 2008b). In addition, a Plasmodium profilin has been identified, 
which is essential for blood-stage replication of P. berghei and is a potential 
interaction partner for the Plasmodium  Formin1 and / or 2 (Kursula et al., 2008). 
 
 
This chapter will outline: 
¾ The detailed bioinformatic analysis of MISFIT and its Plasmodium orthologues, 
which identified MISFIT as a novel Plasmodium formin-like protein.  
¾ An in-depth analysis of misfit developmental transcription and MISFIT-MYC 
expression. 
¾ The localisation of MISFIT to the nucleus of male gametocytes, zygotes and 
ookinetes. 
¾ Genetic crossing experiments revealing an absolute requirement for male-
specific inheritance of misfit. 
¾ The detailed investigation of Δpbmisfit ookinetes, demonstrating no significant 
invasion defect despite abnormality detected at an ultrastructural and gene 
regulatory level. 
¾ Evidence that Δpbmisfit ookinetes fail to complete meiosis, resulting in 
ookinetes with an incomplete genome value of 3n. 
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5.2 MISFIT is a male-inherited nuclear formin-like protein  
5.2.1 MISFIT is a novel formin-like protein conserved among Plasmodia  
As established during the candidate selection procedure, misfit encodes a large 
(180kD) putative transmembrane protein, with orthologues present in all sequenced 
Plasmodia spp. During the course of this study, the P. berghei genome sequence 
coverage was increased and gene annotation was improved. A more in-depth 
bioinformatic analysis of pbmisfit and its orthologues was therefore conducted. The 
analysis revealed that all Plasmodia misfit encode putative formin homology 2 (FH2) 
domains and one or multiple nuclear localisation signals, (NLS), (Figure 5.1).  
 
 
Figure 5.1. MISFIT proteins encoded by Plasmodia. The schematic protein models of 
Plasmodium MISFIT were generated by in silico sequence analysis and reveal that all misfit 
Plasmodium orthologues encode a formin homology two domain (FH2; dark grey solid 
rectangle), in a conserved C-terminal position. In addition, all orthologues encode a DAD-
like domain and contain one, or multiple predicted nuclear localisation signal(s), (NLS; solid 
red rectangle). Intriguingly, the predicted transmembrane domain (TM; solid yellow 
rectangle) is consistently positioned within the FH2 domain. A putative kinase-like domain 
(light grey solid rectangle) is predicted in P. berghei, P. yoelii and .P. falciparum MISFIT. 
(Pb), P. yoelii (P.y), P. falciparum (Pf), P. knowlesi (Pk) and P. vivax (Pv). Adapted from 
(Bushell et al., 2009). 
 
PbMISFIT (Pb000064.01.0) shares 92% sequence identity with its homologue in the 
rodent parasite P. yoelii (PY00811). Unsurprisingly, the full-length sequence identity 
is much lower with its more evolutionary distant counterparts in the human parasites 
P. falciparum (PF14_0035; 32%), P. vivax (Pv086245; 32%) and the simian malaria 
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parasite Plasmodium knowlesi (PKH_134310; 33%). However, the position and 
composition of the putative FH2 and transmembrane (TM) domains is remarkably 
conserved (Figure 5.1; for full sequence alignment see Appendix 2). The only 
exception is the prediction of centrally located, additional TM in P. falciparum.  
 
A putative kinase-like domain is predicted upstream of the FH2 domain in P. 
falciparum and the rodent malaria spp. No kinase-like domain was identified in P. 
knowslei or P. vivax. Nevertheless, the corresponding region is characterized by a 
high level of amino-acid sequence conservation between all orthologues (Figure 5.1, 
Appendix 2). Thereby, whether this region has retained its kinase activity or not, it 
appears essential for MISFIT function. An additional, highly conserved motif of 25 
amino acids, lacking functional prediction, is positioned towards the N-terminus of 
MISFIT (Appendix 2). A putative, regulatory diaphanous auto-regulatory domain 
(DAD-like domain) is also encoded by all MISFIT orthologues (Figure 5.1).  
 
In contrast to the conserved nature of the FH2 and TM domains, the position and 
number of NLS vary among the species. All orthologues, except for PfMISFIT are 
predicted to encode an N-terminally located, classical Lysine (K) and Arginine (R) 
repeat bipartite NLS motif composed of either KKKR or KRRK, separated by 12 
non-conserved amino acids and followed by a consensus sequence of RKK 
(Appendix 2). In P. falciparum, a single NLS of central location is predicted, which 
is not predicted in the other orthologues. Nevertheless, the initial RKK motif of the 
predicted PfMISFIT NLS is conserved among all orthologues (Appendix 2). In P. 
vivax and P. knowlesi, multiple NLS are predicted, with a second NLS positioned at 
the C-terminal of the protein in both orthologues and a third centrally positioned NLS 
predicted for PkMISFIT. A second, C-terminal NLS is not predicted in the rodent 
parasites. However, again the corresponding region is characterized by a conserved 
RK-XXX -RRK motif, consistent with a classical bipartite NLS and again, it exhibits 
strong sequence conservation among all spp., which indicates an important role in 
MISFIT function (Appendix 2). The accuracy of the multiple NLS prediction and / or 
the significance of the variable number and multiple NLS sites is not known.  
 
In order to better understand the relationship between MISFIT and the different 
Apicomplexan formins, a phylogenetic analysis of the MISFIT FH2 domain and the 
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FH2 domain of formins encoded by T. gondii, Cryptosporidium parvum, Theileria 
annulata and Plasmodia was performed (Figure 5.2). While only two formins have 
been identified in Plasmodia and T. annulata, three formins are found in T. gondii 
and four in C. parvum. A strong to moderate sequence conservation is observed 
among Formin1 and Formin2 proteins across all species. Similarly, Formin3 from T. 
gondii and C. parvum are most closely related to each other (Figure 5.2). 
Interestingly, MISFIT FH2 shows a higher degree of similarity to the FH2 of 
Cryptosporidium parvum Formin 4 than that of either PfFormin1 or 2 (Figure 5.2).  
 
 
 
 
Figure 5.2. Phylogenetic analysis of MISFIT FH2 and Apicomplexan formin-like 
proteins. Red and blue circles show 75% and 50% bootstrap support for groups, respectively. 
PfFormin1 (PFE1545c), PfFormin2 (PFL092w), PvFormin1 (PV079720), PvFormin2 
(PV123615), PyFormin1 (PY01292), PyFormin2 (PY01855), TgFormin1 (Tg20.m05986), 
TgFormin2 (Tg20.m03963), TgFormin3 (Tg20.m00924), TaFormin1 (TA03495), TaFormin2 
(TA09030), CgFormin1 (cgd6_4150), CgFormin2 (cgd8_2450), CgFormin3 (cgd8_1500), 
CgFormin4 (cgd2_3850), Bni1p (NP_014128) and AFH1 (NP_189177). T. gondii (Tg), 
Theileria annulata (Ta); C. parvum (Cp), Saccharomyces cerevisiae (Sc); Arabidopsis 
thaliana (AT). Adapted from (Bushell et al., 2009). 
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5.2.2 MISFIT is a nuclear protein of male gametocytes, zygotes and ookinetes. 
5.2.2.1 Misfit transcriptional and translational activity peaks in the gametocyte 
In a qRT RT-PCR-based transcriptional survey of misfit expression during infection 
of A. gambiae its associated transcript was present already during uptake of an 
infected blood meal and remained elevated up to the time of ookinete midgut invasion 
(24 hours). At five days post-infection, the transcript was no longer detectable 
(Chapter 3.4). In agreement with transcriptional data, preliminary Western blot 
analysis demonstrated that MISFIT is expressed in the mixed blood stages of the 
vertebrate host (Chapter 4.4). In order to investigate the relationship between misfit 
transcription and MISFIT translation in more detail, RT-PCR and Western blot based 
analysis of purified, sexual stage parasites was performed.  
 
Western blot analysis of purified misfit-myc parasites confirmed that MISFIT-MYC is 
expressed already before the parasite is taken up in the bolus of its mosquito vector 
(Figure 5.3, A). Furthermore, MISFIT-MYC is enriched in non-activated and 
activated gametocytes (gametocyte preparations of 80-90% purity), and can be 
detected in mature, purified ookinetes (Figure 5.3, A). The MISFIT-MYC specificity 
was verified by the absence of signal in WT samples (Figure 5.3, A). 
 
The RT-PCR based analysis showed that, consistent with protein expression data, 
misfit is predominantly transcribed in gametocytes (Figure 5.3, B). No signal was 
observed in pure asexual blood-stage samples (derived from the non-gametocyte 
producing Pb2.33 parasite line), (Figure 5.3, B). The transcript signal obtained in 
vivo at 24 hours post-infection is likely to be derived from residual gametocyte 
derived transcripts, as a weak misfit transcript signal was obtained for non-purified 
ookinetes, while no signal was observed for purified ookinetes (Figure 5.3, B). In 
addition, the RT-PCR analysis confirmed the lack of misfit transcript in the Δpbmisfit 
parasite line.  
 
MISFIT was readily detected in western blot analysis of purified microgametes 
(Figure 5.4). Similarly to that of purified ookinetes, misfit transcripts could not be 
detected in zygotes harvested at 8 hour post-culturing (Figure 5.4). 
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Figure 5.3. Developmental profiling of misfit transcriptional activity and protein 
expression in sexual stage parasite populations. Western blot analysis of Pb2.34 misfit-myc 
purified parasite populations, probing with a rabbit anti-MYC antibody. Pb2.34 WT parasites 
were used as a negative control. The anti-MYC antibody detects a single band migrating 
between >150 and <250 kD, which is present in the Pb2.34 misfit-myc, but absent in the WT, 
parasite preparations. Tubulin (α-TUB) was used a loading control and was detected at 50 kD 
with a mouse monoclonal antibody raised against Trypanosoma brucei alpha-tubulin (A). 
RT-PCR-based analysis (30 cycles) of misfit in Pbc507 WT and Δpbmisfit parasite 
populations. Primers specific for misfit detect a 1 Kb band in Pbc507 WT parasite 
populations, which is absent in Δpbmisfit. Primers amplifying pbs21 (sexual stage-specific) 
and the ama1 (blood stage-specific), were utilised as stage-specific and loading controls (B). 
The samples analysed were purified (P), non-purifed (nP), activated (A) and non-activated 
(nA) asexual blood stages (ABS), mixed blood stages (MBS) gametocytes (Gc) and ookinetes 
(Ook). Adapted from (Bushell et al., 2009). 
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Figure 5.4 MISFIT expression in microgametes and zygotes. Western Blot analysis 
detected MISFIT-MYC in purified pbmisfit-myc microgametes, gametocytes and ookinetes 
using a rabbit anti-MYC antibody. PbWT used as a negative antibody detection control. (A). 
RT-PCR using misfit-specific primers fails to readily detect misfit transcript in gametocytes 
but not zygotes harvested 8 hours after activation (Left Panel). Successful fertilisation and 
initiation of post-fertilisation gene expression was confirmed by ctrp and chit1 detection 
(Right Panel), (B). pbs21 was used as a positive control for cDNA quality. A mouse anti-α-
tubulin1 (TAT1) antibody was utilised as a loading control for Western blots as complemeted 
with coomassie staining. Purified gametocytes (Gc), purified ookinetes (Ook) and purified 
microgametes (♂Gm).  
 
5.2.2.2 MISFIT oocyst expression cannot be verified nor excluded 
MISFIT-MYC could not be detected in A. stephensi midguts infected with Pbc507 
misfit-myc parasites at 24 hours, 48 hour or 5 days post-infection (Figure 5.5, A).  
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Figure 5.5. Western blot analysis of protein extracts prepared from A. stephensi midguts 
infected with Pbc507 or Pb2.34 misfit-myc parasites. A lack of MISFIT-MYC detection 
was observed in Pbc507 misfit-myc infected A. stephensi midguts, irrespectively of presence 
or absence of blood meal at 24 hours , 48 hours and five days post-infection (A).No MISFIT-
MYC was detected at day 12 post-infection in midgut extracts derived from Pbc507 or 
Pb2.34 misfit-myc infected A. stephensi midguts (B). MISFIT-MYC was detected by a rabbit-
anti-MYC antibody and pbmisfit-myc mixed blood stage (MBS) parasites derived from the 
gametocyte donor mouse were used as positive controls for MYC-detection. GFP (25kD) or 
CSP full-length (60kD) and cleavage product (40 kD) detection was used as infection and 
loading controls. In Panel A, Coomassie stained midgut extracts were used as an additional 
loading control and Pbc507 WT as a negative control for specificity of MYC detection in 
midgut preparations. 
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Contrary to proteome data (Hall et al., 2005), MISFIT-MYC could neither be 
detected at day 12 post-infection (Pb2.34 and Pbc507 misfit-myc infections), (Figure 
5.5, B). However, there may be some technical difficulties regarding the detection of 
moderate to low abundant proteins in mosquito midgut preparations. The highly 
abundant protein CSP can be readily detected at day 12 post-infection (Figure 5.5, 
B). Similarly, GFP (derived from the Pbc507 reference line) is abundant in midguts 
with intact blood meals collected at 24 hours post-infection. In contrast, the GFP 
signal is substantially decreased following the severe parasite bottle-neck associated 
with midgut invasion (in the absence of the Pbc507 parasite dense blood meal), 
(Figure 5.5, A). Furthermore, despite documented MISFIT-MYC expression in 
gametocytes and ookinetes, no MISFIT-MYC can be detected in midguts at 24 hours 
post-infection, in presence or absence of blood meal (Figure 5.5, A). MISFIT oocyst 
expression could thus neither be refuted nor confirmed. 
 
5.2.2.3 MISFIT remains insoluble in membrane fractionation experiments 
In silico analysis predicted MISFIT to encompass a transmembrane domain. In order 
to experimentally investigate its potential membrane-anchoring capacity, membrane 
fractionations were conducted. Purified Pbc507 misfit-myc and WT gametocytes were 
subjected to sonication followed by membrane extraction in 1% Triton X-100, and 
finally extraction of the non-soluble component in 5% SDS at 100°C. Each fraction 
was collected by ultracentrifugation and subjected to western blot analysis.  
 
MISFIT-MYC was not observed in the cytosolic fraction released by sonication, or in 
the 1% Triton X-100 fraction, where membrane-bound proteins can be expected to 
locate. Instead, MISFIT-MYC was exclusively detected in the non-Triton X-100 
soluble fraction, where proteins only extractable by 5% SDS at 100°C are collected 
(Figure 5.6). This indicates that MISFIT is not membrane bound, but is instead 
completely insoluble under non-denaturating conditions.  
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Figure 5.6. Western blot analysis of membrane fractionations derived from Pbc507 
misfit-myc and WT gametocyte preparations. Fresh gametocyte fractions were collected by 
ultracentrifugation following sonication (Soluble fraction; Sbl.), extraction in 1% Triton X-
100 extraction (Triton soluble fraction; TSbl.) and extraction in 5%SDS at 100°C (Non-triton 
soluble fraction; NTSbl.). All fractions were probed with a rabbit anti-MYC antibody for 
detection of MISFIT-MYC, where Pbc507 WT served as a negative control. Detection of 
GFP by a rabbit anti-GFP antibody served as a control to identify the soluble fraction, α-
tubulin (as before) was used as a loading control to ensure successful extraction of parasite 
proteins in all fractions.  
 
5.2.2.4 MISFIT localises to the nucleus of male gametocytes, zygotes and ookinetes  
Consistent with the NLS prediction of MISFIT, anti-MYC immunofluorescence 
assays on pbmisfit-myc parasites revealed a nuclear localisation of MISFIT in non-
activated and activated gametocytes, zygotes and ookinetes (Figure 5.7). 
Interestingly, MISFIT displayed a strongly male-biased gametocyte staining pattern. 
The sex-specific expressional pattern of MISFIT was confirmed by its co-localisation 
with SET, which plays a putative role in chromatin dynamics and is up-regulated in 
the male gametocyte (Pace et al., 2006), (Figure 5.7, A). In contrast, activated female 
gametocytes (as visualized by anti-Pbs21 co-staining) displayed only a weak 
MISFIT-MYC signal (Figure 5.7, B), barely above that of background intensities.  
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Figure 5.7. MISFIT localisation in gametocytes, zygotes and ookinetes.  MISFIT-MYC 
(Green) localisation in inactivated (A) and activated (B) gametocytes; male gametocytes prior 
(C) and during (D) exflagellation; zygotes at 8 hour (E) and mature ookinetes at 24 hours (F) 
post-culture. All panels are immunofluorescence images from confocal sections of fixed 
Pb2.34 pbmisfit-myc parasite where nuclear DNA is stained by DAPI (Blue). Non-activated 
gametocytes were co-stained with an anti-SET antibody (Purple) to identify male (M) 
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gametocytes (A) and activated female (F) gametocytes, zygotes and ookinetes were identified 
by co-staining with an anti-Pbs21 antibody (Red), (B, E-F). The mitotic spindle of activated 
male gametocytes (C) and microgametes (D) were visualised by anti-α-Tubulin1 (Yellow). 
Fluorescent images of the exflagellating male gametocyte (D) are 3D reconstruction of a 
confocal stack after deconvolution. Figure adapted from (Bushell et al., 2009).  
 
In activated male gametocytes, prior to and during the process of exflagellation, 
MISFIT-MYC staining remains closely associated with the mitotic nucleus (Figure 
5.7, C-D). However, in exflagellating male gametocytes MISFIT-MYC staining was 
always confined within the parental gametocyte nucleus and MISFIT was never 
observed in association with the haploid nuclei of emerging (Figure 5.7, D) or 
released (not shown) male gametes.  
 
The imperfect co-localization with nuclear DNA indicates that MISFIT is not an 
integral chromosome component. However, 3D-projections of confocal microscopy 
stacks of immunofluorescence images of DAPI, α-Tubulin1 and MISFIT-MYC co-
stained, activated male gametocytes show that MISFIT is closely associated with the 
DNA of the mitotic nucleus, and occupy a spatial localization within the mitotic-
spindle (as visualized by anti-α-Tubulin1 staining), (Figure 5.7, C). MISFIT stayed 
associated with the parasite nucleus post-fertilisation with a clear nuclear MISFIT 
staining observed in zygotes and ookinetes (Figure 5.7, E-F) 
 
Rabbit polyclonal antibodies, raised against C-terminal and N-terminal peptides of 
MISFIT, have recently been developed. Preliminary analysis of native MISFIT 
expression and localization has successfully confirmed its nuclear localization 
(Appendix 3). 
 
5.2.3 There is an absolute requirement for paternal inheritance of misfit 
A powerful way of determining if a P. berghei gene is required in the early, or only 
during the later stages of mosquito stage development, is to perform genetic 
complementation experiments with sex-specific P. berghei mutants (Raine et al., 
2007). If both female- and male- derived alleles can rescue the mutant phenotype, the 
associated gene product is not required until after both the male and female genomes 
become available for transcription in the developing zygote. In contrast, if only the 
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female- or male-derived allele is capable of rescuing the KO phenotype, the gene 
product must be present and functional pre-fertilisation, or in very early post-
fertilisation developmental stages.  
 
Genetic crosses between Δpbmisfit parasites and P. berghei transgenic lines, which 
are unable to produce either fertile female (Δpbs47) or male (Δpbs48/45) gametes 
(Khan et al., 2005, Mair et al., 2006, van Dijk et al., 2001) revealed that the functional 
copy of pbmisfit must be inherited from the male gamete (Figure 5.8, Table 5.1). 
This is consistent with the observed MISFIT expressional peak during early mosquito 
stages and its male-biased gametocyte expression pattern. Crosses between Δpbs47 
and Δpbmisfit parasite lines yielded oocysts of normal morphology and numbers, 
which were able to produce sporozoites. In contrast, crosses between Δpbs45/48 and 
Δpbmisfit parasites invariable displayed a Δpbmisfit phenotype with low oocyst 
density and small oocysts which failed to produce sporozoites (Figure 5.8).  
 
The absolute requirement for male-specific inheritance of pbmisfit is not restricted to 
crosses with the Δpbs47 and Δpbs48/45 mutants, which could potentially be due to 
hidden mutant artefacts in either transgenic line. Genetic crosses between Δpbmisfit 
and additional mutants, which are also unable to produce either functional female 
(Δpbnek4),(Reininger et al., 2005) or male (Δpbmap2 and Δpbcdpk4), (Tewari et al., 
2005, Billker et al., 2004) gametes confirmed that the Δpbmisfit phenotype can only 
be rescued when fertile male gametes are provided (Table 5.1 and Figure 5.9). 
Furthermore, these results were corroborated by crosses with the independent Pb2.34 
Δmisfit clone (Table 5.1).  
 
In addition, the requisite for paternal inheritance is specific to Δpbmisfit, since the 
Δpplp5 mutant phenotype can readily be rescued by crosses with both Δpbmap2 and 
Δpbcdpk4 (Table 5.1). PPLP5 is specifically required during midgut invasion and its 
functional requirement is restricted to the mature ookinete (Ecker et al., 2007) at a 
time when both male and female derived genomes are available for transcription. 
Thus, either a female- or male- derived WT pplP5 allele can restore function.  
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Figure 5.8. Sex-specific complementation of Δpbmisfit by genetic crossing. Oocyst 
numbers following genetic crosses between Δpbmisfit and the female-deficient Δpb47 and 
male-deficient Δpb48/45 mutant lines (A). Midguts with representative oocyst densities (X10 
magnification) are depicted in (B) and typical morphology and oocyst size (X63 
magnification) at day 15 post-infection is illustrated in (C). Diagnostic PCRs were conducted 
on gDNA derived from input parasite populations (collected from gametocyte donor mice) in 
order to confirm the presence of both mutant and WT pbmisfit, and pbs47 or pb48/45 alleles 
in the input parasite population (D). GFP is derived from constitutive expression by the 
Pbc507 Δmisfit line.  
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Table 5.1. Genetic crosses between Δpbmisfit and a panel of female / male deficient P. berghei mutants 
Genetic crosses Average oocyst # Prevalence Oocyst size Sporulation # of midguts Type of feed 
Δpbmisfit (Clone 7, Pbc507 GFP background) 
Δpbmisfit x Δpbs47 (♀+♂-) 62  100% Normal √ 20 membrane 
 53  100% Normal √ 40 membrane 
 13 100% Normal √ 12 membrane 
 179 100% Normal √ 45 membrane 
Δpbmisfit x Δpbs45/48(♀-♂+) 22 43% Small − 30 membrane 
 9  16% Small − 44 membrane 
 21 40% Small − 10 membrane 
Δpbmisfit x Δpbcdpk4(♀-♂+) 19 83% Small − 29 membrane 
 21 92% Small − 51 direct 
Δpbmisfit x Δpbmap2(♀-♂+) 18 100% Small − 58 membrane 
 31 100% Small − 15 direct 
Δpbcdpk4(♀-♂+) x Δpbpplp5 30 96% Normal √ 50 direct 
 39 86% Normal √ 50 direct 
Δpbmisfit (Clone 3, Pb2.34  WT background)  
Δpbmisfit x Δpbs47 (♀+♂-) 97 100% Normal √ 45 membrane 
Δpbmisfit x Δpbs45/48(♀-♂+) 1 37% Small − 22 membrane 
Δpbmisfit x Δpbcdpk4(♀-♂+) 7 83% Small − 47 direct 
 3.1 82% Small − 50 direct 
Δpbmisfit x Δpbnek4(♀+♂-) 34 96% Normal √ 49 direct 
 213 100% Normal √ 50 direct 
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Table 5.1 Sex-specific complementation of Δpbmisfit by genetic crossing with an 
extended panel of sex-specific P. berghei mutants. Summary of oocyst numbers, prevalence 
and observed oocyst size and sporulation following genetic crosses between two independent 
Δmisfit clones in Pbc507 (GFP) and Pb2.34 ANKA (WT) genetic backgrounds and the 
female-deficient Δpbs47 and Δpbnek4 and male-deficient Δpb48/45, Δpbcdpk4 and Δpbmap4 
mutant lines. Type of feed; ookinete membrane feed vs. direct feed on infected mice with 
mixed mutant-line infections, is also indicated. Adapted from (Bushell et al., 2009). 
 
Δpbcdpk4 (♀+♂-) x ΔpbmisfitΔpbnek4 (♀-♂+) x Δpbmisfit Δpbmap (♀+♂-) x Δpbmisfit
DIC
 
Figure 5.9. Oocyst morphology following Δpbmisfit crosses with an extended panel of 
mutants. Representative images of oocyst size and morphology following crosses between 
Pbc507 Δmisfit and the female-deficient Δpbnek4 and male-deficient Δpbcdpk4 and Δpbmap4 
transgenic lines. Images were captured at X63 magnification at day 15 post-infection. 
 
 
5.2.4 Discussion 
MISFIT was not identified in previous in silico searches for Plasmodium or 
Toxoplasma gondii formins (Baum et al., 2008b). In contrast to MISFIT, PfFormin1 
and 2 possess a FH1-domain upstream and adjacent to their respective FH2 domains. 
Curiously, PfFormin1 and 2 lacks any of the known accessory, regulatory domains 
found in classical formins such as ScBNi1p, which carry a GTPase-binding and a 
DAD domain (Baum et al., 2008b). All MISFIT orthologues encode a putative DAD-
like domain. However, the MISFIT DAD-like domain prediction is overlapping with 
the second C-terminal NLS found in some of the orthologues. The true function of 
this region thus remains to be elucidated. It can also be hypothesised that the MISFIT 
putative kinase-like domain may play a key part in regulation of MISFIT activity by 
phosphorylating putative interaction partners or cell signalling components. 
Perplexingly, in all MISFIT orthologues the conserved TM domain is predicted to lie 
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within the putative FH2 domain, which raises questions about its functionality. It is 
most likely this stretch of hydrophobic amino acids is simply a conserved feature of 
the FH2 domain that resembles a TM.  
 
Functional genomics data has provided conflicting indications of misfit expression. In 
P. falciparum, MISFIT was first reported to be present in trophozoites and 
gametocytes (Florens et al., 2002). This finding was corroborated by the P. berghei 
sex-specific gametocyte proteomics survey, where MISFIT was detected in the male, 
and to lesser extent, female gametocyte (Khan et al., 2005). However, in the P. 
berghei full life-cycle proteomic analysis, which served as the basis for candidate 
selection in this study, MISFIT was exclusively detected in the mature oocyst (Hall et 
al., 2005).  
 
In this study MISFIT was readily detected in mixed blood stages, purified 
gametocytes and ookinetes but not in the oocyst. Due to the much stronger signal 
obtained in pure gametocyte preparations compared to mixed blood stages, the weaker 
signal obtained with mixed blood-stage parasites is expected to be derived mostly 
from the sexual (gametocyte) component of this preparation. In addition, misfit is also 
foremost transcribed in gametocytes with no signal detected in pure asexual blood-
stage samples or purified ookinete preparations. This further supports that the protein 
and transcript signals observed in the mixed blood-stage or non-purified ookinete 
preparations primarily derive from its gametocyte component. Together these data 
indicate that misfit transcription and translation is well correlated on a temporal level 
and that MISFIT is primarily expressed in gametocytes.  
 
MISFIT is non-soluble under non-denaturing conditions. In eukaryotic cell 
fractionation experiments, including those of Apicomplexan parasites, proteins that 
form integral parts of the cytoskeleton or are bound to cytoskeletal components are 
known to be of Triton-X100 insoluble nature (Morrissette and Sibley, 2002). The 
observed lack of MISFIT solubility is thus well correlated with a putative role in 
modulation of actin or microtubule dynamics, as potentially conferred by its FH2 
domain. However, any additional membrane associations conferred by the putative 
transmembrane domain, could potentially be masked by its putative insoluble bond to 
cytoskeletal proteins, and can hence neither be completely rejected nor confirmed. 
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MISFIT localizes to the nucleus of male gametocytes, zygotes and ookinetes. The 
strong male-biased and low-level female MISFIT gametocyte expression pattern 
observed  here is well correlated with P. berghei sex-specific proteome data (Khan et 
al., 2005).  MISFIT is closely associated with the DNA of the male gametocyte, and 
resides within the mitotic-spindle surrounding the mitotic nucleus of the activated 
male gametocyte. The exact sub-cellular localization of MISFIT remains unknown. 
Interestingly, MISFIT localization in male gametocytes, as well as zygotes and 
ookinetes, does not completely overlap with nuclear DAPI staining. Instead MIISFIT 
often covers a somewhat larger area of the cell, and sometimes displays a either 
polarized or peripheral nuclear distribution. This suggests that MISFIT is not an 
integral chromosome component. Future work will encompass the co-staining of the 
nuclear envelope with an anti-nucleoporin antibody in order to enable the spatial 
localization of MISFIT to within or outside the nuclear envelope.  
 
Consistent with its male biased expression patter, misfit displays an absolute 
requirement for paternal inheritance. P. berghei sex-specific inheritance of gene 
products that act post-fertilisation has previously thought to be confined to that of 
female inheritance, as exhibited by nek4 (Reininger et al., 2005, Khan et al., 2005), 
the lap family (Ecker et al., 2008, Raine et al., 2007) and genes which pre-synthesised 
transcripts are under the post-translational control of DOZI (Mair et al., 2006).  misfit 
is the first P. berghei gene to be discovered to exhibit an absolute requirement for 
paternal inheritance and with an effect post-fertilisation. All other P. berghei genes 
with a known male-specific functions act either pre-fertilisation (cdpk4 and map2), 
(Tewari et al., 2005, Billker et al., 2004, Khan et al., 2005) or during fertilisation 
(p48/45 and  hap2 / gcs1), (van Dijk et al., 2001, Liu et al., 2008, Hirai et al., 2008).  
 
Four possible scenarios underpinning misfit inheritance can be envisaged. Firstly, the 
male gamete may contribute misfit mRNA, exclusively transcribed in the male and 
translated post-fertilisation. Secondly, the male gamete may directly contribute 
MISFIT protein, or a combination of transcript and protein. Thirdly, no meaningful 
contribution of transcript or protein may be made by the male gamete during 
fertilisation, but with only the male-derived copy of misfit being available for 
transcription post-fertilisation. Finally, MISFIT may play a hidden but crucial role in 
male gametogenesis. In the latter case, in the Δpbmisfit mutant line it is not the lack of 
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male-derived misfit coding capacity, mRNA or protein which eventually causes the 
mutant phenotype, but rather the inheritance of a defective male gamete. 
 
The inability to detect MISFIT by immunofluorescence in the microgamete, and the 
absence of misfit transcript post-fertilisation, is poorly correlated to the strong 
MISFIT expression observed in the nucleus of zygotes and ookinetes. The zygotes 
assayed were harvested at 8 hours post-fertilisation. It is possible that misfit re-
expression occurs exclusively from the male genome or from male inherited misfit 
mRNA more or less directly after fertilisation, and that 8 hours is too late to detect 
misfit transcripts. In situ based misfit detection was unsuccessful, most likely to low 
transcript abundance coupled to a lack of sensitivity in the chromatographic detection 
assays employed. A more detailed RT-PCR based assay is currently underway and is 
expected to yield further insight into the developmental timing of misfit transcription.  
 
The domain composition of MISFIT, its nuclear localization, male-gametocyte 
expressional bias and dispensable role during asexual blood-stage replication, 
implicates MISFIT as a novel Plasmodia formin that is essential for sexual 
development and is distinctly different from the previously identified P. falciparum 
Formin 1 and 2.  
 
5.2.5 Summary 
¾ misfit encodes a FH2 domain, which is the defining domain of the formin protein 
family. 
¾ However, MISFIT lacks the accompanying FH1 domain characteristic of classical 
formins and its FH2 domain differ in composition from that of PfFormin1 and 2. 
¾ misfit transcription and translation is temporally well-correlated, with an 
expressional peak in the gametocyte. 
¾ MISFIT displays a strong male-biased gametocyte expression. 
¾ MISFIT expression in the oocyst stage could neither be confirmed nor rejected. 
¾ Consistent with its NLS prediction, MISFIT is present in the nucleus of male 
gametocytes, zygotes and ookinetes. 
¾ MISFIT is completely non-soluble under non-reducing conditions, indicating that 
MISFIT may bind cytoskeletal components. 
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¾ Genetic crossing experiments revealed an absolute requirement for paternal 
inheritance of misfit. 
¾ Male-inheritance confirm that misfit is required during early mosquito-stage 
development; pre-initiation of actual oocyst development. 
¾ The oocyst defective Δpbmisfit phenotype is thereby likely to be a knock-on effect 
from the lack of MISFIT during an earlier developmental event (s). 
¾ The exact mechanism for male-inheritance of misfit is unknown, with 
microgamete mediated transfer of MISFIT protein to the fertilised zygote and 
remaining a viable hypothesis. 
 
 
5.3 Δpbmisfit ookinetes display significant developmental defects and as a result 
fail to complete sporogonic endomitosis 
5.3.1 The Δpbmisfit transmission-blockade is independent of midgut invasion 
5.3.1.1 Normalisation of ookinete input does not restore the Δpbmisfit phenotype 
To rule out that the marginally lower ookinete conversion ratio observed for Δpbmisfit 
(Chapter 4.3) is a determining factor of its oocyst defective phenotype, ookinete 
membrane feeds were conducted.  
 
Equal numbers of WT and Δpbmisfit in vitro cultivated, mature ookinetes were fed to 
A. stephensi and A. gambiae mosquitoes, and oocyst numbers were counted at day 10 
post-infection. The assay revealed that Δpbmisfit oocyst numbers could not be 
restored to that of the WT by normalising the input number of ookinetes (Figure 
5.11). In contrary, an even larger discrepancy between WT and Δpbmisfit oocyst 
numbers was observed compared to that of the direct feeds previously conducted 
(Chapter 4.3). This firmly confirms that the rate of ookinete formation is not a 
decisive factor of the Δpbmisfit transmission blockade. 
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Figure 5.10. Δpbmisfit ookinete membrane feeds. An equal number of mature, in vitro 
cultivated ookinetes derived from the Δpbmisfit and WT P .berghei c507 lines were 
harvested, re-suspended in naïve blood and fed through membranes to A. gambiae and A. 
stephensi mosquitoes. Oocyst numbers were counted 10 day post-infection and are displayed 
as an average number calculated from >30 midguts. Standard error of the mean is indicated. 
 
 
5.3.1.2 Δpbmisfit ookinetes are capable of  invading the mosquito midgut  
To determine whether the reduced oocyst numbers observed in the absence of 
MISFIT were influenced by a reduced invasive ability of the Δpbmisfit ookinetes, 
invasion assays were performed in CTL4 KD A. gambiae mosquitoes. In CTL4 KD 
mosquitoes, where the key melanisation-inhibitor CTL4 is depleted by RNAi, there is 
a significant increase in the ability of the mosquito to kill and melanise invading 
ookinetes (Osta et al., 2004). Ookinetes, which have successfully traversed the midgut 
barrier, come in contact with immune components present in the haemocoel that 
occupy the sub-epithelial space between the midgut epithelium and basal lamina, and 
are subsequently melanised. This melanotic encapsulation facilitates the visualisation 
and enumeration of invading ookinetes, and thereby CTL4 KD mosquitoes provides 
an good ookinete invasion model (Ecker et al., 2008)♣♣♣. 
                                                 
♣♣♣ Reverse genetics screen identifies six proteins important for malaria development in the mosquito 
(2008). Andrea Ecker, Ellen S. C. Bushell, Rita Tewari and Robert E. Sinden. Molecular Microbiology 
2008; 70(1), 209–220 
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Figure 5.11. Δpbmisfit ookinete invasive ability as assayed in a CTL4 KD invasion model. 
The number of melanised Pbc507 Δmisfit and WT ookinetes as counted at 10X 
magnification under a light microscope at day 7 post-infection. Individual values (ookinete 
number per midgut) are indicated (black diamonds) as well as the average of all midguts 
enumerated (black horizontal bar) for each parasite line. The number of melanised ookinetes 
is slightly lower for Δpbmisfit (70% of that of WT), however the difference is non-significant 
in a two-tailed, unpaired Student T-test of equal variances (p=0.12), (A). Representative light 
microscopy images of Pbc507 Δmisfit and WT infected midguts collected from CTL4 KD 
mosquitoes are also shown at X10 magnification with insets of individual ookinetes captured 
at X63 magnification (B). 
 
Δpbmisfit infections of CTL4 KD mosquitoes demonstrated that Δpbmisfit parasites 
are melanised at a rate that is slightly lower (71.2 % of that of WT ookinetes) but 
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which is not significantly different to that of WT (p>0.05), (Figure 5.11). 
Importantly, this indicates that Δpbmisfit oocyst defective phenotype can not be 
explained by a pure ookinete invasion defect. 
 
5.3.1.3 By-passing the midgut barrier does not rescue the Δpbmisfit phenotype  
To confirm that the Δpbmisfit oocyst defective phenotype is independent of any defect 
during midgut invasion, in vitro cultivated, mature Δpbmisfit ookinetes were injected 
directly into the haemocoel of A. stephensi mosquitoes, thus completely by-passing 
the midgut epithelial barrier. As assayed by enumeration of salivary gland sporozoites 
and infectivity to C57/BL6 mice, ookinete haemocoel injections does not rescue the 
Δpbmisfit transmission blockade (Table 5.2). The observed phenotype was identical 
to that of direct feeds on Δpbmisfit gametocyte donor mice, with no salivary gland 
sporozoite present in Δpbmisfit injected mosquitoes resulting in complete block in 
transmission.  
Table 5.2. Δpbmisfit ookinete haemocoel injections 
Parasite strain 
Salivary gland sporozoites Infectivity to mice 
Average SEM d21 
pbWT 1,028 728 2/2 
 15,259 0 2/2 
 6,078 3,443 2/2 
    
Δpbmisfit  0 0  0/2  
 0 0 0/2 
 0 0 0/2 
Table 5.2. Δpbmisfit ookinete haemocoel injections fail to restore transmission. Salivary 
gland sporozoites were enumerated from salivary glands derived from three batches of ten 
mosquitoes at day 21 post-injection. Infectivity to C57/BL6 mice was assayed by allowing 
Pbc507 Δmisfit or WT infected A. stephensi mosquitoes feed on anaesthetised mice (day 21 
post-injections), where mice subjected to bites by Δpbmisfit infected mosquitoes received at 
least twice as many bites as the WT sporozoite recipients. Parasitaemia of recovered 
sporozoite-recipient mice was assayed by Giemsa-stained thin blood smears on day 5, 7 and 
14 post-inoculation, with infected mice culled on the first day presence of blood-stage 
parasites could be confirmed. 
 
 211
5.3.2 Δpbmisfit ookinetes exhibit abnormal ultra-structure and gene expression 
Ookinete motility and invasion involves the apical discharge of microneme vesicles 
(Li et al., 2004). Micronemes are synthesised and loaded with cargo in the Golgi 
apparatus (Schrevel et al., 2008), (Lal et al., 2009) and subsequently trafficked along 
the subpelliclular microtubules to the apical complex (Bannister et al., 2003) where 
they accumulate prior to release (Lal et al., 2009).  
 
5.3.2.1 Δpbmisfit ookinetes display a severe microneme-deficiency 
By light microscopy, Δpbmisfit ookinetes appeared to be morphologically 
indistinguishable from WT ookinetes (Chapter 4.3). In contrast, electron microscopy 
revealed significant changes at an ultra-structural level in ookinetes developed in the 
absence of MISFIT (Figure 5.12), with Δpbmisfit ookinetes being largely deficient in 
micronemes. 
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Figure 5.12. Transmission electron microscopy of Δpbmisfit and WT mature ookinete 
sections. Transmission electron micrographs (TEM) of WT (A-D) and Δmisfit ookinetes (E-
G). Panels of increased magnification of ookinete nuclei (B, E) and apical ends (C-D, F-G) 
depicting normal nuclear architecture of but a severe micronemal defect in Δmisfit ookinetes 
compared to that of WT.  Apical Polar Ring (APR), MtSp (Meiotic spindle), Mn 
(Micronemes) N (Nucleus), No (Nucleolus), and SpMt (Subpellicular microtubules). 
 
5.3.2.2 Δpbmisfit ookinetes deviate in their gene expression repertoire 
In order to investigate whether the absence of MISFIT during ookinete development 
also transcends to a defect in gene expression, the transcriptional activity of in vitro 
cultivated WT and Δpbmisfit ookinetes was compared. Microarray analysis identified 
231 genes which were >1.7 fold, up- or down-regulated in the absence of MISFIT 
(Figure 5.13). In accordance with the observed Δpbmisfit micronemal-defect, cht1, 
which encodes the ookinete micronemal chitinase protein 1 (Dessens et al., 2001), 
was the single most affected gene. Remarkably, cht1 associated transcripts were 
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nearly completely depleted in Δpbmisfit ookinetes, displaying a 160-fold (-7.3 Log2) 
down-regulation recorded in the absence of MISFIT.  
 
INTERPRO domain scans and GO-ontology assignments of the 231 differentially 
regulated genes revealed a dysregulation of numerous genes with putative functions in 
cell-cycle regulation and transcriptional responses commonly associated with cell-
cycle progression. Among the genes which are upregulated in the Δpbmisfit ookinete 
is a member of the regulator of chromosome condensation 1 (RCC-1) superfamily, 
which are known to be critical regulators of the eurkaryotic cell cycle (Hadjebi et al., 
2008). Known modulators of chromatin dynamics such as hmgb2, a regulator of of 
sexual stage gene expression in P. yoelii (Gissot et al., 2008) and a SET-domain 
contaning protein (Canela et al., 2003) is also upregulated in MISFIT depleated 
ookinetes. 
 
 Furthermore, the expression of four transcription factors is affected in the absence of 
MISFIT. Out of these, three are basal transcription factors; two members of the TFIID 
complex and Tfb2, which is a subunit of the TFIIH complex and the most highly 
upregulated gene (1.7 fold, Log2) in Δpbmisfit compared to WT ookinetes. The fourth 
is the specific transcription factor Myb-1 that has been implicated as a major regulator 
of the P. falciparum intra-erythrocytic cell cycle (Gissot et al., 2005). However, the 
Myb-1 study was largely conducted by dsRNA mediated RNAi (recently shown to be 
non-functional in Plasmodium (Baum et al., 2009)), which casts some doubts over the 
true function of Myb-1.  
 
Other genes subjected to dysregulation in MISFIT depleted ookinetes included a 
cyclin-4 homologue, several cyclin-dependent kinases and a putative homologue of 
the yeast cell cycle control protein Cwf15/Cwc15 (Ohi et al., 2002). Five DNA/RNA 
helicases and several other genes with putative roles in transcription and translation 
were also affected in the Δpbmisfit genetic background. 
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Gene ID Expression ratio (Log2) Functional Prediction (Consensus) 
Genes down-regulated in Δpbmisfit compared to WT ookinetes 
PB001032.02.0 -7.3 Chitinase; Carbohydrate metabolic process 
PB100817.00.0 -3.1 Pb-fam-4 protein 
PB000040.01.0 -2.7 Hypothetical Protein 
PB000765.00.0 -2.3 Conserved Hypothetical Protein 
PB000026.01.0  -2.1 DNA /RNA helicase with Zn-finger motif, 
PB000900.03.0 -2.1 Conserved Hypothetical Protein 
PB300672.00.0 -1.9 Lipoate synthase; Lipoate metabolic process 
PB001142.00.0 -1.5 Multi antimicrobial extrusion protein MatE; Multidrug transport 
PB000958.01.0 -1.4 Methyltransferase type 11; Metabolic transport 
PB000452.02.0 -1.3 P-type ATPase; Ion transport 
PB100823.00.0 -1.3 Hypothetical Protein 
PB000504.00.0 -1.2 Cyclin 4; Cell cycle Regulation 
Genes up-regulated in Δpbmisfit compared to WT ookinetes 
PB000329.03.0 1.7 Conserved Hypothetical Protein 
PB000407.00.0 1.6 Transcription factor Tfb2; Transcription 
PB000839.00.0 1.5 HSP20-like chaperone; Heat shock protein 
PB000068.02.0 1.5 Tumor metastasis-suppressor / Longevity-assurance protein 
PB000299.03.0 1.5 Serine/threonine protein kinase; Protein Phosphorylation 
PB000752.02.0 1.5 Protein of unknown function DUF841 
PB000151.01.0 1.4 Ribosomal protein S12; Translation 
PB001511.02.0 1.3 Kelch repeat protein; Protein-Protein interaction 
PB104045.00.0 1.3 Hypothetical Protein 
PB000099.00.0 1.3 Hypothetical Protein 
PB000852.02.0  1.3 DNA-directed RNA polymerase; Transcription 
PB000264.03.0 1.3 RNA polymerase Rpc34-like; Transcription 
PB000802.00.0 1.3 RNA-binding protein Lupus La; RNA processing 
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Figure 5.13 Δpbmisfit ookinete microarrays 
Microarray Ratio-Intensity (R-I) plot showing differential gene expression measurements 
between control WT and Δpbmisfit ookinetes (Top Panel). Measured intensities are plotted as 
a function of the logarithm of their product. Red and green dots represent genes that are up or 
down regulated by at least 1.7 fold, respectively, in Δpbmisfit compared to WT ookinetes. 
Grey dots represent genes that do not show significant regulation. Details of the genes 
displaying the highest level of down- (<-1.3 Log2) and up- (>1.3 Log2) regulation in the 
absence of MISFIT are outlined (Bottom Panel). The consensus functional domain prediction 
above is summarised from respective PlasmoDB annotations, INTERPRO scans and manual 
GO ontology assignments for each gene. Gene list published in full in (Bushell et al., 2009). 
 
 
5.3.2.3 The Δpbmisfit ookinete microneme deficiency translates to a transcriptional 
down-regulation of a sub-set of micronemal genes 
The microneme-defect and down-regulation of the micronemal protein chitinase in 
Δpbmisfit ookinetes prompted further investigation of transcript levels of other known 
micronemal proteins in the absence of MISFIT. Semi-quantitative RT-PCR confirmed 
the cht1 deficiency (Figure 5.14). Furthermore, the transcriptional activity of pplp3 
(Kadota et al., 2004) and warp (Yuda et al., 2001) were also down-regulated in 
Δpbmisfit ookinetes, albeit to varying extent, and with both genes less severely 
affected than cht1 (Figure 5.14). In contrast, ctrp (Dessens et al., 1999) and soap 
(Dessens et al., 2003) transcription remain unchanged in the absence of MISFIT.  
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Figure 5.14. Semi-quantitative RT-PCR of P. berghei genes encoding micronemal 
proteins in Δpbmisfit and WT ookinetes. Gene specific primers were used to amplify cht1, 
ppl3, ctrp, soap and warp from cDNA pools obtained from bead purified, in vitro cultivated 
Δpbmisfit and WT ookinetes, under increasing cycle numbers (25 and 30 cycles). Pbs21 
primers were used as a cDNA quality and loading control. Amplicon size ranges from 0.6-
1kb. 
 
5.3.3 Δpbmisfit zygotes fail to complete meiosis: An event not essential for 
invasion 
The nuclear localisation of MISFIT and the developmental arrest ensuing upon 
ookinete-oocyst transformation in absence of MISFIT, prompted a closer 
investigation of the ability of Δpbmisfit zygotes to enter and complete meiosis. DNA 
measurements were performed on fluorescence microscopy images of DAPI-stained 
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mature ookinetes where measurements were normalized to the DNA content of 
asexual haploid parasites A control group of WT parasites were treated with the DNA 
polymerase inhibitor aphidicolin (derived from Nigrospora sphaerica; added 1h post 
fertilization). Aphidicolin treatment inhibits the DNA replication associated with 
zygotic meiosis, and thus artificially produce ookinetes with diploid genomes (Janse 
et al., 1986). 
 
5.3.3.1 Δpbmisfit ookinetes display incomplete genome values 
A quantitative comparison between the DNA amounts of aphidicolin-treated (n=2.3) 
and untreated (n=4.5) WT ookinetes, and that of Δpbmisfit ookinetes (n=3.2) showed 
that ookinetes developing in the absence of MISFIT display a genome value that is an 
intermediate of the DNA content of diploid and tetraploid ookinetes (Figure 5.15, A).  
 
Flow-cytometric measurements of independent Δpbmisfit and WT ookinete samples, 
stained with the fluorescent DRAQ5 DNA-binding dye, corroborated the DNA 
deficiency observed in Δpbmisfit ookinetes (Figure 5.16, B). A closer inspection of 
the microscopic images that the DNA measurements were derived from revealed that 
the difference in DNA content is consistently reflected in the appearance of the DAPI-
stained nuclei. For the informed observer, the difference in size (DAPI distribution of 
Δpbmisfit nuclei, compared to that of the WT untreated and aphidicolin-treated WT 
ookinetes) is discernable by eye (Figure 5.15, C). Remarkably, aphidicolin treated 
ookinetes developed into crescent-shaped ookinetes of mature appearance (Figure 
5.15, C).  
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Figure 5.15. DNA measurements of Δpbmisfit ookinetes. Measurements of total intensity 
(average pixel intensity x total nuclear area) made in ImageJ from images of fixed, DAPI 
stained, mature ookinetes. Measurements were normalized to the DNA content of asexual 
haploid parasites. A control group of WT parasites were treated with the DNA polymerase 
inhibitor aphidicolin. The individual genome values of each measured ookinete (n=20) are 
indicated (solid blue diamond) as well as the average genome content of each group (black 
horizontal bar), (A). Flow-cytometric measurements of independent Δpbmisfit and WT 
unfixed, mature ookinete samples stained with DRAQ5 (B). Representative images of 
untreated and aphidicolin-treated WT and Δpbmisfit ookinetes as used for DNA 
measurements (C). 
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5.3.3.2 Completion of meiosis is not a prerequisite for midgut invasion 
The above results imply that completion of meiosis is not a prerequisite for ookinete 
development or midgut invasion, but is an absolute requirement for subsequent oocyst 
development. In order to validate the above hypothesis, untreated and aphidicolin-
treated WT and Δpbmisfit ookinetes were fed to control (LacZ KD) and CTL4 KD 
mosquitoes.  
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Figure 5.16. Ookinete invasion and oocyst development in absence of MISFIT or 
presence of the DNA inhibitor aphidicolin. Oocyst numbers in dsLACZ KD A. gambiae 
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mosquitoes (Left panel) and melanised ookinetes in dsCTL4 KD A. gambiae mosquitoes 
(Right panel) at day 10 post-infection from membrane feeds of untreated and aphidicolin-
treated WT and Δpbmisfit ookinetes. Individual number of oocysts (green solid diamonds) 
and ookinetes (black solid diamonds) are indicated as well as the average number per midgut 
for each treatment group (black horizontal bar), (A). Representative images of dsLacZ (Top 
panels; Fluorescent microscopy oocyst images) and dsCTL4 (Bottom panels; Light 
microscopy melanised ookinete images) infected midguts were captured at X10 magnification 
with insets of individual parasites captured at X63. The individual, inset oocyst images were 
captured with DIC to illustrate presence of sporulated oocysts in the untreated WT infection, 
in contrast to the aphidicolin-treated WT and Δpbmisfit infected midguts where oocyst were 
completely void of sporozoites. 
 
Compellingly, aphidicolin-treated WT ookinetes and Δpbmisfit displayed 
indistinguishable invasion-competent, but oocyst-deficient phenotypes (Figure 5.16, 
A-B). Aphidicolin-treated WT ookinetes invaded the midgut of CTL4 KD mosquitoes 
at a comparable rate to that of both Δpbmisfit and untreated WT ookinetes. Whilst the 
oocyst phenotype of aphidicolin treated WT ookinetes appeared near identical to that 
of Δpbmisfit, with very low infection densities, a shift to smaller oocyst size and an 
absence of sporulated oocysts.  
 
5.3.4 Sporogony is initiated but not completed in the absence of MISFIT 
In order to better understand the consequences of entering endomitosis with an 
incomplete genome value, transmission electron microscopy (TEM) was performed 
on young (d3) and mature (d13) Δpbmisfit oocysts. In parallel, midguts were infected 
with WT oocysts and served as timing and condition specific controls. 
 
5.3.4.1 Young Δpbmisfit oocysts appear ultrastructurally normal 
In agreement with comparative analysis of WT sections and previously published 
observations (Sinden and Strong, 1978, Garnham et al., 1969), TEM sections of 
young Δpbmisfit oocysts revealed no observable developmental defects. Δpbmisfit 
oocysts contain a large nucleus, occupying a significant proportion of the oocyst 
cytoplasm (Figure 5.17). The substantial nuclear size, in conjunction with the 
presence of multiple clearly identifiable mitotic spindles (Figure 5.17, 5.19), 
indicated that endomitosis may be at least initiated in MISFIT deficient oocysts. 
Furthermore, the residual apical complex (micronemes and subpellicular 
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microtubules) inherited from the motile ookinete, were re-absorbed into the cytoplasm 
as the crescent shape of the ookinete was lost and the young Δpbmisfit oocyst obtain a 
spherical shape (Figure 5.17). In accordance with TEM analysis of Δpbmisfit 
ookinetes, an absence or reduction in the number of micronemes was observed in 
Δpbmisfit compared to WT young oocysts.  
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Figure 5.17. Transmission electron microscopy images of young (d3) WT and Δpbmisfit 
oocysts. The TEM images depict day 3 WT (Panel A- B) and Δpbmisfit (Panel C-D) oocysts, 
demonstrating typical oocyst morphology (Left panels) and enlargements of the residual 
apical complex, retracting into the cytoplasm (Right panels) derived from separate sections 
of respective parasite lines. Other identifiable organelles and structural features are also 
indicated accordingly; Apical complex (AP), Cr (Crystalloid), Cyst wall (CW), Api 
(Apicoplast), Mit (Mitochondrion), MtSp (Mitotic spindle), Mn (Micronemes) N (Nucelus) 
and SpMt (Subpellicular microtubules). 
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In addition, the young Δpbmisfit oocysts were showing signs of development of an 
electron dense, protinaceous capsule (the developing cyst wall) and normal 
distribution of endoplasmic reticulum, mitochondria and apicoplasts, all of the 
expected morphology (Figure 5.17). In conclusion, despite their significant reduction 
in numbers compared to that of WT, young Δpbmisfit oocysts display a normal 
ultrastructural morphology.  
 
5.3.4.2 Δpbmisfit oocysts initiate but fail to complete endomitosis  
In contrast to the normal morphology of the young Δpbmisfit oocysts, TEM sections 
of mature day 13 oocyst revealed significant ultrastructural deviations. Sections 
derived from multiple WT and Δpbmisfit oocysts were analysed and classified into 
three categories: Type1 (oocysts displaying a large, digitated endomitotic nucleus and 
containing fully formed sporozoites), Type 2 (oocysts displaying a large, digitated 
endomitotic nucleus but with no observable sporozoites) and Type 3 (highly 
vacuolated oocysts with a sick appearance indicating death or progress of cell death).  
 
For the WT control (25 sections analysed), Type 2 oocysts dominated (60%) with 
oocysts displaying a large number of foci of a large, highly lobed nucleus but in 
which no sporoblasts or sporozoites were observable (Figure 5.18 A, E-F). Thus, at 
the time of harvest (d13), the majority of the WT oocysts had undergone extensive 
endomitotic genome replication, whilst the nuclear division and cytokinetic events 
that generate individual sporozoites, had not yet been completed. A smaller 
proportion of Type 1 (28%) oocysts were also identified, for which sporogony was 
completed to a high degree and mature sporozoites were readily observable within the 
oocysts (Figure 5.18 A, C-D). A small number (12%) of sick or dying Type 3 oocysts 
were also identified in the WT cohort (Figure 5.18 A). These oocysts were 
characterized by swollen mitochondria, where the mitochondria become dilated due to 
a loss of ability to maintain the mitochondrial membrane potential (Arambage et al., 
2009), rendering the cells a vacuolated appearance.  
 
Contrastingly, TEM of day 13 Δpbmisfit oocysts (16 sections analysed) revealed that 
mature, sporulated Type 1 oocysts were completely absent from this cohort (Figure 
5.18, B). This is consistent with the sporulation deficiency previously observed by 
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light microscopy (Chapter 4.3). Whilst 44% of the Δpbmisfit oocysts were of Type 2, 
displaying an enlarged and digitated nucleus, the number of nuclear lobe foci were 
substantially fewer compared to that observed for WT oocysts (Figure 5.18 B, G-H). 
The mature Δpbmisfit oocysts that do persist to day 13 appear to arrest at a 
developmental stage corresponding to that of day 7 WT oocysts, as indicated by their 
number of nuclear foci (R. E. Sinden, personal communication). 
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Figure 5.18. Transmission electron microscopy images of mature (d13) WT and 
Δpbmisfit oocysts. Pie charts demonstrate proportions of Type1 (oocysts displaying a large, 
digitated endomitotic nucleus and containing fully formed sporozoites), Type 2 (oocysts 
displaying a large, digitated endomitotic nucleus but with no observable sporozoites) and 
Type 3 (Highly vacuolated oocysts with a sick appearance indicating death or progress of cell 
death) WT (Panel A) and Δpbmisfit (Panel B) mature oocysts. The TEM images depict day 
13 WT (Panel C-F) and Δpbmisfit (Panel G-L) oocysts, demonstrating typical oocyst 
morphology (Left panels and Panel K-L) and enlargements of significant features (Right 
panels; Exception of Panel K-L) derived from separate sections of respective parasite lines. 
Identifiable organelles and structural features are indicated accordingly; Apical complex 
(AP), Chr (Chromatin), Cr (Crystalloid), Cyst wall (CW), Api (Apicoplast), Mit 
(Mitochondrion), MtSp (Mitotic spindle), Mn (Micronemes) N (Nucelus) and SpMt 
(Subpellicular microtubules). 
 
The majority of Type 2 Δpbmisfit oocysts exhibited different degrees of vacuolation, 
with mitochondria of typical swollen appearance (Figure 5.18, I-K). Some sections 
also displayed atypical vacuolated compartments, possible also of mitochondrial 
origin but undergoing a different type of oocyst cell death not previously described in 
literature (Figure 5.18, I-K), (R. E. Sinden, personal communication). Chromatin 
condensation, another established marker of programmed cell-death in P. berghei 
(Arambage et al., 2009), was also observed (Figure 5.18, I-J). The Type 2 Δpbmisfit 
oocysts thus appear immature and “unhealthy” in comparison to Type 2 WT oocysts. 
This is indicative of that in the absence of MISFIT, endomitosis is initiated but does 
not reach its full potential and is aborted due to impeding cell-death. Or conversely, 
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programmed cell-death may be triggered due to Δpbmisfit oocysts’ inability to 
complete endomitosis.  
 
The majority of the Δpbmisfit oocysts were of Type 3 (56%), appearing dead or in the 
process of dying with no observable, normal sub-cellular architecture remaining. 
Intriguingly, in a sub-set of Type 3 Δpbmisfit oocysts the retracting apical complex 
and associated micronemes remained visible at day 13 (Figure 5.18, L), a feature 
never observed in mature WT oocysts. These oocysts are likely to have died shortly 
after completing its ookinete to oocyst transformation.  
 
The hall mark of mitosis, mitotic spindles, were observed in the nucleus of young and 
mature Δpbmisfit oocysts (Figure 5.19), supporting the observation that endomitosis 
is at the very least initiated, but not completed in the absence of MISFIT. 
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Figure 5.19. Transmission electron microscopy images of the nucleus of young (d3) and 
mature (d13) Δpbmisfit oocysts. The TEM images depict the presence of mitotic spindles in 
day 3 (Panel A) and day 13 (Panel B) Δpbmisfit oocysts, indicating endomitotic activity. 
Organelles and structural features are indicated accordingly; Endoplasmic reticulum (ER), N 
(Nucelus) and Mitotic spindle (MtS). 
 
5.3.4.3 Clearance of Δpbmisfit oocysts is influenced by mosquito immunity 
The exact nature of the observed Δpbmisfit cell-death is not fully understood, with the 
persisting Δpbmisfit oocysts displaying features compatible with markers of 
programmed cell death previously described in Plasmodium (Al-Olayan et al., 
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2002b). Depletion of the mosquito immune component LRIM1, a key parasite 
antagonist (Osta et al., 2004), by RNAi restores Δpbmisfit oocyst numbers to above 
that of the WT indicating that the mosquito immune response may be at least partially 
responsible for the gradual clearance of Δpbmisfit oocysts (Figure 5.20).  
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Figure 5.20. Pbc507 WT and Δpbmisfit infections of dsGFP and dsLRIM1 knock-down 
experiments in A. gambiae. Oocyst numbers for individual midguts are displayed for Pbc507 
WT and Δpbmisfit infections of dsGFP and dsLRIM1 depleted mosquitoes. Black horizontal 
bars indicate the mean number of oocysts from two independent biological experiments. The 
sample sizes were as follows; WT/dsGFP (n=24), WT/dsLRIM1 (n=18), Δpbmisfit/dsGFP 
(n=33) and Δpbmisfit/dsLRIM1 (n=44). The counts were conducted on day seven post-
infection (Left panel). Fluorescent images of WT and Δpbmisfit oocysts in midguts isolated 
from LRIM1 depleted mosquitoes were captured at day seven post-infection at X40 
magnification and included as an indication of representative relative oocysts morphology and 
size difference between WT and Δpbmisfit (Right panel). 
 
However, Δpbmisfit oocyst numbers in LRIM1 KD mosquitoes do not reach anywhere 
near the elevated numbers observed for WT parasites in a LRIM1 KD background. 
Furthermore the Δpbmisfit oocysts that persist to day seven remain small in size even 
in the absence of LRIM1 (Figure 5.20), confirming the existence of a parasite 
intrinsic Δpbmisfit defect which cannot be completely overcome by suppressing the 
mosquito immune response. 
 228
5.3.5 Discussion 
Δpbmisfit oocyst numbers in A. gambiae at day 3 post-infection only reaches 9.6% of 
that of WT oocysts (Chapter 4.3). In contrast, invasion assays revealed that Δpbmisfit 
ookinetes are capable of invading the mosquito midgut epithelium at a rate 
comparable to that of WT ookinetes. These results are in stark contrast to data 
obtained from genes that are known to be essential for ookinete midgut invasion. For 
example, since CTRP expression is critical for ookinete motility and midgut invasion, 
Δpbctrp infections of a melanotic refractory A. gambiae strain (L3-5) completely 
abolished the presence of melanised ookinetes (Dessens et al., 1999). Similarly, the 
perforin-like protein PPLP5 is essential for midgut invasion but plays no known role 
after the traversal of the midgut epithelial barrier. Its transmission blocking phenotype 
can thus be completely reversed by injecting Δpplp5 ookinetes directly into the 
haemocoel (Ecker et al., 2007).  
 
In contrast to PPLP5, PbCTRP has been suggested to play an additional role in 
ookinete-oocyst transformation (Arrighi and Hurd, 2002). However, the dispensable 
nature of CTRP during in vitro oocyst cultivation (Nacer et al., 2008a) indicates that 
CTRP is foremost a component of the ookinete motility/invasion machinery. Such 
notion is further supported by the successful rescue of the Δpbctrp transmission 
blockade by Δpbctrp ookinete hemocoel injections (Nacer et al., 2008a). It would be 
interesting to see whether hemocoel injections of mutant lines of any of the other P. 
berghei genes whose associated gene products have been suggested to bind basal 
lamina components, would fully restore their respective mutant phenotypes.  
 
The crucial ookinete to oocyst transition is poorly characterised at a molecular level, 
and the subject is especially exciting in the light of apparent functional redundancy in 
cell-free systems of some of the ookinete encoded proteins, which were previously 
implicated in this process (Nacer et al., 2008a). Importantly, the invasive ability of 
Δpbmisfit ookinetes, the early detection of an oocyst developmental defect (<3 days 
post-infection) and the failure to restore Δpbmisfit transmission by ookinete 
haemocoel injections, strongly indicate that the absence of MISFIT causes a 
developmental arrest specifically during ookinete-oocyst transformation. The 
discovery and characterisation of misfit has thus led to the identification of the first 
gene, whose absence causes a block at the onset of oocyst development. 
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The results presented here clearly demonstrate that completion of meiosis is not 
essential for ookinete development or midgut invasion, but is an absolute prerequisite 
for successful oocyst development. Furthermore, it identifies ookinete to oocyst 
transformation as a major, obligate cell-cycle check point. The major bottleneck 
during Δpbmisfit development clearly is that of ookinete-oocyst transition. How some 
Δpbmisfit oocysts escape check-point implementation and make it to a relative 
advanced developmental stage, whilst others are lost already during early oocyst 
development remains to be explored, but may indicate a less strict cell cycle control in 
Plasmodia than in other organisms. Although cell cycle check points evidently are in 
place, such as that of the requirement for a tetraploid genome prior to entry into 
sporogonic endomitosis, in Plasmodium sexual development these seem to be less 
than perfect. The checkpoint implementation at the ookinete-oocyst transition still 
allow a highly reduced number of defective parasites through (as shown for both 
Δpbmisfit and aphidicolin treated WT ookinetes), causing the development of 
defective parasites to slowly grind to a halt rather than coming to a sharp stop. Such a 
“transmit at all costs policy” is perhaps logical for a unicellular parasite, whose only 
concern is the parasites that do transmit appropriately throughout the transmission 
cycle, and cares little about those that fail to do so, and with none of the concern 
regarding metastatic growth that strongly influences the metazoan cell cycle. 
 
Taking into account the FH2 and DAD-like domains of MISFIT, a putative role in 
stabilizing the mitotic or meiotic spindle during chromosome segregation can be 
envisaged. This hypothesis is supported by the documented role of the mammalian 
diaphanous formin Dia3 in microtubule attachment to kinetochores (Yasuda et al., 
2004). Furthermore, another diaphanous formin, Dia2, is known to confer microtubule 
stabilisation, a property independent of its actin polymerization activity conferred by 
its FH1-FH2 composite-domain architecture (Bartolini et al., 2008). For MISFIT two 
alternative, pre- or post- fertilization hypotheses for MISFIT function can be 
postulated.  
 
Development in Δpbmisfit parasites may proceed normally until the point of meiosis, 
post-fertilisation. Zygotic DNA replication may be initiated but not completed in 
Δpbmisfit zygotes due to inherent problems during chromosome segregation, caused 
by a destabilized meiotic spindle or problems in kinetochore attachment in the 
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absence of MISFIT. In Mus musculus, Formin-2 is involved in correct positioning of 
the meiotic spindle and deletion of its FH1 domain leads to a metaphase arrest during 
meiosis and aunploid offspring (Leader et al., 2002). However, mFormin-2 is 
maternally inherited and since MISFIT lacks a FH1 domain, any direct comparison is 
tenuous. Nevertheless, it clearly demonstrates the diverse role of formins, acting not 
only during mitosis but also meiosis. The diversification and evolution of formins in 
Apicomplexa, and its unorthodox cell cycle, may have resulted in different types of 
formins, such as the atypical MISFIT, being adapted to fill roles occupied by other 
formins present in mammals but absent in Plasmodium. Importantly, the above 
hypothesis is in line with the observation of distinct meiotic spindles in Δpbmisfit 
ookinetes; in the absence of MISFIT, meiotic spindles are formed but may be unable 
to execute chromosome segregation. 
 
Alternatively, a pre-fertilisation genome-defect can be envisaged. It is possible that 
during mitotic DNA replication in activated, MISFIT-depleted male gametocytes, the 
microtubules of the mitotic spindle are destabilized or insufficiently anchored to the 
kinetochores, resulting in inefficient genome segregation and generating male 
gametes carrying incomplete haploid genomes. The Δpbmisfit male gamete may thus 
make an abnormally low genomic DNA contribution during fertilisation (<1n), 
resulting in a lower DNA starting material for zygotic meiosis in Δpbmisfit compared 
to that of the WT. Since DNA synthesis and gametogenesis are incredible rapid, 
concurrent processes (completed within 10 min of activation), mitotic cell-cycle 
checkpoints may be absent at this stage (Doerig, 2004). Such a notion is supported by 
the frequent observation of released male gametes lacking nuclei (Sinden et al., 1978) 
and is compatible with the nuclear expression of MISFIT in male gametocytes. 
Abnormally low male gamete DNA content may thus not lead to an arrest during 
exflagellation or subsequent fertilization, however, post-fertilisation meiotic events 
may be compromised due to asymmetric sister-chromatid or chromosome pairing, 
resulting in failure to complete meiosis and subsequent check-point implementation 
and developmental arrest during ookinete-oocyst transition. To confirm or refute the 
latter hypothesis, DNA measurements of microgametes have to be performed.  
 
The incomplete DNA value observed for Δpbmisfit ookinetes is likely to be linked to 
the disruptions in normal transcriptional activity observed in MISFIT depleted 
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ookinetes. However, whether the transcriptome alterations directly results from the 
incomplete DNA value (in form of a putative gene-dosage effect) or transcriptional 
difficulties stemming from chromosomal disarrangements is not known. If the male 
gamete DNA contribution is proven normal in the absence of MISFIT, it would be 
tempting to speculate that the genes which are down-regulated in the Δpbmisfit 
ookinete may be transcriptionally linked to the male gamete derived DNA by an 
epigenetic effect, i.e. that the male derived DNA is abnormally “marked” or silenced.  
Experimental evidence for an incomplete male gamete genome value, or epigenetic 
silencing of the male gamete genome, would indicate that the strict requirement for 
male inheritance of misfit is linked to the inheritance of a defective male genome by 
the Δpbmisfit zygote. However, it does not exclude a role for male gamete inherited or 
de novo synthesised MISFIT post-fertilisation. Alternatively, if the Δpbmisfit male 
genome is shown to be completely functional and meiotic chromosome segregation is 
directly affected by the absence of MISFIT, there may be a link to spatial (loci 
chromosomal location) or temporal (timing) gene expression. Genes of specific 
chromosomal locations or with early vs. late post-fertilisation expression patterns may 
be differentially affected in the Δpbmisfit zygote. Such a scenario would support a 
link between the strict requirement of male-inheritance and the direct transfer of 
MISFIT protein (and / or mRNA) from the male gamete to the zygote during 
fertilization. 
 
Based on the MISFIT FH2 domain-prediction and a putative role in microtubule 
remodelling, it is tempting to also make a direct link between the absence of MISFIT 
and the observed lack of micronemes in Δpbmisfit ookinetes. For example, it could be 
envisaged that in the absence of MISFIT, microtubule-mediated microneme 
trafficking is disrupted, thus resulting in a lack of apical complex micronemes. 
However, no evidence exists in support for this hypothesis. In contrary, the 
exclusively nuclear localisation of MISFIT directly opposes such a conclusion, since 
mitosis and meiosis are uncoupled from the invasion machinery in Plasmodia by 
being under control by two distinct spatially separated MTOCs, the spindle pole 
plaque in the nucleus (mitosis and meiosis) and the apical polar ring (motility and 
invasion), (Morrissette and Sibley, 2002). It seems improbable that MISFIT could 
influence subpellicular microtubule dynamics by residing exclusively within or 
around the ookinete nucleus. 
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Instead, as indicated by differential gene regulation in Δpbmisfit ookinetes, it is 
possible that the observed micronemal deficiency stems form altered expression of 
genes directly (vesicle biogenesis and trafficking) or indirectly (signaling) involved in 
microneme synthesis. The lack of micronemes could originate from reduced cargo 
protein synthesis such as CHT1 and WARP. This would be in line with the significant 
reduction in osmophilic bodies observed in female gametocytes in the absence of its 
major cargo protein, Pfg377 (de Koning-Ward et al., 2008). Conversely, defective 
microneme trafficking could potentially result in accumulation of micronemal cargo 
in the Golgi apparatus. This in turn may act as a critical component of a potential 
negative feed-back loop, ultimately serving so to down-regulate further transcriptional 
activity of micronemal cargo genes such as WARP and Chitinase. However, the 
existence of proteins synthesis and secretion feedback-loops are poorly understood in 
Plasmodium and any such theories remain to be experimentally explored.  
 
The mechanisms underlying the microneme defect in Δpbmisfit ookinetes is likely to 
be less-straight forward than a simple synthesis-secretion feed-back mechanism. 
While microneme cargo is constituted of a complex mixture of proteins, transcription 
of only a sub-set of micronemal genes is affected in the absence of MISFIT. For 
example, ctrp and soap transcription remain unaltered, while cht1 and warp 
transcription is down-regulated. This differential effect on micronemal gene 
transcription is intriguing as CTRP, Chitinase and WARP are all found within the 
same microneme population (Li et al., 2004). Many questions remain to be answered, 
such as if the reduction of cargo protein production is indeed the cause of the highly 
reduced microneme population observed in MISFIT-depleted ookinetes, what is the 
cause of the transcriptional mis-regulation of specific sub-sets of not only micronemal 
genes, but also genes involved in cell cycle regulation, DNA replication, membrane 
biogenesis and vesicle trafficking? Why is cht1 by far the most severely affected gene 
with a down-regulation of 170-fold (i.e. near complete depletion) compared to WT 
ookinetes? 
 
Another pertinent question is how Δpbmisfit ookinetes are able to invade the mosquito 
midgut with such a substantial reduction of their microneme population and with no 
other apical complex secretory organelles identified in the ookinete. CTRP is essential 
for motility / invasion (Dessens et al., 1999) and CTRP must thereby be successfully 
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translocated onto the ookinete surface to facilitate invasion. Furthermore, ctrp 
transcript levels remain unaffected in the absence of MISFIT. Anti-CTRP IFAs were 
conducted to investigate CTRP distribution in Δpbmisfit ookinetes, however, a strong 
surface-staining, but no apical accumulation, was observed in both WT and Δpbmisfit 
ookinetes, undermining confidence in staining-specificity, and thus no conclusions 
could be drawn from this experiment. Since only a marginal reduction (<30%) in 
invasive ability of Δpbmisfit ookinetes was observed, it is reasonable to assume that 
CTRP is successfully secreted on to the ookinete surface. 
 
It is possible that the micronemal deficiency observed in mature 24 hour ookinetes is 
related to either timing or dosage. Normal micronemal secretion may be initiated, but 
subsequently aborted during ookinete development (timing factor). Or that the few 
micronemes observed in the Δpbmisfit ookinetes are sufficient to facilitate motility / 
invasion (dosage factor) or a combination of both factors. A dosage factor appears 
plausible, especially for the proteins secreted into the mosquito midgut lumen. Even if 
a reduced amount of cargo is produced, such as for PPL3, which is essential for 
invasion (Kadota et al., 2004) but down-regulated in Δpbmisfit ookinetes, the high 
density of P. berghei ookinetes in the bolus may facilitate invasion by a concerted 
secretion effort. In contrast, WARP and Chitinase are not essential for midgut 
invasion (Dessens et al., 2001, Ecker et al., 2008).  
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5.3.6 Summary 
¾ Δpbmisfit ookinetes display highly reduced microneme populations and the 
absence of MISFIT results in significant alterations of the ookinete 
transcriptome. 
¾ Neverthesless, Δpbmisfit ookinetes are capable of invading the midgut. 
¾ Complete circumvention of midgut-invasion does not rescue transmission of 
Δpbmisfit and defective midgut invasion is thus not the determining factor in 
the Δpbmisfit transmission blockade. 
¾ Δpbmisfit ookinetes display incomplete genome values, indicating that meiotic 
DNA replication is initiated but not completed, or that the starting material 
following fertilization is lower, in MISFIT-depleted ookinetes. 
¾ dsCTL4 invasion assays and oocyst counts in control mosquitoes revealed that 
completion of meiosis is not a pre-requisite for ookinete midgut invasion.  
¾ In contrast, completion of meiotic DNA replication is an absolute requirement 
for ookinete-oocyst transformation. 
¾ Absence of MISFIT results in a developmental arrest during, or shortly after, 
the ookinete-oocyst transition. 
¾ Despite their significant reduction in numbers and inability to complete 
meiosis, young Δpbmisfit oocysts appear ultrastructurally normal. 
¾ TEM analysis of mature Δpbmisfit oocysts reveals that endomitosis is initiated 
but not completed in the absence of MISFIT and as a result Δpbmisfit oocysts 
fail to mature and form sporozoites.  
¾ Δpbmisfit oocysts are gradually cleared from the mosquito midgut, a process at 
least partially mediated by the mosquito immune response.  
 
5.4 Concluding remarks  
misfit is a novel P. berghei formin-like protein that is conserved among Plasmodia. 
MISFIT displays a strict requirement for paternal inheritance and is accordingly 
expressed in the nucleus of male gametocytes, zygotes and ookinetes. Zygotes 
developing in the absence of MISFIT fail to complete meiosis and the resulting 
ookinetes are largely void of micronemes and display significant gene reguation 
defects. As a consequence, Δpbmisfit oocyst fail to complete sporogonic endomitosis 
and rodent malaria transmission is blocked in the MISFIT deficient oocysts. 
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The results presented above have suggested a role of MISFIT during the 
chromosmome segregation events associated with mitosis and / or meiosis. However, 
some major aspects of the role of MISFIT during P. berghei sexual and sporogonic 
development still remains to be explored. The timing of functionality of MISFIT is 
undeniably intimately linked to its molecular mechanism of action, which in turn 
raises the question of what confers MISFIT its stage specificity?  
 
Mitosis occurs across the life-cycle; in the liver and blood-stages as well as during 
microgametogenesis and sporogony. The dispensable nature of MISFIT in the 
vertebrate stages testifies against a generic role in mitosis. It is nevertheless 
perplexing that MISFIT function is redundant in blood schizogony since there is low-
level expressional evidence of MISFIT in P. falciparum trophozoites and schizonts 
(Florens et al., 2002). If a role of MISFIT is envisaged as spanning only across 
microgametogenesis, zygotic meiosis and sporogony, the existence of a sexual stage-
specific chromosome segregation and / or cytokinetic machinery has to be considered.  
 
Such a notion may not be too far fetched since Plasmodium contains multiple forms 
of both actin and tubulin genes. The chief component of microtubules is a heterodimer 
of α- and β- tubulin. Plasmodia genomes encode a single β-tubulin gene and two 
isoforms of α-tubulin, denoted I and II (Kooij et al., 2005). In P. falciparum α-tubulin 
II was initially reported to be specific to the male gametocyte, where it forms an 
integral component of the male gamete axoneme during exflagellation (Rawlings et 
al., 1992). Recent evidence for α-tubulin II expression during P. falciparum asexual 
replication has now refuted an absolute male gametocyte specificity of α-tubulin II 
(Fennell et al., 2008). Similarly, in P. berghei α-tubulin I and II are expressed across 
the lifecycle and appear to both be essential for asexual blood-stage replication. 
However, α-tubulin II is strongly upregulated in the male gametocyte and was 
confirmed to play an important role in microgametogenesis (Kooij et al., 2005). A 
single copy of γ-tubulin is encoded by P. falciparum (Maessen et al., 1993).  
 
Taking the all of the above into account, a simple correlation between MISFIT stage-
specific functionality and stage-specific expression of tubulin isoforms is unlikely to 
exist. However, tubulin proteins are commonly post-translationally modified, a 
process which is thought to generate functional diversity and determine microtubule 
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stability and interactions with tubulin-binding proteins (Kooij et al., 2005). Such post-
translational modifications may be at the core of determining the specificity of a 
potential interaction between MISFIT and microtubule proteins. There is also 
indications that alternative splicing of α-tubulin I and II transcripts (Kooij et al., 
2005), as in the case of the chromatin remodelling protein SET (Pace et al., 2006), 
may act to confer stage specificity. Compellingly, undergoing RACE (Rapid 
Amplification of cDNA Ends) analysis of the 5’UTR region of misfit has identified a 
potential intron, opening up the possibility of the existence of misfit splice variants. 
The small size of the potential intron may have prohibited the detection of any 
potential splice variants by gel electrophoresis, which has prompted the initiation of 
analysis of stage specific transcript pools by Northern blot. 
 
Intriguingly, mitosis in the vertebrate stages of malaria displays a peculiar feature, 
that of a lack of any observable chromosome condensation (Morrissette and Sibley, 
2002). In contrast, distinct chromosome condensation is observable during both 
microgametogenesis and zygotic meiosis (Sinden et al., 1985, Sinden, 1991). A dual 
role of MISFIT in these two latter events may thus be linked to the specific 
occurrence of chromosomal condensation. In contrast to mitosis, meiosis is confined 
to the zygote, the first stage that the Δpbmisfit phenotype is manifested. A specific 
role in meiosis would thus be the most straight forward explanation for a putatively 
zygotic stage-specificity of MISFIT. Either of the above hypotheses is compatible 
with the transcriptional dysregulation of genes with putative functions in cell-cycle 
regulation, DNA replication, transcription, chromosome condensation and DNA 
repair and cell signaling observed in the Δpbmisfit ookinete 
 
Ongoing electron microscopic examination and transcriptional profiling of Δpbmisfit 
gametocytes are expected to yield further insight into a potential role of MISFIT pre-
fertilisation. An answer to whether MISFIT is required prior to fertilisation may also 
be provided by a promoter-swap study in which the native misfit promoter will be 
exchanged for the ctrp promoter. ctrp transcription is delayed until post-fertilisation 
(>4 hours), (Vlachou et al., 2004). If MISFIT is required in the preceding 
microgametogenesis stage, the Δpbmisfit phenotype is expected to be manifested 
when the native misfit gene is under the control of the ctrp promoter. The expression 
of recombinant P berghei and P. falciparum FH2 domains is also underway, with 
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subsequent X-ray crystallisation attempts and actin / microtubule polymerisation 
assays expected to provide further insight into the molecular mechanisms of MISFIT 
function. 
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6. RESEARCH PERSPECTIVES 
 
The characterization of the developmental transcription profile of P. berghei in the 
mosquito vector has provided novel insights into the parasite gene expression patterns 
that underpin malaria dissemination. Importantly, the focus of this study has enhanced 
our molecular understanding of the previously poorly characterised oocyst stage. 
Significantly, the results of the present study are complemented by those deriving 
from a parallel analysis of the transcriptional profiling of the vector A. gambiae 
responses to P. berghei infection (Dina Vlachou, Personal Communication). In the 
context of this broader framework, the study presented in this thesis may assist the 
identification of putative parasite candidate genes that may interact with mosquito 
molecules and is expected to open new avenues for understanding the transmission of 
malaria. 
 
Prior to the study outlined in this thesis, three classes of genes had been identified 
with critical functions in Plasmodium transmission biology; genes that are expressed 
in gametocytes and play roles in gamete development or fertilization, genes expressed 
de novo in the zygote with roles in ookinete motility and invasion and maternally 
inherited genes with developmental effects post-fertilization. The characterisation of 
misfit, the first gene with a paternal effect on Plasmodium post-fertilisation 
development, has identified a new class of genes that are critical for Plasmodium 
transmission. 
 
This study has set the exploratory stage for future research aiming to explore the role 
and relative contribution of the female and male genomes to Plasmodium early 
sporogonic development. Several studies have generated a notion that the male 
genome is not active in the first hours following fertilisation, as many of the genes 
expressed in these stages only require functional female copies. MISFIT adds a new 
perspective by identifying a key regulatory role for the male genome in meiotic and 
post-meiotic development. Furthermore the identification of  MISFIT provides a tool 
for studies that may provide novel insight into Plasmodium cell cycle regulation.  
 
The developmental events that occur in the mosquito are targets for interventions 
aiming to block transmission of the disease; understanding of their genetic and 
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molecular basis will facilitate identification of such potential targets. Due to the high 
level of conservation in genome organisation and individual gene content between the 
rodent and human malaria parasites, there is good reason to believe that the results 
presented in this thesis can be relevant to transmission of human malaria parasites. It 
will guide the generation of transgenic parasites that will help to elucidate the roles of 
genes and could potentially lead to the identification of new targets toward novel 
malaria control approaches.  
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Appendix 1. Genotyping of a second independent misfit (pdog-2) KO transgenic line in 
the Pb2.34 ANKA strain. Diagnostic PCR of the ppDOG2-TgDHFR-TS transfected Pb2.34 
parasite population displays the successful integration of the disruption vector into its misfit 
(pdog-2) target locus. The ppDOG2-TgDHFR-TS construct, potentially maintained as an 
episome or integrated, and the WT locus is also detected. The positive control confirms that 
the integration primer is working (A) Pulse field gel electrophoresis analysis (left panel) of 
three dilution cloned Δpbmisfit populations and the blot (right panel), probed with a tgdhfr-ts 
fragment. Integration of ppDOG-2-TgDHFR-TS is confirmed by a hybridisation signal on 
chromosome 10 (B) Diagnostic PCR analysis performed on the three clonal Δpbmisfit parasite 
populations. Successful integration of the disruption vector is demonstrated by the detection 
of the Δmisfit locus in all three clones, which also lack the misfit WT locus (C). pb2.34 
Δmisfit clone 3 was utilised for the phenotypic analysis of a second independent Δpbmisfit 
clone. 
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Consensus  ***:  . **:.:.:   .    .         :  :  :      :.        :     .     :            
 
 
 
                   570       580       590       600       610       620       630       640 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   EKLGIEKSDKINFPNVQKLSYSPLTLEDIEKLIKDEEKDKEISVNNNLNQSLIKENDFACMKKNICIDKDNLKNLVCLPE 
PyMISFIT   EKLGIEKSDKINFPNVQKLSYSPLTLEDIEKLIEDEEKDTGISVNNNLNPSLTKENDGICMKKNICIDKDDLKNLVCLPE 
PkMISFIT   ------RKESLDMVVYFHHSYEPLTLENVEFLMGNEIIDGEHARGGNSLGDNQEGDVGRDDRVHISSVENGKRGEYYMKE 
PvMISFIT   ------RKESPNMVAYFHLSYEPLTLKNVELLMGSEIIDGEHSLGGSSLGDDT------------SSVENAKRGKDYTRG 
PfMISFIT   -----DISKNISYIYDNLNTYIPITLEHIKNLIEWDDADYEDIKKYTFGNILHLKDTNYNILEGIDLECDKTKCMEKICE 
Consensus         ... .       :* *:**:.:: *:  :  *       .                      :  :        & 
 
                   650       660       670       680       690       700       710       720 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   KNQTYI------KIEKNCDDNGENISQINELKKEDKINGDNNKNTNFGASTINSENINNEVVGYIENPLSDNLIKVEKKI 
PyMISFIT   K--------------KNCDDNGENISQVNGIKKENKINEDNNENSNLLANTINSEIINNEVVGHIGKPLSDNLIKVEKNI 
PkMISFIT   CLAR-----------TEGYSP------EAEEHNAGFVSFKKETLSKLVQKGEEKSSIHLGEITPVGDDMDGHSNEKSAHS 
PvMISFIT   WPPR-----------TEGYSAGGEEPQEGEKRNAGDVPLKKEAVSNLAQKGEEKSSLHLGEVTPVGGDMDSHS------- 
PfMISFIT   KTNEDVPTYKNMYPIYKGDNMKGELYIKDEKCNIQNINNKSDDKKKCYLTKYKNVHIYKSDISSCPNEYKNNVDESNEQQ 
Consensus                  :  .            :   :  ..:  .:   .  :.  :    :       ..:         
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                   730       740       750       760       770       780       790       800 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   EEKSS---EYALVKKEGNISMENNSNKMSYNEKCKITKDLEEENMDIDNKKDIKNIENINTKDN---------------- 
PyMISFI    EEKSS---EYALIKKEENISMENNSNKMSYNEKCKITKEVEEENMGIDNKKDIKNIENINTKDN---------------- 
PkMISFIT   GEENFRMNHNSLLGREGTISSGERAKEMDKDHPEGG-RKMKEDKPDMERKNKKEPMKPLSHHMGSEEMGRLNNDSCGEEE 
PvMISFIT   GGEKLGIKRASLLGREGSIPPGDRVNGLDKDHPVGG-SNMKEDDPDMERRNKNDHIQPLNHLSG---------------- 
PfMISFIT   EDSFVRERDNANLDGSNQVHIKKINDNNSNMSTEYTCEQISLKNNKNDGERNHVNKLIIDKVPIN--------------- 
Consensus    .       : :  .  :   .  .  .         .:. ..   : ...      :.                     
 
                   810       820       830       840       850       860       870       880 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   -------------------VKKLDYSAISCGHEEINRKNIILNINDEIKEKIMERECVSGKVGNNSEENVFKKMSEKK-- 
PyMISFIT   -------------------VKKIDYSVISCGHEEINRKNIILNINDEIKEKIMEREGVSGKIENNSEENVCKKMNEKK-- 
PkMISFIT   GEPRVKGGEGIGGIFTVVESGQLGRTKQTRSEMPLKFQSIILSINDEIKRKLKGG-IEKGEIMNASKGAESNTSGNIS-- 
PvMISFIT   -------------------CDQIGRAKRTSSEMPLKFQNIILSINDEIKRKLQGGCSEKGEVSSASKCKEANTSGAKP-- 
PfMISFIT   -----------------------KLIKEPSDDISLKYKNIIFNINDEIKKKVNKEKNEEINEHVESLSKVCNKPRNIKNV 
Consensus                              . ..  :: :.**:.******.*:      . :    *     :.        
 
                   890       900       910       920       930       940       950       960 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   MLISENIRKNLMSSLEKETG---TKCSNINNRANLNIEIDLDCEYVSLDIVNIDLAINEGLYNYKKNEESYIECDEQIKD 
PyMISFIT   MLISENIRKNLMSSLEKETG---TKCSNVNNRANLNIEIDPDFEYVSLDIVNIDLAINEGLYNYKKNEESYIECDEQIKD 
PkMISFIT   DFTKSLKRSMLLCEGEKKNEGVEIERNINNNRANLHIEISTSVGYISLDMIDLDKAMYEGLFSCKDMEGSLIPSEENVKD 
PvMISFIT   SFTASVRKNLLPC-GENTNAGVEIERSVNNNRANLHIQMSTTVGYVSLDMVDLDKAMYEGLFLFKDVERSFIPSEQNVKD 
PfMISFIT   PFPSSLKKNILLESQEKKKN-------PINNRCPLHLDINVDVKYITLNTIDIDETINKGVCPYKDMEDNYISSEEHIKD 
Consensus   :  .  :. *    *: .          ***. *::::.    *::*: :::* :: :*:   *. * . * .::::** 
 
                                                                 Conserved region 
                   970       980       990       1000      1010      1020      1030      1040 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   IKIYNDILKSEKE----ICSDLLFIKKENQFN------NNSVILFKSSNEIKNEISKYVGMSIFDCIN-KFIIPTNSLVN 
PyMISFIT   IKIYNDILKSEKE----ICSDLSFIKKENQFS------NNSVILFKSSNEIKNEISKYVGMSIFDCIN-KFIIPTSSLVN 
PkMISFIT   IAMYDEILKEEAK----GNFNNISPYSINNENKLMFSRRSQISLFKSSQEIKNEMMEFLGVSIFYSINMESLFPSVSLVN 
PvMISFIT   IAMYDEILKGEAK----GSSNNTSPHSKINSNQLGLSGTSQRSLFKSSQEVKNEMMGVLGVSIFYSVNVESLFPSVSLVN 
PfMISFIT   IIIYSDILKTEKETFLYNPNDIEKYDNNDDSNNNVRKIPDTIIHFKSSNEIKNDIIKLVGISIFDCIH-KSYEPTKSLIN 
Consensus  * :*.:*** * :       :     .  : .       .    ****:*:**::   :*:*** .:: :   *: **:* 
 
                                     Conserved region                                   
                   1050      1060      1070      1080      1090      1100      1110      1120 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   DNRLSIWFTKKKKNNN----NMNRSKDNNFDRIENYNDDSKIRRNFIFKKKSEGRLSCMGYFSQPITIMLSSLKRRSEFG 
PyMISFIT   DNRLSIWFTKKKKKNN----NMNRSKDNNFDRIENYNDNSKIRRNFVFKKKSEGRLSCMGYFSQPITIMLSSLKRRSEFG 
PkMISFIT   DEKLALWFTKRVREKN----MNKNVLAKSYYRNNNP-----------LGGRIKKRLSCMGYFTQPVTIMLCSLKRQSEFK 
PvMISFIT   DEKLSLWFTKRVREKN----AHKHALAKSFCRGSNP-----------FGGRIKKRLSCMGYFTQPVTIMLCSLKRQSEFK 
PfMISFIT   DENLEIWFTKREKNKNDDMINNMRGNIVQLNYGQDKELVFEKKKKKKKKNIINKRISSMGYFSQAVVIMLCSLKRQNEYK 
Consensus  *:.* :****: :::*       .    .    .:                 : *:*.****:*.:.***.****:.*:  
 
                                   Conserved region    
                   1130      1140      1150      1160      1170      1180      1190      1200 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   NLKNIITSIILCTCDSSMLEIILHTIPDENSKNYQLWKTSIKKLYTLIG-DRKKDILRNLIFSD---------------- 
PyMISFIT   NLKNIITSIILCTCDSSMLEIILHTIPEENSKNYQLWKTSIKKLYTLIG-DRKKEILRKMIFSD---------------- 
PKMISFIT   NLKKIISAVVLCTCDSTTLEKMLHTIPEASSKNFSLWTEALHRLESQLGLKRKRRIIRKLLRAGGGEDTRRDDERKGMGL 
PvMISFIT   NLKKIVSAVVLCTCDSTTLEKILHTIPEASSKHFSLWTEALHRLESQLGPKRKRSIIRKLLRAGGGEDARKGDNRENAHL 
PfMISFIT   SLKKIIASIILCTCDSSCLEKFLHTIPDENSKNYTLWKETLNKLTSYFGPNKCDEIVERLMIIE---------------- 
Consensus  .**:*:::::******: ** :*****: .**:: **. ::::* : :* .:   *:..::                   
 
                   1210      1220      1230      1240      1250      1260      1270      1280 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   ----KDKTCETHEKDEREGYDENNLIEDKNKYNELNLKTYDFMNTMDNNGYRNFFNSSFSSEAGGNTPINQNNYFSTVPL 
PyMISFIT   ----KDKTFETDEKDEGEGYDENNLIEEKNKYNELNLKTYDFMNTMDNNGYRNFFNSSFSSEAGGNTPINQNNYFSTVPL 
PkMISFIT   ANPRDSDPYVEESGSDENGEDDDQTGRKKKQDDQFELKTYDFMKGMN--TYDGCLSDSFSSKG---VEELDNATHTSMSS 
PvMISFIT   ANPRDSDPYGEDSESDDNDEDDDQTGRKNKHDDQFELKTYDFMKGMN--TYDGCLSDSFSSKG---VEQSDSATHTPVSS 
PfMISFIT  -------------EDEYMNKSKKECREKNDYYEGDNIKSNKNIYNIYNNNDEKDIIKHCKLDN-DMEFFDDHMNNLSFPF 
Consensus                .:  . ...:  ..:.  :  ::*: . :  :        : .  . .        :     ...  
 
                                                            FH2-domain 
                   1290      1300      1310      1320      1330      1340      1350      1360 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   SKTDIKTEKYEEGKENNINILEDEKFCLFICTINDIHKRFQYLLLIENYDFIYSDLIKHIQNKLNNIDLIINKHMLLKQL 
PyMISFIT   SKADVKTEKYEEGKENNINILEDEKFCLFICTINDIHKRFQYLLLIENYDFIYSDLIKHIQNKLNNIDLIINKHMLLKQL 
PkMISFIT   SRGTLIQEKQ---NEENFETYEDEEFCLFICTIPNVHKRFRYLVLIENFHFIYEDLLKHIHNKLMIIELIASKHLLLKQL 
PvMISFIT   SRGTLTREKQ---NEEHFETYEDEEFCLFICTIPNAHKRFRYLLLIENFNFIYEDLLKHIQNKLITIELIASKHLLLKQL 
PfMISFIT   ECNEEHNKKYNDIQEEDDEIYEDEQFCLFICRIKNVHKRFGYLLLIDNFDFVYEDLLKNIRNKLSSIELILTKHILLKQL 
Consensus  .      :*    :*:. :  ***:****** * : **** **:**:*:.*:*.**:*:*:***  *:** .**:***** 
 
                                             FH2-domain 
                   1370      1380      1390      1400      1410      1420      1430      1440 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   FCNVLFLCNWLNEPKCFKWFQWNDVFNKLYNLNGFLENGKISRERCILLLLAEHTGEIFTEKELNELKKTSKLHIKDLYD 
PyMISFIT   FCNVLFLCNWLNEPRCFKWFQWNDVFNKLYNLNGFLENGRISRERCILLLLAEHTGEIFTEKELNELKKTSKLHIRDLYD 
PkMISFIT   FCNILFLCNWLNEPKRYRWFQWDTVVKKVEMLHGYLENGRISRDRCMLVLLAEHTGEIFSDKELQELKKVSKFHLKDLYD 
PvMISFIT   FCNILFLCNWLNEPKTYRWFQWDTVVRKVEMLHGYLENGRISRDRCMLLLLAQHTGEIFSDKELHEMKKVSKFHVKDLYD 
PfMISFIT   FCNILYICNWLNKPRKYEWFEWNMVVKKLRKLYGYSENGRISKERCIMLILAKHTGEIFTNKELYFLKKISTFYIKDLYD 
Consensus  ***:*::*****:*: :.**:*: *..*:  * *: ***:**::**::::**:******::***  :** *.::::**** 
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                                FH2-domain 
                   1450      1460      1470      1480      1490      1500      1510      1520 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   KSIDFINCFLELKNQLETEEFKKSCCIFSS-ELEDVGVEKCSDNFLNDKVLKNDKFLEKVKDFVKKYYKQMVYIIWNLVL 
PyMISFI    KSIDFINCFLELKNQLETEEFKKSCCIFSS-ELEDVEVEKCSDNFLNDKVLKSDKFLEKVKDFVKKYYKQMVYIIWNLVL 
PkMISFIT   RSIDFINSFLELRGEMGTSEFARSCCVGETTGEVNAEVDMETDEE----NLLKDKFLEKVHEFVEKVYGKMLLIISRLVL 
PvMISFIT   RSIDFINSFLELRGEMGTAEFARSCCVGEVPAEVEAEVEAEAEEEDAVGNLLKDKFPEKVHQFVEEVYGKMLLIISRLVL 
PfMISFIT   KCIDFINTYLEIKNDIDTEEFLDSCCIHNLKNEIKDNNTSYNHSS---KYFLHDKFLGIVKKFVQKNYPKILYIIWNIVL 
Consensus  :.***** :**::.:: * **  ***: .     .       ..      :  ***   *:.**:: * ::: ** .:** 
 
    FH2-domain 
                   1530      1540      1550      1560      1570      1580      1590      1600 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   LIKKYLIVMIWLGDVKPFYPLFSYLDE-GKKIKYSEDLFVNLCHFFESYNKYFNIVKQSQEELQKGIGDTSYQGQNEKTK 
PyMISFIT   LIKKYLIVMIWLGDVKPFYPLFSYLDE-GKKIKYSEDLFVNLSHFFESYNKYFNIVKKSQEELQKGIGDTSDQGQNEKTK 
PkMISFIT   LIKQYLALIIWLGDIRPFYPLFSYVDE-TRKVKYSQDLFVNLVAFFESYNKYFNMIQKDNE-----------IGKNSERK 
PvMISFIT   LIKQYLALVIWLGDIRPFYPLFSYVDK-TRKVKYSQDLFVNLVAFFESYNKYIHMIQKDNE-----------MGKNSERK 
PfMISFIT   LIKQYLVIILWFNDIKPFFPLFNYPNDDNKQNKFLQDFFVNFVHFFENYNKYIDILKKENLN-----------EKIKNTS 
Consensus  ***:** :::*:.*::**:***.* :.  :: *: :*:***:  ***.****:.::::.:              : .: . 
 
                   1610      1620      1630      1640      1650      1660      1670      1680 
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
PbMISFIT   NIALNNSDDFIFSADYFEKNTQKEANGIANDSNYTNFKGGNKPNYEVCELRKNKIVEMNNRNYNNGSEYTANNSYIENND 
PyMISFIT   NIALNNSDDFIFSADYFEKNIQKESHEIANDSNYTNFKDGNKPNYETCELRKNKIVEMNNRNYNNDSEYIENNSYIENND 
PkMISFIT   RHALLDG----------------------GTSGCSFRPGFYSPTVDGASVR----VDRNLRGTNGLEHGNGGKKAVN--- 
PvMISFIT   RHALLDG----------------------DTSSCSSRPGFYSPTLDDASLQ----VGGNLRGTNGLERPGGARRAVDGNA 
PfMISFIT   NDIFCDTSN----------------------------------------------ININIPSSENEHNTLTNN------- 
Consensus  .  : :                              DAD’                       :  *  . :.  .    .       
 
                   1690      1700      1710      1720      1730      1740      1750       
           ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|... 
PbMISFIT   ISIKNGNNVKGMLHFMKNNGNLKTENYELKHRKSLTNTIDYGCEIRRKSIEKEKGNNNKFIKGASFENMDEAEFDSSA 
PyMISFIT   ISIKNCNNEKGMLDFMKNNDNLKTENYELKHRKSLTNTIDYGCEIRRKSIEKEKGNNNKFIKGASFENMLEAEFDSSA 
PkMISFIT   -----------NMYGDSLFDSSKALNTEVKKRKSLTNTVDYACEVKRKSVEKERRRRS--VRQTSFEKSCEEEFHLSD 
PvMISFIT   GGRKSDHGGAVNMYGDPFGDSSKALNTEVKKRKSLTNTVDYACEVKRKSVEKERRRRS--VRQTSFEKTCEADFELSD 
PfMISFIT   ----------YDIYTNNRLSHQSTYNAETKKRKSLTNTIDYACLLKRKSAEHKETMEIS--KPSNAGNFSDVEFEPSD 
Consensus              :      .  .: * * *:*******:**.* ::*** *::.  .    : :.  :  : :*. * 
 
Appendix 2. Multiple sequence alignment of MISFIT P. berghei, P.yoelii yoelii, P. 
falciparum, P. knowlesi and P. vivax MISFIT proteins as performed by ClustalW and 
visualised by Bioedit Sequence Alignment Editor. Coloured blocks indicate amino acid 
residues conserved among all spp.  
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APPENDIX 3 
 
A 
MET STOP
KLQDNNMENEDEKYN
Peptide: MISFIT-84
(124-138 AA)
ASFENMDEAEFDSSA 
Peptide MISFIT-83
(1569-1583 AA)
PbMISFIT
 
 
B 
MISFIT-83     MISFIT-84     Anti-Myc
WT KO MYC     WT KO MYC     WT KO MYC250
150
75
50
1/100          1/10 000
Anti-α tub1
WT            KO          MYC
MISFIT-84
WT            KO          MYC
250
150
MISFIT-83
250
150
 
 
C         D 
 
1/
50
0
1/
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0
1/
20
00
1/
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00
1/
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0
1/
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00
1/
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00
1/
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00
PPI 1&2    MISFIT-83    MISFIT-84
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1/
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0
1/
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0
1/
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00
1/
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00
1/
50
0
1/
20
00
1/
10
00
1/
 5
00
   
Pb2.34 WT Gametocytes
DAPI / MISFIT 83 MISFIT 83 DAPI
 
 
Appendix 3. Design and optimisation of anti-MISFIT peptide antibodies. Schematic 
model outlining the position and sequences of of EP080783 (MISFIT-83) and EP080784 
(MISFIT-84) peptide targets. Purified, polycolnal anti-MISFIT IgG was obtained from the 
pooled sera of two immunised rabbits and supplied by Eurogentec. (Panel A). Western Blot 
analysis of Pb2.34 WT, Δpbmisfit and pbmisfit-myc purified gametocytes utilising optimised 
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concentrations of Anti-MISFIT-83 (1/100) and Anti-MISFIT-84 (1/10 000). Anti-MISFIT-83 
clearly detects a protein in the region of the expected 180kD, which is present in WT and 
MYC, but absent in KO parasites. Importantly, in parallel blots using the same sample pools, 
the band is of the same size as that detected by the rabbit Anti-MYC andtibody in the 
pbmisfit-myc parasite line. In contrast, anti-MISFIT-84 performs less satisfactory in Western 
Blot analysis, with high background activity and only at this very low concentration can some 
specificity be observed. A mouse anti α-Tubulin-1 (TAT1) antibody was used as loading 
control. All primary antibodies were incubated at 4ºC over-night. (Panel B). Western Blot 
analysis of serial dilutions of Anti-MISFIT-83 and -84 (1/500-1/2000), displaying poor 
detection of Anti-MISFIT-83 at concentrations >1/500 and high background of Anti-MISFIT-
84 at concentrations <1/2000 when incubating primary antibodies at room temperature for 1 
hour. Pre-immune serum (PPI) was included as a negative control. It should be noted that in 
subsequent Western Blot experiments, excellent results have also been obtained with Anti-
MISFIT-83 at 1/500 dilution when incubated at 4ºC o/n. (Panel C). Immunofluoresence assay 
where MISFIT is detected on formaldehyde-fixed, purifed gametocytes by Anti-MISFIT-83. 
Consistent with results obtained from the pbmisfit-myc parasite line, MISFIT localises to the 
gametocyte nucleus and is not distributed homogenously throughout the mixed sex 
gameteocyte population, supporting the male-biased expression pattern observed with the 
MYC-tagged MISFIT parasite line (Panel D). 
 
 
 
 
 
